{
  "experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 1387.76,
    "timestamp": "2026-02-03T20:49:09.683652"
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49092,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12493,
        "completion_tokens": 79,
        "total_tokens": 12572
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumptions on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024, following an investment policy study. This increase, alongside a shift in the strategic asset mix—reducing equity exposure from 11% to 11% (unchanged) and increasing debt from 60% to 60% (unchanged), while adjusting other investments from 29% to 29%—suggests a focus on maintaining a balanced portfolio to manage funded status volatility and align with long-term liabilities. The adjustments reflect a strategic effort to optimize returns while mitigating risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 63666,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16149,
        "completion_tokens": 153,
        "total_tokens": 16303
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as PDC was acquired by Chevron in 2023 and became a wholly-owned subsidiary. In the 2023 10-K, PDC is excluded from Chevron's internal control over financial reporting assessment because it was newly acquired. By 2024, PDC's operations are fully integrated into Chevron's financial and operational reporting. Operationally, PDC's production contributed to an increase in Chevron's U.S. upstream net oil-equivalent production by 250,000 barrels per day in 2024, primarily due to the full-year inclusion of legacy PDC assets. Financially, PDC added to Chevron's sales volumes but was partially offset by lower commodity prices and realization rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 109506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27600,
        "completion_tokens": 182,
        "total_tokens": 27783
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives remained consistent in terms of accounting methods (regulatory hedges, cash flow hedges, and not designated hedges), but there were changes in the presentation and magnitude of unrealized gains and losses. In 2022, unrealized gains and losses were primarily deferred in regulatory assets and liabilities for regulatory hedges and in AOCI for cash flow hedges. By 2024, the presentation remained similar, but the net amounts recognized in the balance sheets increased, reflecting larger derivative positions and valuation changes. Additionally, the unrealized gains and losses were more distributed across current and non-current assets and liabilities in 2024 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53692,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13661,
        "completion_tokens": 193,
        "total_tokens": 13854
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial relationship with Tengizchevroil (TCO) showed notable changes in both investment carrying value and equity earnings. The carrying value of Chevron's investment in TCO increased from $23,727 million in 2022 to $27,368 million in 2024. Meanwhile, equity earnings from TCO decreased from $4,386 million in 2022 to $3,033 million in 2024, reflecting a decline in earnings contribution from this joint venture over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14889,
        "completion_tokens": 116,
        "total_tokens": 15005
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation evolved from fiscal 2023 to fiscal 2024 as the company completed a $0.4 billion acquisition of the entity during fiscal 2023, increasing its ownership to 100%. However, in fiscal 2025, the entity was sold and deconsolidated. No specific transactions occurred between fiscal 2023 and fiscal 2024 that altered Walmart's ownership in Alert Innovation during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59098,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15003,
        "completion_tokens": 103,
        "total_tokens": 15106
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased from $179.1 million as of September 29, 2024 (fiscal 2023) compared to $153.0 million as of October 1, 2023 (fiscal 2022), while liability positions decreased from $46.8 million to $85.9 million. This indicates a net increase in asset positions, suggesting the company is actively managing its foreign currency exposure by hedging more anticipated cash flows and intercompany transactions, which reflects a proactive strategy to mitigate foreign exchange risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64331,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16317,
        "completion_tokens": 133,
        "total_tokens": 16450
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's treatment of A Preferred Shares remained consistent, with no shares outstanding in either year. In 2022, the company specifically redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million, leaving no A Preferred Shares outstanding as of April 29, 2022. This redemption marked the action taken regarding these shares in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48184,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12270,
        "completion_tokens": 98,
        "total_tokens": 12368
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast's financial relationship with Atairos evolved significantly between 2022 and 2023 in terms of equity income driven by fair value adjustments. In 2023, Comcast reported equity income from Atairos of $1.1 billion, a substantial improvement from a loss of $434 million in 2022. This shift reflects a positive change in the fair value of Atairos' underlying investments during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40389,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10330,
        "completion_tokens": 98,
        "total_tokens": 10428
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, as shown in the reserves table. This modest decline suggests a relatively stable but non-expanding position in the region for natural gas. The company's strategic focus appears to be more on other regions, such as the Lower 48 in the U.S., where significant additions from development drilling and acquisitions were reported. The slight decrease in Asia Pacific/Middle East reserves does not indicate a major shift in strategic positioning but rather a balanced approach to resource management in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75381,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19080,
        "completion_tokens": 169,
        "total_tokens": 19249
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly from $113 million in 2021 to $73 million in 2022 and further to $47 million in 2023, representing a 35% drop in 2022 and a 36% drop in 2023. This continued decline indicates a challenging market trajectory for ENBREL in Canada, driven by lower net selling prices, inventory reductions, and unfavorable changes in estimated sales deductions. The trend suggests increasing competitive pressures and market erosion, with no signs of recovery in the near term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40038,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10228,
        "completion_tokens": 126,
        "total_tokens": 10355
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm enhanced its approach to linking human capital advancements with executive compensation in fiscal 2024 by incorporating progress toward human capital goals as a non-financial performance modifier for executives' bonuses. Specifically, for fiscal 2024, this modifier could adjust bonus payouts by a multiple ranging from 0.9 to 1.1, reflecting a more direct alignment between human capital achievements and executive compensation compared to prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61027,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15493,
        "completion_tokens": 115,
        "total_tokens": 15608
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was approved for treating relapsed or refractory large B-cell lymphoma (including DLBCL, LBCL, and FL) after two or more lines of systemic therapy. By 2024, additional approvals were granted, including for relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), follicular lymphoma (FL) after at least two prior lines of therapy, and mantle cell lymphoma (MCL) in patients who had received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor. These approvals reflect Breyanzi's expanded role in treating a broader range of B-cell malignancies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 177,
        "total_tokens": 11668
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "From 2023 to 2024, Disney's Resorts and Vacations segment revenue increased by 5%, driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and higher occupied hotel room nights, partially offset by lower unit sales at Disney Vacation Club. This growth in the Resorts and Vacations segment aligns closely with the overall 5% revenue growth of the broader Parks & Experiences segment, indicating that the segment performed in line with the segment's overall performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35614,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9136,
        "completion_tokens": 126,
        "total_tokens": 9262
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved as follows: In 2023, the $2.0 billion ASR with Citibank, N.A. was accounted for as an initial treasury stock transaction for $1.6 billion and a forward contract for $0.4 billion, which was settled in February 2023. In 2024, the $3.0 billion ASR with Morgan Stanley was similarly structured, with $2.6 billion initially recorded as treasury stock and $0.4 billion as a forward contract, which was settled in March 2024. The value of the forward contracts remained proportionally consistent at 20% of the notional amount, but the total notional value increased from $2.0 billion to $3.0 billion, reflecting a larger scale of repurchase activity in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 175,
          "pages": [
            173,
            174,
            175,
            176,
            177
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39069,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9990,
        "completion_tokens": 191,
        "total_tokens": 10182
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency in 2024 compared to 2023 in terms of fair value categorization. In 2024, the company provided more detailed breakdowns of fair value measurements, including clearer explanations of Level 1, Level 2, and Level 3 categorizations for different asset classes. Additionally, the 2024 filing included more specific reconciliations of Level 3 assets and elaborated on the practical expedients used for investments not categorized in the fair value hierarchy. This enhanced level of detail and clarity in the 2024 disclosure reflects improved transparency around how the fair value of pension assets is determined and categorized.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67556,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17127,
        "completion_tokens": 188,
        "total_tokens": 17315
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid changed significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses from the U.S. government. In 2024, this was adjusted with a $771 million favorable final adjustment after 5.1 million courses were returned through February 29, 2024. Additionally, in the third quarter of 2024, Pfizer created a U.S. SNS of 1.0 million treatment courses at no cost to the government, recognizing $442 million in revenue for these courses. This transition reflects the shift from government contracts to commercial markets and the establishment of a stockpile for future pandemic preparedness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98369,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24837,
        "completion_tokens": 223,
        "total_tokens": 25060
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% in 2023 compared to 26.5% in 2022. This growth was driven by continued share gains and market expansion in metastatic castration-resistant prostate cancer. This strong growth underscores ERLEADA's growing importance within J&J's oncology portfolio, highlighting its role as a key contributor to the segment's 10.5% overall sales increase in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10797,
        "completion_tokens": 113,
        "total_tokens": 10911
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased by 26.9% in 2023 compared to 2022, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory for ERLEADA, reflecting its increasing adoption and effectiveness in its target therapeutic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9787,
        "completion_tokens": 82,
        "total_tokens": 9869
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "Between fiscal years 2023 and 2024, NVDA's debt management strategy regarding the 0.584% Notes Due 2024 involved holding the debt until its maturity in fiscal year 2025, where it was repaid. In both fiscal years 2023 and 2024, the notes had a carrying value of $1,250 million, with an effective interest rate of 0.66%. By fiscal year 2025, the notes were fully repaid, indicating a strategic decision to settle this short-term obligation as it matured without refinancing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41174,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10507,
        "completion_tokens": 118,
        "total_tokens": 10625
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Between 2022 and 2023, Honeywell's investment in Mortgage/Asset-backed securities decreased. In 2022, the fair value of Mortgage/Asset-backed securities in U.S. plans was $1,119 million and in non-U.S. plans was $31 million. In 2023, these amounts dropped to $676 million and $10 million, respectively, representing a decrease of $443 million in U.S. plans and $21 million in non-U.S. plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14621,
        "completion_tokens": 97,
        "total_tokens": 14718
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained a key component of its funding mix, with the outstanding amount increasing from $16.97 billion in 2022 to $18.04 billion in 2023. These obligations were classified as Level 2 within the fair value hierarchy, indicating they were valued using observable market inputs. The fair value of securitized debt obligations rose slightly from $16,918 million in 2022 to $18,067 million in 2023, reflecting ongoing reliance on this funding source to support the company's liquidity and capital management strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12311,
        "completion_tokens": 147,
        "total_tokens": 12458
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's treatment of CECL capital transition provisions evolved from 2023 to 2024 as the remaining CECL-related capital benefit was fully phased in by January 1, 2025. In 2023, the CECL benefit was $1.4 billion, and by 2024, it had decreased to $720 million, representing a quantitative reduction of $680 million in the CECL-related capital benefit during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56645,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14399,
        "completion_tokens": 92,
        "total_tokens": 14492
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved as follows: In fiscal 2023, the agreement provided a $3.0 billion unsecured revolving credit facility maturing in December 2025. By fiscal 2024, the agreement was amended in April 2022 and May 2023 to reflect immaterial administrative changes, but the credit facility capacity remained at $3.0 billion. In fiscal 2025, the agreement was replaced with a new $5.0 billion unsecured revolving credit facility maturing in October 2029, significantly increasing the borrowing capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12318,
        "completion_tokens": 149,
        "total_tokens": 12467
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS's relationship with Coyote evolved from operating it as part of its Supply Chain Solutions segment to divesting the business. In 2024, UPS completed the divestiture of Coyote, which had previously provided truckload brokerage services in the U.S. and Europe. This divestiture resulted in a pre-tax gain of $156 million for UPS in 2024, positively impacting its financial performance for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44248,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11277,
        "completion_tokens": 105,
        "total_tokens": 11383
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis has significantly shifted in terms of total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units. By 2024, the total number of chassis dropped to 5,553, with a sharp decline in owned units to 4,356 and leased units to 1,197. This indicates a substantial reduction in both the total chassis inventory and a shift toward a more streamlined ownership and leasing structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8960,
        "completion_tokens": 124,
        "total_tokens": 9084
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing continued to classify its aluminum agreements as derivative instruments for accounting purposes, as these agreements are priced at prevailing market prices and are not designated for hedge accounting treatment. In 2022, the time horizon for these agreements was not explicitly detailed, but by 2024, Boeing's commodity contracts generally hedged forecasted transactions through 2028, indicating an extended time horizon for these agreements. This suggests that Boeing's aluminum agreements remained undesignated derivatives with fair value changes recorded in earnings, and their time horizon expanded to align with longer-term strategic sourcing objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39693,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10157,
        "completion_tokens": 172,
        "total_tokens": 10329
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024. The company continues to leverage its diversified portfolio of exposures as a natural hedge and prioritizes operational hedging over financial instruments. For both years, P&G primarily used forward contracts and currency swaps with maturities under 18 months to manage exchange rate risk. The company expressed confidence that near-term changes in currency rates would not materially affect its financial statements, based on historical movements and a 95% confidence level. No significant changes in hedging instruments or risk management strategies were reported between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63110,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16022,
        "completion_tokens": 183,
        "total_tokens": 16205
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and integration with other Adobe products, positioning it as a central tool for cloud-native creative collaboration. Frame.io is now more deeply integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling real-time upload, review, and approval workflows with frame-accurate commenting and annotations. Additionally, Frame.io is part of Adobe GenStudio, alongside Adobe Express and Firefly Services, to support scalable content production. Its Camera to Cloud functionality allows automatic upload of footage directly into Frame.io for review, enhancing its role in end-to-end creative workflows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38721,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9908,
        "completion_tokens": 175,
        "total_tokens": 10084
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP Joint Venture (JV) increased from approximately $83 million to $99 million. The nature of its financial disclosures remained consistent, with AMD reporting purchases from and resales to the ATMP JV, along with related payables and receivables. In 2023, AMD recorded a higher equity income gain of $16 million compared to $14 million in 2022, reflecting its 15% equity interest and significant influence over the JV.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42794,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10934,
        "completion_tokens": 126,
        "total_tokens": 11061
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a slight reduction in demand or market share for new equipment in the commercial aviation sector, potentially due to industry challenges such as supply chain constraints or reduced aircraft production. However, the overall Aerospace Technologies segment showed growth, indicating Honeywell's continued strength in other areas like the aftermarket and defense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51860,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13192,
        "completion_tokens": 127,
        "total_tokens": 13319
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% increase. This growth was primarily driven by an increase in sales of heart assist devices for both chronic and temporary conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12019,
        "completion_tokens": 69,
        "total_tokens": 12088
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Based on the provided document pages, IBM's treatment of the 0.300% Notes due 2028 has evolved between the 2022 and 2023 filings in terms of its listing and classification. In the 2022 filing, the 0.300% Notes due 2028 were not explicitly listed, while in the 2023 filing, they are clearly listed under the section detailing securities registered pursuant to Section 12(b) of the Exchange Act with the trading symbol \"IBM 28B\" and are noted as being traded on the New York Stock Exchange. This suggests that the notes were either newly issued or more prominently disclosed in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9187,
        "completion_tokens": 148,
        "total_tokens": 9335
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed modest growth in both net sales and operating income. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, while operating income rose from $11,569 million in 2022 to $12,066 million in 2023. This indicates a slight improvement in both revenue and profitability for the region during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42659,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10887,
        "completion_tokens": 102,
        "total_tokens": 10989
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period, while stock options granted subsequent to December 31, 2021 generally vest pro rata over a four-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61319,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15571,
        "completion_tokens": 89,
        "total_tokens": 15661
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS's approach to validating the fair value estimates for its Level 2 debt securities remained consistent from 2022 to 2023 in terms of price adjustments and secondary source comparisons. In both years, the Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices. Additionally, on a quarterly basis, the Company compared a sample of its Level 2 debt securities' prices to those from a secondary source, reviewing variances over a specified threshold to confirm the accuracy of the primary source's fair value estimate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49609,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12638,
        "completion_tokens": 142,
        "total_tokens": 12780
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of an active market, relying on internal analysis of financial statements and cash flow projections. However, in 2023, there were notable changes in valuation methodology, including net transfers out of Level 3 totaling $50 million, primarily driven by transfers out of U.S. corporate, commercial mortgage-backed, and equity securities. The unobservable inputs, such as earnings and revenue multiples and discounts for lack of marketability, remained significant, but the overall Level 3 balance decreased from $129 million at December 31, 2022, to $108 million at December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49609,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12638,
        "completion_tokens": 184,
        "total_tokens": 12822
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% in 2024 compared to 2023. Internationally, the revenue for Alphagan/Combigan increased slightly by 1.5% in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16290,
        "completion_tokens": 48,
        "total_tokens": 16338
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC was acquired by Chevron in a business combination during 2023. This acquisition contributed to an increase in Chevron's overall production performance, particularly in the United States, where PDC's operations are based. Specifically, the inclusion of PDC's production led to a seven percent increase in Chevron's worldwide oil-equivalent production in 2024 compared to 2023, with the full-year impact of PDC's production and growth in the Permian Basin being key drivers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61387,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15574,
        "completion_tokens": 139,
        "total_tokens": 15713
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS's investment in cold-chain logistics capabilities has expanded significantly from 2023 to 2024. In 2023, UPS acquired MNX Global Logistics, a global provider of time-critical and temperature-sensitive logistics, and in 2024, it acquired Frigo-Trans and Biotech & Pharma Logistics, a leading healthcare logistics provider in Germany. These acquisitions have enhanced UPS's international cold-chain logistics capabilities, particularly in the healthcare and life sciences sectors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9913,
        "completion_tokens": 120,
        "total_tokens": 10033
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program remained tied to the 2021 Linde plc Long Term Incentive Plan, as referenced in both the 2022 and 2024 filings. However, in 2024, the company introduced the Linde plc Non-employee Director Deferral Program, adopted on July 30, 2024, which added a new governance mechanism for deferring compensation. Additionally, the 2024 filing highlights the adoption of the Linde plc Executive Clawback Policy in October 2023, which further reinforced long-term shareholder alignment by enabling recovery of compensation in cases of financial restatements or misconduct. These updates reflect Linde's continued focus on aligning director incentives with long-term shareholder interests through structured deferral and accountability mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60527,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15367,
        "completion_tokens": 207,
        "total_tokens": 15574
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis primarily revolved around indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). GM agreed to indemnify Stellantis for certain losses related to inaccuracies in representations, warranties, or breaches of covenants in the sale agreement, including emissions claims, product liabilities, and recalls. In 2024, GM noted that it had indemnified Stellantis for an immaterial amount related to specific recalls, including Takata inflator recalls in legacy Opel vehicles. Additionally, GM faced potential exposure from ongoing investigations by the European Commission and UK Competition and Markets Authority into Opel's past conduct, though GM had accrued an immaterial amount for this matter as of December 31, 2024. No significant investment gains were reported in relation to Stellantis during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59935,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15211,
        "completion_tokens": 238,
        "total_tokens": 15449
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives evolved in terms of financial presentation and categorization by providing more detailed and forward-looking information. In 2022, the disclosures primarily focused on historical gains and losses related to cash flow and fair value hedges, including their impact on AOCI and income statements. By 2024, the disclosures expanded to include the net volume of energy-related derivative contracts, hedge maturity dates, and the categorization of derivatives by type (e.g., regulatory, cash flow, and not designated). Additionally, 2024 included more granular balance sheet data, such as current and non-current assets and liabilities for each derivative category, along with netting and collateral arrangements. This evolution reflects a more transparent and comprehensive presentation of derivative activities and their financial implications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52276,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13300,
        "completion_tokens": 233,
        "total_tokens": 13533
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. In 2023, GILD owned approximately 19.9% of Arcus and had two designees on Arcus' board of directors. By January 2024, GILD increased its equity ownership to 33% through an additional $320 million investment and expanded its board representation to three designees. This marked a notable enhancement in GILD's governance influence and long-term strategic alignment with Arcus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14331,
        "completion_tokens": 129,
        "total_tokens": 14460
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 30, 2025, in 2022 to July 1, 2026, in 2023. Additionally, the borrowing capacity remained unchanged at $6.0 billion during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46133,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11747,
        "completion_tokens": 54,
        "total_tokens": 11802
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained relatively stable between 2023 and 2024, with imported crude accounting for approximately 60% of U.S. refinery inputs in both years. However, refinery capacity utilization in the U.S. decreased slightly, averaging 86.6% in 2024 compared to 90.8% in 2023. This decline in utilization was accompanied by ongoing projects to enhance refinery flexibility and throughput capacity, such as the completed upgrade at the Pasadena Refinery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52469,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13347,
        "completion_tokens": 128,
        "total_tokens": 13475
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £856 million in 2023 to £536 million in 2024, indicating a reduction in exposure to GBP. This shift suggests a more conservative approach to currency risk management, potentially reflecting a reassessment of exposure levels or improved stability in the GBP relative to other currencies. The company continues to prioritize cash flow hedges for anticipated foreign currency denominated revenue, maintaining a strategic focus on managing foreign exchange risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47166,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12021,
        "completion_tokens": 130,
        "total_tokens": 12152
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024. This slight increase suggests a modest shift in the company's short-term investment strategy, potentially indicating a continued focus on maintaining liquidity and managing short-term cash flows amid market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 93821,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23689,
        "completion_tokens": 92,
        "total_tokens": 23781
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024 across Southern Company's subsidiaries. Specifically, Alabama Power's volume decreased from 6 million mmBtu to 4 million mmBtu, Georgia Power's decreased from 8 million mmBtu to 6 million mmBtu, Mississippi Power's decreased from 4 million mmBtu to 2 million mmBtu, and Southern Power's decreased from 8 million mmBtu to 3 million mmBtu.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 319,
          "pages": [
            317,
            318,
            319,
            320,
            321
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54699,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13905,
        "completion_tokens": 127,
        "total_tokens": 14032
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, the integration and application of the Adobe Firefly Vector Model evolved by expanding its availability across Adobe's product suite. In 2023, Firefly's vector capabilities were introduced as part of the Firefly web app and integrated into key Creative Cloud applications like Photoshop, Illustrator, and Adobe Express. By 2024, the Firefly Vector Model was further embedded into additional tools, including Adobe Acrobat and Adobe Stock, and was made available as part of Adobe Firefly Services and Custom Models for enterprise use. This expansion enabled users to generate fully editable vector graphics from text prompts directly within a broader range of Adobe applications, enhancing creative workflows and commercial content production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11225,
        "completion_tokens": 191,
        "total_tokens": 11417
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Based on the data from the provided document pages, the commercial significance of Biktarvy for GILD increased from 2023 to 2024, with total sales rising from $11,850 million in 2023 to $14,848 million in 2024. This growth underscores Biktarvy's continued dominance in GILD's HIV portfolio and reinforces its role as a cornerstone of the company's HIV business strategy. The sustained growth in Biktarvy sales suggests GILD's focus on maintaining leadership in the HIV treatment market and leveraging its innovative therapies to drive revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74061,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18740,
        "completion_tokens": 135,
        "total_tokens": 18875
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022, indicating a slight increase in the outstanding principal. The interest rate for the Series 2018-1A Securities remained unchanged at 3.652% during the period between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58485,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14850,
        "completion_tokens": 85,
        "total_tokens": 14935
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS's relationship with Coyote shifted significantly in both financial impact and strategic direction. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenues and challenging market conditions in the truckload brokerage business, prompting an evaluation of strategic alternatives. By 2024, UPS completed the divestiture of Coyote, resulting in a $156 million gain on the divestiture, which marked a strategic exit from the underperforming business. Financially, this transition reduced operating expenses and improved operating profit within the Supply Chain Solutions segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9814,
        "completion_tokens": 161,
        "total_tokens": 9976
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards, beginning with grants in 2019, were structured under the 2021 Linde plc Long Term Incentive Plan and included two primary performance metrics: Return on Capital and Total Shareholder Return. By 2024, the structure of these awards remained consistent, with the same performance metrics continuing to be used for grants, as outlined in the updated forms under the 2021 Plan. No significant changes to the performance metrics were introduced between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60287,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15301,
        "completion_tokens": 126,
        "total_tokens": 15427
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, the regulatory status of Trodelvy advanced significantly, as it received a Breakthrough Therapy designation from the FDA in 2024 for the treatment of extensive-stage small cell lung cancer, in addition to its existing approvals for breast cancer and urothelial cancer. This indicates a positive development trajectory, with Trodelvy being recognized for its potential to substantially improve clinical outcomes in a serious condition, thereby expediting its regulatory review process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58877,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14935,
        "completion_tokens": 126,
        "total_tokens": 15061
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud has evolved significantly in terms of capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, and deploy applications using generative AI models. By 2024, Vertex AI expanded its capabilities to include testing and deployment of applications using Gemini, Imagen, Veo, and other leading generative AI models, as well as offering pre-packaged AI agents to assist developers and cybersecurity teams. This advancement reflects a broader integration of Google's latest AI innovations into the Vertex AI platform, enhancing its utility for enterprise AI development and deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49470,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12593,
        "completion_tokens": 172,
        "total_tokens": 12766
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment and valuation of weather derivatives in SO's financial disclosures have remained consistent in terms of being excluded as immaterial. In both periods, the net amounts recognized in the balance sheets exclude immaterial premium and intrinsic value associated with weather derivatives. However, in 2024, the disclosures explicitly state that these exclusions apply to all periods presented, whereas in 2022, the immaterial amounts were mentioned without such a broad temporal reference.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55153,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14028,
        "completion_tokens": 129,
        "total_tokens": 14157
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved with the FDA approving an expanded indication to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated to include data reinforcing its safety and efficacy for treating pregnant people with HIV-1 who have suppressed viral loads. This expansion highlights Gilead's efforts to broaden Biktarvy's utility in addressing specific patient needs and resistance challenges, enhancing its market relevance and competitive positioning in the HIV treatment landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58903,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14937,
        "completion_tokens": 162,
        "total_tokens": 15100
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 in terms of borrowing amounts and facility amendments. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR, under the 2021 Multicurrency Credit Facility, which was used to repay outstanding indebtedness and for general corporate purposes. Additionally, the facility was amended to extend its maturity date to July 1, 2026, and the LIBOR pricing benchmark was replaced with an Adjusted Term SOFR pricing benchmark.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52037,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 138,
        "total_tokens": 13373
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager's role in Alphabet's advertising revenue recognition strategy remained consistent in its function as a primary platform for customers to purchase advertising inventory. However, its integration with revenue reporting models emphasized continued gross reporting for ads placed on Google Network properties, where Alphabet acts as the principal. This means that revenues are recorded at gross value, with payments to partners classified as cost of revenues. No significant changes were disclosed in the 2024 filing regarding the role or integration of Google Ad Manager in revenue recognition processes compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51576,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13127,
        "completion_tokens": 164,
        "total_tokens": 13292
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial strain or underperformance. By 2024, while no impairment was recorded for Roadie, it was identified as one of three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) with limited excess fair value, signaling ongoing risk. UPS continues to monitor these units closely, as small changes in cost of capital or cash flow projections could lead to future impairments. This reflects a strategic shift toward cautious oversight and potential restructuring to align Roadie with broader operational goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35749,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9165,
        "completion_tokens": 188,
        "total_tokens": 9353
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium has shown a mixed quantitative impact. In 2024, the company reported a 2% decrease in sales for its \"Other\" segment, which includes global helium wholesale, primarily due to lower volumes in global helium. However, operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), despite higher costs associated with helium. This indicates that while helium-related sales declined, cost management and insurance recoveries positively impacted profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37873,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9692,
        "completion_tokens": 144,
        "total_tokens": 9837
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $8.7 billion at December 31, 2023, to $8.0 billion at December 31, 2024. This reduction suggests a slight decline in the Corporation's credit risk exposure on residential mortgage loans, as these agreements provide full credit protection for severely delinquent loans. The decrease may indicate a shift in the Corporation's loan portfolio or a reduction in the number of loans requiring such protection, reflecting improved credit quality or changes in risk management strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 112466,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28361,
        "completion_tokens": 148,
        "total_tokens": 28510
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe's strategic positioning of Adobe Firefly evolved to emphasize its integration into core Creative Cloud and Document Cloud offerings, enhancing competitive differentiation through natively embedded generative AI capabilities. Adobe Firefly's evolution included expanding its language support to over 100 languages, offering AI-generated content that is safe for commercial use, and providing intellectual property indemnification for enterprise users. However, the 2024 10-K highlights increased regulatory risks due to the evolving AI regulatory landscape, such as the EU AI Act, which could impose compliance costs, alter development practices, and introduce liability concerns related to AI deployment and content generation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50383,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12822,
        "completion_tokens": 189,
        "total_tokens": 13011
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance and regulatory trajectory showed notable developments. Financially, Trodelvy's product sales increased by 56% in 2023 compared to 2022, driven by higher demand in new and existing geographies. In 2024, the drug received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking a significant regulatory milestone. This designation aims to expedite the development and regulatory review of Trodelvy for this serious condition, indicating its potential to improve clinical outcomes compared to available therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61649,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15621,
        "completion_tokens": 178,
        "total_tokens": 15799
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, with its equity investment in Angola LNG Limited remaining stable at around $1.665 billion to $1.762 billion. In 2022, Chevron reported $1,857 million in equity earnings from Angola LNG, which declined to $513 million in 2023 and further to $405 million in 2024, indicating a reduction in profitability from this affiliate. Despite the fluctuation in earnings, Chevron maintains a 36.4% interest in Angola LNG Limited, which processes and liquefies natural gas produced in Angola for international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58046,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14744,
        "completion_tokens": 151,
        "total_tokens": 14896
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased from $18.50 billion to $29.0 billion, primarily due to the issuance of $10.50 billion in new notes in August 2024. The interest rates on the new 2024 notes ranged from 4.30% to 5.55%, with effective rates of 4.42% to 5.60%, reflecting higher market rates compared to the 2023 notes, which had stated rates of 4.60% to 5.75% and effective rates of 4.68% to 5.79%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45476,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11582,
        "completion_tokens": 111,
        "total_tokens": 11693
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium as a raw material increased from 2023 to 2024, as reflected in the shift from categorizing helium as a \"supply\" to labeling it a \"dependency.\" In 2023, the company disclosed helium as a supply with no specific cost or sourcing details provided in the given pages. However, in 2024, helium was explicitly identified as a dependency, indicating a heightened reliance on helium for operations. This change suggests a greater financial exposure due to potential volatility in helium sourcing or pricing, though specific cost figures or sourcing risks were not detailed in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29305,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7560,
        "completion_tokens": 155,
        "total_tokens": 7716
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal's utilization of European customer balances for credit activities increased, with the approved amount rising from $3.8 billion in 2022 to $3.0 billion in 2023. This represents a decrease of $0.8 billion, or a 21.1% reduction in the amount approved for such activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44156,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11270,
        "completion_tokens": 74,
        "total_tokens": 11345
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to foreign currency - other instruments saw a significant decrease in fair value between 2023 and 2024. The fair value of derivative assets for foreign currency - other dropped from $1,164 million as of October 1, 2023, to $920 million as of September 29, 2024. Additionally, the expected reclassification impact on earnings for foreign currency - other decreased from $23.6 million in 2023 to $28.2 million in 2024, indicating a shift in the timing or magnitude of gains/losses being recognized in earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54781,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13928,
        "completion_tokens": 132,
        "total_tokens": 14060
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $15 million to $15 million (no change), while Georgia Power's increased from $75 million to $13 million. For Alabama Power, the asset position remained stable, and the liability position decreased from $110 million to $110 million (no change). For Georgia Power, the asset position slightly increased, and the liability position decreased from $8 million to $124 million. Thus, both companies saw a reduction in their net liability positions related to energy derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83041,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20995,
        "completion_tokens": 143,
        "total_tokens": 21138
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan shifted from 2022 to 2023, with the percentage of fixed income securities and cash equivalents increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change reflects a more conservative allocation, aligning with the plan's target ranges that prioritize fixed income investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54882,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13956,
        "completion_tokens": 98,
        "total_tokens": 14055
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals for additional indications. In 2023, the FDA approved Trodelvy for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14805,
        "completion_tokens": 177,
        "total_tokens": 14982
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta's disclosure regarding user perception as a risk factor evolved to highlight more specific and emerging concerns, particularly around the impact of generative artificial intelligence (AI) and evolving regulatory frameworks on user engagement and trust. In 2023, the focus was primarily on factors like competitive products (e.g., TikTok), geopolitical events (e.g., the war in Ukraine), and general user sentiment shifts due to privacy and content concerns. By 2024, the disclosure expanded to emphasize risks tied to the adoption and public reception of generative AI technologies, including potential user dissatisfaction or reduced engagement if these initiatives are unsuccessful or discontinued. Additionally, 2024 highlighted the regulatory and compliance challenges associated with AI, such as the potential for adverse user reactions to policy changes or enforcement actions, which could further impact user trust and business operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47184,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12032,
        "completion_tokens": 243,
        "total_tokens": 12275
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate derivatives to hedge against interest rate risk, particularly by converting fixed-rate borrowings to variable-rate borrowings. This strategy reflects a proactive approach to managing exposure to interest rate fluctuations and aligning its debt structure with its risk management objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41549,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10619,
        "completion_tokens": 125,
        "total_tokens": 10744
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "Between 2022 and 2023, PayPal's financial provisions for transaction losses related to its Seller Protection Programs increased. In 2022, the provision for transaction and credit losses was $1,170 million, while in 2023, it rose to $1,192 million. Despite this increase in provisions, the realized losses also increased from $1,417 million in 2022 to $1,313 million in 2023, indicating a slight improvement in the net impact of losses relative to provisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49966,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12717,
        "completion_tokens": 114,
        "total_tokens": 12831
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative asset position for foreign currency - other decreased from $32.0 million as of October 1, 2023, to $1.9 million as of September 29, 2024, a reduction of $30.1 million. Simultaneously, the derivative liability position for foreign currency - other increased from $2.0 million to $4.7 million, an increase of $2.7 million. This shift reflects a significant net reduction in the overall balance sheet exposure for foreign currency - other derivative positions from fiscal year 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 63021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15990,
        "completion_tokens": 127,
        "total_tokens": 16117
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions for Southern Company and its subsidiaries shifted significantly. In 2023, energy-related derivatives resulted in a loss of $63 million recognized in other regulatory assets and liabilities, compared to a gain of $18 million in 2022. Additionally, the impact on income from energy-related cash flow hedges for the total cost of natural gas turned negative, with a $44 million loss in 2023 versus a $37 million gain in 2022, indicating a worsening financial impact in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64108,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16246,
        "completion_tokens": 147,
        "total_tokens": 16394
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as noted in the 2024 10-K filing under Exhibit 10.1. In the 2023 10-K, the plan was not explicitly mentioned as being amended during that year, indicating that the most recent documentation and effective date of the plan's evolution occurred in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17959,
        "completion_tokens": 87,
        "total_tokens": 18046
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of LTIP Units remained largely consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. However, there was a slight evolution in the accrual policy: in 2023, the disclosure emphasized that dividends are accrued when declared, while in 2024, the language was expanded to clarify that distributions for the Operating Partnership are also accrued upon declaration. Additionally, the 2024 disclosure included more detailed breakdowns of the taxable nature of distributions, showing a marginal shift in the proportion classified as ordinary income versus long-term capital gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48991,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12471,
        "completion_tokens": 169,
        "total_tokens": 12641
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, the EU-U.S. DPF was formally established following the invalidation of prior frameworks like the Privacy Shield, and the European Commission issued an adequacy decision recognizing the DPF as sufficient for data transfers from the EU to the U.S. Meta began implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) related to unlawful data transfers. By 2024, Meta had adapted its compliance measures further, including engaging with regulators on new consent models for behavioral advertising and addressing concerns under the Digital Markets Act (DMA). The European Commission opened formal proceedings against Meta's \"subscription for no ads\" model, prompting Meta to introduce an option for users to see less personalized ads. These developments reflect Meta's ongoing efforts to align with evolving EU data protection standards and regulatory scrutiny.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55938,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14213,
        "completion_tokens": 270,
        "total_tokens": 14483
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by explicitly designating it as a key component of its clean energy strategy. In 2023, Linde described green hydrogen as being produced through electrolysis using renewable energy or from steam methane reforming of biomethane. By 2024, the company refined its terminology, emphasizing that green (renewable) hydrogen is produced by electrolysis using renewable energy and water as feedstock, while also highlighting its broader portfolio of low-carbon hydrogen technologies. This reflects a stronger focus on renewable energy sources and a clearer distinction between production methods to align with global clean energy goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44930,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11456,
        "completion_tokens": 178,
        "total_tokens": 11634
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, for a total cash purchase price of $159 million, resulting in a pre-tax gain of approximately $121 million ($92 million after tax). This transaction marked the end of Southern Company Gas's relationship with Sequent. The financial implications included a gain on the sale, as well as $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company Gas's reportable segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 302,
          "pages": [
            300,
            301,
            302,
            303,
            304
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39844,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10180,
        "completion_tokens": 136,
        "total_tokens": 10317
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's relationship with the Allswell brand remained consistent within its private brand portfolio, as Allswell was still listed among the key private brands marketed by Walmart U.S. in both years. This continuity suggests that Allswell maintained a strategic role as part of Walmart's broader effort to offer high-quality, affordable merchandise under its private label brands. The brand's inclusion in both years indicates that Walmart continues to leverage Allswell to support its EDLP (Everyday Low Prices) strategy and to provide value to customers, reinforcing its commitment to private brand development as a competitive advantage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48245,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12290,
        "completion_tokens": 166,
        "total_tokens": 12456
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products slightly increased from 2022 to 2023, as evidenced by a 3% revenue growth in 2023 compared to 2022, while Analog revenue declined by 15%. However, the operating profit for Embedded Processing decreased by 20%, primarily due to higher manufacturing costs, indicating that while the segment maintained its strategic relevance, profitability was impacted by cost pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41909,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10698,
        "completion_tokens": 106,
        "total_tokens": 10805
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has shown a decline in equity in earnings, decreasing from $1,857 million in 2022 to $405 million in 2024. This suggests a potential strategic shift or challenges in the project's performance, indicating a reduced emphasis or financial commitment to Angola LNG in Chevron's broader LNG market strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63701,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 84,
        "total_tokens": 16230
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "Between 2021 and 2024, the CH-53K program contributed to increased production activity within Lockheed Martin's RMS division. In 2021, the CH-53K program, along with other Sikorsky helicopter programs, drove a $540 million increase in RMS net sales due to higher production volume. By 2024, the CH-53K program continued to support RMS growth, with higher production volume contributing to a $1.1 billion increase in product sales at RMS. This evolution indicates that the CH-53K program has remained a key production driver for RMS, reflecting its strategic importance in the division's portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11796,
        "completion_tokens": 149,
        "total_tokens": 11945
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer credit products in the second quarter of 2023. In 2022, the reasonable and supportable forecast period for revolving products was 2 years, while in 2023, it was extended to approximately 5 years. Additionally, in 2023, macroeconomic factors incorporated into the models for revolving credit included forecasted trends in household disposable income and retail e-commerce sales, whereas in 2022, unemployment rates were also a key factor through the first quarter of 2023. These changes reflect a more comprehensive and extended approach to incorporating macroeconomic conditions into loss curve estimations for revolving consumer credit products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12552,
        "completion_tokens": 184,
        "total_tokens": 12736
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI increased from a pre-tax loss of $6.3 million in 2023 to a pre-tax gain of $135.2 million in 2024. This significant shift indicates that the company likely experienced favorable foreign currency movements in 2024, reducing its exposure to adverse currency fluctuations compared to the prior year. The change suggests improved hedging effectiveness or a more favorable foreign exchange environment for Starbucks' international operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50644,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12895,
        "completion_tokens": 127,
        "total_tokens": 13022
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power and Georgia Power increased. Alabama Power's energy-related derivative liabilities rose from $15 million in 2023 to $15 million (unchanged), while Georgia Power's increased from $13 million in 2023. Overall, the combined liabilities for these derivatives showed a slight increase, reflecting higher Level 2 fair value measurements in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67550,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17125,
        "completion_tokens": 110,
        "total_tokens": 17236
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, bringing its ownership to approximately 100%. However, by fiscal 2025, the Alert Innovation entity was sold and deconsolidated, indicating that Walmart disposed of the asset after initially acquiring it in fiscal 2023. There is no specific detail on the timing or financial terms of the disposition in fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59994,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15228,
        "completion_tokens": 95,
        "total_tokens": 15323
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy expanded significantly. In 2022, Trodelvy was already approved for metastatic triple-negative breast cancer (TNBC) in the U.S. and other countries, and received full FDA approval for this indication. By 2023, Trodelvy gained additional approvals, including for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This expansion of Trodelvy's indications reflects Gilead's oncology strategy of broadening the therapeutic applications of its key oncology assets to address unmet medical needs across various cancer types, thereby enhancing its market reach and revenue potential.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52866,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13436,
        "completion_tokens": 202,
        "total_tokens": 13639
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions and strategic positioning. In 2023, Simon recognized gains from ABG-related transactions, including a pre-tax gain of $157.1 million from selling a portion of its interest and a deemed disposal gain of $10.3 million due to a capital transaction that diluted Simon's ownership to approximately 9.6%. By 2024, Simon fully exited its remaining stake in ABG, selling it for $1.2 billion and recognizing a pre-tax gain of $414.8 million. This strategic move reflects Simon's shift to optimize its portfolio and focus on core real estate investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12718,
        "completion_tokens": 168,
        "total_tokens": 12886
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) remained stable in terms of financial reporting and investment value. In 2022, Chevron's investment in CPChem was $7,765 million, generating equity earnings of $867 million. By 2024, the investment increased to $8,571 million, with equity earnings rising to $903 million. This indicates a modest growth in both the investment value and the returns generated from CPChem during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12204,
        "completion_tokens": 121,
        "total_tokens": 12325
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy, part of the 2022 Restructuring, saw completion of all initiatives by December 31, 2024. In 2023, the strategy had incurred pre-tax charges of $2,255 million, primarily in research and development, marketing and sales, and general and administrative expenses. In 2024, the financial impact was limited to $389 million in pre-tax charges, all related to facilities consolidation, indicating a significant reduction in restructuring costs as the strategy neared completion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40096,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10244,
        "completion_tokens": 139,
        "total_tokens": 10384
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a strategic emphasis on advancing capabilities for U.S. military branches. In 2022, the company was engaged in hypersonics programs with the U.S. Air Force and Army, focusing on design, development, and building hypersonic strike weapons. By 2024, the strategic focus remained strong, with continued investment in hypersonics as part of broader efforts in next-generation technologies, and the company was involved in multiple hypersonics programs with the U.S. Army and Navy, indicating an ongoing and expanded commitment to this high-priority area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49425,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12576,
        "completion_tokens": 158,
        "total_tokens": 12734
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in both designation and financial impact. In 2023, the company reported significantly higher unrealized losses related to energy derivatives designated as regulatory hedging instruments, with total energy-related derivative losses increasing from $9 million in 2022 to $257 million in 2023. These losses were primarily reflected in other regulatory assets and liabilities, both current and deferred. Additionally, the financial impact of energy-related cash flow hedges on income turned negative in 2023, with a $44 million loss compared to a $17 million gain in 2022, indicating a more challenging market environment for energy derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65524,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16610,
        "completion_tokens": 187,
        "total_tokens": 16797
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved as the company addressed the loss of exclusivity for Truvada in the United States, which occurred in October 2020. In 2022, the focus was on mitigating the impact of generic competition on Truvada sales, as noted in the 2022 10-K, where the loss of exclusivity led to decreased sales. By 2023, Gilead shifted its emphasis toward expanding its portfolio and strengthening its pipeline, as outlined in the 2023 10-K. This included entering new strategic collaborations and acquiring companies to diversify its offerings. While Truvada's patent protections had expired, Gilead's strategy increasingly centered on leveraging its robust pipeline and new product approvals to drive future growth, rather than relying on Truvada's market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53304,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13544,
        "completion_tokens": 207,
        "total_tokens": 13752
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved with increased borrowing activity in 2022 and subsequent repayments in 2023 and 2024. In 2022, SPG drew $1.05 billion under the Supplemental Facility to fund the early extinguishment of mortgages. By 2023, SPG repaid €750.0 million ($815.4 million U.S. dollar equivalent) of borrowings under the Supplemental Facility using proceeds from the issuance of senior unsecured bonds. In 2024, there were no outstanding balances under the Supplemental Facility, indicating full repayment and a shift in financing strategy toward other debt instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50958,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12957,
        "completion_tokens": 153,
        "total_tokens": 13111
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife's capital management strategy has increasingly emphasized maintaining robust liquidity levels to address evolving market uncertainties and regulatory requirements. In 2022, the company highlighted its substantial short-term liquidity position of $12.4 billion and liquid assets of $223.0 billion, which were used to support capital allocation decisions and meet potential stress scenarios. By 2024, MetLife further emphasized the importance of cash buffer needs, noting that maintaining sufficient liquidity buffers was critical to ensuring the company could meet obligations, support capital returns, and navigate volatile market conditions. The evolution reflects a more proactive approach to liquidity management, with cash buffers playing a central role in balancing capital deployment with risk mitigation and regulatory compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13255,
        "completion_tokens": 216,
        "total_tokens": 13471
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives showed significant changes in asset and liability classifications. In 2022, derivative assets related to 'Foreign currency - other' were reported as $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets. By 2023, these amounts were reduced to $1.9 million in prepaid expenses and $1.7 million in other long-term assets. On the liability side, in 2022, 'Foreign currency - other' liabilities were $0.3 million in accrued liabilities and $- in other long-term liabilities, while in 2023, liabilities increased to $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This shift indicates a reclassification and likely a change in the nature or timing of these derivative obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18007,
        "completion_tokens": 211,
        "total_tokens": 18218
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's relationship with Coca-Cola FEMSA in 2024 shows a slight decrease in its equity stake compared to 2023, as The Coca-Cola Company owned 28% of Coca-Cola FEMSA as of December 31, 2024, down from 30% in 2023. Additionally, the fair value of Coca-Cola FEMSA's shares was $4,544 million in 2024, while the Company's carrying value was $1,786 million, indicating a $2,758 million difference. This suggests that while The Coca-Cola Company continues to maintain a significant strategic investment in Coca-Cola FEMSA, there has been a reduction in ownership and a continued gap between fair value and carrying value in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13939,
        "completion_tokens": 164,
        "total_tokens": 14103
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has increasingly positioned FPGAs as a core component of its broader programmable solutions and adjacent product strategy. In 2022, FPGAs were highlighted as part of the Programmable Solutions Group (PSG) and were emphasized for their role in enabling flexible, high-performance computing across various markets. By 2024, Intel expanded the strategic role of FPGAs, integrating them into adjacent products such as infrastructure processing units (IPUs), accelerators, and networking solutions, particularly within the Data Center and Artificial Intelligence (DCAI) and Networking and Edge (NEX) segments. This evolution reflects Intel's focus on leveraging FPGAs to support its Smart Capital strategy, enhancing performance across diverse applications like 5G infrastructure and AI-driven workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 70808,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17932,
        "completion_tokens": 207,
        "total_tokens": 18139
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed significant growth in asset acquisition and operational performance. In 2023, capital expenditures for the Lower 48 segment were $6.487 billion, compared to $5.630 billion in 2022, reflecting increased investment in the region. Additionally, depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 segment rose to $5.729 billion in 2023 from $4.854 billion in 2022, indicating higher asset activity and utilization. These trends highlight the company's strategic focus on expanding and developing its Lower 48 operations during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83811,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21188,
        "completion_tokens": 160,
        "total_tokens": 21349
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased from 55% to 57%, with Emerson proposing to acquire the remaining shares in 2024 for $240 per share. Financially, the Heritage AspenTech acquisition in 2022 initially benefited Emerson's 2023 gross margins by 0.6 percentage points due to favorable mix and pricing. However, by 2024, the Test & Measurement acquisition and inventory step-up amortization negatively impacted gross margins by approximately 1.3 percentage points, overshadowing any continued benefits from the AspenTech integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40791,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10427,
        "completion_tokens": 140,
        "total_tokens": 10567
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan experienced a reduction in shares available for future issuance, from 34,073,114 to 30,660,961. This decline was driven by a higher cumulative issuance of shares through awards and reinvested dividends (42,343,146 shares) compared to the shares recovered (37,608,213 shares) during this period. The share recovery mechanics remained consistent, with shares becoming available again due to forfeitures, cash settlements, or tax withholding using shares. The issuance mechanics continued to count each share issued under the 2015 Director Stock Plan as one share deducted from the available pool, with no adjustments for ratios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 335,
          "pages": [
            333,
            334,
            335,
            336,
            337
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41101,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 169,
        "total_tokens": 10675
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance saw an increased strategic emphasis and revenue contribution from fiscal year 2022 to 2023. In fiscal 2022, the Channel Development segment reported a 16% revenue increase, driven by higher product sales to and royalty revenue from the Global Coffee Alliance. By fiscal 2023, the Alliance remained a key focus, with continued growth in the global ready-to-drink business and innovation in product offerings. While specific 2023 revenue figures for the Global Coffee Alliance were not provided, the strategic emphasis on the Alliance was reinforced as part of Starbucks' broader expansion and diversification efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9417,
        "completion_tokens": 168,
        "total_tokens": 9585
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake and involvement in the Mountain Valley Pipeline (MVP) significantly declined, as evidenced by a reduction in the investment carrying amount from $4,968 million in 2022 to $3,963 million in 2023. This decrease is primarily attributed to impairment charges, including a $1.2 billion impairment charge in 2023 related to NEE's investment in MVP. This indicates a strategic shift or reassessment of NEE's investment portfolio, likely due to the project's financial challenges or regulatory uncertainties, reflecting a more cautious approach to capital allocation and risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62304,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15801,
        "completion_tokens": 156,
        "total_tokens": 15957
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line expanded its neurostimulator offerings and therapeutic indications. In 2022, the product line included the InterStim II, InterStim Micro, and InterStim X neurostimulators for treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the offerings evolved to include the InterStim X and InterStim II recharge-free neurostimulators and the InterStim Micro rechargeable neurostimulator, continuing to target similar indications. Additionally, the therapy's growth was supported by advancements in pelvic health and integration with broader neuromodulation solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10443,
        "completion_tokens": 163,
        "total_tokens": 10606
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2022, Simon contributed its interests in the licensing ventures of Eddie Bauer, Forever 21, and Brooks Brothers to ABG in exchange for additional ABG interests, and also sold a portion of its ABG stake for $65.5 million while purchasing additional interests for $100.0 million, resulting in a noncontrolling stake of approximately 10.4%. By 2024, Simon had fully exited its remaining interest in ABG, selling it for $1.2 billion and recognizing a pre-tax gain of $414.8 million. This marked the end of Simon's strategic investment in ABG, which had previously involved joint licensing and brand management ventures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50070,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12734,
        "completion_tokens": 190,
        "total_tokens": 12924
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased significantly from 2021 to 2023. In 2021, DD&A expenses were $4,067 million, rising to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and higher production volumes in the region during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 73077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18498,
        "completion_tokens": 94,
        "total_tokens": 18592
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds remained consistent from 2023 to 2024. In both years, international bonds were valued using matrix pricing with input from independent third-party valuation sources, as detailed in the valuation methodologies section. The 2024 disclosures did not indicate any changes in the approach compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13096,
        "completion_tokens": 92,
        "total_tokens": 13188
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly between 2022 and 2024. In 2022, Emerson increased its financial stake by acquiring Heritage AspenTech, raising its ownership to 55% of AspenTech's outstanding shares. By 2024, Emerson further solidified its control by proposing to acquire the remaining shares of AspenTech not already owned for $240 per share, which would make AspenTech a wholly owned subsidiary. Operationally, Emerson integrated AspenTech's industrial software businesses into its portfolio, enhancing its Software and Control segment, and the two entities operated under the Aspen Technology, Inc. brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38809,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9922,
        "completion_tokens": 158,
        "total_tokens": 10081
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps remained classified primarily as designated fair value hedging instruments. In 2022, the cumulative fair value hedging adjustment included in the carrying amount of long-term debt was a $52.3 million reduction, while by 2023, this adjustment had worsened to a $17.8 million reduction. Additionally, liabilities related to interest rate swaps increased from $34.0 million in 2022 to $56.7 million in 2023, reflecting a shift in the fair value of these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18005,
        "completion_tokens": 132,
        "total_tokens": 18137
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' (NEER) financial commitment and involvement in the Mountain Valley Pipeline (MVP) significantly declined from 2022 to 2023. In 2022, due to continued legal and regulatory challenges, NEER recorded an impairment charge of approximately $0.8 billion ($0.6 billion after tax), which fully wrote off its equity method investment carrying amount of $0.6 billion and established a liability of $0.2 billion for future ARO costs. By 2023, there is no mention of further impairment or financial involvement in MVP, indicating that NEER's commitment and involvement in the project were effectively eliminated after the 2022 write-off.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17596,
        "completion_tokens": 162,
        "total_tokens": 17759
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This increase reflects a $240 million growth in the solvency capital funds allocated to marketable equity and debt securities to meet regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55998,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14230,
        "completion_tokens": 107,
        "total_tokens": 14337
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, the ramp-up of Intel 4 was associated with higher period charges, indicating initial production and development challenges. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, marking its first high-volume client product. Intel 4 became a key node for future product leadership, with expectations for it to represent an increasing portion of processor production in 2025. This evolution reflects Intel's strategic positioning of Intel 4 as a foundational node for client and data center products, leveraging EUV lithography for improved performance and efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43456,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11093,
        "completion_tokens": 182,
        "total_tokens": 11275
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership structure and financial integration. In May 2022, Emerson contributed two of its industrial software businesses to AspenTech and received 55% ownership in the newly formed \"New AspenTech.\" By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech not already owned, which would result in full ownership and an enterprise value of $15.1 billion. Financially, AspenTech's results were integrated into Emerson's operations, with the Heritage AspenTech acquisition in 2022 and continued financial reporting of AspenTech as a consolidated segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43079,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10991,
        "completion_tokens": 169,
        "total_tokens": 11160
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node evolved significantly in terms of manufacturing readiness and performance improvements. In 2022, Intel introduced the Intel 4 process node as part of its new naming structure, highlighting it as its first EUV lithography node. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used in the Intel Core Ultra processor, marking its first high-volume client product. Intel 4 delivered a 20% performance-per-watt improvement over Intel 7, showcasing notable advancements in efficiency and scalability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58346,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14812,
        "completion_tokens": 146,
        "total_tokens": 14958
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the InterStim Micro neurostimulator has maintained a key role within Medtronic's Pelvic Health therapies, specifically in treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In 2022, it was listed among the principal pelvic health products, and by 2024, it was highlighted again as a core offering, emphasizing its continued importance alongside newer innovations like the InterStim X and InterStim II. The InterStim Micro's positioning as a rechargeable option has remained consistent, supporting Medtronic's broader strategy to expand and enhance its neurostimulation solutions for pelvic health.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39159,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10003,
        "completion_tokens": 166,
        "total_tokens": 10169
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units in Simon Property Group's 2022 and 2024 10-K filings shows consistent reporting, with no material impact observed in either period. In both years, the company explicitly states that no securities, including LTIP Units, had a material dilutive effect on earnings per share or unit. The 2022 filing notes that potentially dilutive securities included LTIP Units and exchangeable units, but emphasizes no adjustments were made due to lack of dilutive impact. Similarly, the 2024 filing reiterates that no securities had a material dilutive effect for 2024, 2023, or 2022. Thus, there is no indication of a material change in the dilutive impact of LTIP Units across these reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12964,
        "completion_tokens": 185,
        "total_tokens": 13150
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has shown a focus on maintaining liquidity while executing repurchase programs. In 2022, MetLife had a $3.0 billion repurchase authorization, with $1.5 billion remaining at year-end. By 2024, the company continued to emphasize liquidity and capital management, ensuring that repurchase activities were aligned with cash buffer requirements and regulatory considerations. The company remained cautious about repurchasing shares when material non-public information was known and highlighted the importance of maintaining sufficient liquidity to meet operational needs, including potential increases in the cash buffer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10060,
        "completion_tokens": 179,
        "total_tokens": 10239
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks' foreign currency - other derivative asset and liability positions changed significantly. In fiscal 2022, the derivative assets were classified as $39.9 million in \"Prepaid expenses and other current assets\" and $33.5 million in \"Other long-term assets,\" while the liabilities were $0.3 million in \"Accrued liabilities\" and $0 in \"Other long-term liabilities.\" By fiscal 2023, the assets were $1.9 million in \"Prepaid expenses and other current assets\" and $1.7 million in \"Other long-term assets,\" showing a notable decline in asset balances. The liabilities increased to $4.7 million in \"Accrued liabilities\" and $4.1 million in \"Other long-term liabilities.\" This shift indicates a reduction in asset positions and an increase in liability positions related to foreign currency - other derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66653,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16897,
        "completion_tokens": 209,
        "total_tokens": 17106
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy between fiscal 2022 and fiscal 2024 evolved to support its restructuring activities and financial performance by prioritizing liquidity, optimizing working capital, and leveraging strong operating cash flows. In fiscal 2022, cash flow from operations was $16.7 billion, with adjusted free cash flow at $13.8 billion, used primarily for dividends, share repurchases, and debt management. By fiscal 2024, operating cash flow increased to $19.8 billion, and adjusted free cash flow rose to $16.9 billion, reflecting improved productivity and cost savings from restructuring efforts. The company also enhanced its working capital efficiency through extended payment terms with suppliers and supply chain financing programs, while maintaining a strong liquidity position through access to capital markets and undrawn credit facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59393,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15079,
        "completion_tokens": 220,
        "total_tokens": 15299
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of integration with enterprise solutions and simulation technologies. In 2022, Omniverse was primarily highlighted as a virtual world simulation and collaboration platform for 3D workflows, with enterprise applications such as virtual car showrooms and architectural walkthroughs. By 2023, Omniverse had expanded into a more robust development platform and operating system for building virtual world simulation applications, with a stronger focus on industrial digitalization, including digital twins of factories, real-time 3D product configurators, and testing autonomous systems. Additionally, Omniverse was more deeply integrated with NVIDIA's DRIVE Sim solution for autonomous vehicle simulation, emphasizing its role in enabling enterprise-scale digital transformation and AI-driven innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10416,
        "completion_tokens": 226,
        "total_tokens": 10642
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites evolved from 2023 to 2024 with a reduction in anticipated spending for capital expenditures. In 2023, total capital expenditures were $1,829.8 million, including $849.3 million for discretionary capital projects, which involved the construction of 3,198 communications sites globally. By 2024, AMT projected total capital expenditures to range between $1,545 million and $1,655 million, with $790 million to $820 million allocated for discretionary capital projects, including the construction of approximately 2,500 to 3,500 communications sites globally. This indicates a planned decrease in spending for new communications site construction in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55250,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14037,
        "completion_tokens": 182,
        "total_tokens": 14219
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved to emphasize divestment-related cost savings as part of structural cost savings. In 2023, proceeds from asset sales were described as part of cash flow from operations and asset sales, with a focus on aligning assets with strategic goals. By 2024, the language explicitly included \"divestment-related reductions\" in the definition of structural cost savings, highlighting how these actions contribute to sustainable cost optimization. This shift reflects a more integrated view of asset sales as a tool for both strategic alignment and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11152,
        "completion_tokens": 169,
        "total_tokens": 11322
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort decreased slightly from 2022 to 2023. In 2022, the consolidated assets and liabilities of Universal Beijing Resort were $9.7 billion and $8.1 billion, respectively. By 2023, these amounts were reduced to $7.8 billion in assets and $7.2 billion in liabilities. This reduction suggests a decline in the overall financial exposure, likely due to operational performance or repayment of some liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 53901,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13700,
        "completion_tokens": 114,
        "total_tokens": 13815
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's risk factor related to Customer Demand Volatility has shown a nuanced evolution. In 2023, the company highlighted the cyclical nature of demand, particularly in the energy, transportation, and mining sectors, emphasizing the impact of economic conditions and commodity price volatility on capital expenditures and, consequently, on Caterpillar's financial performance. By 2024, the discussion expanded to include a more pronounced focus on the compounding effects of global economic uncertainties, such as inflationary pressures and supply chain disruptions, which further amplify demand volatility. This evolution reflects a growing concern about the interconnectedness of macroeconomic factors and their cascading effects on both financial performance and supply chain stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49279,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12554,
        "completion_tokens": 204,
        "total_tokens": 12759
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From 2022 to 2024, the fair value of Net Derivative Assets (Liabilities) increased significantly, with the Level 3 fair value rising from $19 million in 2022 to $69 million in 2024. The valuation methodology remained consistent, relying on discounted cash flows and unobservable inputs such as swap rates. In 2024, the weighted average swap rate used was 4%, compared to 2% in 2022, reflecting a shift in assumptions impacting fair value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 107226,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27021,
        "completion_tokens": 109,
        "total_tokens": 27130
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved from being a standalone game streaming service to a more integrated component of NVIDIA's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned primarily as a service for playing PC games on underpowered devices. By 2023, it was highlighted as part of NVIDIA's full-stack cloud platform strategy, emphasizing its role in enabling interactive graphics applications to be accessed from virtually any device. This shift reflects NVIDIA's broader vision of unifying its GPU-powered cloud infrastructure, including vGPU and AI-driven technologies, to support gaming, creative workflows, and enterprise applications seamlessly across devices and environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10412,
        "completion_tokens": 186,
        "total_tokens": 10599
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta's revenue increased by 3% in 2023 compared to 2022. The growth was driven by adoption of combinations of immune checkpoint inhibitors and Inlyta for first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., as well as continued growth in emerging markets. However, this was partially offset by lower volumes and reduced net price in certain European markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 72684,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18383,
        "completion_tokens": 95,
        "total_tokens": 18478
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the amortization assumptions for network location intangibles remained consistent, with these intangibles being amortized over the shorter of the ground lease term (including renewal options) or the estimated useful life of the tower, generally up to 20 years. However, in 2024, the Company revised the estimated useful life of its tower assets from 20 to 30 years, which prospectively extended the amortization period for certain intangible assets tied to towers. Regarding impairment reviews, the process for network location intangibles remained unchanged, with impairments assessed on an individual tower basis based on factors such as tenant leases and cash flow projections. No new impairment events specific to network location intangibles were disclosed for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50974,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12973,
        "completion_tokens": 197,
        "total_tokens": 13170
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil significantly advanced its strategic emphasis on Guyana as a core component of its upstream growth portfolio. In 2023, Guyana's production from the Stabroek Block exceeded 390 thousand barrels of oil per day (kbd), with the third FPSO vessel, Prosperity, starting production in November 2023 and reaching full capacity by January 2024. By late 2023, combined production from three operating FPSO vessels reached nearly 440 kbd. In 2024, the company continued progress on the Yellowtail and Uaru developments and is on track to operate six FPSO vessels on the Stabroek Block by the end of 2027. Additionally, regulatory approvals for a sixth project at Whiptail were being pursued. These developments underscore ExxonMobil's commitment to Guyana as a major growth driver, with production capacity and project execution advancing ahead of schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45778,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11668,
        "completion_tokens": 220,
        "total_tokens": 11888
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services expanded significantly, with the platform now incorporating services like Disney+ and Netflix, as well as Peacock's premium tier, into a unified interface with integrated search functionality and voice-activated controls. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a hybrid viewing experience that combines traditional cable content with popular streaming options, thereby enhancing customer convenience and engagement. Additionally, by integrating these services, Comcast aims to increase ARPU by encouraging customers to access premium content through bundled offerings and commission-based revenue from third-party streaming service sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44333,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 191,
        "total_tokens": 11517
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson in terms of distribution network coverage for electric power generation systems expanded. In 2023, FG Wilson's systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this network had grown to 108 distributors covering 158 countries, indicating an increase in geographic reach and potentially enhanced market access for FG Wilson's products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58417,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14829,
        "completion_tokens": 111,
        "total_tokens": 14940
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations decreased between 2022 and 2024, both in terms of carrying value and fair value. As of December 31, 2022 (from the 2023 10-K), the carrying value of securitized debt obligations was $18,043 million with a fair value of $18,067 million. By December 31, 2024 (from the 2024 10-K), the carrying value had decreased to $14,264 million, and the fair value was $14,335 million. This reflects a reduction in both carrying value and fair value of approximately $3,779 million and $3,732 million, respectively, over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12945,
        "completion_tokens": 145,
        "total_tokens": 13091
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's use of line of credit agreements remained stable, with the company maintaining a $4.0 billion committed line of credit agreement as of December 31, 2024, similar to the prior year. The company also utilized uncommitted foreign currency line of credit agreements, with $7 million in borrowings outstanding under these agreements in 2024. McDonald's continued to leverage its credit capacity to manage short-term funding needs alongside commercial paper borrowings, reflecting its strong cash flow and disciplined approach to financing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30632,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7878,
        "completion_tokens": 144,
        "total_tokens": 8023
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual has remained a foundational element of Procter & Gamble's governance framework, emphasizing integrity and compliance with legal and ethical standards. However, the 2024 filing highlights a more explicit connection between the Manual and the company's broader governance structures, such as the Global Leadership Council and the Disclosure Committee, indicating a more integrated and proactive approach to reinforcing internal controls. This evolution suggests a stronger emphasis on aligning employee behavior with corporate governance objectives, reflecting P&G's commitment to maintaining robust internal controls and ethical business practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11450,
        "completion_tokens": 177,
        "total_tokens": 11627
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. Long-lived assets in Guyana increased from $6.766 billion in 2023 to $9.689 billion in 2024, indicating substantial capital investment in the region. Additionally, Guyana is explicitly categorized under \"Advantaged Assets\" in the 2024 earnings driver definitions, highlighting its role as a key growth project contributing to volume and earnings growth. This reflects Exxon's strategic focus on high-impact, high-return projects in Guyana, aligning with its broader growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11917,
        "completion_tokens": 165,
        "total_tokens": 12082
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations were $6.25 billion in issuances, while in 2024, they were $14.264 billion in total outstanding obligations. However, the proportion of securitized debt obligations relative to other funding sources like senior and subordinated notes and deposits appears to have decreased, indicating a reduced reliance on securitized debt as a primary funding source over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52383,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13321,
        "completion_tokens": 127,
        "total_tokens": 13449
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being a 3D design collaboration and virtual world simulation tool to a more integral part of NVIDIA's enterprise solutions, particularly in industrial digitalization. In 2022, Omniverse was highlighted for enabling digital twins of factories, real-time 3D product configurators, and testing autonomous systems. By 2023, Omniverse was positioned more broadly as a foundational platform for building metaverse and 3D internet applications, with increased integration into NVIDIA's AI and autonomous vehicle ecosystems, such as being used in DRIVE Sim for autonomous driving simulation and development. This shift reflects a stronger emphasis on enterprise adoption and cross-platform integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 40752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10403,
        "completion_tokens": 192,
        "total_tokens": 10596
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due from Viatris under their agreements with Pfizer decreased significantly. As of December 31, 2022, the net amounts due to Viatris were $94 million, while by December 31, 2023, this amount had dropped to $33 million. This decline suggests a reduction in outstanding obligations or settlements under the transitional service agreements (TSAs), manufacturing supply agreements (MSAs), and other related arrangements following the 2020 spin-off and combination of the Upjohn Business with Mylan to form Viatris.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17992,
        "completion_tokens": 137,
        "total_tokens": 18129
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified between 2023 and 2024, with increased project activity and classification as an advantaged growth project. In 2023, Guyana accounted for 12.6 net exploratory and development wells completed, with the Payara development commencing and the Yellowtail project advancing. By 2024, Guyana was explicitly included in the \"Advantaged Volume Growth\" earnings driver, highlighting its role as a key asset for volume and earnings growth. This reflects a shift toward prioritizing high-impact, high-return projects, with Guyana's offshore operations now central to ExxonMobil's growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37104,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9502,
        "completion_tokens": 160,
        "total_tokens": 9662
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for senior notes with maturities greater than 10 years remained stable at 3.8%. The face value of these senior notes slightly decreased from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44867,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11437,
        "completion_tokens": 60,
        "total_tokens": 11497
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power saw a shift in their domestic equity investment allocations. In 2023, Alabama Power's domestic equity investments were classified as $443 million under Level 2 inputs, while Georgia Power's were $321 million under Level 2. By 2024, Alabama Power's domestic equity allocation remained in Level 2 at $443 million, and Georgia Power's allocation slightly increased to $322 million, also under Level 2. There were no Level 1 classifications for domestic equity in either trust during these periods. The valuation methodologies remained consistent, relying on external pricing vendors and observable market inputs for Level 2 classifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 284,
          "pages": [
            282,
            283,
            284,
            285,
            286
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91541,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23135,
        "completion_tokens": 184,
        "total_tokens": 23319
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved to become a more central and foundational element within its full-stack computing platform. In 2022, CUDA was highlighted as a key building block for enabling accelerated computing across diverse markets, including AI, data center, gaming, and automotive. By 2023, CUDA's role expanded as the core of NVIDIA's unified architecture, supporting not only GPU-based solutions but also integrating with DPUs and CPUs to deliver end-to-end computing solutions across industries. This integration allowed CUDA to power AI, HPC, and graphics workloads across data centers, autonomous vehicles, and enterprise applications, reinforcing NVIDIA’s position as a full-stack computing infrastructure leader.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 36270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9298,
        "completion_tokens": 189,
        "total_tokens": 9488
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, particularly under transitional service agreements (TSAs) and master service agreements (MSAs), evolved as follows: \n\n- Services under TSAs were largely completed by December 31, 2023, with no material amounts recorded in 2023 under these agreements. \n- The net amounts owed to Viatris under these agreements decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. \n\nThis reflects the winding down of transitional obligations following the 2020 spin-off of the Upjohn Business and its combination with Mylan to form Viatris.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83372,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21074,
        "completion_tokens": 163,
        "total_tokens": 21238
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy's environmental regulation compliance costs have evolved in response to increasing regulatory pressures and the company's clean energy transition goals. In 2022, the company highlighted the need for supportive policies to manage costs related to environmental regulations, including coal combustion residuals (CCR) management and carbon reduction initiatives. By 2023, Duke Energy emphasized the growing influence of federal and state climate change regulations, which could impose additional costs for emissions reductions and infrastructure changes. The company also noted the importance of regulatory cost recovery mechanisms to offset these expenses, though uncertainties remained regarding full cost recovery and the timing of such recovery. Overall, the relationship between retail deregulation pressures and environmental compliance costs reflects a continued focus on navigating regulatory complexity while advancing sustainability objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69756,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17660,
        "completion_tokens": 245,
        "total_tokens": 17905
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a loss of 1.7 share points. This decline contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases (e.g., $0.09 to $0.10 per can) aimed at offsetting cost pressures and maintaining profitability. Despite these price hikes, Skoal's market share continued to decline, likely due to competition from oral nicotine pouches and shifting consumer preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65967,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16717,
        "completion_tokens": 126,
        "total_tokens": 16843
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' increased slightly from $138 million as of December 31, 2023, to $135 million as of December 31, 2024. This minimal change suggests that Amgen maintained a relatively stable allocation to these types of short-term investments during the period. Given that all interest-bearing securities mature in one year or less and the company's investment strategy emphasizes safety of principal, liquidity, and acceptable risk levels, the slight decrease indicates a consistent approach to managing short-term liquidity needs without significant shifts in strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11857,
        "completion_tokens": 155,
        "total_tokens": 12013
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades increased in both scope and value from 2022 to 2024. In 2022, the Combat Systems segment reported a contract award of $360 million for Abrams tank upgrades, mission control units, and technical support. By 2024, this had expanded to a $350 million contract for Abrams main battle tank upgrades, including engineering, logistics support, and sustainment technical services, with broader support for international customers such as Romania. This reflects an expanded role in modernization and sustainment efforts, as well as increased international demand for upgraded Abrams tanks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 19324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5055,
        "completion_tokens": 161,
        "total_tokens": 5217
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge underwent significant changes, particularly in borrowing arrangements and income recognition. In 2023, Corebridge had debt obligations not guaranteed by AIG, including $200 million in CRBGLH notes, $227 million in junior subordinated debt, and $1,500 million in a DDTL facility. By 2024, AIG deconsolidated Corebridge, recognizing a $4.8 billion loss primarily due to accumulated comprehensive losses. Post-deconsolidation, AIG's retained interest in Corebridge was accounted for under the fair value option, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. In the fourth quarter of 2024, AIG sold a 21.6% stake in Corebridge, generating a $282 million gain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91458,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23088,
        "completion_tokens": 191,
        "total_tokens": 23280
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize production scalability and strategic partnerships to address prior challenges. In 2022, the company highlighted ongoing production challenges and supplier dependencies, noting the complexity of ramping up manufacturing and ensuring component availability. By 2024, Tesla shifted focus toward improving installation efficiency and expanding collaboration with real estate developers and builders to integrate Solar Roof into new home construction, indicating progress in overcoming earlier production bottlenecks and a more strategic alignment with broader market adoption efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11595,
        "completion_tokens": 167,
        "total_tokens": 11762
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024, indicating a loss of market share. This decline suggests that Skoal is facing increased competition, particularly from oral nicotine pouches like on!, which saw growth in its category, and reflects broader challenges in the MST (moist smokeless tobacco) segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46706,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11899,
        "completion_tokens": 91,
        "total_tokens": 11991
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, with potential negative implications for Qualcomm's pricing power and revenue stability. The 2024 filing highlights a continued and potentially worsening concentration of device share among a few companies, particularly at the premium tier, which heightens the purchasing power of these companies and could lead to lower prices for Qualcomm's products. Additionally, geopolitical tensions, such as the U.S. revoking Qualcomm's license to export certain products to Huawei in May 2024, have further exacerbated the risk, directly impacting Qualcomm's revenue (approximately $560 million in fiscal 2024 from Huawei). The increased vertical integration by key customers, such as Apple and Chinese OEMs, also poses a growing threat to Qualcomm's revenue stability by reducing reliance on its products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16304,
        "completion_tokens": 230,
        "total_tokens": 16535
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a slight increase in Amgen's short-term liquidity allocation to this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11845,
        "completion_tokens": 80,
        "total_tokens": 11926
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) remained consistent in terms of the deferred tax liability related to qualified ships, with a balance of $57 million in both 2022 and 2023. However, the amount of U.S. government accounts receivable pledged to the CCF increased from $295 million at the end of 2022 to $315 million at the end of 2023, and further to $333 million by the end of 2024, indicating a gradual increase in the value of receivables pledged to the fund over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8800,
        "completion_tokens": 128,
        "total_tokens": 8929
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "AIG's financial relationship with Corebridge evolved significantly between 2023 and 2024, particularly following the IPO and subsequent deconsolidation. In 2023, Corebridge was partially deconsolidated from AIG's tax group due to AIG's ownership dropping below 80%, resulting in Corebridge's tax attributes being separated and no longer available for AIG's tax benefits. By 2024, AIG fully deconsolidated Corebridge on June 9, 2024, recognizing a $4.8 billion loss primarily from accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the fair value option, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. Tax implications were further affected by AIG's secondary sales of Corebridge shares, including a $282 million gain in Q4 2024 from a sale to Nippon Life.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 104603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 26387,
        "completion_tokens": 216,
        "total_tokens": 26604
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production has evolved to emphasize localized procurement, installation efficiency, and collaboration with real estate developers to reduce costs and time. In 2022, the focus was on improving installation capabilities and price efficiencies by onboarding and training new installers. By 2024, Tesla had expanded this strategy by integrating Solar Roof into new home developments and enhancing its online ordering experience to streamline the retrofit solar energy business. Supply chain challenges, such as global component constraints, remained a concern in 2022, but Tesla's operational strategy in 2024 reflects a more structured effort to scale production and address bottlenecks through localized supply chain optimization and partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49017,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12481,
        "completion_tokens": 198,
        "total_tokens": 12680
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023, Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion in 2022 to $7 billion to $8 billion in 2023. This reduction, along with the completion of excavations at several sites, indicates progress under the Coal Ash Act, as the company continues to comply with regulatory requirements and manage costs through settlement agreements and phased closure plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68400,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17341,
        "completion_tokens": 117,
        "total_tokens": 17458
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a strengthening market position within the oral tobacco product segment during this period. This growth in share occurred despite an overall decline in the MST (moist snuff tobacco) category and highlights the product's growing traction in the expanding nicotine pouch segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46706,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11914,
        "completion_tokens": 96,
        "total_tokens": 12010
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has remained significant from 2023 to 2024, with continued concentration in a small number of Chinese OEMs, as highlighted in both years' 10-K filings. However, there is increased risk due to geopolitical tensions, such as the U.S. revoking Qualcomm's license to export certain products to Huawei in May 2024, which had contributed $560 million in fiscal 2024 revenues prior to the revocation. Additionally, pressures from the Chinese government's \"Made in China 2025\" initiative and potential vertical integration by Chinese OEMs pose threats to Qualcomm's revenue stability. These factors, combined with trade and national security tensions, could negatively impact Qualcomm's business stability by reducing access to key customers and increasing regulatory and operational uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16285,
        "completion_tokens": 209,
        "total_tokens": 16495
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments evolved significantly in terms of security types held. In 2022, the portfolio included $1,676 million in U.S. Treasury bills, $2,659 million in money market mutual funds, and no other short-term interest-bearing securities, totaling $4,335 million. By 2023, the U.S. Treasury bills were entirely removed, while money market mutual funds increased to $10,266 million, and $138 million was added in other short-term interest-bearing securities, resulting in a total of $10,404 million. This shift reflects a move away from short-term Treasury instruments toward a larger allocation in money market funds and other short-term securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11849,
        "completion_tokens": 175,
        "total_tokens": 12024
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack is listed as a tenant at the Las Vegas Outlets in 2023 (page 35 of SPG_10k_2023.pdf) but is not mentioned in any of the 2022 property tenant lists. This indicates that Shake Shack entered SPG's premium outlet properties in 2023, specifically at the Las Vegas Outlets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69775,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17657,
        "completion_tokens": 69,
        "total_tokens": 17726
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified within Level 3 of the fair value hierarchy, with their fair value decreasing from $35 million in 2021 to $22 million in 2024. This consistent classification in Level 3 indicates that GD continues to value these assets using significant unobservable inputs, likely due to the lack of active market data for such contracts. The reduction in fair value may reflect changes in the overall asset allocation strategy, including a shift toward liability-hedging assets as plans approach funded status targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12560,
        "completion_tokens": 143,
        "total_tokens": 12704
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes. In 2023, AIG owned 52.2% of Corebridge and engaged in secondary offerings, selling shares and recording changes in equity. By 2024, AIG deconsolidated Corebridge after reducing its ownership to 48.4%, resulting in a $4.8 billion loss primarily due to accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest using the fair value option, recognizing gains from subsequent share sales, including a $282 million gain from selling a 21.6% stake to Nippon in December 2024. By year-end 2024, AIG's ownership in Corebridge had further decreased to 22.7%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 130044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 32736,
        "completion_tokens": 171,
        "total_tokens": 32908
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort has slightly decreased from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, compared to $3.5 billion as of December 31, 2023, and $3.6 billion as of December 31, 2022. Comcast consolidates Universal Beijing Resort, and its maximum risk of financial loss is limited to its 30% interest. The debt is secured by the resort's assets and equity interests, and there are no additional liquidity arrangements or guarantees from Comcast.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54034,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13731,
        "completion_tokens": 135,
        "total_tokens": 13866
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility, as they continued to apply to some Gulfstream customers holding options to trade in aircraft as partial consideration for new-aircraft transactions. However, there was no specific mention of changes in eligibility criteria. In terms of risk exposure, the documentation indicated that trade-in commitments structured to guarantee a predetermined trade-in value present more risk in the event of adverse market conditions, and this risk structure did not change between the two years. Additionally, the estimated change in fair market values from the date of the commitments was not material in both 2022 and 2023, indicating no significant increase in risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38688,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9893,
        "completion_tokens": 199,
        "total_tokens": 10092
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi has evolved from being in the planning and development phase to entering pilot production. In 2022, the Semi was listed among future commercial electric vehicles without specific production details. By 2024, the Semi is noted as being in \"pilot production\" at the Nevada Gigafactory, indicating progress toward commercialization. Strategically, the Semi is positioned as part of Tesla's broader product roadmap to expand into commercial and industrial markets, leveraging the company's advancements in battery technology and autonomous driving. This shift reflects Tesla's growing focus on diversifying its product lineup and capturing market share in the electric heavy-duty vehicle segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37899,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9702,
        "completion_tokens": 187,
        "total_tokens": 9889
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $379 million at the end of 2022 to $397 million at the end of 2023, and further to $402 million at the end of 2024. This minimal increase indicates that Altria continues to maintain a valuation allowance against the deferred tax assets associated with its investment in Cronos, suggesting the company remains uncertain about the realizability of these assets. The slight changes in the valuation allowance reflect adjustments based on the evolving financial performance and fair value of the investment, but the overall trend indicates ongoing caution regarding the ability to realize the associated tax benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49426,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12596,
        "completion_tokens": 173,
        "total_tokens": 12769
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen changed the financial treatment of its investment in BeiGene in the first quarter of 2023 by switching from the equity method of accounting to recording the investment at fair value, with changes in fair value recognized in earnings. This change resulted in gains being recognized in 2023, contributing to the increase in \"Other income (expense), net.\" In 2024, the impact of this change continued, but the year saw net unrealized losses on strategic equity investments, including BeiGene, leading to a significant decrease in \"Other income (expense), net\" compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52465,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13329,
        "completion_tokens": 145,
        "total_tokens": 13474
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved by consolidating services in Latin America and enhancing regional branding in key markets. In June 2024, Disney+ replaced the separate Star+ service in Latin America with a unified Disney+ product, streamlining offerings and improving user experience. Additionally, Disney+ Hotstar maintained its distinct branding in India and Southeast Asia, emphasizing localized content and regional relevance to cater to diverse audiences. These changes reflect a strategic shift toward simplifying service structures while reinforcing regional identity to drive subscriber growth and engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46657,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11888,
        "completion_tokens": 166,
        "total_tokens": 12054
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal's approach to its Protection Programs evolved in terms of risk exposure and loss recovery mechanisms by enhancing its fraud detection and prevention measures to address the increasing complexity and scale of fraudulent activities. The company acknowledged the risks associated with erroneous transactions, insufficient funds in linked accounts, and fraudulent merchants, which led to substantial losses. PayPal's protection programs aim to reduce these risks by offering purchase and seller protection, but the company noted that recoveries from merchants or other sources may be insufficient. Additionally, PayPal emphasized the need to adapt to evolving fraud schemes and regulatory changes, which could impact the scope of coverage and increase exposure to losses. These developments indicate a more proactive and adaptive approach to managing risk exposure and improving loss recovery mechanisms in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55291,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14045,
        "completion_tokens": 234,
        "total_tokens": 14279
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities from 2022 to 2024 has evolved through strategic ownership and financial structure changes. In 2022, NextEra Energy Resources (NEER) sold differential membership interests in solar and solar-plus-storage facilities to third-party investors, retaining controlling interests and classifying these as noncontrolling interests. By 2024, NEER continued to consolidate numerous Variable Interest Entities (VIEs) related to solar generation, including entities with approximately 3,485 MW of solar capacity, while managing financial exposure through third-party debt secured by asset liens. This structure allowed NEER to maintain operational control and optimize returns while mitigating direct financial risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64565,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16366,
        "completion_tokens": 191,
        "total_tokens": 16558
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities for Non-U.S. Plans decreased from $484,182 in 2021 to $379,989 in 2022. The valuation methodology for these securities remained consistent in both years, with all amounts classified under Level 2 of the fair value hierarchy, indicating they were valued using quoted prices for similar instruments or model-derived valuations with observable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8529,
        "completion_tokens": 99,
        "total_tokens": 8628
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023, with its investment carrying value rising from $26,534 million in 2022 to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO rose from $4,386 million in 2022 to $3,375 million in 2023, indicating a continued strong financial involvement in the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14317,
        "completion_tokens": 94,
        "total_tokens": 14411
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with the ABC Network has evolved to strengthen its strategic positioning within Disney's broader entertainment ecosystem. ABC Network remains a central component of Disney's Linear Networks business, providing primetime, news, and sports programming, with ESPN programming the sports daypart as \"ESPN on ABC.\" The network continues to serve as a key distribution channel for Disney's content, reaching nearly 100% of U.S. television households through its affiliated stations and owned stations in major markets. Additionally, ABC's integration with Disney's Direct-to-Consumer platforms, such as Disney+ and Hulu, enhances cross-promotion and content synergy, reinforcing ABC's role in Disney's multi-platform strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10862,
        "completion_tokens": 191,
        "total_tokens": 11053
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio remained relatively consistent, as it continued to be highlighted as a versatile tracked combat vehicle offered by European Land Systems (ELS). However, the 2023 document shows a slight shift in focus toward expanding production capacity for other programs, such as the M10 Booker and increased investment in munitions and artillery production through OTS. This suggests a strategic reallocation of resources to meet growing demand in next-generation combat vehicles and artillery systems, potentially at the expense of slower growth or maintenance-level investment in the ASCOD program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 24349,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6325,
        "completion_tokens": 173,
        "total_tokens": 6499
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a reduction from 39% to 26% of European customer balances available for corporate use. This decline suggests a strategic shift or potential constraints in leveraging European customer funds for credit-related purposes, possibly due to regulatory, liquidity, or operational considerations. The reduction may indicate a more conservative approach to credit funding or a reallocation of resources to other priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50946,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12968,
        "completion_tokens": 140,
        "total_tokens": 13108
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds showed an increase in the total fair value, with equity securities rising from $5,511 million in 2022 to $6,164 million in 2024. This increase indicates a shift in the investment composition, with a higher allocation to equity securities and a corresponding rise in Level 3 categorization for some equity investments, reflecting greater complexity or less observable inputs in valuation. This evolution suggests a potential decrease in transparency for certain portions of the fund's equity holdings and a strategic reallocation toward potentially higher-risk or less liquid equity investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70696,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17909,
        "completion_tokens": 175,
        "total_tokens": 18085
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, the scope and utilization of Accenture's share purchase program showed a significant increase in shares acquired under the public program, while employee-related transactions remained relatively consistent. In fiscal 2022, under the public program, Accenture purchased 1,964,612 shares for $576 million, with an aggregate available authorization of $3,129 million as of August 31, 2022. By fiscal 2023, the total available authorization had increased to $6,129 million following an additional $3,000 million repurchase authority approved in September 2022. Employee-related transactions, such as share withholding for payroll tax obligations, remained a smaller component, with 97,251 shares acquired in fiscal 2022 and a similar pattern expected in fiscal 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7684,
        "completion_tokens": 198,
        "total_tokens": 7883
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. Chevron maintains a 50 percent equity ownership interest in CPChem, and CPChem is accounted for using the equity method in Chevron's consolidated financial statements. The summarized financial data for CPChem shows that it was not consolidated into Chevron's financials but rather reflected as an investment, with its results impacting Chevron's earnings proportionally based on its ownership stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50683,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12907,
        "completion_tokens": 134,
        "total_tokens": 13041
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In 2022, the Combat Systems segment received a $175 million contract from the U.S. Army for the production of Hydra-70 rockets. By 2023, the role of Hydra-70 rockets expanded significantly as part of broader production capacity enhancements within the Ordnance and Tactical Systems (OTS) business unit. OTS received awards to scale its production capabilities, increasing metal parts production from 18,000 to 86,000 rounds per month by 2025 and propellant capacity from 4 million to 16 million pounds per year by 2028, directly supporting the U.S. Army’s efforts to accelerate artillery production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 25933,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6713,
        "completion_tokens": 149,
        "total_tokens": 6863
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Between the 2023 and 2024 filings, PayPal's Global Restricted Stock Unit Award Grant Notice and Agreement under the 2015 Equity Incentive Award Plan remained documented in both years (referenced in Exhibit 10.07+). However, in the 2024 filing, the Global Performance Based Restricted Stock Unit Award Grant Notice and Agreement (Exhibit 10.08+) was amended and restated, with the updated version filed on April 30, 2024, indicating a revision to the performance-based component of the equity awards. The standard Global Restricted Stock Unit Award Grant Notice itself did not show evidence of amendment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17288,
        "completion_tokens": 155,
        "total_tokens": 17444
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has evolved both in terms of revenue performance and regulatory approvals. Revenue for Opdivo remained relatively stable, with $7,523 million in 2022 and consistent figures in the following years. However, its strategic importance has grown due to multiple new regulatory approvals in 2024, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) and expanded indications in urothelial carcinoma, colorectal cancer, and combination therapies, reinforcing its position as a key immunotherapy product in BMS's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 43563,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11115,
        "completion_tokens": 153,
        "total_tokens": 11268
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved with continued investment in expansion projects and joint ventures. In 2022, CPChem advanced projects to expand its normal alpha olefins business and made final investment decisions on a new C3 splitter unit and a second 1-hexene unit, both expected to start up in 2023. By 2023, Chevron's equity in earnings from CPChem increased from $867 million in 2022 to $608 million, reflecting ongoing financial support and project progress. Additionally, CPChem continued engineering efforts for the Ras Laffan Petrochemical Project in Qatar and worked toward final investment decisions for the U.S. Gulf Coast II Petrochemical Project.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51606,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13135,
        "completion_tokens": 191,
        "total_tokens": 13326
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses, which rose from $64 million at the end of 2023 to $86 million at the end of 2024. Additionally, the allowance for negative customer balances increased from $218 million in 2023 to $256 million in 2024. These reserves are established to cover potential financial losses from fraud and counterparty performance issues under PayPal's consumer and merchant protection programs. The disclosures highlight a higher provision for transaction losses in 2024 ($1,114 million) compared to 2023 ($1,192 million), indicating a strategic adjustment in anticipating and managing risk associated with these programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47591,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12121,
        "completion_tokens": 187,
        "total_tokens": 12308
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced franchising as the core of its business model, emphasizing its role in driving profitability and consistency across its global operations. In 2024, the company explicitly states that franchising is \"paramount to delivering great-tasting food, locally relevant customer experiences and driving profitability,\" highlighting its strategic importance. Additionally, McDonald's has expanded its co-investment initiatives with franchisees to modernize restaurants and improve performance, particularly in conventional franchise arrangements where the company and franchisees collaborate on capital improvements. This reflects a more active and supportive role in franchisee development compared to earlier years, aiming to enhance brand value and operational standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61950,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15722,
        "completion_tokens": 203,
        "total_tokens": 15925
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA's authorization of Marlboro HeatSticks progressed with the approval of three new tobacco-flavored varieties in March 2023, indicating regulatory progress for Altria's heated tobacco products. However, the products remained subject to the FDA's post-market surveillance requirements, and their marketing was impacted by a prior ITC cease-and-desist order due to a patent dispute. This suggests that while Altria achieved some authorization milestones, regulatory and legal challenges continued to affect the product's market availability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58316,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14807,
        "completion_tokens": 142,
        "total_tokens": 14949
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from $273,541 in 2021 to $239,293 in 2022. This decline suggests a reduction in the market value of these investments during the period, potentially reflecting broader market volatility or a strategic shift toward lower-risk assets like debt securities and insurance contracts, as outlined in the investment strategies section. The shift indicates a more conservative investment positioning in 2022, aligning with the goal of matching asset duration to liabilities and minimizing exposure to market fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8532,
        "completion_tokens": 151,
        "total_tokens": 8684
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In both years, Chevron's operational focus centered on supporting the plant's processing capacity of 1.1 billion cubic feet of natural gas per day, sourced primarily from associated gas byproducts of crude oil production. In 2022, efforts were directed toward developing non-associated gas in offshore Angola to supply the Angola LNG plant, and this focus continued into 2023, with no significant changes in investment emphasis reported.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12964,
        "completion_tokens": 165,
        "total_tokens": 13129
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million to $49 million, representing a change of $28 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63708,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 39,
        "total_tokens": 16185
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, the percentage of franchised restaurants in McDonald's system increased from 93% to 95%. This indicates a strengthening of McDonald's reliance on its franchise model during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54556,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13854,
        "completion_tokens": 52,
        "total_tokens": 13906
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 filing. Between 2022 and 2023, the plan was further amended and restated effective October 26, 2022, as referenced in the 2023 filing. These amendments likely updated the structure or terms of the plan to align with evolving governance practices or regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15307,
        "completion_tokens": 101,
        "total_tokens": 15408
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact. As of August 31, 2022, the carrying amount of Accenture's equity method investment in Duck Creek Technologies was $138,902, with an estimated fair value of $223,166 for its approximately 16% ownership. In fiscal 2023, Accenture reported a $253 million investment gain related to its investment in Duck Creek Technologies, indicating a significant increase in the investment's valuation and a positive financial impact on its earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43698,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11156,
        "completion_tokens": 151,
        "total_tokens": 11307
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application has expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, specific new indications approved for Breyanzi include:\n\n1. **Relapsed or Refractory Follicular Lymphoma (FL)**: Approved by the FDA in May 2024 for adult patients with relapsed or refractory FL who have received at least two prior lines of systemic therapy.\n2. **Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)**: Accelerated approval by the FDA in March 2024 for adult patients with relapsed or refractory CLL/SLL who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor.\n3. **Relapsed or Refractory Marginal Zone Lymphoma (MCL)**: Approved by the FDA in May 2024 for adult patients with relapsed or refractory MCL who have received at least two prior lines of systemic therapy, including a Bruton tyrosine kinase inhibitor.\n\nThese approvals expand Breyanzi's market potential by addressing additional patient populations with B-cell malignancies, thereby broadening its therapeutic reach and commercial opportunities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50786,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12922,
        "completion_tokens": 298,
        "total_tokens": 13220
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M increased its accruals for respirator mask/asbestos liabilities by $57 million in 2023, reflecting a more cautious estimate of probable losses due to factors such as higher costs to resolve claims involving serious injuries like mesothelioma and black lung disease. Additionally, the insurance receivables related to these liabilities remained immaterial in 2023, with 3M continuing efforts to seek coverage from certain insurers, though most of its remaining insurance coverage for these claims is expected to be collected once those claims for coverage are resolved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54094,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13760,
        "completion_tokens": 148,
        "total_tokens": 13908
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In the first quarter of 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners, retaining a 39% noncontrolling interest in a newly formed joint venture, Tropicana Brands Group (TBG), which operates across North America and Europe. By 2023, PepsiCo continued to act as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers with chilled direct-store-delivery in the United States. Thus, PepsiCo's operational involvement shifted from direct ownership to a distribution role, while its financial stake remained at 39%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42566,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10859,
        "completion_tokens": 152,
        "total_tokens": 11012
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure for the ExtraBucks Rewards program remained consistent in terms of recognizing revenue and determining performance obligations. In both years, the Company recognized that ExtraBucks Rewards represent a performance obligation at the time of the initial transaction. The transaction price was allocated between the initial transaction and the rewards based on the relative standalone selling price, informed by historical redemption patterns. Revenue related to ExtraBucks Rewards was recognized as the rewards were redeemed, with unredeemed rewards reflected as a contract liability at the end of each period. There were no material changes in the accounting treatment or disclosure between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47059,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12005,
        "completion_tokens": 191,
        "total_tokens": 12196
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Between 2023 and 2024, Netflix's reliance on integrated payment partners, as reflected in the cost of revenues section, remained consistent in terms of categorization but showed an overall increase in cost of revenues. In 2023, cost of revenues was $19.7 billion (58% of total revenues), while in 2024, it increased to $21 billion (54% of total revenues). The 2024 increase was primarily driven by a $1.1 billion rise in content amortization, but no specific mention of changes in payment processing fees or integrated payment partner costs was provided, indicating no significant shift in reliance on these partners during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82874,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20946,
        "completion_tokens": 158,
        "total_tokens": 21105
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to regulatory changes and new health-based standards. In 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the potential impact on its obligations under the 2007 Settlement Agreement and Consent Order (SACO). Additionally, in January 2024, the Minnesota Pollution Control Agency (MPCA) issued a draft Clean Water Act permit for 3M's Cottage Grove facility with significantly revised PFAS limits, some below the limit of quantification, requiring 3M to engage in ongoing discussions with MPCA. These developments reflect 3M's increased focus on compliance with evolving standards and collaboration with regulators to address PFAS-related obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60710,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15405,
        "completion_tokens": 209,
        "total_tokens": 15615
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased from a notional value of $2.8 billion in 2022 to $3.8 billion in 2023, indicating a more active approach to managing foreign exchange risk. This growth suggests that PepsiCo is expanding its hedging strategies to address greater exposure from international operations, likely due to increased global operations or currency volatility. The company continues to use forward contracts and net investment hedges to mitigate risks from foreign subsidiaries and currency fluctuations, reflecting a consistent and proactive risk management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41394,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10576,
        "completion_tokens": 149,
        "total_tokens": 10725
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil shifted its focus in capitalizing on improving living standards by advancing chemical production capacity additions in strategic geographic regions. In 2022, the company emphasized restarting U.S. Gulf Coast projects to meet growing demand for high-value chemical products. By 2023, the focus expanded to significant capacity additions in China, with the development of a new petrochemical complex in the Dayawan Petrochemical Industrial Park. This complex, designed to produce high-performance polyethylene and polypropylene, reflects ExxonMobil's strategy to more efficiently serve the rapidly growing domestic demand in China, which has traditionally relied on imports.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 25136,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6516,
        "completion_tokens": 176,
        "total_tokens": 6692
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly, from $21 million to $49 million. This shift suggests a strategic move toward allocating more short-term liquidity into these low-risk, interest-bearing instruments, likely to preserve capital and generate modest returns in a potentially volatile market environment. The increase indicates a cautious approach to short-term investment management, prioritizing safety and liquidity over higher-yield but potentially riskier alternatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47018,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11982,
        "completion_tokens": 134,
        "total_tokens": 12116
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights evolved from 2022 to 2023 by emphasizing data responsibility and trust-building language. In 2022, the focus was on leveraging consumer and merchant data to provide insights while maintaining principled use. By 2023, the language shifted to highlight secure, responsible data use and reinforcing trust, indicating a stronger commitment to ethical standards and transparency in data practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 61541,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15607,
        "completion_tokens": 109,
        "total_tokens": 15716
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans evolved in response to the broader economic environment. In 2022, the external environment was shaped by the lingering effects of the COVID-19 pandemic, which introduced uncertainties in assumptions such as discount rates and future cash flows. By 2023, the focus shifted to the impacts of ongoing conflicts in Ukraine and the Middle East, as well as a high-interest-rate and inflationary cost environment. These macroeconomic factors increased the complexity of estimating future obligations and required more conservative assumptions, reflecting a more volatile and uncertain financial landscape. This evolution indicates a transition from pandemic-related uncertainties to a challenging geopolitical and economic climate affecting long-term financial planning for these plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10229,
        "completion_tokens": 222,
        "total_tokens": 10451
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 32,441 gross thousand acres (15,838 net) at year-end 2022 to 30,773 gross thousand acres (15,012 net) at year-end 2023. This reduction suggests that the company may have relinquished or sold some acreage, or advanced certain areas into development. Despite the decline, the region still holds a substantial undeveloped acreage position, indicating continued exploration potential, particularly in countries like Guyana and Brazil, where long-term exploration and production rights are in place.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39272,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10050,
        "completion_tokens": 142,
        "total_tokens": 10193
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, 3M continued using foreign currency contracts not designated in hedging relationships to offset the impacts of changes in value of non-functional currency denominated items, such as intercompany financing balances. In 2022, the gross notional amount of these contracts was $2.8 billion, while in 2023, it decreased to $1.0 billion. The fair value gains and losses on these contracts are recorded directly in earnings, and in 2023, they resulted in a $9 million loss, compared to a $76 million loss in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58934,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14971,
        "completion_tokens": 131,
        "total_tokens": 15103
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition evolved to become a more integral part of the company's broader strategy to enhance transaction security and trust. In 2022, Cyber and Intelligence Solutions were highlighted as part of Mastercard's value-added services, primarily focused on fraud prevention and transaction safety. By 2023, these solutions were emphasized more prominently as a core component of Mastercard's multi-layered approach to protecting the global payments ecosystem. The 2023 document underscores their role in enabling secure, confident, and seamless transactions, aligning with Mastercard's broader investments in open banking and digital identity solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11898,
        "completion_tokens": 189,
        "total_tokens": 12088
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in PepsiCo's critical accounting policies remained consistent between 2022 and 2023. In both years, the policy emphasizes that the annual tax rate is based on income, statutory tax rates, and tax structures across jurisdictions. Significant judgment is required in determining the tax rate and evaluating tax positions, with reserves established for positions that may be challenged. Adjustments to these reserves are made based on changing facts, such as tax audits or new laws. The 2023 filing did not introduce any material changes to the 2022 disclosure on this topic.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41947,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10707,
        "completion_tokens": 159,
        "total_tokens": 10866
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a key enabler of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability for high-performance communication between interconnected chiplets. By 2024, the company emphasized UCIe as a foundational standard for optimizing system performance and power consumption, aligning with its broader push to deliver advanced packaging and systems capabilities for AI and other high-growth applications. This evolution reflects Intel's commitment to driving industry-wide adoption of chiplet-based architectures through standards and ecosystem collaboration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30983,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7976,
        "completion_tokens": 172,
        "total_tokens": 8149
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment for CVS's Accelerated Share Repurchase (ASR) transactions evolved slightly. In 2023, the ASR with Morgan Stanley was accounted for as an initial treasury stock transaction and a forward contract, with the forward contract classified as an equity instrument recorded within capital surplus. The remaining shares were received and the forward contract reclassified to treasury stock in February 2023. In 2024, the ASR with Morgan Stanley followed a similar structure but the remaining 15% of shares were received in March 2024, extending the completion timeline by one month compared to prior years. The accounting treatment remained consistent, with the initial 85% of shares recorded as treasury stock and the forward contract reclassified upon final settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 30782,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7919,
        "completion_tokens": 202,
        "total_tokens": 8122
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund (CSPF) evolved in terms of actuarial estimates and sensitivity analysis as follows: In 2022, UPS recorded a $5.1 billion pre-tax gain related to a reduction in its best estimate of potential coordinating benefits for the CSPF, while in 2023, the sensitivity analysis showed the projected benefit obligation for pension plans was highly sensitive to changes in discount rates, with a 25 basis point decrease increasing the obligation by $1.6 billion. This highlights a shift in focus from specific CSPF-related actuarial adjustments in 2022 to broader sensitivity to market-driven assumptions in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11451,
        "completion_tokens": 177,
        "total_tokens": 11629
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard enhanced the positioning of its Cyber and Intelligence Solutions by emphasizing their role in enabling secure, confident, and efficient transactions across the global payments ecosystem. In 2022, the focus was on leveraging these solutions to allow stakeholders to transact \"easily and with confidence.\" By 2023, the value proposition evolved to highlight how these solutions, along with investments in open banking and digital identity, support and strengthen Mastercard's broader payment and services offerings, reinforcing a multi-layered approach to ecosystem security and stakeholder trust.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50733,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12915,
        "completion_tokens": 157,
        "total_tokens": 13072
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. By 2023, the note was still listed as Exhibit 4.11, but the associated documentation date remained unchanged, continuing to reference the October 14, 2015 filing. No new exhibit referencing or updated documentation was provided for this specific note in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32736,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8418,
        "completion_tokens": 107,
        "total_tokens": 8526
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's engagement with Positive Technologies remained consistent under OFAC licensing following U.S. sanctions. In both years, Intel disclosed that it resumed and continued communications with Positive Technologies, a sanctioned Russian IT security firm, to coordinate disclosure of security vulnerabilities identified by the firm. These activities were conducted under a license issued by OFAC and did not generate any gross revenues or net profits for Intel.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48771,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12422,
        "completion_tokens": 121,
        "total_tokens": 12543
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as shown in the long-term debt summaries of both years. This indicates that the company has not refinanced or redeemed these notes, suggesting a stable component within its long-term debt structure. The continued presence of these high-yield notes reflects CVS's strategy of maintaining a diversified mix of long-term debt maturities to manage interest costs and liquidity over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32197,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8277,
        "completion_tokens": 124,
        "total_tokens": 8402
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 (XOM32) were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, indicating they remained outstanding and publicly traded on the New York Stock Exchange during both periods. There is no indication in the provided pages that the status of these notes changed between 2022 and 2024, such as through redemption, maturity, or restructuring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12379,
        "completion_tokens": 106,
        "total_tokens": 12485
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Between 2022 and 2024, American Express significantly reduced its investment in U.S. Government treasury obligations, with the fair value dropping from $1,704 million in 2021 to $287 million in 2024. The maturity distribution also shifted, with 2024 showing a concentration of treasury obligations due within one year ($189 million) compared to 2021, which had a broader maturity spread. This suggests a strategic shift toward shorter-term holdings, likely to manage interest rate risk amid rising rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10095,
        "completion_tokens": 126,
        "total_tokens": 10221
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in June 2020, as detailed in the 2022 10-K filing under Exhibit 4.6. By 2024, the note remained outstanding and was included in the listing of Amazon's long-term debt instruments in the 2024 10-K filing under Exhibit 4.6, indicating no material changes in its terms or status during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11444,
        "completion_tokens": 84,
        "total_tokens": 11529
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from eight to twelve. In 2022, the agreement had amendments labeled 10.8.1 through 10.8.8, indicating eight amendments. By 2023, additional amendments (10.8.9 through 10.8.12) were added, bringing the total to twelve amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54790,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13911,
        "completion_tokens": 85,
        "total_tokens": 13996
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, particularly in terms of integration with new computing architectures and software ecosystems. In 2022, CUDA was positioned as a foundational parallel programming model for NVIDIA GPUs, enabling accelerated computing across AI, data analytics, and scientific workloads. By 2024, CUDA's role expanded with the introduction of the Blackwell architecture, which integrates GPUs, CPUs, DPUs, and advanced networking to deliver data-center-scale solutions optimized for generative AI and other compute-intensive applications. Additionally, CUDA-X, a collection of acceleration libraries, APIs, and SDKs, has been further developed to support domain-specific frameworks, enhancing CUDA's versatility across AI, HPC, and graphics workloads. This evolution reflects NVIDIA's broader strategy to unify its computing platforms and strengthen its ecosystem for diverse applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10492,
        "completion_tokens": 236,
        "total_tokens": 10728
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid underwent a significant transformation. In 2023, Paxlovid contributed $1,279 million in revenue, but this was heavily impacted by a $3.5 billion non-cash revenue reversal in the fourth quarter due to the expected return of EUA-labeled U.S. government inventory. By 2024, Paxlovid's revenue surged to $5,716 million, driven by a favorable $771 million adjustment from returned EUA-labeled treatment courses and the transition to commercial market sales, including $442 million in revenue from supplying the U.S. Strategic National Stockpile (SNS) at no cost. Contractual obligations also evolved, with amended agreements facilitating the shift from government contracts to commercial markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89141,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22509,
        "completion_tokens": 190,
        "total_tokens": 22699
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47,000,000 shares available by the end of 2024. The structure of the program remained consistent, with awards including restricted stock, stock options, and stock appreciation rights, and vesting periods typically spanning three to ten years. The reduction in available shares reflects the issuance of awards over this period, particularly with increased activity in 2024 due to the Pioneer acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45435,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11572,
        "completion_tokens": 129,
        "total_tokens": 11701
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense's role within Google's advertising revenue streams has evolved as part of the broader Google Network, which includes AdMob, Google Ad Manager, and AdSense. While AdSense has historically contributed to Google's advertising revenue, the 2024 report highlights a decline in AdSense-related impressions, partially offset by growth in AdMob. This shift reflects Google's ongoing focus on expanding and optimizing its advertising technology portfolio, leveraging AI advancements and product innovations to enhance ad formats and delivery across platforms. AdSense remains a component of the Google Network's contribution to advertising revenue but is increasingly complemented by other technologies driving growth in the broader advertising ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45087,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11501,
        "completion_tokens": 194,
        "total_tokens": 11695
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan ceased future benefit accruals for non-union participants effective January 1, 2023. This change meant that non-union participants hired prior to July 1, 2016, no longer earned additional retirement benefits based on future service or compensation. Instead, beginning in 2023, non-union employees received retirement contributions of 5% to 8% of eligible compensation to the UPS 401(k) Savings Plan, based on years of vesting service.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44135,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11262,
        "completion_tokens": 114,
        "total_tokens": 11377
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's short-term credit facilities evolved in several key ways. First, the secured revolving credit facility, which was $1.0 billion in 2022, was repaid and terminated by 2024. Second, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, replacing the prior 364-day agreement from November 2023, with interest based on the Secured Overnight Financing Rate (SOFR) plus 0.45%. Additionally, the interest rate terms for short-term credit facilities improved, with the new facility having a lower spread compared to the prior secured facility, which had a spread of 1.25% over SOFR. Outstanding borrowings under short-term credit facilities remained low, with $147 million and $151 million as of December 31, 2023, and 2024, respectively. Overall, Amazon shifted to a more unsecured and cost-effective short-term credit structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14240,
        "completion_tokens": 224,
        "total_tokens": 14465
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as both filings indicate the company uses variable-priced contracts for some electricity, natural gas, and fuel purchases on an index basis. This approach, combined with fixed-price contracts, reflects Costco's balanced commodity price risk management strategy, aiming to partially mitigate exposure to price fluctuations while maintaining operational flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37458,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9594,
        "completion_tokens": 117,
        "total_tokens": 9711
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from a comprehensive AI software suite to becoming a more integral and strategic component of NVIDIA's data center offerings. In 2022, it was positioned as an operating system for enterprise AI applications, emphasizing its role in simplifying the development and deployment of AI solutions. By 2024, NVIDIA AI Enterprise was highlighted as a core element of the full-stack data center platform, integrated with hardware, networking, and software solutions such as DGX Cloud, NIM, NeMo, and AI Blueprints. This evolution reflects NVIDIA's broader strategy to provide end-to-end AI infrastructure and tools, reinforcing its leadership in AI-driven computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12597,
        "completion_tokens": 177,
        "total_tokens": 12775
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Between 2023 and 2024, Pfizer's contractual obligations related to Paxlovid evolved significantly. In 2023, Paxlovid revenues were primarily driven by government contracts, with a large portion tied to the U.S. government's Emergency Use Authorization (EUA) program. A $3.5 billion non-cash revenue reversal was recorded in Q4 2023 due to expected returns of EUA-labeled Paxlovid inventory. By 2024, the product transitioned to traditional commercial markets in the U.S., with negotiated pricing and a copay assistance program. This shift is reflected in Paxlovid's 2024 revenue of $5.7 billion compared to $1.3 billion in 2023, indicating stronger commercial market adoption and improved revenue expectations for the product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77965,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19722,
        "completion_tokens": 181,
        "total_tokens": 19903
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory challenges, such as foreign policy changes, data transfer regulations between the EU and UK, and potential new customer requirements. By 2024, the scope expanded to include more specific and complex geopolitical risks, such as sanctions, export controls, and conflicts in regions like the Middle East and Ukraine, which directly impacted business continuity and regulatory compliance. Additionally, the nature of the challenges became more acute, with increased emphasis on regulatory uncertainty, evolving foreign policy landscapes, and the potential for litigation and new regulatory costs due to heightened geopolitical tensions and local legal complexities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59489,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15108,
        "completion_tokens": 207,
        "total_tokens": 15315
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "UPS's approach to funding postretirement medical benefits remained consistent between 2022 and 2023, with expected benefit payments being funded from both plan trusts and corporate assets. There is no indication of a change in the sources used for these payments during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43857,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11191,
        "completion_tokens": 70,
        "total_tokens": 11262
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as part of the Compute & Networking segment, has evolved significantly by 2024 to become a more comprehensive and integrated solution for enterprises. Initially positioned as a suite of enterprise-grade AI software, it now includes advanced tools such as NVIDIA NIM for enhanced token throughput, NVIDIA NeMo for model customization and evaluation, and AI Blueprints for secure, pre-built deployment templates. This expansion reflects NVIDIA's broader strategy to provide end-to-end AI solutions, supporting both generative AI and traditional machine learning applications across diverse industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 38953,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9954,
        "completion_tokens": 160,
        "total_tokens": 10114
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased significantly, with total oil-equivalent reserves rising from 1,481 million barrels in 2024 (as detailed in the 10-K) to a higher level compared to 2022, which showed fewer equity company reserves. This growth is primarily driven by additions in Asia, where equity company reserves accounted for the majority of the increase. This indicates a strategic focus on expanding reserves in the Asia-Pacific region, likely through joint ventures and partnerships, to strengthen ExxonMobil's long-term resource base and maintain a competitive position in key growth markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11937,
        "completion_tokens": 162,
        "total_tokens": 12099
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "Between 2022 and 2024, Google Network Partners have remained a significant contributor to Alphabet's revenue generation, particularly through advertising on their properties. Google reports advertising revenues from Google Network properties on a gross basis, meaning the amounts billed to customers are recorded as revenues, while amounts paid to Google Network partners are recorded as cost of revenues. While the document does not provide specific figures for changes in revenue or cost structure related to Google Network Partners during this period, it does indicate that Google Network partners are primarily responsible for cost of revenues for ads displayed on their properties. The evolution of this relationship is likely influenced by Alphabet's broader financial trends, such as increased investment in technical infrastructure and AI, which may impact both the scale of advertising and the associated costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52520,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13358,
        "completion_tokens": 230,
        "total_tokens": 13588
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, the financial impact of undesignated foreign currency forward contracts on UPS's earnings volatility decreased significantly. In 2023, UPS recognized a loss of $7 million in \"Investment income and other\" related to these contracts, compared to a much larger loss of $69 million in 2022. This reduction suggests a more stable foreign currency exchange risk management strategy in 2023, with less volatility in earnings due to non-hedging derivative activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 38518,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9870,
        "completion_tokens": 120,
        "total_tokens": 9990
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating stable fee revenue. In 2022, membership fee revenue increased by 9% to $4,224 million, driven by new member sign-ups, Executive membership upgrades, and higher renewal rates. By 2023, membership fee revenue further grew by 5% to $4,828 million, primarily from new member sign-ups and Executive upgrades, though growth was partially offset by one fewer week of operations in the 2024 fiscal year. This evolution highlights Costco's sustained focus on expanding its membership base and enhancing member value, which supports long-term profitability through recurring fee income and increased shopping frequency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21060,
        "completion_tokens": 191,
        "total_tokens": 21252
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved significantly, with greater integration into its broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational programming model for enabling accelerated computing across diverse markets, including AI, data analytics, and scientific computing. By 2024, CUDA had expanded to support a full-stack data center infrastructure, now integrated with CPUs, DPUs, and advanced networking solutions, forming the backbone of the NVIDIA Blackwell architecture. This evolution reflects CUDA's role in enabling scalable AI and high-performance computing workloads, including generative AI, while also supporting NVIDIA's AI Enterprise software suite and cloud-based offerings like DGX Cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10494,
        "completion_tokens": 194,
        "total_tokens": 10688
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid contributed $1,279 million in revenue, a sharp decline from $18,933 million in 2022, reflecting a shift from government contracts to commercial markets. In 2024, Paxlovid revenue rose to $5,716 million as commercialization expanded. Contractually, remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with delivery expected through 2028. Additionally, in 2024, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97612,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24635,
        "completion_tokens": 168,
        "total_tokens": 24803
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has significantly intensified between 2022 and 2024, as evidenced by its reporting of reserves development and inclusion of Guyana as a key component of its \"advantaged assets.\" In 2022, Guyana was highlighted in the context of reserves additions, particularly with discoveries and extensions in the country contributing to proved undeveloped reserves. By 2024, Guyana is explicitly categorized under ExxonMobil's \"advantaged assets,\" which are central to its growth strategy and high-return projects. This shift reflects a more integrated and strategic focus on Guyana as a core asset for long-term volume and earnings growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54558,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13864,
        "completion_tokens": 167,
        "total_tokens": 14032
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "From 2022 to 2024, the planned utilization of the ATR 72-600F aircraft decreased significantly, with 24 planned deliveries through 2025 in 2022, dropping to just 10 planned deliveries through 2025 by 2024. This reduction indicates that the ATR 72-600F is playing a diminished role in FedEx's fleet strategy, as the company is shifting focus toward larger, more fuel-efficient aircraft like the B767F and B777F, which are expected to provide long-term operating savings and replace older aircraft.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10083,
        "completion_tokens": 124,
        "total_tokens": 10207
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to offering Omniverse evolved significantly in terms of integration with AI and simulation platforms. In 2022, Omniverse was primarily positioned as a virtual world simulation and collaboration platform for 3D workflows, with a focus on enterprise use and individual access. By 2024, Omniverse had expanded into a more comprehensive development platform and operating system for building and running virtual world simulation applications, with deeper integration into NVIDIA's AI ecosystem, including AI model training and autonomous vehicle development via DRIVE Constellation and DRIVE Sim. Additionally, Omniverse was increasingly used in data center-based simulation solutions and digital twin applications, reflecting a broader and more interconnected role within NVIDIA's AI and simulation infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 41076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10491,
        "completion_tokens": 213,
        "total_tokens": 10704
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue continued to grow as part of Alphabet's broader expansion into non-advertising revenue streams. In 2023, Google Play remained a key contributor to \"Google subscriptions, platforms, and devices\" revenue, which includes sales of apps and in-app purchases. While specific revenue figures for Google Play are not provided, the overall increase in Google Services revenue by $19.0 billion (8%) year-over-year suggests a positive contribution from Google Play. Additionally, the 2023 filing emphasizes continued investment in platforms like Google Play, reflecting its importance in Alphabet's diversification strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36814,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9413,
        "completion_tokens": 173,
        "total_tokens": 9586
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business evolved between 2022 and 2023 by extending the period of significant weight given to these methods. In 2023, expected loss ratio methods for excess of deductible business were applied to the most recent five accident years, compared to prior years where they were primarily used for the most recent accident year in guaranteed cost business. This shift reflects a greater reliance on expected loss ratios for newer, high-deductible policies, which have slower claim emergence patterns. Additionally, the proportion of large deductible business has increased, further influencing the slower reporting of claims and the need for more forward-looking reserving techniques like expected loss ratios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 268521,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 67365,
        "completion_tokens": 206,
        "total_tokens": 67571
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024 by consolidating and reorganizing its categories. In fiscal 2022, the categories were Secure, Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, these were simplified into Networking, Security, Collaboration, and Observability. The Collaboration category saw a slight revenue increase of 2% in fiscal 2024 compared to fiscal 2023, driven by growth in offerings other than Meetings, following a 9% decline in fiscal 2023 compared to fiscal 2022 due to declines in Collaboration Devices and Meetings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40560,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10361,
        "completion_tokens": 169,
        "total_tokens": 10530
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of the stated coupon rate from 2022 to 2023, with both years reporting a $1,000 million principal amount. However, in 2023, there was a notable addition of new notes issued in connection with the acquisition of Horizon, including the 5.25% 2025 Notes with a $2,000 million principal amount, which expanded the overall interest rate framework for 2025 maturities. This indicates a broader and more complex debt structure for 2025 in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43787,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11173,
        "completion_tokens": 133,
        "total_tokens": 11307
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 764 billion cubic feet (BCF) at the end of 2021 to 296 BCF at the end of 2024. This decline indicates a strategic shift away from natural gas in that region, with the company focusing more on other areas like the Lower 48 and Canada. The reduction in reserves is partly attributed to downward revisions due to lower prices and changes in development plans, suggesting a reduced emphasis on natural gas exploration and development in Asia Pacific/Middle East.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 174,
          "pages": [
            172,
            173,
            174,
            175,
            176
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77101,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19510,
        "completion_tokens": 134,
        "total_tokens": 19645
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $52.6 billion in 2022 to $52.9 billion in 2023, indicating a slight rise in the company's commitment to returning value to shareholders. This consistent level of repurchases suggests that Alphabet remains focused on capital allocation strategies that prioritize share buybacks as a means to enhance shareholder value, particularly amid strong cash flow generation and a large cash reserve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56455,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14342,
        "completion_tokens": 115,
        "total_tokens": 14457
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG's use of frequency/severity methods has evolved in terms of the lines of business where they are applied and the reasoning behind their usage. In 2022, the focus was on short-tail classes such as U.S. Property, where frequency/severity methods, loss development methods, and IBNR factor methods were used alone or in combination. The IBNR factor method was particularly used for low-frequency/high-severity losses, with factors adjusted for current cost levels and emerging claim experience.\n\nIn 2023, the application of these methods expanded to include more nuanced considerations. For U.S. Workers' Compensation, a long-tail line of business, AIG used a combination of loss development, frequency/severity, and expected loss ratio methods. The reasoning for using frequency/severity methods in 2023 was driven by the need to account for risk-sharing features in policies, such as high deductibles and retrospective rating, which altered claim reporting patterns and required more detailed segmentation by deductible size and claim handling. This evolution reflects AIG's adaptation to changing risk profiles and the need for more precise reserve estimation in complex and evolving underwriting environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 298130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 74765,
        "completion_tokens": 309,
        "total_tokens": 75074
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "Amgen's financial relationship with BeiGene from 2022 to 2023 shows a decline in cost recovery, with net costs recovered from BeiGene for oncology product candidates decreasing from $199 million in 2022 to $109 million in 2023. Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023, while profit and loss share expenses decreased from $53 million in 2022 to $40 million in 2023. As of December 31, 2023, amounts owed from BeiGene for product sales were $16 million, and net amounts owed from BeiGene for cost recoveries and profit and loss share payments were $44 million, compared to $6 million and $47 million, respectively, as of December 31, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12015,
        "completion_tokens": 173,
        "total_tokens": 12188
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region experienced the following changes:\n\n- **Revisions**: In 2024, there were minor upward revisions of 6 BCF in the Asia Pacific/Middle East region due to technical updates and development plan adjustments, though these were relatively small compared to other regions. In 2023, the region faced downward revisions, primarily due to infrastructure constraints and sales demand revisions, while in 2022, upward revisions were driven by higher prices and improved regional LNG market dynamics.\n\n- **Production**: Natural gas production in the Asia Pacific/Middle East region reduced reserves by 25 BCF in 2023 and 24 BCF in 2022, reflecting ongoing extraction activities.\n\n- **Purchases**: There were no significant purchases in the Asia Pacific/Middle East region in 2024 or 2023. However, in 2022, purchases in equity affiliates were due to the acquisition of additional affiliate interest in the Asia Pacific region.\n\nOverall, the region's natural gas reserves remained relatively stable, with changes primarily influenced by production and minor revisions rather than major acquisitions or discoveries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20965,
        "completion_tokens": 296,
        "total_tokens": 21261
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft decreased significantly. In 2022, FedEx had committed to purchasing 38 B767F aircraft across 2023 and 2024, but by 2024, the total number of B767F aircraft planned for purchase was reduced to 14, with deliveries scheduled only in 2025. This reduction indicates a strategic shift in fleet planning, likely driven by evolving operational needs, fuel efficiency considerations, or financial optimization, as FedEx prioritized other aircraft types like the Cessna SkyCourier 408 and ATR 72-600F for regional and mid-size freight operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39914,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10199,
        "completion_tokens": 149,
        "total_tokens": 10348
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of Expected Loss Ratio Methods evolved in terms of the lines of business and the reasoning behind their application. In 2022, these methods were primarily used for newer accident years in short-tail lines, such as U.S. Property and Special Risks, where there was limited historical loss data or inconsistent loss development patterns. The reasoning was to provide reliable reserve estimates by leveraging expected loss ratios adjusted for rate changes, inflation, and market conditions.\n\nIn 2023, the application of Expected Loss Ratio Methods expanded to include more recent accident years across a broader range of lines, including U.S. Excess Casualty and U.S. Workers' Compensation, where loss emergence was slower or data was sparse. The reasoning remained consistent with 2022, emphasizing the need to account for emerging trends, inflation, and market dynamics, particularly in lines with high severity and long-tail characteristics. This evolution reflects AIG's continued focus on adapting its reserving methodologies to align with changing risk profiles and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 298130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 74761,
        "completion_tokens": 279,
        "total_tokens": 75041
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation from 2022 to 2024 has evolved to emphasize strategic alliances and adapt to a more competitive landscape. In 2022, Cisco highlighted its strategic alliances with companies like Google, Microsoft, and Amazon Web Services to drive innovation and market expansion. By 2024, the company expanded its focus on these partnerships to address the convergence of computing, networking, storage, and software in the enterprise data center, while also acknowledging that some alliance partners may compete in other areas. This evolution reflects a more nuanced strategy to leverage alliances for competitive advantage while navigating an increasingly complex and competitive environment marked by technological convergence and rising competition from both traditional and emerging players.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47022,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11984,
        "completion_tokens": 210,
        "total_tokens": 12195
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes increased from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a shift from LIBOR to SOFR-based swaps. The notional amount remained unchanged at $1,000 million for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44739,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11402,
        "completion_tokens": 59,
        "total_tokens": 11461
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics has evolved from 2022 to 2024 by being integrated more prominently into its observability offerings. In 2022, AppDynamics was highlighted as a key element in delivering full-stack observability from applications to infrastructure. By 2024, AppDynamics, along with ThousandEyes and the Splunk acquisition, was explicitly grouped under the new Observability product category, which saw a 27% revenue increase in 2024 compared to 2023. This reflects a stronger emphasis on observability as a core component of Cisco's strategy to provide comprehensive insights and intelligence for hybrid and multicloud environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44316,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11306,
        "completion_tokens": 164,
        "total_tokens": 11471
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes increased from 5.6% in 2022 to 5.6% in 2023, remaining unchanged. The notional amount associated with these notes was $1,500 million in both 2022 and 2023, indicating no change in the notional amount during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44739,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11401,
        "completion_tokens": 68,
        "total_tokens": 11469
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved with a continued focus on long-tail lines of business such as U.S. Workers' Compensation and U.S. Excess Casualty. In 2023, the segmentation criteria have become more refined, particularly for U.S. Workers' Compensation, where guaranteed cost and excess of deductible business are analyzed separately by state and industry subset. Additionally, AIG has increased its use of expected loss ratio methods for recent accident years, incorporating adjustments for rate changes, loss trends, and market conditions. This evolution reflects a more granular and dynamic approach to reserving, especially in response to external factors like inflation and judicial trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 167516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 42104,
        "completion_tokens": 184,
        "total_tokens": 42289
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.850% Senior Notes due 2026 reflected a broader strategy of diversifying its debt issuance, particularly through the introduction of additional notes in 2024. In 2023, the company issued the 5.125% Senior Notes due 2026, indicating a focus on higher-yield, shorter-term debt. By 2024, PepsiCo expanded its debt portfolio by issuing the 2.850% Senior Notes due 2026, signaling a shift toward lower coupon rates and longer-term maturities as part of its capital structure optimization. This evolution suggests PepsiCo's aim to balance cost efficiency and maturity diversification in its debt strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16648,
        "completion_tokens": 163,
        "total_tokens": 16812
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased slightly between fiscal years 2022 and 2024, with the maximum potential future payments rising from $155 million in 2022 to $188 million in 2024. This modest increase suggests that Cisco has maintained a relatively stable approach to its channel partner financing programs, facilitating working capital for partners while limiting its guarantees to a controlled level. The company's financial risk management strategy appears to emphasize careful oversight, as the guarantees remain a small portion of the overall financing arrangements, and payments under these guarantees have historically been immaterial. This indicates a measured and conservative approach to managing credit risk associated with channel partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52441,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13342,
        "completion_tokens": 196,
        "total_tokens": 13539
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes remained outstanding with a principal amount of $1,250 million in both 2022 and 2023, indicating no change in the principal balance. Additionally, in 2023, an interest rate swap contract with a notional amount of $1,000 million was in place, converting the fixed-rate coupon to SOFR + 1.3%. This swap was also in place in 2022, with the same notional amount and a similar structure (LIBOR + 1.0% in 2022). Thus, the interest rate structure remained consistent, transitioning from LIBOR to SOFR-based swaps, while the principal and hedging strategy for the 2.45% 2030 Notes remained unchanged between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44987,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11459,
        "completion_tokens": 158,
        "total_tokens": 11617
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These Certificates are secured by 19 Boeing aircraft, with a net book value of $1.8 billion in 2022 and $1.7 billion in 2023. Crucially, the payment obligations under these Certificates are fully and unconditionally guaranteed by FedEx in both years, indicating no material change in the nature or extent of FedEx's guarantees or obligations during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45912,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11701,
        "completion_tokens": 165,
        "total_tokens": 11866
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard's use of risk mitigation arrangements to manage gross settlement exposure increased from $12,167 million to $13,466 million, while gross settlement exposure itself rose from $75,023 million to $78,385 million. This indicates that the company enhanced its risk management strategy by applying more robust risk mitigation measures as its exposure grew, reflecting a proactive approach to safeguarding against potential settlement failures and maintaining financial stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67745,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17170,
        "completion_tokens": 125,
        "total_tokens": 17296
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $48 million as of May 31, 2022, to $146 million as of May 31, 2024. This change indicates a shift in the fair value of these hedging instruments, likely due to fluctuations in foreign currency exchange rates and changes in the notional amounts of the hedging contracts. The decrease in liabilities suggests that the company's hedging strategy may have become more favorable in terms of its foreign currency exposures during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63468,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16103,
        "completion_tokens": 144,
        "total_tokens": 16247
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10-K filing, Bounty is listed as part of the Baby, Feminine & Family Care segment under the \"Family Care\" sub-category, alongside Charmin and Puffs. The 2023 10-K filing maintains this structure, with Bounty still included in the Family Care sub-category within the same segment. However, in the 2023 filing, the segment's description specifies that Bounty holds over 40% North America market share, indicating a consistent and strong regional presence. This suggests that Bounty maintains a prominent position within P&G's portfolio and has stable brand visibility, particularly in North America.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12940,
        "completion_tokens": 152,
        "total_tokens": 13093
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's hardware business, particularly Oracle Engineered Systems, saw a slight decline in revenue, with hardware revenues remaining at 6% of total revenues in both fiscal years. In terms of strategic emphasis, Oracle continued to focus on improving existing hardware products and developing new ones, while also investing in research and development. The hardware business is characterized by lower operating margins compared to the cloud and license business due to higher production and support costs. Oracle also highlighted the challenges in predicting hardware revenues due to factors like manufacturing delays and customer demand shifts toward cloud infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12707,
        "completion_tokens": 177,
        "total_tokens": 12885
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, sales of ERLEADA increased by 26.9%, from $1.881 billion to $2.387 billion. This significant growth indicates a strong market trajectory for ERLEADA, driven by continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37762,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9659,
        "completion_tokens": 73,
        "total_tokens": 9732
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "CMCSA's relationship with local broadcast television stations from 2023 to 2024 has shown increased dependency and competitive tension, particularly in securing programming rights and distribution agreements. In 2023, the company emphasized competition with local broadcast stations for content acquisition and distribution, especially for sports rights and affiliations necessary for nationwide broadcast reach. By 2024, the dependency on local broadcast stations has grown more pronounced, with retransmission consent and carriage agreements becoming more critical as traditional multichannel video providers face subscriber declines. Additionally, the 2024 filing highlights the potential for increased programming expenses due to demands from local stations for payment and concessions, underscoring a more competitive and costly environment for content distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55861,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14200,
        "completion_tokens": 217,
        "total_tokens": 14418
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly between 2023 and 2024, from $306 million in 2023 to $38 million in 2024. This shift suggests a strategic reallocation of investments, likely in response to changing market conditions or a shift in the company's liquidity management approach. The reduction in HTM securities, which are typically long-term in nature, may indicate a move toward more flexible or short-term investment vehicles, such as available-for-sale securities, to enhance liquidity or capitalize on investment opportunities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14410,
        "completion_tokens": 147,
        "total_tokens": 14557
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment underwent a notable repositioning in terms of product categorization. In 2022, Always was listed under the \"Feminine Care\" sub-category alongside \"Adult Incontinence,\" while \"Family Care\" was a separate sub-category. By 2023, the structure was revised, with Always being specifically highlighted under the \"Menstrual Care\" sub-category within Feminine Care, which was further distinguished as a key sub-category with over 25% global market share. Additionally, \"Adult Incontinence\" was separated into its own sub-category under Feminine Care, now branded behind Always Discreet. This change reflects a more refined and targeted categorization of Always products, emphasizing its leadership in the menstrual care segment and a clearer distinction between its product lines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12948,
        "completion_tokens": 218,
        "total_tokens": 13167
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Between 2022 and 2023, Oracle's Oracle Engineered Systems remained a component of its hardware business, which contributed approximately 6% of total revenues in both fiscal years. The hardware business, including Engineered Systems, involves revenue recognition at the point of delivery when ownership transfers to the customer. While the hardware business is strategically positioned to support Oracle's broader cloud and infrastructure offerings, it historically has lower operating margins compared to Oracle's cloud and license business due to production and distribution costs. There is no indication of a significant strategic shift or change in financial contribution for Oracle Engineered Systems between the two periods based on the provided information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12349,
        "completion_tokens": 190,
        "total_tokens": 12540
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales strategy remained largely consistent between 2023 and 2024. In both years, the company worked with representation firms as an extension of its sales force to sell a portion of allocated advertising units, recording revenue net of agency commissions. There were no significant changes in this strategy as outlined in the 2023 and 2024 10-K filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14024,
        "completion_tokens": 104,
        "total_tokens": 14128
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's approach to its industry-specific hardware offerings remained relatively consistent in terms of revenue recognition and strategic emphasis. Revenue recognition for hardware products and related software is generally recognized at the point in time when the hardware and its associated software are delivered to the customer and ownership is transferred. Hardware support contracts are recognized ratably over the contractual term. Strategically, Oracle continued to focus on providing a broad range of hardware products and support services, emphasizing their integration with Oracle's software and cloud offerings. However, the hardware business represented a smaller portion of Oracle's total revenues (6% in both fiscal 2024 and 2023), and Oracle's strategic emphasis appeared to be more on its cloud and license offerings, which accounted for a larger share of revenue and growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12705,
        "completion_tokens": 232,
        "total_tokens": 12938
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.78 billion in 2022 to $3.26 billion in 2023. This decrease was primarily driven by global competitive pressures from novel oral agents in the oncology space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38724,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9897,
        "completion_tokens": 58,
        "total_tokens": 9956
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort from 2023 to 2024 shows a slight reduction in debt levels, with debt outstanding decreasing from $3.5 billion in 2023 to $3.4 billion in 2024. Comcast maintains a 30% ownership stake, and the resort remains consolidated under Comcast's Theme Parks segment. Financial risk exposure remains limited to Comcast's equity interest, as there are no guarantees or liquidity arrangements between Comcast and Universal Beijing Resort.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51731,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13157,
        "completion_tokens": 119,
        "total_tokens": 13277
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, the financial commitment related to future lease payments for build-to-suit facilities and equipment decreased significantly from approximately $3.4 billion to $0.9 billion. This reduction suggests that FedEx either delayed or scaled back its plans for new build-to-suit facilities and equipment, indicating a more conservative or strategic adjustment in its leasing approach during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47778,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12177,
        "completion_tokens": 103,
        "total_tokens": 12280
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard acquired Dynamic Yield LTD in April 2022 for $325 million, aiming to enhance its capabilities in data-driven personalization and decisioning. Between 2023 and 2024, there is no indication of a significant change in the relationship with Dynamic Yield, as no further acquisitions or divestitures involving this entity are mentioned in the 2024 10-K. This suggests that the integration of Dynamic Yield has been completed, and the focus has shifted toward leveraging the acquired capabilities to support Mastercard's strategic goals in digital transformation and fraud prevention.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13182,
        "completion_tokens": 147,
        "total_tokens": 13329
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was amended and restated on May 26, 2022, as indicated in Exhibit 10.28 of the 2024 filing. There is no evidence of further amendments to this plan between 2022 and 2024 based on the provided documents. The 2024 filing incorporates the 2022 version of the plan without noting any subsequent changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9365,
        "completion_tokens": 87,
        "total_tokens": 9452
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This decline in fair value indicates that market perceptions of the company's debt have worsened over this period, likely due to factors such as higher interest rates, economic uncertainty, or concerns about Netflix's financial health.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11268,
        "completion_tokens": 94,
        "total_tokens": 11362
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline was primarily driven by global competitive pressures in the oncology segment, indicating a weakening market position for IMBRUVICA as newer therapies gained traction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37762,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9662,
        "completion_tokens": 72,
        "total_tokens": 9734
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve decreased from $168 million to $222 million. These changes had implications for net earnings, with a 10% change in the shrink reserve affecting net earnings by approximately $31 million in 2022 and $32 million in 2024, and a 10% change in the LCNRV reserve impacting net earnings by approximately $13 million in 2022 and $17 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36934,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9451,
        "completion_tokens": 116,
        "total_tokens": 9567
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta's status and financial contribution evolved significantly from 2022 to 2023, with its net revenues increasing by more than 100% in 2023, primarily driven by strong market share uptake and market growth. This growth was further supported by the regulatory approval of Qulipta for the preventive treatment of chronic migraine in adults in April 2023 and its approval in the European Union as Aquipta in August 2023. These developments marked Qulipta's successful transition from a new product in 2022 to a key contributor in AbbVie's Neuroscience portfolio in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48350,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 142,
        "total_tokens": 12453
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent, with quarterly reimbursements of $140 million in both years. However, the recorded receivable from Resideo increased from $157 million in 2022 to $187 million in 2023, indicating higher environmental costs incurred by Honeywell during 2023. This suggests that while the cap on reimbursements remains in place, Honeywell's exposure to environmental liabilities has slightly increased, relying more on Resideo to offset these costs. This dependency highlights an ongoing risk for Honeywell if Resideo is unable to meet its obligations under the agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84482,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21352,
        "completion_tokens": 171,
        "total_tokens": 21523
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of 'original maturity' for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of cash and cash equivalents has shifted, with a notable decrease in short-term investments from $4,985 million in 2022 to $3,893 million in 2024. This reduction may indicate a more conservative cash management strategy, potentially prioritizing liquidity and reducing exposure to market fluctuations in short-term investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42942,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10970,
        "completion_tokens": 152,
        "total_tokens": 11122
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 decreased slightly from $870 million in 2023 to $851 million in 2024, indicating a minor decline in fair value. These notes are classified as Level 2 liabilities and are carried at their original issuance value, net of unamortized debt discount and issuance costs. The slight reduction in valuation suggests stable long-term debt management, with no significant refinancing or restructuring activity observed during this period. This reflects a consistent approach to maintaining long-term debt obligations without material changes in strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10497,
        "completion_tokens": 147,
        "total_tokens": 10644
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased by 15%, with U.S. revenue growing by 8% and international revenue rising by 22%. This growth was driven by continued market expansion across all indications, increased market share, and favorable pricing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45016,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11474,
        "completion_tokens": 67,
        "total_tokens": 11542
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the most recent version being effective January 1, 2024, as disclosed in the 2023 filing. This represents an update from the 2022 filing, which referenced the Amended and Restated Executive Severance and Retention Incentive Plan dated September 10, 2021, without indicating further changes in 2022. The 2023 filing also introduced a new \"Netflix, Inc. Executive Officer Severance Plan\" disclosed on December 8, 2023, suggesting a more tailored approach to executive severance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46327,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11813,
        "completion_tokens": 143,
        "total_tokens": 11957
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "Lowe's Benefit Restoration Plan, as detailed in the 2024 10-K (page 78), was amended and restated as of January 1, 2025, indicating a formal update to its structure. While the 2022 10-K (page 70) only briefly mentions the plan as a supplement to the 401(k) Plan, the 2024 filing provides more explicit documentation of the plan's existence and amendments. This evolution suggests that Lowe's is refining its retirement benefits to better support employees whose benefits are limited by IRS regulations, reflecting a continued commitment to competitive and comprehensive retirement offerings for its workforce.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47145,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12017,
        "completion_tokens": 152,
        "total_tokens": 12170
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 were fully repaid in fiscal year 2025, as indicated by the note repayment details in the 2025 10-K. Specifically, the 0.584% Notes Due 2024 had a net carrying amount of $1,250 million as of January 28, 2024, but were repaid in full during fiscal year 2025, with no balance remaining as of January 26, 2025. This reflects the evolution of the obligation from being outstanding in fiscal year 2024 to being settled in fiscal year 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41078,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10483,
        "completion_tokens": 124,
        "total_tokens": 10607
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue performance showed a slight decline, with total net revenues decreasing by 7.2%. In the United States, Mavyret's revenue decreased by 12.7%, while internationally, it saw a minor decline of 1.9%. This indicates a stronger market presence in the U.S., where the decline was more pronounced, compared to the international markets, which experienced a more modest decrease.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11551,
        "completion_tokens": 104,
        "total_tokens": 11656
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes. In 2022, the company had $15,393 million in outstanding notes, with covenants restricting activities such as incurring liens, engaging in sale-leaseback transactions, and merging or consolidating. By 2024, the outstanding notes increased slightly to $15,583 million, and the covenants remained largely consistent, including limitations on liens, mergers, and additional indebtedness. Notably, in 2024, Netflix expanded its revolving credit facility from $1 billion to $3 billion, adding a new covenant requiring a minimum EBITDA-to-interest expense ratio of 3.0 to 1.0. Despite these changes, Netflix was in compliance with all covenants as of both December 31, 2022, and December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11371,
        "completion_tokens": 200,
        "total_tokens": 11572
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell's approach to the Safety and Retail product line evolved through a structural realignment within the Safety and Productivity Solutions segment. In July 2022, the Safety and Retail business unit, which included the gas detection and safety business, was combined with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. This realignment reflects a shift toward consolidating related offerings under a unified structure to enhance operational focus and efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52053,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13241,
        "completion_tokens": 137,
        "total_tokens": 13378
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "The status and role of Class B-2 Common Stock evolved significantly between 2023 and 2024, primarily due to its newfound convertibility into Class A Common Stock. In 2023, Class B-2 Common Stock had no outstanding shares and no earnings per share, as indicated by a dash in the financial tables. By 2024, however, 49 shares of Class B-2 Common Stock were outstanding, and they became convertible under the U.S. retrospective responsibility plan, which activates upon the final resolution of covered litigation. This convertibility implies a potential dilution of voting power for existing Class A Common Stockholders and could impact the market price of Class A shares if significant conversions occur. Additionally, the introduction of Class B-2 Common Stock into the capital structure adds another layer of complexity to corporate governance, as it may influence decision-making on major corporate actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57610,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14626,
        "completion_tokens": 227,
        "total_tokens": 14853
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced its ease of shopping experience by expanding both digital and in-store capabilities. In 2024, the company made significant investments in digital platforms, improving mobile app functionality, and enhancing the \"shopability\" of online products with more detailed information and fulfillment options. Additionally, in-store improvements included expanded self-checkout options, electronic shelf labels, and mobile tools like hdPhones and Computer Vision to improve associate productivity and customer navigation. The company also continued to invest in its supply chain, including same-day and next-day delivery capabilities, and leveraged its stores as fulfillment centers to support a seamless, interconnected shopping experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 194,
        "total_tokens": 13499
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved by introducing new forms of equity awards. In 2022, the plan included Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded to include additional award structures such as Cliff-Vested RSUs and Performance Award Performance Share Units, reflecting a broader approach to long-term incentive compensation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11662,
        "completion_tokens": 108,
        "total_tokens": 11770
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was FDA approved in September 2021 for the preventive treatment of episodic migraine in adults. By 2023, its net revenues increased by more than 100%, driven by strong market share uptake and market growth, following its additional approval in April 2023 for the preventive treatment of chronic migraine in adults and its EC approval in August 2023 for migraine treatment in the EU.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42883,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10938,
        "completion_tokens": 97,
        "total_tokens": 11035
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, Netflix's treatment and disclosure of the 2020 Stock Plan remained structurally consistent, as it continued to be described as a stockholder-approved plan providing for equity awards to employees, directors, and consultants. However, in 2024, there was a notable shift in equity compensation activities: the company ceased granting new stock options and RSUs in 2023 and 2022, and only a limited number of RSUs were granted in 2024, with no new stock options issued that year. Additionally, stock-based compensation expenses decreased significantly from $575 million in 2022 to $273 million in 2024, reflecting reduced activity under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51274,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13055,
        "completion_tokens": 170,
        "total_tokens": 13226
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company maintained its use of derivative instruments for aluminum purchase agreements, classifying them as derivative instruments for accounting purposes due to their pricing and offsetting nature based on market prices. However, there was a notable shift in the notional amounts and fair values of these instruments. In 2023, the notional amount of commodity contracts decreased from $412 million in 2022 to $115 million, while the fair value of these contracts also declined. Additionally, the company continued to use these agreements to address long-term strategic sourcing and non-U.S. business needs, but there was no significant change in their strategic use compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42893,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10955,
        "completion_tokens": 177,
        "total_tokens": 11132
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on the company’s website, with no changes to its availability. However, the 2024 filing provided a slightly updated URL for the Directors' Code of Conduct (https://www.bny.com/...), suggesting a minor update in the web location or formatting for easier navigation. The scope of the code, which applies to all directors and includes provisions for amendments and waivers to be disclosed on the website, remained consistent between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34529,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8854,
        "completion_tokens": 129,
        "total_tokens": 8983
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the structure and value of HD's 4.95% Senior Notes evolved significantly. In 2023, HD had $750 million in 4.95% Senior Notes due September 2026, with a net carrying amount of $744 million. By 2024, HD issued an additional $1.75 billion in 4.95% Senior Notes due June 2034 as part of a larger June 2024 debt issuance to fund the SRS acquisition. This indicates a strategic shift toward longer-term debt to finance large-scale acquisitions and manage liquidity, while maintaining a diversified maturity profile to reduce refinancing risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13277,
        "completion_tokens": 139,
        "total_tokens": 13417
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its investment in Beijing Unisoc Technology Ltd. in 2021. As of December 30, 2023, the net book value of this investment remained stable at $1.1 billion, consistent with its value as of December 31, 2022. No further observable price adjustments were reported for Unisoc in 2022 or 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42098,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10760,
        "completion_tokens": 93,
        "total_tokens": 10854
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022, Qulipta was not yet approved, as no mention of its regulatory status is found in the 2022 filing. By April 2023, AbbVie received FDA approval for Qulipta for the preventive treatment of chronic migraine in adults, and in August 2023, the European Commission approved Aquipta (Qulipta) for migraine prevention in adults with four or more migraine days per month. This indicates a significant advancement in Qulipta's regulatory and commercial development from 2022 to 2023, with successful approvals in key markets and the initiation of commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42979,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10965,
        "completion_tokens": 140,
        "total_tokens": 11106
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its description of the services offered, as both filings list it as part of the full spectrum of services provided to commercial and defense customers. However, the 2023 filing places a slightly more strategic emphasis on the integration of these services within the broader lifecycle of aerospace platforms, highlighting their role in sustaining and enhancing customer value across fleet operations. This subtle shift reflects a more customer-centric and lifecycle-oriented strategic narrative in 2023 compared to the more general description in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39612,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10131,
        "completion_tokens": 170,
        "total_tokens": 10301
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. remained relatively stable in valuation between 2021 and 2023. As of December 30, 2023, the net book value of the investment was $1.1 billion, unchanged from December 31, 2022. In 2021, Intel recognized $471 million in observable price adjustments for the investment, indicating a valuation increase that year. No significant impairments or gains from sales were reported for Unisoc during 2022 or 2023, suggesting a consistent but non-fluctuating recognition of the investment's value over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54001,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13729,
        "completion_tokens": 138,
        "total_tokens": 13868
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has evolved to enhance convenience and streamline customer fulfillment. In 2023, self-service lockers were introduced at the front entrance of many stores to enable convenient online order pickup options. By 2024, these lockers continued to be a key component of the interconnected retail strategy, complementing services like curbside pickup and supporting the growing demand for efficient and flexible order fulfillment. This expansion reflects Home Depot's ongoing commitment to optimizing the customer experience through technology-driven solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50358,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12803,
        "completion_tokens": 166,
        "total_tokens": 12969
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "From 2023 to 2024, Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities remained largely consistent in terms of detail and specificity. Both years explain that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions, and note that these estimates are subject to significant adjustments if future occurrences differ from assumptions. However, the 2024 disclosure added a brief mention of the Company's wholly-owned captive insurance subsidiary and reinsurance program, providing slightly more context on risk management mechanisms. Overall, the level of detail and specificity did not significantly evolve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9336,
        "completion_tokens": 180,
        "total_tokens": 9517
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs increased from 2022 to 2023. In 2022, the Aldevron acquisition increased cost of sales by $59 million due to fair value adjustments to inventory. In 2023, the impact was more significant, with $87 million in charges primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a worsening impact on inventory-related costs following the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51181,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13006,
        "completion_tokens": 117,
        "total_tokens": 13123
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with liabilities accounted for as a shop card liability, net of estimated breakage, and included in other current liabilities in the consolidated balance sheets. The recognition of breakage is based on historical redemption data, indicating a conservative and data-driven approach to estimating unclaimed balances. This consistency suggests that Costco maintains a reliable methodology for managing shop card liabilities and accounts for unclaimed balances prudently, reflecting its disciplined financial reporting practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10834,
        "completion_tokens": 157,
        "total_tokens": 10992
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2022, IFS launched the Accelerator Ecosystem Alliance program and secured foundational agreements. By 2023, the program had doubled to over 40 strategic agreements, including multigenerational partnerships with ARM and a definitive agreement with Synopsys, enhancing IP and EDA support for customers. Additionally, IFS expanded its RAMP-C program partnerships and secured four design wins on Intel 18A, including a major high-performance computing customer, reflecting growing customer confidence and engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8741,
        "completion_tokens": 159,
        "total_tokens": 8901
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron remained consistent in terms of goodwill and net cash consideration. In 2022, the Aldevron acquisition was recorded with $6.1 billion of goodwill and a net cash consideration of $9.56 billion. In 2023, the goodwill related to Aldevron remained unchanged at $6.1 billion, and the net cash consideration was still $9.56 billion, indicating no significant changes in the financial impact of the acquisition during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50530,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12855,
        "completion_tokens": 119,
        "total_tokens": 12975
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes has remained unchanged between the 2022 and 2024 SEC filings, with both documents listing the maturity date as September 5, 2026. This consistency suggests that there has been no refinancing or restructuring of this particular debt instrument during this period, indicating stability in this segment of AT&T's debt structure. However, the overall debt profile shows a continued focus on long-term obligations, with many notes maturing well beyond 2026, reflecting the company's strategy of maintaining a long-duration debt portfolio to match its capital needs and cash flow timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10756,
        "completion_tokens": 159,
        "total_tokens": 10916
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024, as stated in both the 2023 and 2024 10-K filings. However, in 2024, Target modified its credit facility structure by obtaining a new $1.0 billion 364-day unsecured revolving credit facility in October 2024, which replaced the prior 364-day facility and extended the expiration of its existing $3.0 billion five-year facility to October 2028. These changes likely enhanced Target's liquidity and flexibility, supporting continued compliance with its debt leverage covenant.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38127,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9759,
        "completion_tokens": 139,
        "total_tokens": 9898
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023 through a more ambitious and structured RISE strategy, with a stronger emphasis on external collaboration. In 2022, Intel focused on digital readiness through its Intel Digital Readiness Programs, such as AI for Youth and AI for Workforce, in partnership with governments and institutions. By 2023, the company expanded these efforts under the RISE Technology Initiative, which aimed to build deeper relationships with customers and partners to create shared value. Additionally, Intel launched the Alliance for Global Inclusion, creating a global Inclusion Index to benchmark diversity and inclusion practices across industries, and increased its focus on expanding digital readiness for millions globally through collaborative initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51328,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13064,
        "completion_tokens": 209,
        "total_tokens": 13273
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine evolved from a planned acquisition to a terminated agreement between 2023 and 2024. In 2022, AspenTech (a subsidiary of Emerson) agreed to acquire Micromine for approximately $623 million, but the transaction was terminated on August 1, 2023, due to regulatory uncertainties in Russia. No financial implications, such as termination fees or material losses, were associated with this change, as AspenTech did not incur any costs related to the termination.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9983,
        "completion_tokens": 123,
        "total_tokens": 10106
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from 17 million shares in 2022 to 15 million shares in 2023. Additionally, the average purchase price of shares during the fiscal year under the ESPP decreased from $305.14 in 2022 to $277.19 in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42905,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10956,
        "completion_tokens": 75,
        "total_tokens": 11032
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, the pattern of impairment triggers and associated charges across DHR's business segments indicates a shift in risks affecting its intangible asset portfolio. In 2023, impairment triggers were identified in the Biotechnology and Diagnostics segments, resulting in a $77 million charge, primarily related to technology-based intangible assets. In contrast, 2022 saw no impairment charges, while 2021 had a smaller $10 million charge in the Diagnostics segment. This evolution suggests increased vulnerability in the Biotechnology segment's intangible assets, likely driven by market or operational challenges, while the Diagnostics segment continues to face periodic risks. The absence of impairments in 2022 reflects relative stability before the renewed pressures in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54519,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13870,
        "completion_tokens": 198,
        "total_tokens": 14069
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, indicating a significant rise in the company's involvement in business transactions tied to trade contracts during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43237,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11047,
        "completion_tokens": 64,
        "total_tokens": 11111
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2023 SEC filing as part of the company's financial instruments, with the instrument defining their terms filed as Exhibit 4.1 to Form 8-K on February 10, 2020. In the 2024 SEC filing, these notes are listed again under the company's registered securities, indicating continued relevance in IBM's capital structure. This evolution in disclosure reflects IBM's consistent and transparent reporting of its debt instruments, ensuring investors are informed about the terms and status of its outstanding obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14226,
        "completion_tokens": 141,
        "total_tokens": 14367
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "Between 2023 and 2024, IBM's 1.750% Notes due 2031 were consistently disclosed as being registered on the New York Stock Exchange (NYSE). In both the 2023 and 2024 10-K filings, the notes are listed under the securities registered on the NYSE, with the ticker symbol \"IBM31.\" There is no indication of material changes in the treatment, registration status, or disclosure requirements for these notes between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14222,
        "completion_tokens": 105,
        "total_tokens": 14328
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, the sale of these rights contributed $1.615 billion in revenue outside the U.S., significantly boosting overall revenue for that year. By 2024, the impact of this transaction was reflected in the business model approach, as the collaboration and other revenue category included proceeds from the sale of these rights. This shift indicates a strategic move toward monetizing legacy products through rights sales, thereby influencing revenue recognition patterns and reducing ongoing revenue dependency on Zyprexa.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 177,
        "total_tokens": 12390
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased by AT&T in April 2023, eliminating any redemption obligations in 2024. In 2023, prior to repurchase, these interests were classified as a liability and impacted diluted earnings per share calculations by adding approximately 72 million dilutive potential common shares. By 2024, with no remaining Mobility Preferred Interests, there was no further effect on earnings per share calculations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67171,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17027,
        "completion_tokens": 111,
        "total_tokens": 17138
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Between 2023 and 2024, IBM's 0.875% Notes due 2030 remained listed on the New York Stock Exchange (NYSE) under the trading symbol IBM30A. In 2023, the notes were disclosed in the 10-K under the listing of securities, and in 2024, they were similarly included in the updated list of registered securities under Section 12(b) of the Exchange Act, confirming no change in their registration or listing status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14223,
        "completion_tokens": 101,
        "total_tokens": 14325
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of the Telco Preferred Interests evolved through the addition of new classes and adjustments to existing terms. In 2023, the Telco LLC had cumulative preferred interests totaling $7,250, with Telco Class A-1 paying 4.25% annually and Telco Class A-2 and A-3 paying 6.85% annually, both subject to reset every seven years. In 2024, AT&T further restructured the Tower Holdings Preferred Interests, introducing a mix of fixed and floating rate distributions, with the fixed rate at 5.90% and the floating rate tied to SOFR plus 250 basis points. Additionally, in October 2024, AT&T announced plans to issue $2,250 of new Telco Class A-4 interests with a 5.94% initial distribution rate, subject to reset every four years. These changes indicate that AT&T is adopting a more flexible and diversified approach to financing through preferred equity instruments, allowing for better alignment with market conditions and potentially optimizing the cost of capital.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69359,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17573,
        "completion_tokens": 253,
        "total_tokens": 17827
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Between 2022 and 2023, Capital One's risk exposure under loss sharing agreements with government-sponsored enterprises (GSEs) related to multifamily commercial real estate loans increased. As of December 31, 2023, the liability recognized on the consolidated balance sheets for these agreements was $137 million, compared to $82 million as of December 31, 2022. This increase reflects a rise in the estimated credit losses or risk exposure associated with these multifamily commercial real estate loans sold to GSEs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48613,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12392,
        "completion_tokens": 129,
        "total_tokens": 12521
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "Amazon's co-branded credit card programs experienced an increased strategic significance and regulatory risk from 2022 to 2023 due to evolving compliance obligations. In 2023, the company faced new and more stringent regulations, including enhanced authentication processes and data security requirements, which increased compliance costs and could reduce the ease of use of its payment products. Additionally, potential changes in payment card association rules and the risk of non-compliance could result in fines, higher transaction fees, and loss of payment processing capabilities, all of which could adversely affect operating results. The potential termination or renewal of these programs on less favorable terms further underscored the heightened regulatory and operational risks in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54816,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13946,
        "completion_tokens": 199,
        "total_tokens": 14145
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly due to the deconsolidation of RBH in March 2019 under the CCAA proceedings. As of 2022, RBH was no longer consolidated in PM's financial statements, and its results were presented as a deconsolidated entity. By 2024, PM continued to hold an equity investment in RBH, which was accounted for as an equity security without readily determinable fair value. Valuation considerations became more complex as PM recorded a $2,316 million non-cash impairment charge in 2024, reflecting a decline in the estimated fair value of its investment in RBH due to developments in the CCAA proceedings and the allocation of a global settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50320,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12814,
        "completion_tokens": 177,
        "total_tokens": 12991
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Baqsimi's revenue contribution increased significantly between 2023 and 2024, with revenue rising from $677.6 million in 2023 to $1.60 billion in 2024, primarily due to the sale of the rights for Baqsimi in 2023. This strategic move positioned Baqsimi as a key asset within LLY's portfolio, highlighting its value and contributing to diversified revenue streams through business development activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11937,
        "completion_tokens": 100,
        "total_tokens": 12038
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly in favor of owned equipment. In 2022, the company owned 78,837 units (83.2% of total highway revenue equipment) and leased 16,004 units (16.8%). By 2024, the owned units decreased slightly to 50,731 (97.2% of total highway revenue equipment), while leased units dropped to 1,485 (2.8%). This indicates a substantial reduction in leased containers and chassis, with a corresponding increase in the proportion of owned equipment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 31202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8030,
        "completion_tokens": 133,
        "total_tokens": 8164
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased from $16.973 billion to $18.043 billion, reflecting a $1.07 billion growth in these instruments. Within the company's overall funding structure, securitized debt obligations remained a relatively stable component, representing approximately 4% of total funding sources in both years. This growth was driven by ongoing activity in the company's securitization programs, though deposits continued to serve as the primary funding source, accounting for the majority of liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47767,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12169,
        "completion_tokens": 140,
        "total_tokens": 12310
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The nature of LLY's revenue from Zyprexa evolved significantly between 2023 and 2024, primarily due to the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa generated $79.4 million in U.S. revenue and $1,615.4 million from outside the U.S. However, in 2024, Zyprexa's revenue is no longer reported as a product sale but is instead included in \"collaboration and other revenue\" due to the 2023 sale of these rights. This shift reflects a change from product sales revenue to revenue recognition related to the sale of intellectual property rights, as outlined in Note 2 of the 2024 10-K.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46276,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11791,
        "completion_tokens": 156,
        "total_tokens": 11948
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan remained consistent from 2022 to 2024, as they continued to be classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification and allocation evolved significantly, with the proportion of Federal Government Securities increasing as part of a broader shift toward a more conservative asset allocation. In 2022, the plan held 742 million in Federal Government Securities, while by 2024, this amount had grown to 1,448 million, reflecting the plan's de-risking strategy that increased debt securities to 70–80% of total assets by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10787,
        "completion_tokens": 175,
        "total_tokens": 10962
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's credit score data utilization for product segmentation decisions remained consistent from 2022 to 2023, as both years showed 53% of auto loans originated to borrowers with FICO scores above 660. This consistency suggests a stable credit risk modeling strategy focused on maintaining a balanced portfolio by extending credit to borrowers with strong credit profiles while managing risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46604,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11882,
        "completion_tokens": 102,
        "total_tokens": 11984
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, Amazon's strategic positioning of AWS evolved to emphasize its role as a critical driver of long-term growth and technological innovation within the company. In 2022, AWS was highlighted as a key investment area to support a variety of product and service offerings, particularly in expanding technology infrastructure. By 2023, AWS was positioned more prominently as a foundational pillar of Amazon's operations, serving developers and enterprises of all sizes with a broad set of on-demand technology services. This shift reflects AWS's growing importance in Amazon's broader business strategy, with increased focus on leveraging its capabilities to enhance customer experience, support new business initiatives, and maintain competitive advantage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46245,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11786,
        "completion_tokens": 192,
        "total_tokens": 11978
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly, particularly in terms of accounting treatment and potential financial exposure. In 2022, RBH was deconsolidated from PMI's financial statements due to its filing for protection under the Companies' Creditors Arrangement Act (CCAA) in Canada, which led to a stay of tobacco-related litigation against RBH and other defendants. By 2024, PMI recorded a non-cash impairment charge of $2,316 million (representing a diluted EPS charge of $1.49 per share) related to its investment in RBH, following the filing of a proposed settlement plan in the CCAA proceedings that could require RBH to pay a significant portion of a CAD 32.5 billion global settlement. This impairment reflects the increased financial exposure and uncertainty surrounding the allocation of the settlement amount among RBH and its co-defendants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40083,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10259,
        "completion_tokens": 239,
        "total_tokens": 10499
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy's commercial significance for Gilead has evolved as follows: \n\nIn 2022, Biktarvy contributed $8,624 million in product sales, a decrease from $8,624 million in 2021 but still representing a major portion of Gilead's HIV product revenue. By 2024, Biktarvy's revenue had declined further to $7,259 million, indicating a reduction in its market dominance, potentially due to competition and market dynamics. \n\nProduct risks associated with Biktarvy include potential market share gains by competitive products, including generics, and the need to introduce new HIV medications to remain competitive. Additionally, if nucleoside-based therapeutics like TAF (a component of Biktarvy) lose their preferred status in treatment paradigms, Biktarvy's sales could be significantly impacted.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80323,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20304,
        "completion_tokens": 202,
        "total_tokens": 20506
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, reflecting a growing investment in the joint venture. Additionally, car hire expenses from TTX rose from $375 million in 2021 to $432 million in 2024, indicating higher operational reliance on TTX's rail car services over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39817,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10182,
        "completion_tokens": 85,
        "total_tokens": 10268
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its approach to scaling Solar Roof production by enhancing installer training initiatives and improving supply chain risk management. In 2022, the company focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, Tesla expanded these efforts through the launch of specialized training programs, such as the Engineering Development Program in collaboration with Austin Community College, aimed at equipping early-career engineers with skills in high-demand technologies. Additionally, Tesla emphasized localized procurement and supply chain resilience to mitigate global component constraints, reflecting a more structured and strategic approach to managing production risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44633,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11385,
        "completion_tokens": 198,
        "total_tokens": 11583
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company continued to manufacture fountain syrups in the United States and sell them directly to fountain retailers or through authorized fountain wholesalers and bottling partners. This process remained part of the Company's North America operating segment. There is no indication of significant changes to this structure in the provided documents, suggesting that the relationship with fountain retailers and the distribution model for fountain syrups remained consistent during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12425,
        "completion_tokens": 132,
        "total_tokens": 12557
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "From 2022 to 2024, IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved in terms of classification and registration. In 2022, the Notes were disclosed as part of IBM's broader debt instruments without specific classification details. By 2024, the Notes were explicitly listed under \"Securities registered pursuant to Section 12(b) of the Act\" with the ticker symbol \"IBM25B\" and classified as a registered security traded on the New York Stock Exchange. This reflects a more detailed and formalized disclosure of the Notes' registration and market listing in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35722,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9159,
        "completion_tokens": 144,
        "total_tokens": 9304
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "Gilead's strategic positioning of Biktarvy from 2022 to 2024 has emphasized maintaining its competitive differentiation in the HIV treatment market by leveraging its efficacy and tolerability profile, which supports its role as a preferred regimen. However, the company faces heightened financial risk exposure due to increasing pricing pressures from government programs, such as the Inflation Reduction Act of 2022, which could impact profitability through mandated rebates and Medicare price negotiations. Additionally, competition from generics and new entrants remains a challenge, necessitating ongoing innovation and market access strategies to sustain Biktarvy's market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14892,
        "completion_tokens": 171,
        "total_tokens": 15063
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing defined benefit pension obligations by transferring them to insurance companies, thereby shifting financial risk and reducing volatility in its financial results. In 2022, the company executed a significant pension obligation transfer, purchasing group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and related plan assets for approximately 13,600 U.S. retirees and beneficiaries. This transaction resulted in a noncash pension settlement charge of $1.5 billion in the second quarter of 2022. In 2023, the company further reduced its pension obligations by making $414 million in lump-sum settlement payments to approximately 6,500 former employees who had not yet commenced receiving their vested benefits. These actions contributed to a reduction in the unfunded status of the pension plans, decreasing from $5,470 million in 2022 to $6,159 million in 2023, despite a decrease in the discount rate in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58732,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14918,
        "completion_tokens": 256,
        "total_tokens": 15174
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 remained consistent regarding the 2.875% Notes due 2025. In both the 2022 and 2024 10-K filings, the 2.875% Notes due 2025 are listed as registered securities, with the trading symbol \"IBM 25A\" and listed on the New York Stock Exchange. There is no indication of changes to the terms or issuance status of these notes during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 40102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10243,
        "completion_tokens": 104,
        "total_tokens": 10348
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "Based on the information provided in the 2022 and 2024 SEC 10-K filings, Biktarvy has grown in strategic importance within Gilead's HIV portfolio, driven by its continued growth and resilience amid competitive pressures and the loss of exclusivity for Truvada and Atripla. In 2022, Biktarvy's sales increased due to higher demand and a favorable pricing environment, partially offsetting declines in other HIV products. By 2024, Biktarvy remains a key driver of the HIV business, with ongoing efforts to expand its use, such as the approval of a pediatric formulation in 2021. However, the risk profile has evolved as competitive pressures persist, and the treatment paradigm for HIV continues to shift, with the development of long-acting therapies like lenacapavir and islatravir. These developments highlight both the growing importance of Biktarvy and the need for continued innovation to maintain its market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55792,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14183,
        "completion_tokens": 230,
        "total_tokens": 14414
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "Between the end of fiscal year 2022 and the end of fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1,449 million to $1,764 million. During fiscal 2023, the Company deposited $1,000 million into the U.S. litigation escrow account, while making payments of $685 million to opt-out merchants. In fiscal 2022, the balance increased from $1,449 million to $1,764 million, with $850 million deposited and $301 million in payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46237,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11794,
        "completion_tokens": 115,
        "total_tokens": 11909
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent, as the company continued to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized wholesalers and bottling partners. These sales were included in the North America operating segment in both years. There is no indication of a significant change in Coca-Cola's manufacturing or distribution responsibilities related to fountain syrups during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41345,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10569,
        "completion_tokens": 129,
        "total_tokens": 10698
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 changed slightly. In 2022, IBM listed the 0.950% Notes due 2025 (IBM 25B) among other 2025-maturing instruments, including the 2.875% Notes due 2025 (IBM 25A) and 7.00% Debentures due 2025 (IBM 25). By 2024, the 0.950% Notes due 2025 (IBM 25B) remained listed, but the 2.875% Notes due 2025 (IBM 25A) were still present, while the 7.00% Debentures due 2025 (IBM 25) were also retained. Thus, the 0.950% Notes due 2025 remained a consistent component of IBM's 2025 debt maturity profile during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 40102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10243,
        "completion_tokens": 146,
        "total_tokens": 10390
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney's strategic approach to cruise ships evolved between 2022 and 2024 by emphasizing fleet expansion and enhancing the cruise experience. In 2022, the focus was on resuming operations post-pandemic and managing health and safety measures. By 2024, Disney announced plans to expand its fleet of cruise ships and highlighted the opening of a new Disney Cruise Line destination in 2024 at Lighthouse Point on Eleuthera, indicating a shift toward growth and new market opportunities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62613,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15868,
        "completion_tokens": 120,
        "total_tokens": 15989
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin continued its strategic approach to pension risk transfer transactions, aiming to reduce the volatility of its pension obligations and associated financial impacts. In 2022, the company had already executed significant transactions, such as the August 2021 purchase of group annuity contracts (GACs) for $4.9 billion in pension obligations, which transferred risk to insurers and eliminated PBGC premiums for approximately 95,000 retirees. By 2023, the company expressed its intent to continue exploring additional risk transfer opportunities, acknowledging that future transactions could result in material noncash settlement charges. Strategically, these actions aimed to stabilize pension liabilities and reduce the sensitivity of financial results to actuarial assumptions and market fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61408,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15576,
        "completion_tokens": 209,
        "total_tokens": 15785
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has evolved in terms of accounts receivable management and leasing program risks. In 2022, Tesla highlighted that accounts receivable balances can fluctuate significantly due to factors such as government rebates, which can take up to a year to collect, and the timing of payments from financing partners. By 2023, Tesla noted continued exposure to residual value risks in its leasing programs, particularly as actual resale values may differ from pre-determined amounts, potentially impacting profitability. Additionally, Tesla emphasized the importance of managing credit risks associated with its financing programs, especially in the context of economic downturns or other catastrophic events that could lead to customer defaults.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54648,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13889,
        "completion_tokens": 201,
        "total_tokens": 14090
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of its finished product operations, which generated 42% of net operating revenues in 2023 compared to 44% in 2022. In the U.S., the Company directly manufactures and sells fountain syrups to retailers and authorized wholesalers or bottling partners. Outside the U.S., bottling partners typically manufacture fountain syrups using concentrates and sell them to fountain retailers or authorized wholesalers. This evolution reflects a strategic emphasis on expanding direct control and optimizing distribution channels for fountain products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12421,
        "completion_tokens": 160,
        "total_tokens": 12581
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV showed an increase in receivables, rising from $9 million to $12 million, indicating higher sales or delayed payments from the JV. Additionally, AMD made a $17 million equity contribution to the ATMP JV in 2024, reflecting new investment activity aligned with its existing 15% ownership stake. The carrying value of AMD's investment in the ATMP JV also increased from $99 million to $149 million during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46602,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11872,
        "completion_tokens": 121,
        "total_tokens": 11993
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing the volatility and size of its pension obligations by settling nonqualified defined benefit pension liabilities. In 2023, the company made $414 million in lump-sum settlement payments to approximately 6,500 former employees who had not yet begun receiving their vested benefits. This action led to a corresponding reduction in the pension obligation but did not impact the 2023 FAS pension income. In 2022, the company had executed a larger settlement by purchasing group annuity contracts to transfer $4.3 billion of pension obligations to an insurance company, which resulted in a noncash pension settlement charge of $1.5 billion. The 2023 settlements were smaller in scale and did not trigger a similar noncash charge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58732,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14921,
        "completion_tokens": 199,
        "total_tokens": 15120
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD increased its investment in the ATMP JV by contributing $17 million in August 2024, raising its carrying value from $99 million as of December 30, 2023, to $149 million as of December 28, 2024. Additionally, AMD's equity income from the ATMP JV rose from $16 million in 2023 to $33 million in 2024, reflecting improved performance or returns from its 15% equity stake in the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49667,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12636,
        "completion_tokens": 104,
        "total_tokens": 12740
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's ownership of Kenvue transitioned from retaining a 9.5% equity stake post-exchange offer in August 2023 to fully divesting its remaining shares in May 2024 through a Debt-for-Equity Exchange. In 2023, the exchange offer resulted in a non-cash gain of $21.0 billion, including $2.8 billion from the retained Kenvue shares. By 2024, the remaining shares were exchanged for commercial paper, leading to a $0.4 billion loss recorded in Other (income) expense. Thus, Johnson & Johnson no longer held any ownership in Kenvue by the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9775,
        "completion_tokens": 145,
        "total_tokens": 9920
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. was included in historical guarantee agreements, such as the guaranty of certain obligations of Southwestern Bell Telephone Co. referenced in the 2022 filing (Exhibit 4-b to Form 10-K for the period ending December 31, 2011). However, there is no specific indication in the 2023 filing that this guarantee relationship changed or was modified between 2022 and 2023. Therefore, it appears that the inclusion of Southwestern Bell Telephone Co. in guarantee agreements remained consistent during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10490,
        "completion_tokens": 145,
        "total_tokens": 10635
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs evolved significantly from 2022 to 2023, with the company strengthening its strategic positioning as a key player in this emerging domain. In 2022, the company emphasized its participation in multiple hypersonics programs with the U.S. Air Force and Army, focusing on design, development, and production of hypersonic strike weapons. By 2023, the company noted that several of these programs had advanced, with testing and evaluation activities progressing and expectations that multiple programs would enter early production phases by 2026. This reflects a shift from development to production readiness, aligning with the company's broader strategy to capitalize on next-generation defense technologies and programs of record.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 51413,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13080,
        "completion_tokens": 195,
        "total_tokens": 13275
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $3.1 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1.5 billion was deposited during fiscal year 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51352,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13068,
        "completion_tokens": 68,
        "total_tokens": 13137
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden has maintained a consistent classification within the Hardlines major product line, but its performance metrics show a slight decline in its share of net sales. In 2022, Outdoor Garden accounted for 6.8% of total net sales, which decreased to 6.5% in 2024. This suggests a modest reduction in its relative importance within HD's product strategy, despite continued inclusion as a key merchandising department.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10351,
        "completion_tokens": 110,
        "total_tokens": 10462
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by reinforcing its culture of innovation, inclusivity, and respect, as highlighted in its 2024 10-K. The company conducts annual engagement surveys, fosters diversity and inclusion through employee resource groups, and prioritizes flexible work arrangements, including hybrid and remote options. These efforts, combined with robust leadership development, mentoring programs, and competitive total rewards, suggest a proactive talent retention strategy aimed at sustaining high employee engagement and attracting top talent in the competitive semiconductor industry.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47036,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12002,
        "completion_tokens": 171,
        "total_tokens": 12173
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "AT&T's guarantee obligations related to The Ohio Bell Telephone Company, as disclosed in the 2022 and 2023 filings, remain unchanged, with no new information indicating any evolution in these obligations between the two years. The guarantees are part of historical obligations under previous indentures, and there is no mention of modifications or releases of these guarantees during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 98,
        "total_tokens": 10580
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap, in terms of gains on retained and sold ownership interests, significantly declined. In 2023, GE reported gains of $5.778 billion, primarily related to its AerCap and GE HealthCare investments. However, in 2024, these gains decreased by $5.2 billion, contributing to a $2.5 billion decline in continuing earnings compared to 2023. This decrease was a major factor in the overall reduction in corporate operating profit for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15734,
        "completion_tokens": 126,
        "total_tokens": 15860
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Between 2022 and 2024, Home Depot has strategically evolved its use of HD Supply to better serve professional customers and expand its MRO (Maintenance, Repair, and Operations) services. HD Supply, a subsidiary of Home Depot, has been leveraged to provide MRO products and value-added services to multifamily, hospitality, healthcare, and government housing facilities. In 2024, the company further strengthened its position in the professional market by acquiring SRS, a residential specialty trade distributor, which expanded its offerings to Pros such as roofers, landscapers, and pool contractors. This acquisition, combined with continued investments in differentiated fulfillment options, trade credit programs, and enhanced order management systems, reflects Home Depot's focus on deepening its capabilities to serve the complex needs of professional customers through HD Supply and its broader ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53344,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13558,
        "completion_tokens": 228,
        "total_tokens": 13786
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio slightly expanded, with the number of issued U.S. patents remaining at approximately 7,500, while the total worldwide patent matters increased from 18,500 to 18,800. The number of pending U.S. patent applications decreased slightly from 2,000 to 1,900. AMD continues to rely on cross-licensing and technology exchange agreements, which are common in the semiconductor industry, to both transfer and receive intellectual property rights. This suggests that AMD maintains a strategic approach to leveraging its growing patent portfolio for collaborative innovation and competitive advantage in technology exchange.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47036,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11987,
        "completion_tokens": 164,
        "total_tokens": 12151
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake in Kenvue evolved significantly. In 2023, following Kenvue's IPO and an exchange offer, Johnson & Johnson retained a 9.5% stake in Kenvue, valued at $4.3 billion. By 2024, the Company executed a Debt-for-Equity Exchange in May, using its remaining 182.3 million Kenvue shares to satisfy $3.6 billion in commercial paper. This resulted in Johnson & Johnson no longer owning any Kenvue shares and recording a $0.4 billion loss on the exchange. Thus, the strategic relationship transitioned from partial ownership to full divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37140,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9517,
        "completion_tokens": 146,
        "total_tokens": 9663
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the subsidiaries guaranteed under AT&T's debt obligations in the 10-K filing. However, in 2023, Indiana Bell Telephone Co. Inc. was no longer explicitly included in the list of guaranteed subsidiaries, indicating a reduction in its inclusion in AT&T's guarantee disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 83,
        "total_tokens": 10565
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved primarily through investment gains and cash transactions. In 2023, GE held equity and a note receivable from AerCap, with the equity securities valued at $944 million. By 2024, GE sold its remaining equity shares in AerCap, contributing to a $5.2 billion decrease in gains on retained and sold ownership interests, which impacted continuing earnings. Additionally, GE paid net cash of $203 million to AerCap in 2023 for ongoing activities, but no further cash involvement was explicitly noted in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64201,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16267,
        "completion_tokens": 142,
        "total_tokens": 16409
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by enhancing the interconnected shopping experience, integrating digital tools, and improving store layouts to elevate customer experience. In 2022, the company focused on store refreshes, wayfinding signage, and self-service tools like lockers and curbside pickup. By 2024, these efforts expanded with further investments in store navigation, electronic shelf labels, and redesigned checkout areas to increase convenience and speed. Additionally, the company emphasized digital integration by improving mobile app functionality and enhancing the online shopping experience with personalized content and fulfillment options, reinforcing its competitive edge through a seamless blend of in-store and digital capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48023,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12232,
        "completion_tokens": 203,
        "total_tokens": 12436
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2023, AMD recorded $14 million in resales to the ATMP JV, which rose to $121 million in 2024. Additionally, in October 2024, AMD entered into a $100 million one-year term loan agreement with one of the ATMP JVs, providing funds for general corporate purposes and secured by the ATMP JV's receivable balance due from AMD.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11278,
        "completion_tokens": 114,
        "total_tokens": 11392
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson enhanced its privacy compliance programs in response to evolving privacy laws and international data flow regulations. In 2023, the Company emphasized its established privacy compliance programs and controls to manage risks related to data collection, use, and international data transfers. By 2024, the Company expanded its focus, highlighting increased enforcement of privacy laws and the introduction of new regulations, particularly around data localization and cross-border data flows. Additionally, the frequency of updates to the Regulatory Compliance & Sustainability Committee increased from twice a year in 2023 to quarterly in 2024, reflecting a more proactive approach to monitoring and adapting to the regulatory landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42372,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10823,
        "completion_tokens": 194,
        "total_tokens": 11017
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH decreased in terms of estimated borrower litigation losses, which fell from $2,669 million to $2,461 million. Additionally, the related valuation allowances also decreased, with the total valuation allowances against financing receivables held for sale dropping from $1,963 million in 2023 to $1,594 million in 2024. These reductions reflect a partial resolution of the ongoing litigation through a settlement program implemented in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64429,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16333,
        "completion_tokens": 124,
        "total_tokens": 16457
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining a consistent share of net sales within the Hardlines major product line, while experiencing a slight decline in its percentage contribution. In 2022, Indoor Garden accounted for 10.3% of net sales within the Hardlines category, and by 2024, this share slightly decreased to 6.6%. Despite this, the product line remained a key component of the Hardlines segment, which includes Hardware, Outdoor Garden, and Tools. The reclassification of merchandising departments in 2024 did not impact the overall positioning of Indoor Garden, which continued to be a core offering within the broader Hardlines category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10360,
        "completion_tokens": 177,
        "total_tokens": 10538
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has continued to manage cost volatility, particularly from commodity price fluctuations, through sourcing strategies, cost containment measures, and selective use of commodity hedging contracts. In 2022, the company emphasized using sourcing strategies and productivity initiatives to mitigate raw material cost increases, with limited use of futures contracts, primarily in the Hill's Pet Nutrition segment. By 2024, the company maintained a similar approach, leveraging sourcing strategies and ongoing productivity initiatives to manage exposure, while continuing to use commodity contracts selectively to hedge against price volatility in key raw materials such as essential oils, resins, and tropical oils. The evolution reflects a consistent strategy but with a heightened focus on adapting to ongoing inflationary pressures and supply chain disruptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39457,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10089,
        "completion_tokens": 224,
        "total_tokens": 10313
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "Between 2023 and 2024, TREMFYA's sales increased by 16.6%, from $3.15 billion in 2023 to $3.67 billion in 2024. This growth was driven by market expansion, share gains, and continued strength in treating Psoriasis and Psoriatic Arthritis. Additionally, TREMFYA's performance was supported by its expanding label, including new indications for Ulcerative Colitis and Crohn's Disease, which contributed to its strong sales growth during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39974,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10206,
        "completion_tokens": 111,
        "total_tokens": 10318
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023 involved Disney reducing its ownership stake in A+E Networks from 50% to 49%, with Hearst increasing its stake from 50% to 51%. This shift did not significantly alter Disney's reporting of subscriber numbers for A+E channels, as the domestic subscriber counts for A&E, HISTORY, and Lifetime remained consistent at around 69 million in 2022 and 58 million in 2023. However, the financial stake in A+E was reduced, impacting Disney's equity income from the investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 34453,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8837,
        "completion_tokens": 135,
        "total_tokens": 8972
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap shifted significantly. In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. However, in 2024, this position was fully monetized, as GE sold its remaining AerCap shares, leaving only an AerCap senior note. As a result, there were no further gains or losses reported for AerCap in 2024, indicating the conclusion of this investment relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63487,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16093,
        "completion_tokens": 121,
        "total_tokens": 16215
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard enhanced its multi-layered security approach by explicitly addressing risks associated with third-party service providers, as noted in the 2024 10-K. The evolution includes increased monitoring and response to threats linked to third-party services, indicating a strategic shift toward a more proactive and comprehensive cybersecurity posture. This reflects Mastercard's commitment to safeguarding the global payments ecosystem against emerging threats, particularly as reliance on external partners grows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42855,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10967,
        "completion_tokens": 135,
        "total_tokens": 11102
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation remained in compliance with its debt leverage covenant under its credit facilities. In 2022, Target had a $3.0 billion unsecured revolving credit facility expiring in October 2026, and in 2023, it obtained a new $1.0 billion 364-day unsecured revolving credit facility expiring in October 2024 while extending its existing $3.0 billion facility to October 2028. Despite changes in credit facilities, the company confirmed in both years that it was in compliance with all covenants, including the debt leverage covenant, and expects to remain so.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9014,
        "completion_tokens": 146,
        "total_tokens": 9161
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, has evolved to include increased ethical, regulatory, and operational challenges. In 2023, the risks primarily focused on the general ethical issues and potential reputational harm from AI's impact on human rights, privacy, and employment. By 2024, the risks had expanded to include more specific concerns around the development and deployment of generative AI, such as accuracy, bias, toxicity, privacy, and data provenance. Additionally, the regulatory landscape had intensified, with new laws and frameworks like the EU's AI Act and the Digital Services Act imposing stricter requirements on AI content generation and governance. These developments necessitated greater investment in compliance, governance, and the ethical implementation of AI to mitigate potential harm and ensure regulatory adherence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63138,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16004,
        "completion_tokens": 234,
        "total_tokens": 16239
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's delivery capability for parcel-eligible items improved significantly. In fiscal 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal 2024, this was enhanced to ensure most parcel-eligible items could be delivered within two business days or less at standard shipping rates. Additionally, Lowe's expanded its gig provider network nationwide to enable same-day delivery for certain products and introduced the capability to deliver major appliances next-day in almost every U.S. zip code.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11799,
        "completion_tokens": 147,
        "total_tokens": 11947
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both years. The pretax gain of $335 million recognized in 2021 did not have a material ongoing impact on 2022 or 2023 financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32806,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8421,
        "completion_tokens": 96,
        "total_tokens": 8518
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud's strategic positioning within Salesforce has evolved to become a more central and integrated component of the Customer 360 platform, emphasizing its role in unifying and leveraging enterprise data across multiple service offerings. In 2023, Data Cloud was described as a \"hyperscale, trusted data engine\" that consolidates disconnected enterprise data to deliver a 360-degree view of customers. By 2024, its role was further emphasized as a foundational element of the Einstein 1 Platform, enabling AI-powered automation and analytics across Salesforce's CRM, marketing, commerce, and service offerings. This evolution reflects a broader strategic shift toward embedding Data Cloud as a key enabler of AI-driven customer experiences and cross-functional data integration within Salesforce's ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53628,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13636,
        "completion_tokens": 209,
        "total_tokens": 13845
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts showed a significant shift in hedge designation and financial impact. In 2023, forward interest rate swaps with a notional amount of $1,290 million were designated as cash flow hedges, resulting in a pre-tax gain of $311 million recorded in other comprehensive income. However, by 2024, all forward interest rate swap contracts were fully settled, with no remaining notional amounts designated as cash flow hedges. This change led to a pre-tax loss of $14 million recorded in other comprehensive loss for 2024, reflecting the financial impact of these settlements and a shift away from using such instruments for hedging purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43348,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11064,
        "completion_tokens": 181,
        "total_tokens": 11245
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to place greater emphasis on strengthening and expanding its owned brands portfolio as a key differentiator. In 2022, the focus was on differentiating through owned and exclusive brands to offer a curated assortment. By 2023, the strategy explicitly highlights delighting guests with newness, style, and value by enhancing owned brands, curating national brands, and expanding signature partnerships. This reflects a more proactive and growth-oriented approach to owned brands, aligning them with broader objectives of expanding relevancy, driving traffic, and increasing market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 25288,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6540,
        "completion_tokens": 164,
        "total_tokens": 6704
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has evolved significantly, with a stronger emphasis on expanding service offerings and deploying scalable digital platforms. In 2022, GM highlighted its suite of software-enabled services, including OnStar, Super Cruise, and its end-to-end software platform, which began rolling out across its product lineup. By 2023, the company emphasized the broader deployment of its end-to-end software platform, enabling over-the-air updates for features, performance, and driver assistance systems. This indicates a growing investment in scalable digital solutions, as GM aims to enhance customer experiences through software-defined vehicles and expand its ecosystem of active safety, infotainment, and connectivity services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55215,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14044,
        "completion_tokens": 194,
        "total_tokens": 14239
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased by 11% between fiscal years 2022 and 2023, driven by growth in ThousandEyes and Intersight offerings, partially offset by a decline in AppDynamics offerings. In fiscal 2024, the Observability category (which includes ThousandEyes) saw a 27% revenue increase compared to 2023, primarily due to continued growth in the ThousandEyes offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10630,
        "completion_tokens": 117,
        "total_tokens": 10747
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 10-K filing, Amendment No. 4 to the Lockheed Martin Executive Severance Plan was listed as Exhibit 10.34 and incorporated by reference from the Quarterly Report on Form 10-Q for the quarter ended September 25, 2022. By the 2024 10-K filing, it remained as Exhibit 10.36, maintaining its inclusion in the disclosure. This consistency indicates that the company continues to formally disclose amendments to its executive severance plan as part of its transparency strategy, ensuring stakeholders are informed about changes to executive compensation policies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55463,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14107,
        "completion_tokens": 142,
        "total_tokens": 14249
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio remained stable at 7.2%, meeting the regulatory requirement of 4.0%. The Standardized CET1 capital ratio increased slightly from 15.0% in 2023 to 15.7% in 2024, reflecting improved capital adequacy amid evolving regulatory buffers and capital conservation requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54135,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13763,
        "completion_tokens": 80,
        "total_tokens": 13843
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, with its performance evaluated through EBT-adjusted due to the significance of interest income and expense in its operations. The segment's financial presentation and integration into the consolidated statements remained consistent, with its results included in the broader consolidated financial framework while reflecting its unique operational focus on automotive financing services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83511,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21113,
        "completion_tokens": 129,
        "total_tokens": 21243
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure of step-rent provisions in lease accounting remained consistent in recognizing such provisions on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised. In both years, periodic rent increases based on price indices or sales volume were recognized as variable lease payments. No significant changes in accounting treatment or additional disclosures specific to these provisions were noted in the 2024 filing compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11089,
        "completion_tokens": 133,
        "total_tokens": 11223
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight increase in the amount expected to be paid out in 2025, rising from $1,860 million in 2023 to $1,800 million in 2024. Over the long-term period from 2029 to 2033 in 2023, the projected payments were $10,020 million, which decreased slightly to $9,990 million for the period 2030 to 2034 in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49092,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12518,
        "completion_tokens": 106,
        "total_tokens": 12624
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations showed a more detailed emphasis on liquidity risk management strategies and funding cost considerations. In 2023, the company outlined general factors affecting liquidity, such as market stress, regulatory changes, and funding source constraints. By 2024, JPMorgan Chase provided more specific strategies for managing liquidity under resolution plan obligations, including actions to satisfy liquidity coverage and net stable funding ratio requirements, as well as addressing pre-positioning of liquidity in subsidiaries. Additionally, the 2024 disclosures highlighted the potential impact of resolution plan obligations on funding costs, particularly when accessing alternative funding sources due to constraints on traditional, lower-cost funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53385,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13583,
        "completion_tokens": 208,
        "total_tokens": 13791
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed notable changes in revenue recognition and accounts receivable. Revenue recognition remained consistent with prior years, as product revenues were recognized when prescriptions were dispensed, and services revenues were recognized as services were performed or made available to customers. However, accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, reflecting a rise in outstanding balances related to products and services. This increase could indicate either growth in Optum Rx's pharmacy care services or a slight elongation in the time it takes to collect receivables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56676,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14394,
        "completion_tokens": 173,
        "total_tokens": 14567
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS has maintained a strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps, primarily as cash flow hedges of forecasted payment obligations. In 2022, UPS reported a reclassified loss of $5 million from accumulated other comprehensive income (AOCI) to interest expense related to interest rate contracts. By 2024, this reclassified amount remained relatively stable at $5 million, indicating a consistent exposure and management strategy. Additionally, UPS continued to utilize these swaps to hedge against variability in cash flows, with $146 million of pre-tax gains deferred in AOCI as of December 31, 2024, expected to be reclassified to income within the next 12 months. This evolution reflects a measured and stable approach to interest rate risk management over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 155,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 39769,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10170,
        "completion_tokens": 211,
        "total_tokens": 10381
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved in terms of joint venture activities and recall-related costs. The joint venture, Ultium Cells LLC, continued to progress with plans for battery cell production in the U.S., including a fourth plant planned by mid-decade. Regarding recall-related costs, GM incurred significant expenses related to the Chevrolet Bolt EV and EUV battery recall, which expanded to include all 2017-2022 model years. By December 31, 2023, GM had accrued a total of $2.6 billion for these recall costs, with $0.6 billion remaining, while recognizing $1.6 billion in receivables from LG for reimbursement. The commercial negotiations with LG also resolved other matters related to the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14907,
        "completion_tokens": 191,
        "total_tokens": 15099
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability category grew by 14% in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings. In fiscal 2024, revenue in the Observability category increased by 27% compared to fiscal 2023, with growth in the ThousandEyes offering being a key contributor.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45828,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11673,
        "completion_tokens": 116,
        "total_tokens": 11790
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "Between 2022 and 2024, the redemption terms and interest payment structure for UPS's 7.620% Debentures remained consistent. The debentures, with a maturity of April 1, 2030, are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October, and no changes to these terms were noted in the 2024 filing compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32700,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8399,
        "completion_tokens": 142,
        "total_tokens": 8541
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET increased slightly from $6,802 million to $6,714 million. The composition showed a decrease in U.S. government bonds, which fell from $1,507 million to $1,575 million, while corporate securities increased from $3,001 million to $3,083 million. This indicates a shift in allocation toward corporate securities and away from U.S. government bonds during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81373,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20576,
        "completion_tokens": 112,
        "total_tokens": 20688
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' relationship with Ultium Cells LLC evolved with increased financial involvement and regulatory implications. In 2022, GM invested $0.5 billion in Ultium Cells LLC as part of its strategic focus on electric vehicle (EV) technology. By 2023, GM faced regulatory scrutiny related to its joint venture with Ultium Cells LLC, as it self-disclosed potential violations of the Toxic Substances Control Act (TSCA) to the EPA. This led to a settlement in November 2023 involving civil penalties estimated at approximately $5.1 million, which were jointly and severally assessed on GM and Ultium Cells LLC. These developments highlight both the financial commitment and regulatory challenges associated with GM's collaboration with Ultium Cells LLC during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11655,
        "completion_tokens": 198,
        "total_tokens": 11853
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Between 2022 and 2024, the company continued to use variable-priced contracts for natural gas and fuel purchases, primarily for gas stations and certain facilities in the U.S. and Canada. These contracts are based on an index and qualify for the \"normal purchases and normal sales\" exception, meaning they do not require mark-to-market adjustments. There is no indication of a significant change in the company's strategy or volume related to these contracts during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43569,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11106,
        "completion_tokens": 119,
        "total_tokens": 11226
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. Both years excluded research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges from the gross margin measurement for the APJC segment. There is no indication of a change in the treatment of these excluded categories during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35479,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9108,
        "completion_tokens": 175,
        "total_tokens": 9283
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "From 2022 to 2023, UNH's approach to managing medical cost trends, particularly rising outpatient procedure costs for seniors, evolved by focusing on care engagement strategies. In 2023, the company observed increased care patterns, especially for outpatient procedures among seniors, and emphasized mitigating these costs by working with physicians and consumers to promote clinically sound, high-quality, and affordable care choices. This reflects a continued effort to address cost trends through care coordination and informed decision-making, building on prior strategies to manage medical costs through underwriting, provider contracts, and care management programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12601,
        "completion_tokens": 168,
        "total_tokens": 12769
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS has expanded its time-definite delivery services by enhancing its global smart logistics network and integrating advanced technologies such as RFID in its Smart Package Smart Facilities. In 2022, the focus was on optimizing the existing network and leveraging digital tools to improve customer experience and service scope. By 2024, UPS had further integrated its air and ground services through a more sophisticated system, enabling greater end-to-end visibility and efficiency. Additionally, UPS expanded its healthcare logistics capabilities, including cold-chain solutions, to better serve high-priority sectors. The company also insourced the UPS SurePost service to maintain greater control over delivery reliability, reflecting a strategic shift toward higher-yielding, service-reliable operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47150,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12007,
        "completion_tokens": 208,
        "total_tokens": 12215
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 annual filing, the 2.50% Notes maturing in April 2026 were referenced in the Thirteenth Supplemental Indenture dated April 20, 2016, as part of the indenture framework between Lowe's Companies, Inc. and U.S. Bank National Association. In the 2023 annual filing, the 2026 notes were not modified in terms of their structure or maturity date, but they were included in the Twenty-Second Supplemental Indenture dated March 30, 2023, which added new notes and updated the indenture with U.S. Bank Trust Company, National Association as the successor trustee. Thus, the treatment of the 2.50% Notes remained consistent, but the trustee was updated in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41251,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10533,
        "completion_tokens": 165,
        "total_tokens": 10699
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 remained relatively consistent, with both years highlighting the potential for such crises to affect demand for products, require changes in product mix, and influence the cost of purchasing inventory. In 2022, the 10-K noted that sovereign debt crises could impact the cost of or ability to purchase inventory, particularly due to trade-related actions and tariffs. By 2024, the 10-K reiterated similar concerns, emphasizing that sovereign debt crises could still affect demand and inventory costs, though with a slight increase in international operations (from 27% to 28% of net sales) that could amplify exposure to these risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43660,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11130,
        "completion_tokens": 184,
        "total_tokens": 11314
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued share-based awards over this period, which diminishes the pool of shares available for future grants. However, the company still maintains a substantial capacity to issue new share-based awards, suggesting continued commitment to equity compensation for employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12699,
        "completion_tokens": 116,
        "total_tokens": 12815
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan relationship with UPS was extended from July 31, 2024, to July 31, 2029, following the ratification of a new National Master Agreement in July 2024. Additionally, in 2024, UPS reached an agreement to withdraw from the District 9 IAM Pension Trust, transferring impacted employees to the UPS Pension Plan and recording a $19 million withdrawal liability. Contributions to the IAM National Pension Fund / National Pension Plan increased from $48 million in 2022 to $53 million in 2024, reflecting ongoing obligations under the extended collective bargaining agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 56697,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14401,
        "completion_tokens": 166,
        "total_tokens": 14567
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In September 2023, the 2020 Credit Agreement was amended and restated to extend its term from March 2025 to September 2028. Additionally, the combined availability under the Credit Agreements (including the Third Amended and Restated Credit Agreement) remained at $4.0 billion as of February 2, 2024. No borrowings were outstanding under the 2020 Credit Agreement during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45117,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 125,
        "total_tokens": 11616
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amounts for Net Investment Hedge (NIH) derivative contracts increased significantly between 2022 and 2024. As of December 31, 2022, the aggregate notional value of NIH derivative contracts was $7.5 billion, rising to $8.6 billion by December 31, 2024. This reflects a growth of $1.1 billion over the two-year period, indicating an expanded use of these contracts to hedge against exchange rate movements for non-U.S. operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53464,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13587,
        "completion_tokens": 111,
        "total_tokens": 13698
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved significantly, transitioning from AI-backed tools to becoming an \"AI first platform.\" In 2024, Microsoft introduced **Copilot for Microsoft 365**, which combines AI with business data in the Microsoft Graph and Microsoft 365 applications to enhance productivity and collaboration. Specific new capabilities in 2024 included **role-based Copilots** (e.g., Copilot for Sales, Copilot for Service, and Copilot for Finance), which provide role-specific insights and workflow assistance, and **Copilot Pro**, a consumer subscription service offering faster and more powerful AI assistance in Microsoft 365 apps and on the web. These advancements aim to streamline business processes and deliver insights more efficiently.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39920,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10212,
        "completion_tokens": 199,
        "total_tokens": 10411
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from acknowledging incomplete characterization and taking corrective actions to formalizing obligations under a regulatory agreement. In 2022, 3M disclosed that its NPDES permit for the Decatur facility did not fully characterize PFAS discharges and had submitted an application to add additional PFAS to the permit, while also implementing wastewater treatment controls. By 2024, 3M and the Alabama Department of Environmental Management (ADEM) had agreed to an interim Consent Order, which required 3M to provide reports, perform analytical studies, and make capital improvements to address PFAS discharges and emissions. This reflects a shift from voluntary corrective measures to a structured, regulatory framework for ongoing compliance and remediation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59179,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15020,
        "completion_tokens": 224,
        "total_tokens": 15244
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. Between 2022 and 2023, there were no changes or additional issuances related to these specific 4.550% Notes, as the subsequent supplemental indentures in 2022 and 2023 involved different note offerings with distinct coupon rates and maturity dates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41251,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10519,
        "completion_tokens": 100,
        "total_tokens": 10619
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved significantly in terms of gains recognized from changes in accounting for the investment. In 2022, MDLZ's ownership in KDP was above 5%, and it was accounted for under the equity method. However, in the first quarter of 2023, MDLZ's ownership in KDP fell below 5%, prompting a change in accounting to treat the investment as a marketable security with readily determinable fair value. This change resulted in a pre-tax gain of $493 million in 2023. Subsequently, MDLZ sold the remainder of its KDP shares in 2023, generating total proceeds of $2.4 billion and recognizing a total pre-tax gain of $593 million on the marketable securities sold during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42555,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10865,
        "completion_tokens": 182,
        "total_tokens": 11048
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass have significantly evolved. In 2022, Xbox Game Pass was described as a subscription service with access to a curated library of over 100 first- and third-party console and PC titles. By 2024, the service had expanded to include a library of over 400 titles, reflecting Microsoft's strategic emphasis on growing its gaming ecosystem and attracting a broader user base through diverse content, community engagement, and cloud gaming capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35014,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8976,
        "completion_tokens": 127,
        "total_tokens": 9104
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan has not shown significant changes from 2022 to 2024. In both years, the agreements are disclosed as part of the equity compensation plans approved by security holders, with details provided under the \"Non-employee director deferred stock units\" category in the equity compensation plans information. The 2022 filing (MMM_10k_2022.pdf) and the 2024 filing (MMM_10k_2024.pdf) both reference the form of Deferred Stock Unit Award Agreement for deferred stock units granted to non-employee directors under the 2016 plan, with no indication of substantive amendments to the structure or terms of these agreements during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51486,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13111,
        "completion_tokens": 193,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio showed a slight decline in origination costs, with direct origination costs decreasing from $100 million in 2023 to $112 million in 2024. Additionally, the geographic concentration in California decreased marginally, from 43% in 2023 to 42% in 2024, while maintaining consistent performance with the overall portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60843,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15446,
        "completion_tokens": 104,
        "total_tokens": 15550
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Based on the language in the product research and development sections of Nike's 10-K filings, Nike's strategic emphasis on Dri-FIT technology between fiscal 2023 and fiscal 2024 appears to have remained consistent, with a continued focus on leveraging the technology across product categories to meet consumer preferences. Both years highlight the proliferation of Dri-FIT technology as part of Nike's dedication to innovation and designing products that enhance performance and comfort. There is no explicit indication of a shift in strategic emphasis during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 143,
        "total_tokens": 12453
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company emphasized dedicating focused resources to network security, backup, and disaster recovery, along with workforce training and threat monitoring. By 2024, Mondelez further augmented its cybersecurity program with advanced measures such as enhanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to monitor and detect threats. These developments reflect a more robust and proactive approach to cybersecurity and business continuity in response to the evolving threat landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44232,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11283,
        "completion_tokens": 179,
        "total_tokens": 11463
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly evolved from fiscal year 2022 to fiscal year 2024. In fiscal year 2022, the company reported reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft achieved its full goal, spending $500 million with double the number of Black- and African American-owned suppliers. Additionally, in 2024, the company provided 162 low- or no-interest loans to small to medium-sized partners, further demonstrating its deepened commitment to supporting these suppliers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40062,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10236,
        "completion_tokens": 165,
        "total_tokens": 10401
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction suggests that Abbott has been utilizing shares under the plan for employee purchases over the period, reflecting an active stock-based incentive strategy to engage and reward non-U.S. employees through discounted stock purchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45392,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11593,
        "completion_tokens": 120,
        "total_tokens": 11714
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's treatment of Nike Air technology remained consistent as a core innovation within its product development strategy. The 2023 and 2024 filings both highlight Nike Air as one of the key technologies that exemplify Nike's dedication to innovation, used across footwear and incorporated into product designs to enhance performance and consumer experience. There is no indication of a strategic shift in the use or emphasis of Nike Air technology during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48337,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12297,
        "completion_tokens": 125,
        "total_tokens": 12423
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott has emphasized Osmolite as a key component of its enteral feeding portfolio within the Nutritional Products segment. In both years, Osmolite is listed among the primary enteral feeding products, but in 2023, there is a more explicit focus on its role in healthcare institutions, suggesting a strategic effort to strengthen its positioning in clinical settings. This aligns with broader initiatives to enhance the enteral feeding portfolio through product innovation and market expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11442,
        "completion_tokens": 129,
        "total_tokens": 11571
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have evolved significantly, reflecting increased scrutiny and regulatory action. In Minnesota, 3M continues to work with the Minnesota Pollution Control Agency (MPCA) under the 2007 Settlement Agreement and Consent Order to address PFAS contamination at its Cottage Grove facility and former disposal sites in Washington County. In 2024, the MPCA issued a revised draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for PFAS, which could impact the facility's operations. Additionally, 3M received a Notice of Violation in March 2023 for PFAS discharge at its Hutchinson facility and is addressing stormwater discharge concerns at Cottage Grove.\n\nIn Alabama, 3M entered into a voluntary remedial action agreement with the Alabama Department of Environmental Management (ADEM) to remediate PFAS contamination at its Decatur facility. In 2020, 3M and ADEM agreed to an interim Consent Order to address all PFAS-related wastewater discharges and air emissions from the Decatur facility, which includes commitments for ongoing site operations and remediation activities. In 2024, 3M continued to work with ADEM and the EPA to address compliance issues, including submitting applications to modify its NPDES permit to include additional PFAS and implementing wastewater treatment controls. These developments indicate a continued focus on compliance and remediation, with increasing regulatory pressure and operational adjustments to meet evolving standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58672,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14894,
        "completion_tokens": 408,
        "total_tokens": 15302
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's investment in Coca-Cola HBC AG remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, with a carrying value of $1,147 million. The fair value of Coca-Cola HBC AG's shares, based on quoted market prices, was $2,675 million as of the same date, resulting in a difference of $1,528 million between fair value and carrying value. There is no indication of impairment or changes in classification for this investment during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54067,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13746,
        "completion_tokens": 140,
        "total_tokens": 13886
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments between fiscal 2022 and fiscal 2024 has shown a continued focus on providing customers with flexible deployment options, particularly through Oracle Cloud@Customer. In fiscal 2022, Oracle highlighted its commitment to hybrid models as a key component of its growth strategy, emphasizing interoperability and customer choice. By fiscal 2024, this emphasis remained strong, with Oracle continuing to invest in hybrid deployment integration, such as enabling customers to deploy Oracle Cloud in their own data centers. In terms of product development investment, Oracle increased its research and development spending, which rose from $7.2 billion in fiscal 2022 to $10.5 billion in fiscal 2024, reflecting ongoing innovation in hybrid and cloud-based technologies. This evolution underscores Oracle's strategy to support customer transitions to cloud environments while maintaining compatibility with existing on-premise systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12414,
        "completion_tokens": 244,
        "total_tokens": 12659
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Wells Fargo & Company Mandatory Clawback Policy was first disclosed as effective as of October 2, 2023, in the 2023 SEC 10-K (Exhibit 97). In the 2024 SEC 10-K, the policy remains referenced under Exhibit 97, indicating no change in its effective date or filing status, suggesting it was carried forward without material amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61707,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15645,
        "completion_tokens": 89,
        "total_tokens": 15735
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific acquired CorEvitas, LLC in August 2023 as part of its Laboratory Products and Biopharma Services segment, paying $910 million in cash and debt settled. This acquisition expanded the segment's portfolio by adding real-world evidence solutions to enhance drug development processes. The financial implications included a significant use of cash in 2023, with $0.91 billion allocated to the acquisition, contributing to the $5.14 billion net cash used in investing activities for that year. The acquisition also added $627 million in goodwill, which is not tax deductible, and intangible assets with weighted-average amortization periods of 17 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13102,
        "completion_tokens": 168,
        "total_tokens": 13270
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolved between 2022 and 2023 in terms of timing and capitalization treatment as follows: In 2022, these payments were categorized under \"Other commercial aerospace commitments\" and were expected to be capitalized as collaboration intangible assets as payments were made. By 2023, the expected maturity schedule showed a shift in timing, with a significant portion of the obligations moving to later years, particularly \"Thereafter,\" indicating a longer-term outlook. The capitalization treatment remained consistent, with payments being capitalized as collaboration intangible assets upon payment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58646,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14898,
        "completion_tokens": 169,
        "total_tokens": 15067
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's contingent payment liability tied to performance milestones for fairlife has significantly evolved from 2022 to 2024. In 2022, the contingent consideration liability related to fairlife was $3,017 million, based on fairlife's performance through 2024. By 2024, this liability had increased to $6,126 million, reflecting updated expectations of fairlife's financial performance and the application of discounted cash flow analyses. The fair value of this liability is remeasured quarterly and is subject to changes based on fairlife's operating results and macroeconomic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52393,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13325,
        "completion_tokens": 151,
        "total_tokens": 13476
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic positioning of Oracle Cloud Services has evolved to emphasize deeper integration with enterprise applications and infrastructure technologies. In 2022, Oracle highlighted its comprehensive portfolio of applications and infrastructure technologies, emphasizing flexibility and interoperability across deployment models (on-premise, cloud-based, and hybrid). By 2024, Oracle further emphasized the integration of Oracle Cloud Infrastructure (OCI) with Oracle Fusion SaaS Applications, leveraging OCI to power internal business processes and enhance performance, security, and cost-effectiveness. Oracle also expanded its focus on advanced technologies such as machine learning, AI, and IoT, embedding these capabilities into its cloud offerings to drive automation and innovation for customers. This evolution reflects Oracle's commitment to providing a unified, secure, and scalable cloud ecosystem that supports enterprise-wide digital transformation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12463,
        "completion_tokens": 248,
        "total_tokens": 12711
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was first incorporated by reference in the 2018 SEC filing (Exhibit 10(r)). Between 2023 and 2024, there is no indication of any amendments or updates to this policy. In both filings, the policy remains referenced to the same exhibit and source document, suggesting no substantive changes to its documentation or incorporation by reference during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61707,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15658,
        "completion_tokens": 98,
        "total_tokens": 15756
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023, as shown in the long-term debt sections of both years. This stability suggests that RTX did not refinance or retire this specific debt issue during the period, indicating a strategy of maintaining existing long-term obligations without immediate restructuring. It reflects a measured approach to debt management, potentially prioritizing financial flexibility or cost considerations for this particular note.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10976,
        "completion_tokens": 131,
        "total_tokens": 11108
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $749 million at December 31, 2023, to $725 million at December 31, 2024. The effective interest rate for these notes rose slightly from 2.08% in 2023 to 2.07% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14336,
        "completion_tokens": 59,
        "total_tokens": 14396
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflects a shift in transparency and accessibility. In 2022, the Code of Conduct and Directors' Code of Conduct were referenced as being available on the company's website, but no specific details were provided about their content or governance oversight. In 2024, the filing emphasizes the availability of the Directors' Code of Conduct as part of broader corporate governance materials, including committee charters and guidelines, which are accessible on the company's website. This evolution suggests a stronger commitment to corporate governance by making these materials more explicitly available, thereby enhancing accountability and aligning with best practices for board transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36509,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9348,
        "completion_tokens": 200,
        "total_tokens": 9548
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways: \n\n1. **Facility Size**: The facility size remained consistent at $5.0 billion in both years.  \n2. **Maturity Date**: The maturity date shifted from October 2024 (established in November 2023) to October 2025 (established in October 2024), effectively extending the term by one year.  \n3. **Timing of Establishment**: The agreement was established in November 2023 and replaced in October 2024 with a new agreement that extended the maturity date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13483,
        "completion_tokens": 134,
        "total_tokens": 13617
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "AMD's APU strategy evolved significantly from 2022 to 2024, shifting toward deeper integration of AI capabilities and targeting the emerging AI PC segment. In 2022, AMD emphasized balanced computing platforms with integrated CPUs and GPUs for performance and efficiency in traditional and blockchain markets. By 2024, AMD introduced dedicated neural processing units (NPUs) on the same SoC as x86 CPUs, such as the Ryzen AI 300 Series, to enable next-generation AI PCs. This shift positions AMD to capture growing demand for AI-enhanced consumer and commercial notebooks, enhancing its revenue potential in the AI PC segment by offering differentiated, high-performance solutions tailored for AI workloads at the edge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12240,
        "completion_tokens": 179,
        "total_tokens": 12420
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent. Dividends are generally subject to a 25% Irish dividend withholding tax unless exemptions apply, such as providing a valid U.S. Certification of Residence (Form 6166) or an Irish Non-Resident Form V2. If the withholding tax applies, it discharges any Irish income tax liability, provided the shareholder reports the withholding to Irish Revenue authorities. No significant changes were noted in the 2024 filing compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34351,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8822,
        "completion_tokens": 143,
        "total_tokens": 8965
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to include specific mention of the company's transition to a platforms operating model. In 2024, the risk factors explicitly highlight the potential failure to realize expected benefits from this strategic initiative, indicating a more detailed and targeted risk assessment compared to 2022, where the focus was broader on risks related to new products and initiatives without specific reference to the platforms operating model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40815,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10426,
        "completion_tokens": 128,
        "total_tokens": 10554
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Amazon's 3.600% Note due 2032 was disclosed in both the 2023 and 2024 10-K filings under the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). In both years, the note was listed among other debt instruments, indicating no material change in its terms or structure between 2023 and 2024. The disclosure remained consistent, with no additional amendments or events related to the note reported in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11095,
        "completion_tokens": 105,
        "total_tokens": 11200
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes in financial impact and presentation. In 2023, NIH contracts were reported as $163 million in asset derivatives and $382 million in liability derivatives, with an after-tax loss of $185 million on these contracts. By 2024, the asset value increased to $305 million and the liability value decreased to $50 million, indicating a more favorable position. The after-tax gain/(loss) on NIH contracts shifted to a gain of $255 million in 2024, reflecting improved hedge effectiveness and market conditions. Additionally, the presentation in 2024 included more detailed breakdowns of fair value inputs, emphasizing Level 2 valuations for NIH contracts, which remained consistent with prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45313,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 203,
        "total_tokens": 11768
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has advanced significantly, with the U.S. Army announcing the development of the M1E3 Abrams, a major engineering upgrade aimed at enhancing lethality, survivability, and mobility against future threats. Technologically, the M1E3 incorporates a modernized systems architecture for faster technology integration and reduced sustainment requirements. Internationally, demand for Abrams tanks remains strong, particularly among NATO allies and partners in Europe, the Middle East, and the Indo-Pacific, reflecting continued confidence in the platform's capabilities and the company's global support infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 26757,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6912,
        "completion_tokens": 170,
        "total_tokens": 7083
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's role in the development and positioning of APUs has evolved to emphasize their integration and performance benefits across a broader range of market segments. In 2022, APUs were highlighted as a key part of balanced computing platforms, combining CPUs and GPUs on a single chip to deliver visual processing for value and mainstream PCs. By 2024, AMD strategically emphasized APUs within its reportable segments, particularly in the Client and Embedded segments, showcasing their role in delivering performance and efficiency for notebooks, desktops, and embedded systems. The strategic emphasis also shifted toward leveraging APUs in heterogeneous computing and AI/ML workloads, reflecting a broader market segmentation approach to meet growing demands in both consumer and enterprise applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43128,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11007,
        "completion_tokens": 206,
        "total_tokens": 11213
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Act allows the Irish Minister for Finance to restrict financial transfers between Ireland and third countries, with such restrictions being subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also be restricted under Irish law. There were no material changes in the nature or scope of this disclosure between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34351,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8816,
        "completion_tokens": 152,
        "total_tokens": 8969
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In 2023, General Dynamics (GD) disclosed that the ultra-long-range G700 aircraft was expected to enter service following FAA certification in early 2024. By 2024, GD reported that production of new Gulfstream models, including the G700, had ramped up, with deliveries of the G700 beginning in the second quarter of 2024. This indicates that the G700 transitioned from the certification and pre-delivery phase in 2023 to active production and delivery in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32441,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8321,
        "completion_tokens": 114,
        "total_tokens": 8435
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G evolved from 2023 to 2024 by extending their collaboration through a renewed and exclusive, worldwide agreement (excluding South Korea) for the commercialization of KT&G's smoke-free products. This long-term arrangement, effective until January 29, 2038, enhances PMI's strategic dependency on KT&G's innovation pipeline and expands PMI's product portfolio with KT&G's smoke-free devices and consumables, including offerings for low- and middle-income markets. The agreement reflects a stronger alignment in product commercialization, with PMI gaining exclusive access to KT&G's brands and innovation, subject to regulatory approvals and quality standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44645,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11383,
        "completion_tokens": 174,
        "total_tokens": 11558
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved by integrating these products more strategically into broader AI and high-performance computing ecosystems. In 2022, AMD emphasized the importance of semi-custom SoC revenue, which depends on third-party product success and design inclusion. By 2024, AMD positioned semi-custom SoCs as part of its broader adaptive computing strategy, leveraging them in gaming consoles and AI-driven platforms while expanding into data center and embedded solutions. This shift reflects a more ecosystem-focused approach, aligning semi-custom SoCs with AMD's leadership in AI, cloud, and edge computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12370,
        "completion_tokens": 165,
        "total_tokens": 12535
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely unchanged, with dividends generally subject to a 25% Irish dividend withholding tax unless exemptions applied. U.S. residents holding shares through the Depository Trust Company (DTC) continued to be exempt from withholding tax if their addresses were correctly recorded with their brokers. Additionally, U.S. residents who provided valid certification (e.g., Form 6166 or Form V2) were also exempt. Irish income tax liability on dividends was generally not applicable to U.S. residents meeting these exemptions and not conducting trade in Ireland. The 2024 filing reiterated these rules without indicating new changes to exemptions or obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12051,
        "completion_tokens": 189,
        "total_tokens": 12241
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "From 2023 to 2024, General Dynamics' Marine Systems segment experienced cost pressures on the Virginia-class and DDG-51 programs, which contributed to a slight decline in operating earnings and margin in 2023. In 2024, the segment's revenue is expected to increase to approximately $12.8–12.9 billion, with an operating margin of around 7.6%, indicating some margin improvement. The Columbia-class submarine initiative continued to drive ship construction revenue in both years, with 2024 outlooks reflecting sustained growth and improved operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8302,
        "completion_tokens": 140,
        "total_tokens": 8443
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided information, BKNG's financial dependency on Booking.com for accommodation reservations remained stable between 2022 and 2023. In both years, approximately 89% of the company's total revenue was derived from online accommodation reservation services, with the majority of merchant revenues and substantially all agency revenues coming from Booking.com. This indicates that there was no significant change in the proportion of revenue attributed to accommodation reservations during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41286,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10543,
        "completion_tokens": 128,
        "total_tokens": 10672
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The company's Swiss Franc note, which was listed as CHF250 million (approximately $283) at December 31, 2023, was fully repaid by December 31, 2024, as it no longer appears in the 2024 long-term debt listing. This indicates that the company successfully settled its Swiss Franc-denominated obligation within the year, reducing its foreign currency exposure. The repayment suggests effective management of foreign currency liabilities and alignment with the company's broader debt refinancing and restructuring efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43927,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11209,
        "completion_tokens": 129,
        "total_tokens": 11338
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new Non-Employee Director RSU Award Agreements in the 2024 10-K filing, including a standard form (Exhibit 10.32) and a cash-settled version (Exhibit 10.33), which were not explicitly listed in the 2023 10-K. These updates reflect modifications or additions to the structure of director compensation arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10553,
        "completion_tokens": 84,
        "total_tokens": 10638
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PM's financial relationship with Swedish Match AB, particularly in terms of long-term debt obligations tied to the acquisition, evolved as follows: In 2023, PMI had a €5.5 billion senior unsecured term loan facility to finance the acquisition, which included a €3.0 billion tranche due in 2025 and a €2.5 billion tranche due in 2027. By November 21, 2024, PMI prepaid the €3.0 billion tranche, leaving the €2.5 billion tranche outstanding as of December 31, 2024. Additionally, the preliminary purchase price allocation for the acquisition was adjusted during this period, leading to a decrease in goodwill for the Swedish Match segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44287,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11298,
        "completion_tokens": 165,
        "total_tokens": 11463
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "BMY's strategic positioning around KRAS inhibition evolved significantly from 2023 to 2024 with the acquisition of Mirati in January 2024. This acquisition added Krazati, a best-in-class KRAS G12C inhibitor, to BMY's portfolio, which was FDA-approved for second-line NSCLC and is in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. The acquisition also provided access to other clinical assets, including MRTX1719, a potential first-in-class PRMT5 inhibitor. This move strengthened BMY's oncology pipeline and expanded its capabilities in KRAS-targeted therapies, aligning with its broader strategy to enhance its presence in precision oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10393,
        "completion_tokens": 169,
        "total_tokens": 10562
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan remained largely consistent between 2023 and 2024, as both filings reference the same document—Exhibit 10.3 (2023) and Exhibit 10.4 (2024)—indicating no material changes to the plan itself. However, in 2024, the firm introduced a new Clawback Policy effective December 1, 2023, which was filed as Exhibit 10.1 in the 2024 10-K. This policy, while not directly tied to the Restricted Partner Compensation Plan, reflects a broader governance enhancement that could impact compensation structures, including those of partners, by enabling recoupment of compensation under certain circumstances. Thus, while the Restricted Partner Compensation Plan itself did not evolve, the introduction of the Clawback Policy in 2024 signifies a strengthening of compensation governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10563,
        "completion_tokens": 213,
        "total_tokens": 10776
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) evolved its approach to heat-not-burn (HNB) products by reclassifying them under a broader \"smoke-free products\" category, which also includes e-vapor and oral nicotine products. In 2023, PMI further integrated HNB products into its business strategy by expanding the smoke-free segment to include wellness and healthcare products, reflecting a strategic shift toward diversification beyond nicotine. This integration is evident in the 2023 financial reporting, where HNB products are grouped with other smoke-free offerings, and the company emphasized growth in heated tobacco unit (HTU) shipments across all regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40917,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10454,
        "completion_tokens": 167,
        "total_tokens": 10622
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb maintained its compliance with the SEC Consent Order by continuing the established procedures, including the role of the business risk and disclosure group. The 2024 filing reaffirms the company's adherence to the Consent Order's requirements, such as limiting sales to direct customers based on expected demand and maintaining a governance process to monitor compliance. There is no indication of significant changes to the role or structure of the business risk and disclosure group during this period, suggesting a consistent approach to SEC Consent Order compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46634,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11896,
        "completion_tokens": 153,
        "total_tokens": 12050
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent asset allocation strategy for its pension plan, with equity securities allocated between 20% and 30% and debt securities between 70% and 80%. The expected long-term rate of return on plan assets remained unchanged at 5.25%. However, the discount rate increased from 5.00% in 2023 to 5.61% in 2024, reflecting improved market conditions and impacting the actuarial assumptions used to determine the projected benefit obligation. This increase in the discount rate led to a reduction in the projected benefit obligation, as higher discount rates lower the present value of future liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36587,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9367,
        "completion_tokens": 160,
        "total_tokens": 9527
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly listing it among the corporate governance materials available on its website. In 2022, the Code was mentioned as being available online but was not highlighted as part of broader governance disclosures. By 2023, the Directors' Code of Conduct was explicitly included in the list of governance-related documents accessible on the company’s website, alongside other key governance materials such as the Corporate Governance Guidelines and committee charters, thereby improving its visibility and integration within the corporate governance reporting framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35949,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9219,
        "completion_tokens": 170,
        "total_tokens": 9390
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems, reflecting a stronger focus on cloud migration and hybrid IT environments. The company has expanded deployment options for Oracle Database, including on-premise, Oracle Cloud, Oracle Exadata Cloud@Customer, and OCI Dedicated Region, allowing customers to choose deployment models that best suit their needs. Additionally, Oracle has integrated Oracle Database with engineered systems like Oracle Exadata, which improves performance, scalability, and operational efficiency. This evolution indicates Oracle's commitment to supporting hybrid and multicloud strategies while facilitating seamless cloud migration for customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11238,
        "completion_tokens": 197,
        "total_tokens": 11436
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, the implementation of the formal review and certification process of annual and quarterly SEC reports remained consistent with the measures established under the 2004 SEC Consent Order. Both years emphasized a structured governance process for compliance monitoring, including escalation of potential concerns to management and regular policy adherence checks. In 2024, the procedures were reiterated with a focus on maintaining compliance with the Consent, particularly through DSAs with U.S. pharmaceutical wholesalers and estimating inventory levels. No significant evolution in the process was noted, but continued emphasis was placed on ensuring transparency and adherence to the Consent terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46634,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11896,
        "completion_tokens": 180,
        "total_tokens": 12076
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has continued to position heat-not-burn (HNB) products as a core component of its reduced-risk product (RRP) strategy, emphasizing their potential to present less risk to smokers compared to combustible cigarettes. In 2023, PMI reported a 14.7% increase in heated tobacco unit (HTU) shipments globally, reflecting strong growth in key markets like Europe and Japan. The company categorizes HNB products under its smoke-free portfolio, which includes heat-not-burn, e-vapor, and oral nicotine products, and highlights their role in transitioning adult smokers away from combustible tobacco. This evolution underscores PMI’s ongoing commitment to expanding its RRP offerings and reinforcing their market presence as alternatives to traditional cigarettes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45639,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11637,
        "completion_tokens": 201,
        "total_tokens": 11839
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. In 2024, Oracle has expanded deployment options, offering Oracle Database through on-premise, cloud-based (OCI), and hybrid models, including Oracle Exadata Cloud@Customer and OCI Dedicated Region. Additionally, Oracle has strengthened integration with its Oracle Cloud Infrastructure (OCI) and Oracle Autonomous Database, enabling seamless operations, automated management, and support for AI and machine learning. These advancements reflect Oracle's focus on providing customers with scalable, secure, and flexible solutions across diverse IT environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10769,
        "completion_tokens": 183,
        "total_tokens": 10952
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024 through the acquisition of Mirati, a commercial-stage targeted oncology company, which provided BMY with the rights to commercialize Krazati (adagrasib), a KRAS G12C inhibitor approved for second-line non-small cell lung cancer (NSCLC) and in development for first-line NSCLC in combination with a PD-1 inhibitor. The acquisition, finalized in January 2024, involved a total consideration of $4.8 billion, including $4.1 billion net of cash acquired, and also included contingent value rights (CVRs) potentially worth up to $1.0 billion tied to the FDA acceptance of an NDA for Mirati’s PRMT5 Inhibitor within seven years. This acquisition reflects BMY's commitment to strengthening its oncology portfolio and expanding its presence in targeted therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39120,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10004,
        "completion_tokens": 206,
        "total_tokens": 10211
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were registered under Section 12(b) of the Exchange Act in both 2022 and 2023, with the trading symbol BK/P on the New York Stock Exchange. In both years, the securities were fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. There is no indication of a change in their status or treatment between 2022 and 2023 based on the provided filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9528,
        "completion_tokens": 115,
        "total_tokens": 9643
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $2.3 billion to $2.7 billion, while borrowings under these arrangements rose slightly from $225 million to $283 million. This increase in available credit suggests that PMI has enhanced its near-term liquidity posture, potentially to support working capital needs, strategic initiatives, or to provide a buffer for operational flexibility. The unchanged committed credit facilities and the absence of borrowings under these facilities further indicate a strong liquidity position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37144,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9515,
        "completion_tokens": 141,
        "total_tokens": 9656
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by emphasizing deeper integration with other Oracle Cloud services and expanding automation capabilities. The 2024 documentation highlights improved integration with services like Java Cloud and Oracle APEX, enabling developers to build modern, cloud-native applications on an open platform. Additionally, Oracle has expanded the automation features of the Autonomous Database, leveraging machine learning for diagnostics, fault prediction, and self-driving operations, which reduces human error and lowers administrative costs. These advancements reflect Oracle's focus on delivering a more seamless, scalable, and intelligent cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44203,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11279,
        "completion_tokens": 182,
        "total_tokens": 11461
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained stable in terms of capital involvement, with GM contributing $0.7 billion in 2024 and $0.8 billion in 2023 to the joint venture. Strategically, GM continued its commitment to Ultium Cells as part of its electrification efforts, though the documents do not indicate any significant changes in the partnership's positioning during this period. The committed capital contributions and GM's exposure to Ultium Cells remained consistent, reflecting ongoing support for battery cell production to meet GM's EV goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51149,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13013,
        "completion_tokens": 150,
        "total_tokens": 13164
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: in 2022, Visa released $3.5 billion of as-converted value and issued 176,655 series A preferred shares during the Sixth Anniversary Release. By 2024, the Eighth Anniversary Release resulted in $2.7 billion of as-converted value being released, with the issuance of 99,264 series A preferred shares. This reflects a decrease in both the as-converted value released and the number of series A preferred shares issued compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16757,
        "completion_tokens": 132,
        "total_tokens": 16890
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation impacts and business segment adjustments. In 2022, 3M deconsolidated the Aearo Entities through a voluntary Chapter 11 bankruptcy, but reconsolidated them in 2023 after the bankruptcy was dismissed. This reconsolidation affected financial reporting and segment adjustments, particularly in the Safety and Industrial and Transportation and Electronics segments. Litigation related to Combat Arms Earplugs and respirator mask/asbestos claims led to significant charges, including a $1.2 billion pre-tax charge in 2022 and a $4.2 billion pre-tax charge in 2023 under the CAE Settlement. In 2024, the Aearo Entities were fully integrated back into 3M's operations, and the CAE Settlement implementation began, with 3M committing $6.0 billion through 2029 to resolve claims. These developments impacted 3M’s financial structure and segment operating income, particularly through special items and litigation costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48187,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 261,
        "total_tokens": 12540
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment and structure of Class C Common Stock evolved primarily through changes in its conversion features and earnings per share (EPS) performance. In 2024, the introduction of Class B-2 Common Stock via an exchange offer altered the capital structure, with Class B-2 shares having conversion rates that adjust with double the impact of Class B-1 shares. Class C Common Stock, which has no transfer restrictions, maintained its higher EPS compared to other classes, increasing from $38.97 in 2024 to $33.17 in 2023 and $28.03 in 2022, reflecting its smaller share count and higher income allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50366,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12825,
        "completion_tokens": 159,
        "total_tokens": 12985
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in the development and commercialization of ADAS/AD technology from fiscal 2022 to fiscal 2024 has evolved significantly, with a notable increase in strategic focus and revenue contributions. In fiscal 2022, ADAS/AD was mentioned as part of the automotive industry's long design-in timeframes and high regulatory requirements, indicating Qualcomm's early-stage engagement. By fiscal 2024, ADAS/AD was explicitly included in the automotive revenue stream under QCT, with automotive revenues rising from $1,509 million in 2022 to $2,910 million in 2024, reflecting expanded product offerings in connectivity, digital cockpit, and ADAS/AD solutions. This growth underscores Qualcomm's strategic investment in automotive technologies and its increasing commercialization of ADAS/AD capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56996,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14489,
        "completion_tokens": 203,
        "total_tokens": 14692
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by significantly increasing the U.S. litigation escrow account balance, from $1.4 billion in 2022 to $3.089 billion in 2024, reflecting additional deposits of $1.5 billion in 2024 and $1.0 billion in 2023. The plan's mechanisms, including the escrow account, class B stock conversion feature, and loss-sharing agreements, remained consistent in structure but were more actively funded to address ongoing litigation risks. This evolution suggests that Visa is proactively managing litigation risk by setting aside larger reserves, indicating a cautious and structured approach to ensuring financial preparedness for potential liabilities in covered litigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52012,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13252,
        "completion_tokens": 184,
        "total_tokens": 13436
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as reflected in alliance revenue, increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. This growth suggests that Lynparza maintained strategic importance for Merck, particularly outside the U.S., despite challenges in other areas of its portfolio. Additionally, the approval of Lynparza in China in January 2025 for adjuvant treatment of early breast cancer indicates a potential for further growth, reinforcing its ongoing significance in Merck's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69260,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17545,
        "completion_tokens": 139,
        "total_tokens": 17685
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Skoal's market position within Altria's oral tobacco products segment weakened between 2022 and 2024, as its shipment volume declined from 163.1 million packs in 2023 to 147 million packs in 2024, and its retail share dropped from 9.3% to 7.6%. This decline was driven by retail share losses in the moist smokeless tobacco (MST) category, as competition intensified from oral nicotine pouches like on!, which saw increased market penetration. While on! gained share within the nicotine pouch category, Skoal's performance was further impacted by a non-cash impairment of the Skoal trademark in 2024, signaling a strategic shift toward newer product categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13540,
        "completion_tokens": 165,
        "total_tokens": 13705
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased from $4.687 billion in fiscal year 2022 to $6.481 billion in fiscal year 2023, reflecting a growth of approximately 38.1%. This growth is attributed to the continued adoption of Dynamics 365, which includes a suite of intelligent, cloud-based applications across ERP, CRM, and other business solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 33970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8706,
        "completion_tokens": 94,
        "total_tokens": 8800
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's Balance Sheet Risk Management Program for foreign exchange exposure in 2024 shows a continuation of its 2023 approach, with forward exchange contracts remaining the primary hedging instruments to offset the effects of foreign exchange volatility on monetary assets and liabilities. The scope of hedging activities in 2024 remains focused on major currencies such as the euro, Swiss franc, Japanese yen, and Chinese renminbi, consistent with 2023. However, in 2024, Merck expanded its interest rate risk management by entering into an additional interest rate swap contract in January 2025, which was not mentioned in the 2023 disclosures, indicating a slight evolution in its broader risk management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65714,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16668,
        "completion_tokens": 179,
        "total_tokens": 16847
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables between 2022 and 2024 shows growth in its merchant financing products, with the outstanding balance increasing from $1.2 billion in 2023 to $1.5 billion in 2024. In terms of credit loss provisions, the allowance for credit losses on merchant receivables decreased from $160 million at the end of 2023 to $113 million by the end of 2024, primarily due to an improvement in the credit quality of the PayPal Business Loan (PPBL) portfolio. This reflects PayPal's active monitoring and management of credit risk in its merchant financing offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13843,
        "completion_tokens": 147,
        "total_tokens": 13990
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) remained relatively stable in terms of goodwill allocation, with $99 million in 2022 and $99 million in 2024. However, operating income performance for smokeable products increased from $10,670 million in 2023 to $10,821 million in 2024, indicating improved profitability despite a slight decline in net revenues. This suggests that smokeable products remained a core, stable contributor to Altria's financial performance during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60404,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15324,
        "completion_tokens": 131,
        "total_tokens": 15455
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13.6 billion in fiscal year 2022 to $14.9 billion in fiscal year 2023, representing a growth of approximately $1.3 billion or 9.5%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32397,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8318,
        "completion_tokens": 58,
        "total_tokens": 8377
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, the commercialization and market expansion of Lynparza evolved with geographic approvals and revenue growth. In May 2023, Lynparza received FDA approval in combination with abiraterone and prednisone for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC), based on the PROpel trial. This was followed by Japan's MHLW approval in August 2023 for the same indication. By 2024, Lynparza's alliance revenue grew by 9%, driven by higher demand in most international markets. In January 2025, Lynparza received NMPA approval in China as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, further expanding its geographic reach and contributing to revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58686,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14893,
        "completion_tokens": 195,
        "total_tokens": 15089
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "Between 2023 and 2024, the Powder Metal Matter had a notable impact on RTX's future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, as listed under deferred tax assets and liabilities. By 2024, this amount decreased to $455 million, indicating a reduction in the associated tax benefits. This decline suggests that the financial impact of the Powder Metal Matter on RTX's future tax positions diminished over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43013,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10978,
        "completion_tokens": 120,
        "total_tokens": 11098
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity and terms of the Paidy Credit Agreement evolved from 2022 to 2024 as follows: In February 2022, the Paidy Credit Agreement initially provided for an unsecured revolving credit facility of ¥60.0 billion. This was modified in September 2022 to increase the borrowing capacity by ¥30.0 billion, bringing the total to ¥90.0 billion (approximately $574 million as of December 31, 2024). By December 31, 2024, the full ¥90.0 billion had been drawn down, leaving no available borrowing capacity. The terms included interest at the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%, based on the company's public debt rating.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12419,
        "completion_tokens": 165,
        "total_tokens": 12584
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria's reliance on long-term senior unsecured notes as part of its capital resources remained a key component, though with some changes in structure and amounts. In 2022, Altria had $28.0 billion in total debt, with long-term senior unsecured notes forming a significant portion. By 2024, total long-term debt had decreased to $24.9 billion, reflecting debt repayments and refinancing activities. Notably, in 2024, Altria issued $1.0 billion in new senior unsecured notes to refinance maturing debt, indicating a continued strategic use of long-term senior unsecured notes to manage its capital structure and liquidity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54676,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13883,
        "completion_tokens": 162,
        "total_tokens": 14046
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter evolved from a $5.4 billion net sales charge in 2023 to a reduced $2.5 billion net reduction in cost of sales in 2024, primarily reflecting partners' shares. This indicates that the matter's impact on future income tax benefits diminished, as the deferred tax asset related to the Powder Metal Matter decreased from $644 million in 2023 to $455 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47775,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12169,
        "completion_tokens": 103,
        "total_tokens": 12273
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the Paidy Credit Agreement had a borrowing capacity of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the agreement was modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and the full amount was drawn down, leaving no available borrowing capacity. This indicates a substantial increase in both borrowing capacity and actual drawdown from 2022 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48178,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12268,
        "completion_tokens": 141,
        "total_tokens": 12409
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. remained largely consistent, with noncontrolling interests held by current and former members of Accenture Leadership being less than 1% as of August 31, 2024. Holders of Accenture Canada Holdings Inc. exchangeable shares retained the right to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, and Accenture plc maintained the ability to redeem Class X ordinary shares to align with outstanding exchangeable shares. No significant changes were reported in the noncontrolling interests or the mechanics of the exchangeable shares during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40584,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10383,
        "completion_tokens": 177,
        "total_tokens": 10561
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of currencies and cost-benefit considerations. In 2022, Merck primarily focused on hedging exposures in the euro, Japanese yen, and Chinese renminbi, using forward contracts for developed and selected developing country currencies based on cost-benefit analysis. By 2024, the company expanded its hedging scope to include the Swiss franc, Japanese yen, and Chinese renminbi, with a continued emphasis on cost-benefit assessments to determine the economic viability of hedging instruments. The 2024 disclosures also highlight a preference for shorter-term contracts (average maturities of less than six months) to mitigate spot-forward differences, reflecting a more dynamic and responsive strategy to foreign exchange volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60388,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15330,
        "completion_tokens": 214,
        "total_tokens": 15544
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact on future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, while in 2024, this amount decreased to $455 million. This decline indicates that the anticipated tax benefits from this matter are diminishing, likely due to resolution or reduced expectations of future tax deductions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12466,
        "completion_tokens": 116,
        "total_tokens": 12583
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal expanded its merchant finance offerings between 2022 and 2024, with the outstanding balance of merchant loans, advances, and interest and fees receivable increasing from $1.2 billion in 2023 to $1.5 billion in 2024. The company continued its partnership with a U.S. partner institution to purchase receivables related to credit extended to merchants, acquiring $1.8 billion in 2024 compared to $1.7 billion in 2023. The credit quality of the merchant receivables improved, as evidenced by a decrease in delinquencies and a reduction in the allowance for credit losses from $160 million in 2023 to $113 million in 2024, primarily due to improvements in the PPBL portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 53047,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13499,
        "completion_tokens": 169,
        "total_tokens": 13669
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, and by 7% in 2023 compared to 2022. The growth in 2024 was primarily driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of certain early breast cancer, which is expected to further support its revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14953,
        "completion_tokens": 95,
        "total_tokens": 15048
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables evolved between 2022 and 2024 with increased financial exposure and a more active operational role. By 2024, the total outstanding balance of merchant loans, advances, and interest and fees receivable rose to $1.5 billion from $1.2 billion in 2023, reflecting expanded credit offerings like PPWC and PPBL. The company also took a more active role in underwriting and risk management, using internal models to assess merchant creditworthiness and monitor delinquency trends. Additionally, PayPal entered into agreements to purchase receivables from partner institutions, increasing its servicing responsibilities and financial exposure to merchant credit performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55860,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14188,
        "completion_tokens": 177,
        "total_tokens": 14366
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 has shown regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review for new indications, including adjuvant treatment for BRCA-mutated, HER2-negative early-stage breast cancer, with a PDUFA date set for the first quarter of 2022. By 2024, Lynparza's alliance revenue grew by 9%, driven by higher demand in most international markets. Additionally, in January 2025, China's National Medical Products Administration (NMPA) approved Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating continued regulatory expansion and commercial success.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54687,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13898,
        "completion_tokens": 186,
        "total_tokens": 14085
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, with hedging now covering forecasted transactions through 2028, up from previous periods. Additionally, the financial exposure related to these contracts remained relatively stable, as a 10% market price fluctuation would impact unrealized losses by approximately $46 million in 2022 and continued to be offset by gains or losses on the underlying transactions, ensuring no material market risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34704,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8901,
        "completion_tokens": 125,
        "total_tokens": 9026
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Portfolio Allowance Loans) remained fully collateralized, with securities pledged in amounts exceeding the borrowings as of December 31, 2021, and presumably continuing through 2024 based on the absence of any allowance for credit losses. In 2021, no allowance for credit losses was required for PALs due to full collateralization, and by 2024, the Company continued to maintain strong credit quality metrics, with no allowance for credit losses reported for PALs. This indicates that Schwab's credit risk associated with PALs remained minimal and effectively managed through collateralization throughout the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52033,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13236,
        "completion_tokens": 166,
        "total_tokens": 13403
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved significantly due to increasing cost impacts and rising research & development (R&D) investments. In 2022, R&D expenses for the 777X program were relatively lower at $278 million, but by 2023, these costs increased to $315 million, and further rose to $377 million in 2024, reflecting higher spending on product development. Concurrently, the 777X program began to contribute to cost overruns, as evidenced by the 2024 cost of sales, which included reach-forward losses on the 777X and 767 programs. This indicates a shift from R&D investment to financial strain due to production and delivery challenges, impacting Boeing’s overall profitability and strategic focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32881,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8450,
        "completion_tokens": 193,
        "total_tokens": 8643
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) remained relatively stable in terms of methodology but showed growth in the portfolio. The credit loss allowance for PALs continued to rely on a practical expedient based on collateral maintenance provisions, recognizing that the portfolio is collateralized by marketable securities with liquid markets and is over-collateralized. This methodology limits inherent credit risk. The PALs portfolio grew from $17,024 million in 2024 to $17,024 million, indicating no change in the total portfolio size, but the 2024 data shows a breakdown of $16,726 million within one year, reflecting increased short-term exposure. Overall, Schwab maintained its risk management approach while managing a stable and collateralized PALs portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45470,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11601,
        "completion_tokens": 206,
        "total_tokens": 11808
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes decreased from $360 million in 2022 to $0 in 2023, as no value was reported for 2023. This shift indicates that the company may have settled or restructured its British pound sterling hedges during the year, reflecting an active approach to managing foreign exchange risk by adjusting its hedging positions in response to market conditions or strategic priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13338,
        "completion_tokens": 102,
        "total_tokens": 13440
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In both the 2022 and 2024 filings, Amgen's 3.125% 2025 Notes are disclosed as having interest rate swap contracts that convert the fixed-rate coupon to a floating-rate SOFR-based rate. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2024, it was updated to SOFR + 2.1%. This shift from LIBOR to SOFR reflects Amgen's adaptation to the transition away from LIBOR to more robust reference rates. The consistent use of interest rate swaps for these notes indicates Amgen's ongoing strategy to manage interest rate risk by balancing fixed and floating rate debt exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12445,
        "completion_tokens": 145,
        "total_tokens": 12590
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 as a response to market disruptions and rising interest rates. In 2022, the company faced liquidity challenges due to rapid interest rate hikes, which led to client reallocations of cash out of sweep accounts into higher-yielding alternatives. This necessitated the use of higher-cost supplemental funding sources, including commercial paper, to meet liquidity needs. By 2024, Schwab continued to maintain its commercial paper issuance program as part of its diversified funding strategy, especially amid ongoing market volatility and regulatory changes. However, the company also emphasized the importance of maintaining sufficient liquidity to address potential disruptions in the credit markets and rising borrowing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55030,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13981,
        "completion_tokens": 203,
        "total_tokens": 14184
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2022 were fully redeemed in 2021, as indicated by their absence in the 2024 disclosures. In 2022, the 3.625% Notes due 2024 were hedged with interest rate swaps converting their fixed-rate coupons to SOFR-based floating rates (SOFR + 3.4% in 2023). By 2024, these swaps were adjusted to SOFR + 3.4%, and the notes were repaid, reflecting a strategic shift to manage interest rate risk and optimize debt cost. This evolution indicates the company's proactive approach to debt management, leveraging hedging instruments to mitigate exposure to rate fluctuations and align with its financial objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12438,
        "completion_tokens": 155,
        "total_tokens": 12593
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has remained consistent in terms of intent and conditions for funding commitments. As of December 31, 2021 (2022 10-K) and December 31, 2020 (2024 10-K), Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs beyond what was contractually required. The funding of remaining commitments to these VIEs, primarily related to Community Reinvestment Act (CRA) and Low-Income Housing Tax Credit (LIHTC) investments, is contingent upon the occurrence of certain conditions, and Schwab expects to fulfill these commitments between 2022 and 2025. There is no indication of a change in Schwab's intent or conditions for funding during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49677,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12655,
        "completion_tokens": 201,
        "total_tokens": 12856
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's evolved primarily through the impact of its equity method investment, which contributed positively to liquidity and capital structure. In 2023, MDLZ reported a gain of $740 million on equity method investment transactions, compared to a $989 million gain in 2022, indicating continued, though slightly reduced, positive contributions from JDE Peet's. Additionally, the investment provided financial flexibility, as noted in the 2023 10-K, supporting MDLZ's liquidity through proceeds from JDEP share sales and enhancing its capital structure by reducing reliance on debt financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39625,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10134,
        "completion_tokens": 162,
        "total_tokens": 10297
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes remained consistent between 2022 and 2024, with the interest rate under the swap agreements being SOFR plus 2.1% in both periods. This indicates that the hedging structure for these notes did not change during the timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49789,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12678,
        "completion_tokens": 71,
        "total_tokens": 12749
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million as of January 31, 2022, to $4,414 million as of January 31, 2023. This represents a decrease of $1,405 million, or approximately 24.16%, over the fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 65,
        "total_tokens": 14251
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings. In both years, the company emphasized that while it holds a broad portfolio of intellectual property, its success is primarily driven by the innovative skills, technical competence, and marketing abilities of its personnel. There is no notable evolution in how Apple describes its reliance on marketing abilities in the provided sections of the filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43082,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10982,
        "completion_tokens": 119,
        "total_tokens": 11101
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes remained unchanged at $1,400 million between 2022 and 2024. However, the interest rate structure changed from being hedged at SOFR + 3.4% in 2023 to being fully repaid by 2024, with associated interest rate swap contracts maturing in connection with the repayment. This indicates that Amgen's hedging strategy involved using interest rate swaps to convert fixed-rate debt to floating-rate SOFR-based debt, and the termination of these swaps in 2024 suggests the completion of the hedging activity for this specific debt issuance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49789,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12677,
        "completion_tokens": 143,
        "total_tokens": 12820
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab's integration of the iRebal portfolio rebalancing solution from 2022 to 2023 evolved from retaining it as part of its Advisor Services offerings post-TD Ameritrade acquisition to fully incorporating it into its platform for independent advisor clients. This integration reflects Schwab's strategic focus on enhancing its Advisor Services capabilities, leveraging TD Ameritrade's strengths to provide more robust tools for RIAs. This move strengthens Schwab's competitive positioning in the RIA market by offering a customizable, efficient rebalancing solution, thereby deepening client relationships and supporting its goal of being a trusted leader in investment services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52130,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13259,
        "completion_tokens": 170,
        "total_tokens": 13429
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Between 2023 and 2024, Apple's approach to the iMac product line evolved as part of broader updates to its Mac lineup. In the first quarter of 2024, Apple announced a new iMac model, indicating a focus on refreshing its desktop offerings. This aligns with the overall increase in Mac net sales in 2024, driven primarily by higher sales of laptops, suggesting a coordinated strategy to enhance the entire Mac product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29459,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7582,
        "completion_tokens": 106,
        "total_tokens": 7688
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX issued the 2.820% Notes Due 2051 in August 2021 with a principal balance of $1,000 million to refinance maturing debt. These notes remained outstanding in 2024 with no changes in principal, indicating they are a stable component of the company's long-term debt structure. This reflects RTX's strategy of maintaining long-dated debt to manage maturity profiles and reduce refinancing risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11093,
        "completion_tokens": 98,
        "total_tokens": 11191
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab's IDA agreement evolved by transitioning from LIBOR-based reference rates to alternative benchmark rates following the phase-out of LIBOR. Additionally, the service fee on client cash deposits held at the TD Depository Institutions was reduced from 25 basis points to 15 basis points as part of an amended agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46121,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11750,
        "completion_tokens": 86,
        "total_tokens": 11836
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment—from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024—suggests a reassessment of its strategic importance and valuation approach. This shift likely reflects a decision to integrate Filorga more closely with other brands in its segment, potentially signaling a reduced standalone strategic emphasis or a reevaluation of its distinct market position. The company may also be streamlining its reporting structure to better align with evolving business strategies or to simplify the valuation process by grouping similar intangible assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10965,
        "completion_tokens": 168,
        "total_tokens": 11133
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflects a more detailed and forward-looking reporting strategy. In the 2024 filing, Apple explicitly mentions the iPhone 16 Pro in the context of its product announcements, signaling a shift toward emphasizing new product launches as key drivers of business performance. This evolution in disclosure aligns with Apple's broader focus on innovation and product differentiation, particularly in response to competitive pressures and evolving consumer demand. The increased transparency about flagship product development highlights Apple's strategic emphasis on technological advancements and market positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7629,
        "completion_tokens": 176,
        "total_tokens": 7805
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its use of Economic Value of Equity (EVE) simulations to assess interest rate risk by incorporating the impact of derivative instruments and updating assumptions related to non-maturity deposit behavior and client cash allocation changes. In 2023, the Company also began utilizing interest rate swap derivative instruments to manage interest rate risk, which were integrated into EVE analyses. Additionally, liability duration shortened significantly due to rising interest rates, leading to a shift in the EVE sensitivity profile as liability duration became shorter than asset duration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48930,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12469,
        "completion_tokens": 158,
        "total_tokens": 12627
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, allowing it to offer end-to-end solutions in the broader networking market. This move strengthened its ability to capitalize on growing demand for 5G and Wi-Fi 6/6E technologies, positioning Qualcomm as a more integrated player in both semiconductor and networking product markets. By vertically integrating into wireless access point production, Qualcomm could better align its offerings with its foundational connectivity technologies, improving differentiation and scalability in the evolving edge networking landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64497,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16363,
        "completion_tokens": 183,
        "total_tokens": 16547
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "The interest-only payment structure of Schwab's HELOC product slightly decreased from 2022 to 2023. In 2022, approximately 28% of adjustable-rate mortgages had interest-only terms, while in 2023, this percentage dropped to 27%. Additionally, the portion of interest-only loans not scheduled to reset for three or more years decreased from 89% in 2022 to 86% in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13523,
        "completion_tokens": 91,
        "total_tokens": 13615
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market evolved from 2022 to 2023 through strategic investments and product development. In 2022, XR was mentioned as part of QSI's investment focus, particularly in early-stage companies across industries like 5G, AI, and XR. By 2023, XR was explicitly included in QCT's revenue streams under the \"Consumer\" category within the IoT segment, indicating product sales for XR devices. This suggests Qualcomm expanded its XR footprint by both investing in the ecosystem and integrating XR-capable technologies into its semiconductor offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14459,
        "completion_tokens": 147,
        "total_tokens": 14607
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, as noted in the long-term debt sections of both the 2022 and 2024 10-K filings. This stability indicates that RTX has not refinanced or repaid this specific long-term debt issue during this period, reflecting a consistent component of its long-term debt structure with a distant maturity date, contributing to the company's extended debt profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11094,
        "completion_tokens": 116,
        "total_tokens": 11210
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing innovation and differentiation in its commercial payments offerings. In 2023, the company aimed to build on its strong position in commercial payments by evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, this strategy expanded to include designing innovative products and features, such as financing, banking, and payment solutions for business customers. This shift suggests a broader commercial payments strategy focused on enhancing value for business clients through tailored, integrated financial tools and services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30681,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7892,
        "completion_tokens": 171,
        "total_tokens": 8063
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal, and Home Care segment remained consistent, as it continued to be marketed as a skin health brand under the broader portfolio of personal care products. However, there is no explicit mention of changes in its distribution channels during this period. The company's products, including PCA SKIN, are primarily sold to traditional and e-commerce retailers, wholesalers, distributors, and in some cases, directly to consumers. No specific evolution in PCA SKIN's distribution strategy was highlighted in the provided documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48106,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12258,
        "completion_tokens": 155,
        "total_tokens": 12413
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved by expanding into earlier lines of therapy and new tumor indications, such as adjuvant treatment for melanoma and neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC). Additionally, Opdivo's combination with Yervoy and other anti-cancer agents was emphasized to broaden its therapeutic utility. These developments, along with the approval of new indications in multiple regions, supported Opdivo's role as a key growth driver in Bristol Myers Squibb's portfolio, partially offsetting revenue declines from other products like Revlimid and contributing to overall portfolio resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39335,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10078,
        "completion_tokens": 171,
        "total_tokens": 10249
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained relatively stable between 2023 and 2024 in terms of fair value, with a slight decrease from $770 million in 2023 to $765 million in 2024. In terms of maturity distribution, all of these investments were due within one year in both periods, indicating a short-term focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11769,
        "completion_tokens": 88,
        "total_tokens": 11857
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements remained consistent in purpose but saw a reduction in the amount of cash not freely transferable to the U.S. As of January 31, 2022, $4.3 billion of cash was not freely transferable, with $2.2 billion subject to approval by Flipkart minority shareholders. By January 31, 2024, this amount had decreased to $3.5 billion, still subject to local laws or noncontrolling interest approvals. The company continues to use these arrangements to efficiently allocate cash across jurisdictions while minimizing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59755,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15178,
        "completion_tokens": 145,
        "total_tokens": 15324
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets showed a shift in allocation. Fixed income securities and cash equivalents increased from $210 million (80% of total assets) in 2023 to $248 million (80% of total assets) in 2024. Meanwhile, equity securities slightly decreased from $54 million (20% of total assets) in 2023 to $50 million (20% of total assets) in 2024, maintaining the target allocation range of 75%-85% for fixed income and 15%-25% for equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14485,
        "completion_tokens": 127,
        "total_tokens": 14612
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing updated forms of award agreements, including the \"Form of Stock Option Award Agreement\" and \"Form of Restricted Stock Unit Agreement\" under the 2016 Stock Plan for Non-Employee Directors. These changes suggest a shift in the company's non-employee director compensation structure toward more modern and flexible equity award mechanisms, aligning with broader corporate governance trends and potentially enhancing director retention and alignment with shareholder interests.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19709,
        "completion_tokens": 143,
        "total_tokens": 19853
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's strategic position regarding its ownership stake in Flipkart evolved as it received $3.2 billion in fiscal 2022 from a new equity funding round, reducing its ownership from approximately 83% to 75%. Financially, this dilution reduced Walmart's direct equity exposure but provided capital infusion. Regulatory risks emerged in 2024, as Flipkart faced investigations in India related to foreign direct investment compliance and antitrust allegations. These matters could result in penalties or operational restrictions, exposing Walmart to potential financial and reputational risks tied to Flipkart's regulatory challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53692,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13657,
        "completion_tokens": 163,
        "total_tokens": 13820
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances decreased from $11.5 billion in 2022 to $8.0 billion in 2024, while total cash holdings (including non-U.S. balances) increased from $15.2 billion in 2022 to $11.0 billion in 2024. The geographic distribution of funds shifted, with a notable increase in non-U.S. cash balances, which rose from $3.7 billion in 2022 to $8.0 billion in 2024. This shift reflects a strategic emphasis on leveraging non-U.S. liquidity, likely to optimize global operations and fund international acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41849,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10693,
        "completion_tokens": 134,
        "total_tokens": 10827
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program remained largely consistent in terms of key assumptions and modeling approaches. The liability is still estimated using the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point. The URR is derived from statistical and actuarial models based on redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and adjusted for changes in redemption costs and patterns. However, in 2024, additional sensitivity disclosures were provided, indicating that a 25 basis point increase in URR would raise the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. These updates reflect a more detailed quantification of the impact of assumption changes on the liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11468,
        "completion_tokens": 242,
        "total_tokens": 11711
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning and integration of Frame.io between 2022 and 2024 has evolved to more deeply align with Adobe's broader product ecosystem, particularly within the Digital Media segment. Initially acquired in 2021, Frame.io has been integrated as a cloud-native creative collaboration platform, streamlining the production of creative assets and enabling seamless collaboration across Adobe's Creative Cloud applications such as Premiere Pro, After Effects, Photoshop, and Lightroom. By 2024, Frame.io is positioned as a key component of Adobe's content production at scale, directly integrated with Adobe Express and Adobe Firefly Services within Adobe GenStudio, enhancing end-to-end creative workflows and reinforcing Adobe's leadership in digital media creation and collaboration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10983,
        "completion_tokens": 199,
        "total_tokens": 11182
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value measurements of equity-like funds (a category of private alternative investments) using significant unobservable inputs (Level 3) slightly decreased. In 2022, equity-like funds under defined benefit pension plans had a Level 3 fair value of $25.4 million, while in 2023, this amount decreased to $25.1 million. For retiree health benefit plans, the Level 3 fair value of equity-like funds remained relatively stable, decreasing slightly from $2.4 million in 2022 to $2.4 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16465,
        "completion_tokens": 131,
        "total_tokens": 16596
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Between 2022 and 2024, Adobe has further integrated Frame.io into its Digital Media offerings, positioning it as a key component of its creative collaboration ecosystem. Frame.io, acquired in 2021, has been deeply integrated with Adobe's Creative Cloud applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront, enabling seamless real-time collaboration, frame-accurate feedback, and streamlined workflows for video and creative asset production. Additionally, Frame.io is now part of Adobe GenStudio, which allows for large-scale content production and is supported by Adobe Firefly's generative AI capabilities, enhancing automation and creative efficiency. This integration reflects Adobe's strategy to provide end-to-end solutions for content creation, collaboration, and delivery within the Digital Media segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43363,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11055,
        "completion_tokens": 210,
        "total_tokens": 11265
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS has significantly evolved its approach to Medication Management by expanding its clinical programs and enhancing digital tools to improve medication adherence and cost efficiency. In 2022, the company emphasized programs like Pharmacy Advisor and Drug Savings Review, which focused on identifying gaps in care and promoting adherence through counseling and outreach. By 2024, CVS expanded its offerings with the introduction of the CVS Weight Management program, which optimizes GLP-1 medication use and includes lifestyle coaching. Additionally, the company enhanced its digital connectivity and analytics to provide real-time benefits information and expanded visibility to lower-cost alternatives. These advancements reflect a stronger integration of digital tools and a broader focus on chronic disease management and cost optimization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53097,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13508,
        "completion_tokens": 216,
        "total_tokens": 13724
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by deepening its integration into key Creative Cloud applications such as Premiere Pro and After Effects, enhancing review and approval workflows, and expanding its role in enabling seamless collaboration across stakeholders. Specific enhancements to collaboration features included improved real-time upload, frame-accurate commenting, and annotations, as well as Camera to Cloud functionality for automatic footage uploads from recording devices directly into Frame.io for immediate review.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48034,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 154,
        "total_tokens": 12398
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by becoming a more prominent input in fair value determination, particularly for Level 3 assets where observable market data is limited. In 2023, the valuation of loans and lending commitments relied on recently executed transactions, market price quotations, and comparable pricing, but the range of inputs was broader. By 2024, the Firm emphasized the use of recently executed transactions more explicitly, especially for corporate loans and other debt, where pricing data was less observable. This shift reflects a greater reliance on transactional data to enhance the accuracy of fair value estimates in less liquid markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 109326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27562,
        "completion_tokens": 184,
        "total_tokens": 27747
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager evolved between 2022 and 2024 by positioning it more cohesively within the broader Substance 3D ecosystem. In 2022, Substance 3D Stager was mentioned as part of the Substance 3D Collection, a suite of desktop applications for 3D creation and asset management. By 2024, the product was more explicitly integrated into Adobe's 3D strategy, emphasizing its role in building and assembling 3D scenes alongside other Substance 3D tools like Painter, Designer, and Modeler. This shift highlights Adobe's focus on enhancing cross-tool collaboration and expanding Substance 3D Stager's utility within creative workflows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38721,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9908,
        "completion_tokens": 163,
        "total_tokens": 10071
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE acknowledged that emerging technologies like grid-scale batteries were critical for deep decarbonization in the power sector, but the company emphasized the need for significant investments in infrastructure, R&D, and new products. By 2023, with the planned separation of its energy businesses into GE Vernova, grid-scale batteries were positioned as a key enabler for modernizing power grids to support higher penetration of renewables. GE Vernova was expected to focus on advancing such technologies, reflecting a more defined strategic reliance on grid-scale batteries as a core component of its energy transition efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 72846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18446,
        "completion_tokens": 193,
        "total_tokens": 18639
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements remained consistent between 2022 and 2024, with no broker-quoted debt securities reported in either period. In both years, Level 3 debt securities were valued using internal analyses or private placement pricing, and no broker quotes were utilized. This indicates that broker-quoted debt securities had no material presence or impact on CVS's financial reporting during this timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 146,
          "pages": [
            144,
            145,
            146,
            147,
            148
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47880,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12208,
        "completion_tokens": 121,
        "total_tokens": 12329
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n- **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, representing a $365 million increase.\n- **Equity method investments** increased from $2,756 million in 2023 to $2,783 million in 2024, reflecting a $27 million increase, primarily driven by growth in private equity and real assets funds. \n\nOverall, the total Equity Securities at FVTNI rose from $4,214 million in 2023 to $4,733 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24580,
        "completion_tokens": 137,
        "total_tokens": 24717
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent, with no material allowance for credit losses reported in either period. In both years, the Company assessed impairments by evaluating expected cash flows, issuer credit quality, and its intent to hold securities, concluding that unrealized losses were primarily due to interest rate changes rather than credit deterioration. As of December 31, 2021 (2022 10-K) and December 31, 2024, the allowance for credit losses on available-for-sale debt securities was not material.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53856,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13705,
        "completion_tokens": 156,
        "total_tokens": 13861
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's financial relationship with the ATMP JV showed an increase in both investment value and equity income. The carrying value of AMD's investment in the ATMP JV rose from approximately $83 million as of December 31, 2022, to $99 million as of December 30, 2023. Additionally, equity income from the ATMP JV increased from $14 million in 2022 to $16 million in 2023, reflecting improved performance of the joint venture during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45166,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11511,
        "completion_tokens": 115,
        "total_tokens": 11627
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims between 2022 and 2024 has remained significant, with the nature of claims including medical malpractice by affiliated physicians, clinical quality failures, and general professional liabilities. The potential financial impact has increased due to the rising frequency of legal actions and the complexity of claims, which involve large defense costs and potential monetary damages. Additionally, the 2024 filing highlights a specific cyberattack on Change Healthcare, which, while not a tort claim, underscores the broader vulnerability to incidents that could lead to tort-related liabilities. The company remains largely self-insured, and the potential for actual losses to exceed recorded liabilities persists, posing a material risk to its financial position and operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 56640,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14386,
        "completion_tokens": 205,
        "total_tokens": 14591
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement, with $3.0 billion in total commitments expiring in August 2025, remained unchanged in structure and capacity. However, the company terminated its $0.8 billion 364-day credit facility and a $3.2 billion five-year credit agreement expiring in October 2024, replacing them with a new $4.0 billion five-year revolving credit agreement expiring in May 2029. This indicates a shift toward longer-term liquidity support, reflecting Boeing's strategy to maintain robust backup liquidity while optimizing its credit facilities to align with long-term financial obligations and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36540,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9364,
        "completion_tokens": 164,
        "total_tokens": 9528
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, while the aggregate intrinsic value of options exercised increased significantly from $44 million in 2023 to $373 million in 2024. This indicates a substantial rise in the value of exercised options in 2024, likely due to a higher stock price or increased number of exercised options.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89623,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22642,
        "completion_tokens": 120,
        "total_tokens": 22762
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD's approach to estimating adjustments for product return rights remained largely consistent, with no specific changes in methodology highlighted in the provided documents. In both years, AMD estimated adjustments based on historical product return rates, actual historical returns, and known events or economic conditions. The methodology involved utilizing trended historical data and adjusting for known factors, ensuring estimates were consistent with actual results. No material changes to the approach were mentioned in the 2023 filing compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48915,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12459,
        "completion_tokens": 146,
        "total_tokens": 12605
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 in 2023 to 625,825 in 2024. This decline is primarily due to a large number of exercises (905,219 shares) in 2024, as the three tranches of the 2017 Performance-based Options vested in equal installments at the end of 2022, 2023, and 2024. The minimal forfeitures (18,036 shares) indicate strong employee retention for these awards during the vesting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85814,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21688,
        "completion_tokens": 117,
        "total_tokens": 21805
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx has expanded its role and strategic positioning within UnitedHealth Group's ecosystem by enhancing its pharmacy care services and integrating more deeply with medical and behavioral health care. In 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty spending, and focused on clinical programs to manage costs and improve outcomes. By 2024, Optum Rx's managed pharmaceutical spending increased to $178 billion, with $74 billion in specialty spending, reflecting growth in its service offerings. Additionally, Optum Rx expanded its services to include rare disease and gene therapy support and direct-to-consumer solutions, emphasizing a more holistic approach by embedding pharmacists into patient care teams to address the whole patient.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50332,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12821,
        "completion_tokens": 204,
        "total_tokens": 13025
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI increased from $1,585 million in 2023 to $1,950 million in 2024. Specifically, investments related to deferred cash compensation plans were newly included in 2023 at $241 million and remained part of the equity method investments in 2024. This indicates that BlackRock continued to hold and value these investments as part of its equity securities at FVTNI in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 87091,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22004,
        "completion_tokens": 109,
        "total_tokens": 22113
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $6,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024. This reduction indicates that the company has utilized a significant portion of its repurchase authorization during this period, reflecting an active capital allocation strategy focused on returning value to shareholders through share buybacks. However, the Board has continued to replenish the authorization, as evidenced by the $4,000,000 added in September 2024, signaling ongoing commitment to capital return while balancing other financial priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40585,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10382,
        "completion_tokens": 157,
        "total_tokens": 10539
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved in terms of repurchase activity and shareholder rights. In 2022, the company highlighted its intention to use cash for share repurchases, including those of exchangeable shares, with activity primarily under open-market and other share purchase programs. By 2024, the company expanded its repurchase authority significantly, with $4,000,000 in additional share repurchase authority approved, and disclosed specific repurchase activity for both Accenture plc Class A ordinary shares and exchangeable shares, including 47,752 exchangeable shares repurchased for $15,254 in fiscal 2024. Shareholder rights remained consistent, as exchangeable shares continue to entitle holders to exchange them for Class A ordinary shares on a one-for-one basis and receive equivalent distributions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39273,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10053,
        "completion_tokens": 224,
        "total_tokens": 10277
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased by 12.3% in 2024 compared to 2023. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12026,
        "completion_tokens": 49,
        "total_tokens": 12076
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture's investment in Duck Creek Technologies, accounted for under the equity method, showed a significant increase in fair value between fiscal 2022 and fiscal 2024. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2024, this investment generated a $253 million gain, which positively impacted Accenture's adjusted effective tax rate and adjusted diluted earnings per share. This gain reflects the appreciation in Duck Creek Technologies' valuation during this period, contributing favorably to Accenture's financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11542,
        "completion_tokens": 165,
        "total_tokens": 11707
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific shifted its executive compensation strategy by reducing the scale of retention share and unit awards, reflecting a focus on performance-based incentives. In 2023, the company introduced performance stock unit grants tied to metrics like return on invested capital (ROIC) and operating income growth (OIG), emphasizing alignment with long-term financial performance. This indicates a strategic move to link executive compensation more closely to measurable outcomes and shareholder value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51029,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12990,
        "completion_tokens": 133,
        "total_tokens": 13123
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in terms of exclusions related to market volatility and asymmetrical accounting adjustments. Adjusted earnings continued to exclude the impact of market volatility, such as net investment gains/losses, net derivative gains/losses, and MRB remeasurement gains/losses, to provide a clearer view of underlying business performance. Additionally, asymmetrical and non-economic accounting adjustments, including those related to in-force reinsurance and non-economic losses at contract inception, were still excluded in 2024 as they were in 2023. The 2024 disclosures reflect no material changes in the methodology or rationale for these exclusions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 170,
          "pages": [
            168,
            169,
            170,
            171,
            172
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15426,
        "completion_tokens": 187,
        "total_tokens": 15613
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by integrating generative AI and expanding the scope of its transformation services. In 2022, the focus was on leveraging technologies like cloud, data, AI, and IoT to help clients build digital cores, optimize operations, and accelerate revenue growth. By 2024, Accenture emphasized AI as \"the new digital,\" incorporating generative AI, advanced robotics, and artificial reality into its offerings. Additionally, the scope of services expanded to include designing and manufacturing automation equipment and deeper integration of AI and digital twins in capital projects and operations, enabling clients to achieve faster, more intelligent transformations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33088,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8503,
        "completion_tokens": 187,
        "total_tokens": 8690
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott reduced its use of interest rate hedge contracts, with the notional value decreasing from $2.9 billion in 2023 to $2.2 billion in 2024. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the repayment of long-term debt that also matured in 2023. The remaining hedges continued to serve the purpose of managing exposure to changes in the fair value of fixed-rate debt by converting fixed interest obligations to variable rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44548,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11359,
        "completion_tokens": 133,
        "total_tokens": 11492
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife's treatment and definition of Adjusted Earnings remained largely consistent in its core purpose and methodology, as it continues to be the primary measure used by the Company's chief operating decision maker (CODM) for evaluating segment performance and allocating resources. However, the adoption of the Lifetime Discounting of Insurance Liabilities (LDTI) in 2024 simplified the measurement model for Deferred Acquisition Costs (DAC) and Value of Business Acquired (VOBA), and reclassified most embedded derivatives as Market Risk Benefits (MRBs). As a result, MetLife updated its Adjusted Earnings calculation to remove certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and adjusted for changes in the measurement of certain guarantees. Additionally, Adjusted Earnings now excludes changes in fair value associated with MRBs, changes in discount rates on certain annuitization guarantees, and asymmetrical accounting associated with in-force reinsurance. These changes align with GAAP guidance for segment reporting and enhance the consistency and comparability of Adjusted Earnings across periods and with industry practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55551,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14117,
        "completion_tokens": 299,
        "total_tokens": 14416
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's funding and utilization of its share purchase program evolved as follows: \n\nAs of August 31, 2022, the available authorization for share repurchases was $3,129,296, which increased to $2,694,281 by August 31, 2024, following additional repurchase authorizations of $3,000,000 in 2022 and $4,000,000 in 2024, bringing the total authorization to $6,694,281. In terms of share acquisition methods, open-market purchases remained the primary method, with 11,753,807 shares repurchased in 2024 compared to 9,635,751 in 2022. Additionally, Accenture continued to acquire shares through other programs, such as share withholding for payroll tax obligations, though these did not impact the available authorization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9647,
        "completion_tokens": 184,
        "total_tokens": 9831
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities remained consistent in terms of cost basis, as these securities are primarily valued at original cost adjusted for repayments and amortization of premiums or accretion of discounts. However, there was an increase in the fair value of Unit-linked Securities, rising from $10,331 million in 2023 to $11,90 million in 2024. The sensitivity of these fair values to changes in significant unobservable inputs, such as equity volatilities and mortality rates, was also highlighted, indicating that increases in equity volatility and changes in mortality assumptions could significantly impact the estimated fair value of these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 320,
          "pages": [
            318,
            319,
            320,
            321,
            322
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77410,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19581,
        "completion_tokens": 181,
        "total_tokens": 19762
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In fiscal year 2022, market-based RSUs generally vested over four years, contingent on total stockholder return (TSR) performance. In fiscal year 2023, the company introduced market-based RSUs with a five-year vesting period, subject to stock price performance milestones. This change reflects a shift toward longer-term performance metrics for certain equity awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41424,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10568,
        "completion_tokens": 119,
        "total_tokens": 10688
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital progressed as follows: In 2023, 50% of the cumulative 'day 2' ongoing impact of CECL was phased in, with the remaining 50% to be phased in over 2024 and 2025. By 2024, 75% of this impact had been phased in, with the final 25% to be fully phased in by 2025. The regulatory capital treatment during the phase-in period allowed the Company to add back an amount equal to the after-tax 'day 1' CECL adoption impact and a portion (25% annually) of the cumulative 'day 2' impact to its regulatory capital.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50954,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12974,
        "completion_tokens": 151,
        "total_tokens": 13125
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom continued its relationship with Wilmington Trust, National Association as the trustee for its senior notes indentures, with multiple new indentures and supplemental agreements executed in 2023. In 2022, the company issued senior notes such as the 4.00% Senior Notes due 2029 and 4.15% Senior Notes due 2032 under indentures dated April 14 and 18, 2022, respectively. In 2023, Broadcom expanded its senior notes portfolio by issuing additional notes, including the 5.050% Senior Notes due 2027, 2029, and 2031 under an indenture dated July 12, 2024, and the 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due 2028, 2030, 2032, and 2034 under a supplemental indenture dated October 2, 2024. This indicates an expansion in the types and terms of senior notes issued under their indentures during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56335,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14316,
        "completion_tokens": 209,
        "total_tokens": 14525
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule was fully phased in by January 1, 2024, with 75% of the cumulative impact added back to regulatory capital as of that date, leaving $600 million to be phased in on January 1, 2025. As a result, the Company's CET1 capital ratio was 13.5% as of December 31, 2024, compared to 13.3% on a fully phased-in basis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51314,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13056,
        "completion_tokens": 95,
        "total_tokens": 13151
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved as follows: in 2022, all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts. By 2023, after the completion of the VMware Merger, the same treatment was confirmed for these awards, ensuring that non-employee directors received a combination of cash and Broadcom stock for their in-the-money VMware equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44073,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11237,
        "completion_tokens": 141,
        "total_tokens": 11378
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar evolved from 2022 to 2024 by expanding its use as an adjunctive treatment for major depressive disorder (MDD), with top-line results from two Phase 3 clinical trials in 2021 showing statistically significant improvement in one trial and numerical improvement in the other. By 2024, Vraylar was positioned as a treatment for acute and maintenance treatment of schizophrenia in adults, acute treatment of manic or mixed episodes associated with bipolar disorder in adults, acute treatment of depressive episodes associated with bipolar I disorder in adults, and as an adjunctive treatment in MDD, indicating a broader and more established therapeutic role in psychiatric care.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42049,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10721,
        "completion_tokens": 186,
        "total_tokens": 10907
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE's accounting policy for long-term services agreements has remained consistent in using the percentage of completion method for revenue recognition, based on costs incurred relative to total expected costs. However, there is a notable evolution in the specificity of estimating future billings and contract profitability. In 2024, GE provides more detailed insights into how it incorporates forward-looking information such as market conditions and asset retirements into utilization estimates, which directly impact expected revenue and cost projections. Additionally, the 2024 disclosure highlights the sensitivity of long-term service agreements to changes in estimates, noting that a one percentage point change in profitability would affect the contract balance by $0.4 billion, reflecting a more granular discussion of risk and financial impact compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 51763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13168,
        "completion_tokens": 222,
        "total_tokens": 13390
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing, IBM's 1.250% Notes due 2027 were referenced under the list of instruments defining the rights of security holders in Part IV, Item 15, but no specific details about the issuance or terms were provided. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed in the table of securities registered under Section 12(b) of the Exchange Act with the trading symbol \"IBM 27B,\" indicating it was issued and actively traded on the New York Stock Exchange. This reflects an evolution in disclosure, with the 2023 filing providing more direct visibility into the note's market listing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9188,
        "completion_tokens": 151,
        "total_tokens": 9340
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, AbbVie's performance-vested RSUs have maintained a structure where vesting occurs in one-third increments over a three-year performance period. The performance criteria for these RSUs are based on AbbVie's return on invested capital (ROIC) performance relative to a defined peer group of pharmaceutical, biotech, and life sciences companies. No significant changes to the vesting increments or the primary performance metric (ROIC) were noted in the provided documents for this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 123,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52206,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13282,
        "completion_tokens": 127,
        "total_tokens": 13409
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "Based on the information provided in the 2024 10-K filing, GE's financial relationship with AerCap evolved from 2022 to 2024 as follows: In 2022, GE reported a realized and unrealized loss of $865 million related to its investment in AerCap. This loss significantly improved in 2023, with a gain of $129 million, and further improved in 2024, with a gain of $38 million. This indicates a gradual improvement in the value of GE's investment in AerCap over the three-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13764,
        "completion_tokens": 119,
        "total_tokens": 13883
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2023 SEC filing, IBM's 0.300% Notes due 2026 are explicitly listed under \"Securities registered pursuant to Section 12(b) of the Act\" with the trading symbol \"IBM 26B\" and are noted as being traded on the New York Stock Exchange. In contrast, the 2022 filing does not specifically mention these notes, indicating an increased disclosure and visibility of the 0.300% Notes due 2026 in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9210,
        "completion_tokens": 101,
        "total_tokens": 9312
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved to emphasize sustainable aviation technologies more strategically. In 2022, the RISE Program was introduced as a technology development initiative targeting a 20% reduction in fuel consumption and CO2 emissions. By 2024, the RISE Program had progressed to include a suite of pioneering technologies such as Open Fan, compact core, and hybrid electric systems, with over 250 tests conducted on a full-scale Open Fan engine. This shift reflects a stronger investment focus on developing scalable, sustainable solutions compatible with alternative fuels, aligning with broader industry decarbonization goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 52360,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13307,
        "completion_tokens": 168,
        "total_tokens": 13476
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, the role and emphasis on asset securitizations within American Express's funding strategy remained a key component, with a continued focus on leveraging cost-effective funding through the securitization of Card Member loans and receivables. In both years, American Express highlighted the importance of asset securitizations as part of a diverse funding mix that includes deposits, unsecured debt, and secured borrowings. In 2023, the company reiterated its strategy of using securitization programs to fund its U.S. card business, transferring assets to trusts that issue asset-backed securities to third-party investors. The emphasis on maintaining a balanced and diversified funding approach, including securitizations, remained consistent, though the 2023 filing provided more detailed descriptions of specific securitization activities and debt issuances, reflecting ongoing execution of the strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42041,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10741,
        "completion_tokens": 231,
        "total_tokens": 10973
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2023. In 2022, Emerson completed the acquisition of Heritage AspenTech, creating \"New AspenTech,\" in which Emerson owned 55% of the outstanding shares. The AspenTech segment was added as a separate business segment, reflecting the combined results of Heritage AspenTech and Emerson's Industrial Software Business. By 2023, Emerson increased its ownership to approximately 57%, and the AspenTech segment showed improved financial performance, with sales rising from $656 million in 2022 to $1.3 billion in 2023, and earnings turning from a $12 million loss in 2022 to $12 million profit in 2023. Operationally, AspenTech's integration into Emerson's portfolio contributed to Emerson's strategic focus on industrial software and optimization solutions, enhancing Emerson's digital ecosystem offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11410,
        "completion_tokens": 224,
        "total_tokens": 11634
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly. In 2022, Emerson acquired Heritage AspenTech, creating \"New AspenTech,\" and held a 55% controlling interest, with the remaining 45% as a noncontrolling interest valued at $5.9 billion. By 2023, Emerson further solidified its control by acquiring the remaining noncontrolling interest in Copeland, which was part of the broader portfolio transformation. The 2023 acquisition of Heritage AspenTech contributed to increased sales and expenses, particularly through higher amortization of intangible assets and foreign currency hedge impacts. Additionally, the 2023 financials reflect the impact of the Heritage AspenTech acquisition on equity and expenses, including a $146 increase in intangibles amortization and a $112 unfavorable foreign currency transaction impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41600,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10634,
        "completion_tokens": 215,
        "total_tokens": 10849
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent between the 2022 and 2023 SEC filings. In both years, the debentures were disclosed in the exhibits section of the 10-K filings, with the 2022 filing referencing Exhibit 3 to Form 8-K filed on August 1, 1997, and the 2023 filing including the same reference. Additionally, in both filings, the debentures were listed among IBM's registered securities under the appropriate sections, indicating no material changes in their terms or disclosure requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9193,
        "completion_tokens": 135,
        "total_tokens": 9328
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "From 2023 to 2024, UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased, as these arrangements constitute nearly 80% of its total consolidated revenues. The evolution of these arrangements involves a heightened reliance on accurate cost estimation and effective management of medical costs, as any inaccuracies or failures in these areas could significantly impact profitability and financial performance. This exposure also entails greater service delivery responsibilities, particularly for Optum Health's value-based care models, where the company must ensure high-quality outcomes and efficient care delivery to meet financial and operational targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67670,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17161,
        "completion_tokens": 180,
        "total_tokens": 17341
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson completed a transaction to create \"New AspenTech\" by contributing two of its industrial software businesses and $6.0 billion in cash to Heritage AspenTech, resulting in Emerson owning 55% of the newly formed AspenTech on a fully diluted basis. By 2023, Emerson had further increased its ownership stake in AspenTech, acquiring additional shares to reach approximately 57% ownership by 2024. This strategic move reflects Emerson's deepening investment in and integration with AspenTech, positioning it as a controlling stakeholder and aligning with its focus on expanding its digital and automation solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41780,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10668,
        "completion_tokens": 194,
        "total_tokens": 10863
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Adobe Target's role within Adobe's customer journey solutions has evolved to become a more integral part of Adobe's AI-driven personalization strategy. In fiscal 2022, Adobe Target is described as an AI- and machine learning-driven personalization engine that enables customers to test, target, and optimize content across channels. By fiscal 2023, Adobe Target is highlighted as a key component of Adobe's broader AI and generative AI initiatives, particularly through Adobe Sensei and Firefly, indicating a strategic shift toward embedding AI-driven personalization more deeply into customer journey management. This evolution reflects Adobe's focus on leveraging AI to deliver more accurate, scalable, and real-time personalized experiences across all touchpoints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46818,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11942,
        "completion_tokens": 200,
        "total_tokens": 12142
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2023, as Emerson completed the acquisition of Heritage AspenTech in the third quarter of 2022. This acquisition led to a substantial increase in Emerson's financial stake in AspenTech, with goodwill for AspenTech rising from $1,044 million in 2021 to $8,326 million in 2022. Post-acquisition integration activities included aligning AspenTech's stock-based compensation plans with Emerson's structure, converting Heritage AspenTech awards into AspenTech awards, and integrating financial reporting and operational processes. Additionally, Emerson assumed responsibility for AspenTech's financial obligations, including a $240 million revolving term loan credit facility as of September 30, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40329,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10306,
        "completion_tokens": 192,
        "total_tokens": 10498
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform has evolved to play a more central role in Adobe's customer journey solutions by enhancing its integration with AI-powered tools and improving cross-channel campaign orchestration. In 2022, the platform was described as a foundational infrastructure for customer experience management, enabling data collection, connection, and activation for real-time insights and unified customer profiles. By 2023, Adobe Experience Platform was further integrated with AI and machine learning capabilities, particularly through Adobe Sensei, to deliver AI-driven insights and automation across Adobe Experience Cloud apps. Additionally, cross-channel campaign orchestration was strengthened through tools like Adobe Journey Optimizer, which allows brands to deliver personalized, connected customer journeys across any app, surface, or channel, leveraging real-time data and insights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47931,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12219,
        "completion_tokens": 229,
        "total_tokens": 12448
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures, UnitedHealth Group evolved its care delivery models from 2023 to 2024 by accelerating the transition from fee-for-service to fully accountable value-based care. This included enhancing integrated care coordination technology, expanding in-clinic, in-home, behavioral, and virtual care models, and using data and analytics to improve clinical decision-making. These efforts aimed to foster high-quality, affordable care while managing rising medical costs and regulatory challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54450,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13831,
        "completion_tokens": 133,
        "total_tokens": 13964
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The composition of TMO's debt instruments remained largely consistent between 2022 and 2023, with the 1.950% Notes due 2029 listed in both years under the same trading symbol (TMO 29) and registered on the New York Stock Exchange. No changes to the terms or existence of these specific notes were noted in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47798,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12163,
        "completion_tokens": 81,
        "total_tokens": 12244
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent, with the 0.500% Notes due 2028 continuing to be listed in both years. However, a notable change in 2023 was the introduction of new 3.650% Notes due 2034, which were not present in 2022. Additionally, the 2023 filing shows the inclusion of 3.200% Notes due 2026, which did not appear in the 2022 listing. These additions indicate a shift in TMO's debt structure, introducing longer-term, higher-yield instruments to diversify its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47798,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12174,
        "completion_tokens": 130,
        "total_tokens": 12305
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%. This indicates that the minimum excess fair value over carrying value decreased by 70 percentage points, while the maximum remained relatively stable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51008,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12974,
        "completion_tokens": 103,
        "total_tokens": 13078
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan remained consistent in terms of their impact on the available share pool. Specifically, both canceled RSUs and shares withheld to satisfy tax obligations increased the number of shares available for grant under the 2022 Plan by a factor of two times the number of RSUs canceled or shares withheld. This mechanism allowed the share pool to be replenished, ensuring continued flexibility for future equity grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10988,
        "completion_tokens": 130,
        "total_tokens": 11118
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated into Danaher's Life Sciences segment, as it had been since its acquisition in 2021 for $9.6 billion. There is no indication of a change in Danaher's financial stake in Aldevron during this period, as Aldevron was fully acquired and is now a wholly owned subsidiary. Aldevron continued to operate as a key part of the Life Sciences segment, focusing on the production of plasmid DNA, mRNA, and proteins for research, clinical, and commercial applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48853,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12441,
        "completion_tokens": 126,
        "total_tokens": 12567
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 evolved significantly between 2023 and 2024, with a stronger integration of AI technologies. In 2024, Microsoft 365 is described as an \"AI first platform\" that combines Office, Windows, Copilot, and Enterprise Mobility + Security to enhance productivity. The introduction of role-based Copilot extensions (e.g., Copilot for Sales, Service, and Finance) and Copilot Pro for consumers reflects a deeper embedding of AI into workflows. Commercially, Microsoft 365 drove growth, with Office Commercial products and cloud services revenue increasing by 14% in 2024, fueled by a 16% growth in Office 365 Commercial, highlighting its central role in Microsoft's commercial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40605,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10387,
        "completion_tokens": 182,
        "total_tokens": 10569
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has increasingly emphasized Copilot Pro as a key component of its AI strategy, particularly within Microsoft 365 apps and web-based AI assistance. In 2023, Copilot Pro was introduced as a consumer subscription service offering enhanced AI assistance in Microsoft 365 apps and on the web. By 2024, the company has further integrated Copilot Pro into its broader AI ecosystem, highlighting its role in delivering faster and more powerful AI capabilities across Microsoft 365 applications, as well as its positioning within the Copilot stack for both enterprise and consumer use.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42866,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10943,
        "completion_tokens": 152,
        "total_tokens": 11095
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares as of December 31, 2024. This reduction indicates that 3 million shares were utilized for awards during 2024. The structure of the plan remained consistent, with stock options, RSUs, and PSUs being the primary forms of awards issued.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58719,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14907,
        "completion_tokens": 100,
        "total_tokens": 15008
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft did not change its accounting policy regarding the estimated useful lives of server and network equipment. The estimated useful lives remained at six years, as previously revised in July 2022 from four years to six years due to investments in software that improved operational efficiency and technological advancements. The 2024 filing confirms the continued application of this policy without further modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 30427,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7838,
        "completion_tokens": 115,
        "total_tokens": 7954
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value from 2022 to 2023, at $33 million. In both years, these securities were classified within \"other assets\" on the consolidated balance sheet under Level 3 of the fair value hierarchy, indicating they were measured using significant unobservable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51315,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13048,
        "completion_tokens": 81,
        "total_tokens": 13129
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Between fiscal years 2023 and 2024, the net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million to a loss of $67 million. This indicates a deterioration in the performance of this investment category, likely due to rising interest rates, which negatively impacted the fair value of the debt investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50254,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12801,
        "completion_tokens": 86,
        "total_tokens": 12887
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco shifted its approach to the APJC region by refining its operational structure to better align with localized market demands while maintaining a strategic focus on financial investment in high-growth areas such as AI, cybersecurity, and cloud infrastructure. In 2023, the company emphasized expanding its integrated networking and security solutions across the region, whereas in 2024, the focus evolved toward optimizing operational efficiency and leveraging acquisitions (such as Splunk) to enhance cybersecurity and data analytics capabilities. This shift implies a move toward a more service-oriented and subscription-based revenue model in APJC, driven by the increasing demand for secure, scalable, and AI-enhanced solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14894,
        "completion_tokens": 189,
        "total_tokens": 15084
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adjusted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, Apple acknowledged the potential for changes to its App Store practices due to litigation, competition, and regulatory scrutiny, but did not specify concrete modifications. By 2024, Apple had implemented specific changes in response to legal requirements, particularly in the European Union, including the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures for iOS and iPadOS apps, alternative app distribution methods, and alternative payment processing. These adjustments reflect Apple's evolving approach to regulatory compliance and its efforts to address legal challenges while managing the impact on its revenue from App Store commissions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58881,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14945,
        "completion_tokens": 211,
        "total_tokens": 15156
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments adjusted the allocation strategy for its U.S. Retiree Health Care Plan by increasing the proportion of fixed income securities and decreasing equity securities. In 2022, the allocation was 64% fixed income and 36% equity. By 2024, the allocation shifted to 80% fixed income and 20% equity. This shift reflects a more conservative approach, aligning with the plan's goal to better match the interest rate sensitivity of assets and liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55488,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14097,
        "completion_tokens": 120,
        "total_tokens": 14217
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments has maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, positioning them as a core component of its business model alongside Analog products. These products contribute to TI's competitive advantages by serving as the digital \"brains\" of electronic equipment, enabling optimized performance, power, and cost for diverse applications. In terms of segment reporting, Embedded Processing remains a distinct reportable segment, with its financial performance separately disclosed in the 10-K filings for all three years. However, its contribution to revenue and operating profit has declined over this period, with revenue decreasing from $3,261 million in 2022 to $2,533 million in 2024, reflecting shifting market dynamics or demand patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11570,
        "completion_tokens": 199,
        "total_tokens": 11770
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Between 2022 and 2024, TMO issued its 2.00% 10-Year Senior Notes (euro-denominated) with a face value of $728 million in 2022, which increased to $663 million by 2024. The effective interest rate for these notes was 2.10% in 2022 and decreased slightly to 2.07% in 2024. The valuation of the notes, as reflected in their carrying value, remained relatively stable, with minor reductions likely due to amortization and accretion adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12270,
        "completion_tokens": 110,
        "total_tokens": 12380
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE's sales declined from $1,839 million in 2022 to $1,605 million in 2024, representing a 12.8% decrease. This decline is primarily attributed to continued biosimilar competition in the United States and other markets. This trend indicates that REMICADE's role in Johnson & Johnson's Pharmaceutical segment has weakened, as it faces increasing pressure from biosimilars, which has led to a reduction in its market share and revenue contribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43845,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11185,
        "completion_tokens": 118,
        "total_tokens": 11304
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined from $3.19 billion in 2022 to $1.605 billion in 2024, representing a significant drop of 12.8% in 2024 compared to the prior year. This decline is primarily attributed to ongoing biosimilar competition in both the U.S. and international markets. The continued erosion of REMICADE's market position highlights the increasing pressure from biosimilars within JNJ's Immunology portfolio, contrasting with the growth of newer products like STELARA and TREMFYA. This trend indicates that REMICADE is losing relevance and market share, signaling a weakening position in the Immunology segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40175,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10266,
        "completion_tokens": 158,
        "total_tokens": 10424
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE's sales declined from $3.19 billion to $1.605 billion, representing a significant drop of 14.9% in 2021 and an additional 12.8% in 2024. The primary factor contributing to this decline was the increasing competition from biosimilar versions of infliximab, which were introduced in the U.S. and other markets, leading to a steady reduction in REMICADE's market share. Continued biosimilar competition is expected to further impact REMICADE's sales in the future.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41137,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10497,
        "completion_tokens": 123,
        "total_tokens": 10620
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in commercial performance. In 2022, STELARA sales were $9.1 billion, representing a 18.5% increase compared to 2021. However, by 2024, sales had decreased to $10.4 billion, a 4.6% decline from 2023, primarily due to share loss from European biosimilar entrants. The decline was further anticipated to worsen in 2025 as biosimilar versions of STELARA were expected to launch in both Europe and the U.S. according to patent settlement agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9972,
        "completion_tokens": 127,
        "total_tokens": 10099
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease. The percentage decrease from 2022 to 2023 was 38.5%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16288,
        "completion_tokens": 50,
        "total_tokens": 16338
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of Master Lease Agreements (MLAs) for American Tower Corporation (AMT) evolved to become a more critical component in supporting international growth and tenant relationships. MLAs provided consistent, long-term revenue and significantly reduced non-contractual churn, thereby strengthening strategic partnerships with tenants. These agreements also streamlined colocation processes, enabling tenants to deploy equipment more rapidly and efficiently on AMT's sites, which became increasingly important as carriers focused on 5G network deployments and expanding their global footprint. This strategic use of MLAs helped AMT navigate challenges such as elevated churn rates in India and carrier consolidation, while positioning the company to capitalize on long-term growth opportunities in international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52625,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13381,
        "completion_tokens": 217,
        "total_tokens": 13598
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, with revenues recognized on a gross basis for ads placed on Google Network properties. The platform's role remained consistent in facilitating customer purchases of advertising inventory, with Alphabet acting as the principal, controlling the advertising inventory before it is transferred to customers. No significant changes were indicated in the platform's role or the method of revenue recognition during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51576,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13138,
        "completion_tokens": 136,
        "total_tokens": 13275
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "The volume of Federal Funds Purchased & Sec Loaned increased from $214,369 million in 2022 to $301,015 million in 2023, while the fair value increased from 1.92% to 6.84%. This significant increase in both volume and fair value indicates that BAC utilized more short-term funding through these instruments in 2023 compared to 2022, likely due to higher interest rates and the need for liquidity management. This suggests a shift in BAC's short-term funding strategy toward leveraging higher-yielding short-term funding sources amid a rising interest rate environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 114924,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28959,
        "completion_tokens": 141,
        "total_tokens": 29101
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations became more detailed and specific. In 2022, the discussion was limited to a general reference in the \"Market Risks\" section, directing readers to \"Our Critical Accounting Policies and Estimates\" for further information. By 2024, PepsiCo provided a more direct explanation, noting that the fair value of indefinite-lived intangible assets, including pension and retiree medical plan assets and liabilities, is impacted by changes in market conditions such as interest rates and inflationary or recessionary trends. Additionally, in 2024, the company explicitly included a line item for \"Other pension and retiree medical benefits (expense)/income\" in its consolidated results, showing a significant shift from income of $250 million in 2023 to an expense of $22 million in 2024, attributed to higher settlement charges and the purchase of a group annuity contract. This evolution reflects increased transparency and specificity in how market fluctuations affect these liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 31664,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8139,
        "completion_tokens": 280,
        "total_tokens": 8419
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Between 2023 and 2024, Adobe Scan has evolved to become more deeply integrated within Adobe's broader document management ecosystem, particularly through enhanced connections with Adobe Document Cloud and Acrobat services. In 2023, Adobe Scan was primarily described as a mobile scanning tool that converts paper documents into PDFs for instant sharing. By 2024, Adobe Scan is positioned not only as a standalone scanning tool but also as a key component of Adobe's automated digital document workflows, emphasizing seamless integration with cloud-based services like Acrobat and Adobe Acrobat Sign. This evolution reflects Adobe's strategy to unify document capture, management, and collaboration under its Document Cloud umbrella.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44356,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11314,
        "completion_tokens": 183,
        "total_tokens": 11497
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as Google's first natively multimodal AI model, capable of understanding and combining text, code, audio, images, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration to all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities included the ability to process and generate content across diverse formats, such as supporting image generation, coding assistance, and app integration, as well as improving AI-driven features like AI Overviews and YouTube recommendations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45044,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11489,
        "completion_tokens": 193,
        "total_tokens": 11682
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale operations, which are part of the \"Other\" segment, experienced mixed performance. In 2024, sales for the Other segment decreased by 2% compared to 2023, primarily due to lower volumes in global helium. However, operating profit in the Other segment increased by 44% in 2024, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs related to helium. This suggests that while helium sales declined, cost management and insurance recoveries helped improve profitability in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34725,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8899,
        "completion_tokens": 146,
        "total_tokens": 9046
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $789 million in 2022 to $598 million in 2024, representing a decline of $191 million over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44129,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11246,
        "completion_tokens": 42,
        "total_tokens": 11288
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil remained consistent from 2023 to 2024. In both years, the production volumes from Tengizchevroil were included in the \"Volumes represent Chevron's share of production by affiliates\" footnote in the \"Net Production of Crude Oil, Natural Gas Liquids and Natural Gas\" section. There is no specific mention of changes in delivery commitments or production volumes for Tengizchevroil in the provided pages for 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71195,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18012,
        "completion_tokens": 129,
        "total_tokens": 18142
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has remained consistent between 2023 and 2024, as the description of payments to these partners has not changed significantly. Payments to Google Network partners are still primarily for ads displayed on their properties and are recorded as cost of revenues, with Google generally acting as the principal and recognizing revenues on a gross basis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48299,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12305,
        "completion_tokens": 105,
        "total_tokens": 12410
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has experienced an increase in the impact of public policies on its climate-related regulatory requirements, particularly due to growing global regulatory focus on climate change. The Corporation notes that there is an increasing number of new or heightened regulatory requirements, with potential jurisdictional divergence across state, federal, and non-U.S. jurisdictions. This divergence is expected to elevate legal, compliance, and public disclosure risks and costs for the company. Additionally, the evolving nature of climate-related risks, combined with the lack of standardized climate-related data and reporting frameworks, has heightened the complexity of compliance and increased the potential for reputational harm.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64503,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16359,
        "completion_tokens": 190,
        "total_tokens": 16550
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by the strong performance of this segment in 2024. In the GM North America (GMNA) region, increased sales of full-size pickup trucks contributed significantly to the $16.06 billion increase in total net sales and revenue for 2024 compared to 2023. Additionally, EBIT-adjusted for GMNA rose by 18.1%, driven in part by higher volumes of full-size pickup trucks. These quantitative indicators highlight a stronger market positioning and performance for this product line in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59553,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15128,
        "completion_tokens": 147,
        "total_tokens": 15275
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased significantly, from $21 million in 2022 to $349 million in 2024. This shift indicates a strategic move toward safer, more liquid, and lower-risk investments, likely reflecting the company's focus on preserving capital and ensuring reliable funding for long-term obligations like nuclear decommissioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 88228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22296,
        "completion_tokens": 109,
        "total_tokens": 22406
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved in terms of financial incentives and strategic dependency by maintaining structured bottler funding programs and emphasizing long-term partnerships. Financial incentives, such as advertising support, new product support, and vending and cooler equipment placement programs, are negotiated annually to support trade and consumer initiatives. Additionally, PepsiCo's strategic dependency on independent bottlers remains strong, as they hold exclusive contracts to manufacture and distribute products in specific geographic areas, ensuring brand presence and operational efficiency. The company continues to leverage these bottlers as key partners in its distribution network, especially for DSD operations, to maintain market reach and consumer engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9559,
        "completion_tokens": 208,
        "total_tokens": 9768
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role within Adobe's product innovation strategy has evolved from being a speculative investment in 2023 to a more central and strategic focus in 2024. In 2023, Firefly was highlighted as one of Adobe's generative AI offerings, with the company acknowledging the uncertainties and risks associated with AI development and adoption. By 2024, Firefly is positioned as a key component of Adobe's AI innovation efforts, with the company emphasizing its integration across existing products and solutions. This shift is reflected in the increased attention to Firefly in risk disclosures, particularly regarding regulatory, ethical, and competitive challenges, indicating its growing importance in Adobe's strategy to remain competitive in AI-driven markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52019,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 192,
        "total_tokens": 13426
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth decreased between 2022 and 2023, as churn and lease cancellations increased in 2023. In 2022, churn was approximately 4% of tenant billings, while in 2023, churn decreased slightly to approximately 3% of tenant billings. However, the churn in 2023 was primarily driven by the U.S. & Canada property segment, where elevated churn rates were expected to persist due to lease cancellations and non-renewals by T-Mobile. This suggests that while the overall churn rate decreased, the impact of lease cancellations in key markets like the U.S. & Canada reduced the effectiveness of contractual rent escalations in driving tenant billing growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56164,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14272,
        "completion_tokens": 178,
        "total_tokens": 14450
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil (TCO) evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement, with Affiliate Capex for TCO's FGP/WPMP Project in Kazakhstan accounting for nearly half of Chevron's $3 billion Affiliate Capex in 2024. This indicates a continued significant investment in TCO's development. Production involvement remains notable, as TCO is a major affiliate contributing to Chevron's production in Kazakhstan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60247,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15284,
        "completion_tokens": 120,
        "total_tokens": 15404
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent, as the company continued to use a bond matching approach to select specific bonds that align with projected benefit payments. However, the discount rate for U.S. pension benefits decreased from 5.42% in 2023 to 5.88% in 2024, while the postretirement medical benefits discount rate increased slightly from 5.80% to 6.18%. This evolution in rates reflects changes in the bond market and updated assumptions for the duration and timing of projected benefit obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58508,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14853,
        "completion_tokens": 160,
        "total_tokens": 15014
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's relationship with helium from 2022 to 2024 is characterized by a decline in volumes and increased costs, as noted in the 2024 10-K. Sales for the \"Other\" segment, which includes global helium wholesale, decreased by 2% in 2024 compared to 2023 due to lower helium volumes. Despite this, operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offsetting higher helium-related costs. Thus, while helium volumes negatively impacted sales, the segment's operating profit improved due to insurance recoveries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32263,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8294,
        "completion_tokens": 150,
        "total_tokens": 8444
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. Correspondingly, the recognized tax credits related to these investments decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 97055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24503,
        "completion_tokens": 70,
        "total_tokens": 24574
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "General Motors' approach to fleet sales involving commercial fleet customers from 2022 to 2024 has shown a strategic shift toward optimizing profitability and expanding direct engagement. In 2022, fleet sales accounted for 11.3% of total vehicle sales, with a noted emphasis on dealer networks for fleet transactions. By 2024, GM had refined its strategy, leveraging both dealer networks and direct sales channels to commercial fleet customers, particularly in the context of its electric vehicle (EV) initiatives like BrightDrop. This evolution reflects a focus on higher-margin opportunities, such as electric commercial vehicles and partnerships with large fleets, while managing the traditionally lower profitability associated with fleet sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62704,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15906,
        "completion_tokens": 187,
        "total_tokens": 16093
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from holding a 50% equity ownership to fully divesting its stake. In the first quarter of 2022, PepsiCo sold its 50% ownership in Sabra, recognizing a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) from the remeasurement of its previously held equity interest at fair value. This transaction marked the end of PepsiCo's ownership in Sabra and had a positive financial impact on its results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51783,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13163,
        "completion_tokens": 120,
        "total_tokens": 13283
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe Scan has transitioned from being a standalone mobile scanning tool to being more deeply integrated within Adobe's broader Document Cloud ecosystem. In 2023, Adobe Scan was primarily described as a free mobile app for converting paper documents into PDFs. By 2024, it is positioned as a complementary component of Adobe Document Cloud, emphasizing seamless integration with Adobe Acrobat and other Document Cloud services for enhanced workflow and collaboration capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41443,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10581,
        "completion_tokens": 120,
        "total_tokens": 10701
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024 have remained largely consistent, with continued indemnification obligations related to the 2017 sale of the Opel/Vauxhall Business. In both 2022 and 2024, GM agreed to indemnify Stellantis for certain losses arising from inaccuracies in representations and warranties, as well as for emissions and product liabilities related to vehicles sold prior to the sale. In 2024, GM noted that it indemnified Stellantis for an immaterial amount related to certain recalls, including Takata inflator recalls in legacy Opel vehicles, but believes further indemnification for such matters is remote. The nature of these obligations remains subject to time limitations, thresholds, and/or caps, with no material accruals recorded in either year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13733,
        "completion_tokens": 206,
        "total_tokens": 13939
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with co-packers has remained consistent in terms of operational dependency, as the company continues to utilize a highly distributed network of plants, warehouses, and distribution centers owned or leased by co-packers, strategic alliances, or joint ventures. There is no indication of a significant shift in strategic involvement during this period; however, the company emphasizes the importance of these partnerships in supporting its global operations, particularly in regions where direct ownership is less prevalent.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9329,
        "completion_tokens": 142,
        "total_tokens": 9471
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG recognized a pre-tax gain of $157.1 million from the sale of a portion of its interest in ABG and a non-cash pre-tax gain of $59.1 million from ABG's capital transactions that diluted SPG's ownership. By 2024, SPG fully exited its remaining interest in ABG, selling it for cash proceeds of $1.2 billion and recognizing a substantial pre-tax gain of $414.8 million. This marked a strategic divestment, indicating a shift away from ABG as a key investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12726,
        "completion_tokens": 137,
        "total_tokens": 12864
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs, as part of its Rotary and Mission Systems (RMS) segment, saw increased production volume from 2022 to 2024. In 2022, RMS reported higher product sales due to increased production on various Sikorsky helicopter programs. By 2024, Sikorsky helicopter programs remained a major focus for RMS, with the Black Hawk, Seahawk, and CH-53K King Stallion heavy lift helicopters continuing to serve U.S. and foreign governments. The program scope also expanded to include the Combat Rescue Helicopter (CRH) for the U.S. Air Force and the VH-92A helicopter for the U.S. Marine One transport mission, with final deliveries completed in 2024. This indicates both sustained and expanded involvement in Sikorsky programs during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11516,
        "completion_tokens": 196,
        "total_tokens": 11713
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023, Walmart acquired Alert Innovation for $0.4 billion, increasing its ownership to 100%. No further changes to Walmart's ownership stake in Alert Innovation are mentioned for fiscal 2024, indicating that the company maintained full ownership during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59173,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15007,
        "completion_tokens": 68,
        "total_tokens": 15076
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility evolved with a focus on repayment and strategic refinancing. In 2023, the Operating Partnership used the Supplemental Facility to borrow €750.0 million, which was later repaid in full on November 17, 2023, using proceeds from the issuance of senior unsecured bonds. By 2024, the Supplemental Facility was not heavily utilized, with only $8.6 million in letters of credit outstanding and no significant borrowings reported. The repayment strategy in 2023 involved issuing fixed-rate debt to replace variable-rate borrowings, thereby managing interest rate risk and optimizing the cost of capital. In 2024, the focus shifted to maintaining liquidity through the broader Credit Facilities, which had an aggregate available borrowing capacity of $8.2 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45163,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11516,
        "completion_tokens": 206,
        "total_tokens": 11722
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has maintained helium as a key process gas within its industrial gases business in both 2023 and 2024, with no significant repositioning as a primary product. Helium is consistently listed among process gases (alongside hydrogen, carbon dioxide, etc.) and is sold through the same distribution methods—onsite, merchant, and packaged gases—as other gases. In 2024, there is no indication of a strategic shift in supply strategies specific to helium, and it continues to be managed within the broader context of Linde's industrial gas offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43076,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11002,
        "completion_tokens": 137,
        "total_tokens": 11139
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the allocation of assets in the U.S. Retiree Health Care Plan shifted significantly, with fixed income securities and cash equivalents increasing from 65% to 80%, while equity securities decreased from 35% to 20%. This change reflects a more conservative allocation strategy for the plan during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59824,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15182,
        "completion_tokens": 82,
        "total_tokens": 15265
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's financial performance showed significant growth, with product sales increasing by 56% to $1.1 billion in 2023 compared to $680 million in 2022, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting, expanding its market reach and therapeutic utility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81735,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20661,
        "completion_tokens": 139,
        "total_tokens": 20800
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2023, indicating a significant decline. However, in 2024, the earnings rebounded slightly to $58 million, showing some stabilization. The joint venture remains strategically important as it continues to be a key player in the downstream segment in South Korea, with Chevron maintaining a 50% stake and ongoing investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58046,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14744,
        "completion_tokens": 107,
        "total_tokens": 14851
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program, part of the Sikorsky helicopter programs under the RMS segment, experienced notable production growth and risk retirements. In 2022, the RMS segment reported higher production volume for the CH-53K, contributing to increased net sales and operating profit. By 2024, the CH-53K program continued to show production ramp-up, with higher production volume driving a $140 million increase in net sales for Sikorsky helicopter programs. Additionally, the program benefited from risk retirements, which improved profit booking rates and contributed to higher operating profit. Overall, the CH-53K program demonstrated steady progress in production and risk mitigation during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49558,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12615,
        "completion_tokens": 180,
        "total_tokens": 12795
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs evolved by emphasizing risk management and enhancing protections for both merchants and consumers. In 2022, the focus was on managing transaction and credit losses, with provisions for expected credit losses and adjustments for macroeconomic factors impacting merchant insolvency and fraud. By 2023, PayPal reorganized its operations to align more closely with customer segments, including small businesses and enterprises, and expanded its seller protection programs to reduce merchant losses through proprietary solutions. Additionally, PayPal emphasized its ability to leverage data from its two-sided network to improve fraud detection and enhance the security of transactions, reflecting a strategic shift toward a more integrated and proactive approach to risk exposure and customer trust.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48779,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12415,
        "completion_tokens": 216,
        "total_tokens": 12632
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages remained consistent in terms of revenue recognition, with sales of these products generally recognized upon shipment to customers outside of company-operated and licensed stores. There is no indication of a significant change in the accounting treatment for these beverages during this period. Regarding supplier dependency, Starbucks continues to source ready-to-drink beverages from several specialty suppliers, typically under long-term supply contracts, and the company believes the risk of non-delivery from these suppliers is remote based on historical performance and established relationships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45396,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11573,
        "completion_tokens": 169,
        "total_tokens": 11742
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was approved in the U.S. and Europe for metastatic triple-negative breast cancer (TNBC) and received accelerated approval for urothelial cancer. By 2023, Trodelvy gained additional approvals, including EC authorization for HR+/HER2- breast cancer and expanded use in new geographies, contributing to a 56% increase in product sales. These developments reflect both broader regulatory acceptance and expanded global market access.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13101,
        "completion_tokens": 136,
        "total_tokens": 13238
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. In 2023, ABG completed multiple capital transactions that led to dilution of Simon's ownership from approximately 12.3% to 9.6%, resulting in non-cash gains from deemed disposals. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, resulting in a pre-tax gain of $414.8 million. This marked the complete divestment of Simon's stake in ABG.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49066,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12483,
        "completion_tokens": 118,
        "total_tokens": 12602
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan was amended in the 2024 filing with the addition of a Fourth Amendment, disclosed in Exhibit 10.2(C)+ filed on August 1, 2024. Additionally, new forms of award agreements were disclosed in the 2024 filing, specifically under Exhibit 10.2(K)+, filed on April 25, 2024. No new amendments or forms of award agreements were disclosed in the 2023 filing beyond those previously disclosed in earlier years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43325,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11057,
        "completion_tokens": 107,
        "total_tokens": 11165
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the treatment and valuation of capitalized software licenses showed an increase in both the balance and amortization. The capitalized software licenses rose from $152 million in 2022 to $223 million in 2023, while the amortization expense increased from $54 million to $63 million. This indicates a significant investment in software licensing by the company during 2023, reflecting a growing reliance on or expansion of software assets within its operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47850,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12191,
        "completion_tokens": 120,
        "total_tokens": 12312
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, with the approved amount rising from $2.7 billion (27% of European customer balances) in 2022 to $3.0 billion (39% of European customer balances) in 2023. This indicates a strategic shift toward leveraging internal liquidity sources to fund credit products, reflecting PayPal's effort to expand its credit offerings while managing liquidity needs more efficiently.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49449,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12595,
        "completion_tokens": 118,
        "total_tokens": 12713
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a carrying value of $211.9 million as of September 29, 2024, indicating no significant change from the prior fiscal year. The financial impact of this investment on Starbucks' consolidated statements was not material during fiscal 2024, as the related financial statement activities were described as non-material.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45230,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11553,
        "completion_tokens": 92,
        "total_tokens": 11646
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) experienced a notable shift in both competitive advantages and financial contribution. Financially, Analog revenue decreased by 15% in 2023 compared to 2022, and operating profit dropped by 30%, primarily due to lower revenue and higher manufacturing costs linked to planned capacity expansion and reduced factory loadings. Despite this, TI maintained its focus on strengthening its competitive advantages, particularly in manufacturing and technology, as well as market channel reach. However, the financial performance of the Analog segment weakened in 2023, reflecting broader market challenges and operational costs, even as TI continued to invest in long-term strategic goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9282,
        "completion_tokens": 193,
        "total_tokens": 9475
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, as reflected in the increase in depreciation, depletion, and amortization (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, indicating higher capital investment and asset utilization. However, impairments remained relatively stable, at $0 million in both years, suggesting that asset values in the Lower 48 were not significantly impacted by write-downs during this period. This evolution reflects a focus on maintaining and developing existing assets rather than significant divestitures or impairments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57009,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14481,
        "completion_tokens": 151,
        "total_tokens": 14632
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has positioned FWA broadband as a more integral part of its product portfolio, leveraging its 5G and 4G LTE networks to serve both residential and business customers. In 2023, FWA was highlighted as an alternative to traditional landline internet access, primarily within the Consumer segment. By 2024, FWA broadband is explicitly integrated into both the Consumer and Business segments, with a focus on expanding its availability and enhancing its role in delivering high-speed internet access. The target customer segments have also broadened, with FWA being marketed not only to residential users but also as a scalable solution for businesses, particularly in areas where traditional wired infrastructure is limited.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12710,
        "completion_tokens": 187,
        "total_tokens": 12898
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a 55% ownership stake in a newly formed \"New AspenTech\" in May 2022 to proposing a full acquisition of the remaining shares in November 2024. In 2022, Emerson contributed its industrial software businesses to Heritage AspenTech in exchange for 55% ownership. By 2024, Emerson proposed to acquire the remaining 43% of AspenTech for $240 per share, signaling full ownership. This evolution impacted Emerson's financials: the 2024 gross margin increased to 50.8% (up from 49.0% in 2023), partly due to the Test & Measurement acquisition, while the equity structure was affected by the $279 pre-tax loss on the Copeland note receivable and the $539 pre-tax gain on the sale of the Copeland equity interest.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39765,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10166,
        "completion_tokens": 200,
        "total_tokens": 10366
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. from 2022 to 2023 remained largely unchanged in terms of their obligations and capital structure involvement. FPL Group Capital Inc., now known as NextEra Energy Capital Holdings, Inc., continued to issue junior subordinated debentures, which are typically long-term obligations with deferred interest payments. These debentures, such as the Series L, M, N, O, and P, were created under various officer certificates and indentures, indicating ongoing capital structure management by NEE. No new significant changes or additional obligations were introduced in 2023 compared to 2022, suggesting a stable and consistent approach to capital structure and financing arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 94735,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23917,
        "completion_tokens": 185,
        "total_tokens": 24103
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the positioning and market acceptance of the InterStim II neurostimulator evolved as part of Medtronic's broader Pelvic Health therapies. In 2022, the InterStim II was highlighted alongside the recently launched InterStim Micro and InterStim X neurostimulators, indicating a diversified product portfolio targeting overactive bladder, urinary retention, and bowel incontinence. By 2024, the InterStim II was positioned as a recharge-free option within the InterStim therapy suite, alongside the rechargeable InterStim Micro and the newer InterStim X. This evolution reflects a strategic emphasis on offering tailored solutions to meet patient and physician preferences, supporting continued growth in Pelvic Health therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10454,
        "completion_tokens": 187,
        "total_tokens": 10641
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The Supplemental Facility's borrowing capacity increased from $3.5 billion to a potential $4.5 billion during its term, with an extended maturity date to January 31, 2029, and an option to extend further to January 31, 2030. In terms of interest rate strategies, the facility continued to offer flexibility with borrowing options tied to SOFR-based rates and base rates, with interest rates adjusted based on Simon's credit rating. Repayment actions included the repayment of €750.0 million in Euro-denominated borrowings under the Supplemental Facility in November 2023, funded by the issuance of exchangeable bonds. Additionally, the company utilized the Supplemental Facility to manage liquidity needs, with available borrowing capacity reaching $8.2 billion by December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51155,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13024,
        "completion_tokens": 228,
        "total_tokens": 13252
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to device payment plans has shifted toward more flexible financing structures and targeted promotional incentives. In 2023, Verizon no longer offered new fixed-term, subsidized service plans for Consumer customers, though Business customers could still access subsidized plans. By 2024, the focus had evolved to device payment plans, where customers pay for devices in installments over time, typically over a 36-month term. These plans include non-interest-bearing installment notes and may feature billing credits contingent on maintaining service, which are allocated to performance obligations based on relative selling prices. Additionally, promotional incentives such as trade-in rights and early-upgrade options have been introduced, with trade-in rights accounted for as guarantee obligations, reducing the revenue recognized upon device sale. This evolution reflects a strategic shift toward flexible, customer-centric financing while managing credit risk through detailed allowance calculations and pooling receivables by customer credit quality.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52161,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13262,
        "completion_tokens": 273,
        "total_tokens": 13535
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal relationship with Aqua-Chem remained largely unchanged, with the Georgia Case still subject to the 2004 stay pending the outcome of insurance coverage litigation. In 2024, no new developments were disclosed regarding the Company's stance on liability for Aqua-Chem's asbestos-related claims, as the litigation remained unresolved. The Company continues to assert that it has no obligation for Aqua-Chem's liabilities, a position consistent with prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75563,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19120,
        "completion_tokens": 127,
        "total_tokens": 19248
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits had a more significant negative impact on its effective tax rate in 2024 compared to 2022, with a reduction of 5.6% in 2024 versus 11.4% in 2022. This indicates that the company continued to benefit from its international tax strategy by leveraging lower tax rates in jurisdictions like Hong Kong, Ireland, Israel, and Malaysia, where it conducts eligible activities under conditional tax holidays. However, the reduced impact in 2024 suggests either a shift in the proportion of income derived from these low-tax jurisdictions or a decline in the overall benefit from tax credits, while still emphasizing the strategic use of international operations to manage tax liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10224,
        "completion_tokens": 180,
        "total_tokens": 10404
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and regulatory influence. The company has increasingly utilized asset/liability management (ALM) strategies, including interest rate derivatives, to hedge against reinvestment risks and gross margin compression caused by fluctuating interest rates. Regulatory developments, such as evolving capital requirements and reserving standards, have also influenced the company's approach to managing pension risk transfers, particularly in ensuring statutory reserve adequacy and compliance with evolving insurance regulations. Additionally, the company's ability to adjust crediting rates and manage cash flows has been critical in mitigating the impact of both rising and declining interest rate scenarios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51263,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13043,
        "completion_tokens": 209,
        "total_tokens": 13252
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved by expanding its integration into broader pelvic health therapies and emphasizing its role in treating overactive bladder, urinary retention, and chronic fecal incontinence. In 2022, the InterStim Micro was highlighted as a key driver of Pelvic Health growth, alongside the InterStim II and InterStim X neurostimulators. By 2024, the strategy shifted to emphasize the InterStim Micro as a rechargeable neurostimulator within a broader portfolio of Pelvic Health therapies, including the InterStim X and InterStim II recharge-free options, reflecting a focus on patient-centric, less invasive treatment solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10438,
        "completion_tokens": 182,
        "total_tokens": 10620
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility evolved with a reduction in outstanding borrowings and several repayment actions. As of December 31, 2021, the Operating Partnership had $1.05 billion outstanding under the Supplemental Facility, which was repaid in January 2022 after issuing new senior unsecured notes. By December 31, 2024, the outstanding balance under the Supplemental Facility had dropped to zero, with the Operating Partnership having repaid €750.0 million of borrowings in November 2023 using proceeds from the issuance of senior unsecured bonds. The Supplemental Facility's available borrowing capacity increased to $8.2 billion by 2024, reflecting improved liquidity and refinancing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49846,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12688,
        "completion_tokens": 187,
        "total_tokens": 12875
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "From 2022 to 2023, COP's depreciation, depletion, amortization, and impairments expenses in the Lower 48 region increased from $4,854 million to $5,729 million. This indicates a significant rise in investment activity and asset utilization in the Lower 48 region during 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 172,
          "pages": [
            170,
            171,
            172,
            173,
            174
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14380,
        "completion_tokens": 73,
        "total_tokens": 14453
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has emphasized enhancing its Intelligent Edge Network to support business customers with improved performance and scalability. The Business segment's service description now highlights advanced communication services, including corporate networking solutions, security, and managed network services tailored for enterprises and public sector clients. The Business segment's operating income slightly decreased from $2,066 million in 2023 to $2,058 million in 2024, reflecting a strategic focus on optimizing operations and investing in next-generation infrastructure rather than immediate revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12704,
        "completion_tokens": 169,
        "total_tokens": 12873
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained consistent in its sensitivity analysis methodology, which estimates potential fair value changes under hypothetical market conditions. However, the impact of U.S. dollar appreciation on FVO securities evolved slightly. In 2022, a 10% appreciation of the U.S. dollar led to a potential loss of $54 million for FVO securities. By 2024, while the specific figure for FVO securities is not directly provided, the broader sensitivity to foreign currency exchange rates showed a potential loss of $7,239 million for the portfolio, with FVO securities likely contributing a small portion of this loss. The overall sensitivity decreased slightly compared to 2022, reflecting changes in the composition of assets and liabilities and the continued economic offset from insurance contract liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84140,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21267,
        "completion_tokens": 221,
        "total_tokens": 21489
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities between 2022 and 2023 showed significant evolution, particularly in energy trading services and financial performance. In 2023, operating revenues for NEER increased by $5,952 million, driven by gains from non-qualifying commodity hedges due to changes in energy prices, higher revenues from new investments in wind, solar, and battery storage facilities, and increased revenues from customer supply and gas infrastructure businesses. However, this growth was partially offset by lower revenues from existing clean energy assets due to reduced wind resource availability. Financial performance was also impacted by increased operating expenses, primarily from higher O&M and depreciation costs, as well as a significant increase in interest expenses due to higher average interest rates and debt balances. Additionally, equity in losses of equity method investees rose in 2023, partly due to an impairment charge related to the investment in NEP. Overall, these factors contributed to a substantial increase in NEER's net income for 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 57701,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14656,
        "completion_tokens": 278,
        "total_tokens": 14934
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake ownership in Coca-Cola FEMSA remained at 28%. However, the carrying value of the Company's investment in Coca-Cola FEMSA increased from $1,786 million in 2023 to $1,786 million in 2024, while the fair value based on quoted prices rose from $4,544 million to $4,544 million. The Company's equity income from Coca-Cola FEMSA, as part of equity method investees, was $1,770 million in 2024 compared to $1,691 million in 2023, indicating a slight increase in the contribution to The Coca-Cola Company's consolidated net income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51932,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13213,
        "completion_tokens": 144,
        "total_tokens": 13357
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed a significant shift. Production volumes in the Lower 48 increased from 447 thousand barrels per day in 2022 to 447 thousand barrels per day in 2023, indicating stable crude oil production. However, depreciation expenses for the Lower 48 rose from $4,854 million in 2022 to $5,729 million in 2023, reflecting increased capital investment and asset utilization in the region. This suggests a growing operational and financial commitment to the Lower 48 in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 169,
          "pages": [
            167,
            168,
            169,
            170,
            171
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61653,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15640,
        "completion_tokens": 139,
        "total_tokens": 15780
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a foundational role in its network infrastructure and growth initiatives, particularly in supporting fixed wireless access (FWA) broadband services as an alternative to traditional landline internet access. While the company is focused on advancing its 5G capabilities, the 4G LTE network remains integral to its offerings, especially in areas where 5G deployment is still in progress. Additionally, the 4G LTE network supports Verizon's expanding FWA business and complements its fiber-based network expansion strategy, including the acquisition of Frontier in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44134,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11262,
        "completion_tokens": 158,
        "total_tokens": 11421
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's financial and strategic relationship with AspenTech evolved significantly. In 2022, Emerson contributed two industrial software businesses to Heritage AspenTech and received 55% ownership in the newly formed AspenTech. By 2024, Emerson had increased its stake to 57% and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion. This acquisition would be financed through cash and credit. The impact on financial metrics includes a notable increase in AspenTech's backlog from $328 million in 2022 to $1,042 million in 2022, primarily due to the Heritage AspenTech acquisition. While specific gross margin details for AspenTech are not provided, Emerson's overall gross margin improved from 49.0% in 2023 to 50.8% in 2024, partly influenced by the Test & Measurement acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38271,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9807,
        "completion_tokens": 211,
        "total_tokens": 10019
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly declined between 2022 and 2023. In 2022, NEE's investment in MVP was reflected in its equity method investments, with an impairment charge recorded in 2020 and an additional impairment in early 2022 that completely wrote off its investment. By 2023, NEE no longer held a material investment in MVP, as indicated by the absence of any mention of MVP in the 2023 equity method investments or capital expenditures. This indicates a strategic shift away from the MVP project, likely due to regulatory or financial challenges, and a reallocation of capital to other projects within NEE's regulated and competitive energy businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69969,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17716,
        "completion_tokens": 176,
        "total_tokens": 17893
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited within the Global Ventures segment has evolved from 2023 to 2024 by integrating Costa's direct-to-consumer retail operations more closely into the segment's strategic focus. In 2023, Costa's operations were included in the Global Ventures segment, emphasizing their role in selling finished beverages directly to consumers. By 2024, Costa's inclusion in the Global Ventures operating segment continued, with the segment now explicitly highlighting its role in managing key businesses like Costa, along with other ventures such as innocent and doğadan. This integration reflects a strategic positioning to leverage Costa's retail presence and brand strength to drive growth and innovation within the Global Ventures portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13144,
        "completion_tokens": 192,
        "total_tokens": 13336
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically in terms of the fair value of economically hedged marketable debt investments, has decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, for 2024, Intel recorded net losses of $464 million on these hedged investments, compared to net gains of $534 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54315,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13809,
        "completion_tokens": 112,
        "total_tokens": 13922
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus regarding communications sites evolved by emphasizing recurring revenue generation through long-term leases with multi-year terms and periodic rent escalations, ensuring stable future cash flows. In 2024, the company also addressed asset retirement liabilities, with an estimated $4.5 billion in undiscounted future cash outlays for site remediation and asset removal. This reflects a strategic shift toward managing long-term obligations while maintaining a strong recurring revenue base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47964,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12218,
        "completion_tokens": 132,
        "total_tokens": 12351
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's (XOM) strategic positioning in Guyana has evolved under the legal framework established by the Petroleum Activities Act 2023. This act enables petroleum agreements with an exploration period typically up to 10 years and a production period of 20 years for oil fields, each with a renewal period of up to 10 years. This legal structure supports XOM's business growth emphasis by providing a clear and extended timeline for exploration, development, and production activities, facilitating long-term planning and investment in Guyana's oil resources. The framework aligns with XOM's focus on advantaged projects, such as those in Guyana, which are integral to its strategy for volume growth and higher returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45424,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11580,
        "completion_tokens": 186,
        "total_tokens": 11766
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its Energy & Transportation segment in both 2023 and 2024. In 2024, the segment reported increased sales in rail services, partially offset by lower sales of reciprocating engine aftermarket parts. Strategically, Caterpillar continued to focus on remanufacturing and leasing of diesel-electric locomotives and components, along with providing related services. Operationally, the company emphasized service solutions and product support for rail applications, aligning with its broader strategy to enhance service offerings and support customer needs in the transportation sector.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39570,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10126,
        "completion_tokens": 168,
        "total_tokens": 10294
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source increased from 2022 to 2024. In 2022, securitized debt obligations accounted for 4% of total funding sources, rising to 4% in 2024. This slight increase, combined with the emphasis on net issuances in securitization programs, suggests the company is diversifying its funding strategy to include more structured financing options alongside its primary reliance on deposits. This indicates a strategic effort to maintain liquidity and optimize funding costs through a mix of traditional and alternative funding sources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13186,
        "completion_tokens": 148,
        "total_tokens": 13334
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees remained largely consistent in terms of financial reporting and relationship management. Developmental licensees continue to operate under license agreements, paying royalties based on a percentage of sales and typically initial fees. Financially, these arrangements are reported within the \"International Developmental Licensed Markets & Corporate\" segment, which remained 98% franchised in both years. In 2024, there was a slight increase in operating income for this segment, from $120.8 million in 2023 to $311 million in 2024, likely reflecting growth in developmental licensee markets. Relationship management practices, such as oversight and support, appear unchanged, with McDonald's maintaining its focus on franchisee success and system-wide growth. No significant changes in accounting policies or management strategies specific to developmental licensees were noted in the provided documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13446,
        "completion_tokens": 243,
        "total_tokens": 13690
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw an increase in share availability, with 26.9 million shares available for awards under the plan as of December 31, 2023. The plan includes stock options and performance share units, and there were no material changes in the structure of executive award disclosures during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 232,
          "pages": [
            230,
            231,
            232,
            233,
            234
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80922,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20463,
        "completion_tokens": 92,
        "total_tokens": 20556
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3%, with a 5% growth in the U.S. driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC, partially offset by lower volumes and lower net price in certain European markets. The factors contributing to this growth trajectory include the expanded use of Inlyta in combination therapies and continued growth in emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98760,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24909,
        "completion_tokens": 117,
        "total_tokens": 25026
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company continued to recognize revenue from franchisees through fees for technology platforms on a gross basis, indicating that these services are distinct from the franchise agreement and the Company acts as the principal in these arrangements. Additionally, the Company shared costs for certain restaurant improvements with franchisees, with McDonald's generally managing the projects and providing upfront funding, later allocating costs between its Property and Equipment and Accounts Receivable. This reflects a collaborative financial structure where both the Company and franchisees contribute to capital investments while maintaining distinct revenue recognition practices for technology services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62385,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15832,
        "completion_tokens": 228,
        "total_tokens": 16060
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $199 million (assets) and $210 million (liabilities) to $55 million (assets) and $358 million (liabilities). This indicates a significant rise in the company's exposure to energy market fluctuations, particularly in liabilities, reflecting greater financial risk due to changes in natural gas and power prices during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84049,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21249,
        "completion_tokens": 112,
        "total_tokens": 21361
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024 in terms of remaining shares available for future issuance. In 2022, the plan had 119 million shares available, while by 2024, this number decreased to 77 million shares. This reduction indicates increased utilization of the plan for granting securities during this period, reflecting its ongoing role in the company's executive and employee compensation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68537,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17364,
        "completion_tokens": 122,
        "total_tokens": 17486
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company's approach to managing the risk of large losses in its pension plan assets remained focused on diversification and formal rebalancing programs, but there was a slight shift in emphasis toward increasing allocations in private equity and private credit. In 2023, private equity represented 9% of the portfolio, rising to 12% in 2024, while private credit moved from 3% to 1% (though still within the target range). Additionally, the company continued to use derivative instruments for hedging and maintained a strong emphasis on diversification across major asset classes, with no significant concentrations of risk. The 2024 disclosures also highlighted a more detailed discussion of risk management practices, indicating a heightened focus on monitoring and managing risk beyond diversification.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62309,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15812,
        "completion_tokens": 208,
        "total_tokens": 16020
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the development and supply of the CUDA platform evolved from being a foundational element of its accelerated computing strategy to becoming a central pillar of its broader AI and computing ecosystem. In 2022, CUDA was highlighted as the core programming model enabling GPU-based parallel computing for AI, data analytics, and scientific workloads. By 2023, CUDA's role expanded significantly, with NVIDIA emphasizing its integration into full-stack solutions like NVIDIA AI Enterprise and DGX Cloud, as well as its support for generative AI, large language models (LLMs), and enterprise applications. This shift indicates a strategic focus on solidifying CUDA as the backbone of NVIDIA's AI and high-performance computing (HPC) platforms, enabling broader industry adoption and reinforcing its leadership in AI-driven innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49188,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12523,
        "completion_tokens": 217,
        "total_tokens": 12741
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris, formed through the 2020 spin-off and combination with Mylan, remained largely stable in terms of supply agreements and outstanding balances. The manufacturing and supply agreements under Master Services Agreements (MSAs) continued to operate, with Pfizer and Viatris manufacturing products for each other. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022. These amounts were not material to Pfizer's overall operations during either year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89897,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22696,
        "completion_tokens": 150,
        "total_tokens": 22846
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations evolved in terms of increased specificity and updated financial metrics. In 2023, the disclosures focused on securitization structures, repayment activities, and the cash flow mechanisms tied to communications sites securing debt, such as the 3,343 sites backing the Series 2015-2 Notes. By 2024, the disclosures provided more granular details on debt obligations, including updated debt service coverage ratios (DSCR) and reserve account balances, as well as the number of sites securing debt (e.g., 3,338 for the 2015 Securitization and 5,029 for the Trust Securitizations). Additionally, 2024 emphasized the conditions under which excess cash flow could be distributed or restricted, reflecting a more dynamic and risk-focused approach to managing site-related debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61681,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15636,
        "completion_tokens": 222,
        "total_tokens": 15858
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained largely consistent in terms of revenue recognition, with fees from NBC and Telemundo retransmission consent agreements being recognized as programming is provided on a monthly basis under multiyear contracts. However, in 2023, there was a notable emphasis on expanding distribution models, particularly through the integration of streaming services like Peacock, where revenue from monthly subscription fees is recognized alongside traditional multichannel video provider agreements. This shift reflects a broader strategy to adapt to evolving viewer consumption habits by combining linear and digital distribution channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10724,
        "completion_tokens": 177,
        "total_tokens": 10902
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives remained consistent from 2023 to 2024, as both years highlight the company's continued focus on manufacturing and supporting diesel-electric locomotives and rail-related products and services. In 2023, the Energy & Transportation segment explicitly included diesel-electric locomotives and components, along with remanufacturing and leasing services. In 2024, the segment description reiterated this focus, emphasizing the production of diesel-electric locomotives and related rail services, with no notable changes in strategy or scope.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39332,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10050,
        "completion_tokens": 159,
        "total_tokens": 10210
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent, with a few notable developments. Revenue recognition continued to follow the same principles, with royalty revenues based on a percentage of franchisee sales recognized at the time of the underlying sales, and initial fees recognized over the franchise term. Cost-sharing arrangements for restaurant improvements persisted, with McDonald's managing projects and estimating cost allocations between the Company and franchisees. However, in 2024, the Company acquired additional restaurants from franchisees (including 228 in Israel), which involved cost-sharing for improvements and resulted in goodwill additions, though these acquisitions did not significantly impact revenue or net income. Overall, the framework for revenue and cost-sharing remained stable, with operational adjustments supporting franchising initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16725,
        "completion_tokens": 246,
        "total_tokens": 16971
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending the terms of its equity awards under the Southern Company 2021 Equity and Incentive Compensation Plan. Specifically, the company revised plan documentation to include the \"Form of Terms for Named Executive Officer Equity Awards,\" which was updated and designated in filings in 2024. Additionally, Southern Company amended its change-in-control protections and severance plans for executives, with the Amended and Restated Southern Company Change in Control Benefits Protection Plan and related severance plans being updated and effective as of August 15, 2022, reflecting continued alignment with corporate governance standards. These changes emphasize enhanced clarity and alignment of award terms with executive compensation strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 276,
          "pages": [
            274,
            275,
            276,
            277,
            278
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 87160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22015,
        "completion_tokens": 210,
        "total_tokens": 22225
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has increased from 2022 to 2024, reflecting a broader shift toward optimizing retail execution and channel diversification. In 2022, membership club stores were listed among key customers, but by 2024, the company emphasized a more intentional focus on these channels as part of its strategy to enhance retail execution and consumer value. This evolution indicates P&G's broader retail channel strategy to strengthen relationships with high-volume, high-efficiency retailers and adapt to changing consumer shopping behaviors, particularly in the face of growing e-commerce and omnichannel demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 59647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15139,
        "completion_tokens": 165,
        "total_tokens": 15304
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit indicates that there were no outstanding amounts as of December 31, 2024, compared to $3.4 million in 2023. This suggests that the financial obligations related to these instruments were fully settled or drawn upon during the period, with any drawn amounts due 270 days from the date of drawing and bearing interest based on SOFR plus a spread. The absence of a carrying value in 2024 implies that AMT no longer holds any active obligations under these letters of credit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49605,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12630,
        "completion_tokens": 130,
        "total_tokens": 12760
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts shifted from being classified under Level 3 (significant unobservable inputs) to being excluded from the fair value hierarchy. In 2022, these contracts were valued using significant unobservable inputs with a fair value of $38 million, whereas by 2024, they were reclassified as investments measured using NAV as a practical expedient, with a fair value of $22 million. This change indicates a shift in the company's approach to reporting these assets, likely reflecting a move toward more liquid or standardized valuation methods, reducing reliance on internal assumptions and enhancing transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44367,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 175,
        "total_tokens": 11501
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Based on the information provided in the document pages, the fair value hierarchy classification for restricted cash for securitization investors remained unchanged between 2022 and 2024. In both 2024 and 2022, restricted cash for securitization investors was classified entirely within Level 1 of the fair value hierarchy, with no amounts classified in Level 2 or Level 3. This indicates that the composition and valuation method for this asset remained consistent during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14025,
        "completion_tokens": 121,
        "total_tokens": 14146
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management as reflected in the increased number of franchised restaurants and the acquisition of additional restaurants from franchisees to support key franchising initiatives. The total franchised restaurants increased from 39,680 in 2023 to 41,432 in 2024, with notable growth in both conventional franchised and developmental licensed categories. Additionally, the Company acquired restaurants from franchisees, particularly in Israel, resulting in the recording of $240 million in goodwill. These acquisitions were part of strategic efforts to enhance franchisee support and optimize asset management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68921,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17448,
        "completion_tokens": 181,
        "total_tokens": 17630
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the 2019 Stock and Incentive Compensation Plan remained the sole active equity compensation plan for future grants at Procter & Gamble. In 2022, the plan had 119 million shares available for future issuance, while by 2024, this number had decreased to 77 million shares, reflecting ongoing use of the plan for equity awards. The plan continued to serve as the primary vehicle for granting stock options, stock appreciation rights, and full-value awards like RSUs and PSUs, with older plans such as the 2001 and 2014 plans no longer permitting new grants. This evolution highlights the 2019 Plan's central role in the company's equity compensation strategy during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68537,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17378,
        "completion_tokens": 174,
        "total_tokens": 17553
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations between 2022 and 2023 remained consistent, as the brand was listed as a tenant in multiple international Premium Outlets across Japan, South Korea, Canada, and Thailand in both years. For example, Ferragamo was present in the Gotemba Premium Outlets (Japan), Yeoju Premium Outlets (South Korea), Toronto Premium Outlets (Canada), and other locations in 2022, and its presence was similarly noted in 2023 in these and other international outlets. There is no indication of a significant expansion or contraction of Ferragamo's footprint during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12709,
        "completion_tokens": 160,
        "total_tokens": 12870
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region saw an increase in total proved natural gas reserves from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, indicating a slight decline. However, this region remained a focus for exploration and development, with extensions and discoveries in the Middle East and Australia in 2024. The decline in reserves was primarily due to downward revisions from lower prices and changes in development plans, partially offset by technical revisions and acquisitions. This suggests that while COP is maintaining a strategic interest in the region, operational focus may be shifting toward optimizing existing assets rather than significant new development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74127,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18761,
        "completion_tokens": 184,
        "total_tokens": 18945
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways from 2022 to 2024 has evolved with a stronger strategic emphasis on enhancing customer connectivity and expanding network capabilities. In 2022, wireless gateways were highlighted as part of the broadband services, combining an internet modem with a Wi-Fi router to improve in-and-out-of-home coverage. By 2024, the company increased its investment in scalable infrastructure and line extensions to support multigigabit symmetrical speeds and the continued deployment of wireless gateways, reflecting a commitment to upgrading its network and meeting growing customer demand for high-speed connectivity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11876,
        "completion_tokens": 160,
        "total_tokens": 12037
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolution has shown notable growth. By the end of 2022, cumulative deliveries of the G500 and G600 totaled almost 150, while by the end of 2024, this figure had more than doubled to over 300. The G600 has solidified its role within Gulfstream's product lineup as a key ultra-long-range, ultra-large-cabin aircraft, replacing older models and contributing to Gulfstream's leadership in innovation and performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31311,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8055,
        "completion_tokens": 119,
        "total_tokens": 8174
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes. As of December 31, 2023, AIG held a 52.2% ownership stake in Corebridge. However, by June 9, 2024, AIG deconsolidated Corebridge after reducing its ownership to 48.4% and waiving its majority board representation. This deconsolidation resulted in a $4.8 billion pre-tax loss, primarily driven by an accumulated comprehensive loss. Post-deconsolidation, AIG accounted for its remaining stake using the equity method, recognizing equity method income of $601 million for the period June 10, 2024, to December 31, 2024. By December 31, 2024, AIG's ownership had further decreased to 22.7% after additional share sales, including a $3.8 billion transaction with Nippon Life in December 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 96687,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24394,
        "completion_tokens": 196,
        "total_tokens": 24590
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved with a greater emphasis on localized manufacturing and addressing operational challenges. In 2022, Tesla highlighted its reliance on Gigafactory New York for Solar Roof production and noted the need to manage supply chain dependencies and localized procurement. By 2024, the company had expanded its manufacturing capabilities and workforce development programs, such as apprenticeships and technical training, to support skilled labor needs. Additionally, Tesla continued to focus on integrating automation and optimizing production processes to enhance efficiency and reduce costs, while also navigating supply chain constraints and ensuring compliance with regulatory requirements in various markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49971,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12717,
        "completion_tokens": 196,
        "total_tokens": 12914
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm has increasingly emphasized on-device artificial intelligence (AI) as a core component of its strategic focus, leveraging its foundational technologies in high-performance and low-power computing. In 2023, Qualcomm highlighted its advancements in AI as part of its broader innovation efforts across mobile and emerging industries. By 2024, the company explicitly positioned on-device AI as a key differentiator, integrating it into its wireless connectivity and computing solutions to scale across industries like automotive and IoT. This evolution reflects a more targeted investment approach, with Qualcomm aiming to drive growth through AI-enabled products and expanding its leadership in next-generation technologies beyond traditional mobile handsets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65349,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16566,
        "completion_tokens": 196,
        "total_tokens": 16762
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana expanded its presence in SPG-operated properties, notably appearing in multiple U.S. Premium Outlets such as Las Vegas Outlets, Houston Premium Outlets, and others. This growth indicates that SPG is strategically enhancing its premium outlet locations by attracting high-end luxury brands like Dolce & Gabbana, reinforcing its focus on curating a luxury retail experience to drive foot traffic and higher sales in these destinations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12727,
        "completion_tokens": 118,
        "total_tokens": 12845
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region decreased between 2023 and 2024, as evidenced by the drop in exploratory wells from 3 in 2023 to zero in 2024, while development activities remained stable. This shift indicates a strategic pivot toward development and optimization of existing assets rather than new exploration in the region. The company appears to be focusing on maximizing returns from established reserves and partnerships rather than pursuing high-risk, high-cost exploration initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 156,
          "pages": [
            154,
            155,
            156,
            157,
            158
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 76997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19485,
        "completion_tokens": 135,
        "total_tokens": 19621
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remains at a 30% interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion of debt outstanding, including a $3.1 billion term loan, as of December 31, 2023. Comcast consolidates Universal Beijing Resort as a variable interest entity (VIE), and its maximum risk of financial loss is limited to its 30% equity stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43060,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10977,
        "completion_tokens": 121,
        "total_tokens": 11099
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $4,985 million to $5,460 million, primarily due to a reduction in derivative assets and liabilities. The settlement activity showed a net outflow, with derivative liabilities increasing and derivative assets decreasing. This indicates a shift in the company's exposure to derivative instruments, suggesting a potential reduction in hedging activities or changes in market conditions affecting the fair value of these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 199,
          "pages": [
            197,
            198,
            199,
            200,
            201
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 192,
          "pages": [
            190,
            191,
            192,
            193,
            194
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63136,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16021,
        "completion_tokens": 125,
        "total_tokens": 16146
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of their dilutive effect and valuation modeling as follows: \n\nIn 2022, SPG disclosed that LTIP units were subject to performance and market conditions, with vesting dates set for January 1, 2025, and the valuation of market-based awards was estimated using a Monte Carlo model. By 2023, the 2023 LTI Program extended the vesting period to January 1, 2027, and continued to use a similar valuation approach for performance-based awards, with a maximum potential fair value at grant date of $42.5 million. Additionally, the 2023 disclosures emphasized the inclusion of a TSR modifier for FFO performance conditions, indicating a more nuanced valuation model. The dilutive effect remained minimal in both years, with no material impact on earnings per share or unit calculations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51522,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13104,
        "completion_tokens": 214,
        "total_tokens": 13318
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's financial commitment to Atairos Group, Inc. evolved as follows: \n\n- **Capital Funding**: In 2022, Comcast contributed $52 million, increasing to $145 million in 2023 and $73 million in 2024. As of December 31, 2024, the total investment in Atairos, including advances, was $5.1 billion, down from $5.5 billion in 2023. \n- **Management Fee Commitments**: Comcast committed to funding $40 million annually for a management fee in 2024, down from $45 million in 2022. \n\nComcast's unfunded capital commitment also decreased to $1.4 billion in 2024 from $1.5 billion in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43908,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 150,
        "total_tokens": 11359
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This decline, despite some upward revisions in technical estimates, was primarily driven by lower prices impacting reserves and development plan changes. The reduction suggests a decreased operational focus or strategic shift in the region, as COP appears to be reallocating resources or facing economic constraints in maintaining or expanding its natural gas reserves in Asia Pacific/Middle East.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17443,
        "completion_tokens": 139,
        "total_tokens": 17582
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast's wireless gateway procurement strategy focused on offering wireless gateways to customers to enhance in-and-out-of-home Wi-Fi coverage and provide features like personalized network management and advanced security through the xFi platform. By 2024, the company shifted its focus toward network deployment investments, emphasizing scalable infrastructure and line extensions to expand capacity and deliver multigigabit symmetrical speeds. This shift reflects a broader strategy to upgrade the network for future demand while continuing to support customer-facing technologies like wireless gateways.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47596,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12112,
        "completion_tokens": 154,
        "total_tokens": 12266
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved in terms of strategic importance and production challenges. In 2022, Solar Roof was highlighted as part of the energy generation and storage segment, with deployments increasing due to product introductions like Megapack and Powerwall, though it operated at a lower gross margin due to manufacturing underutilization during the product ramp. By 2024, Solar Roof remained a key part of Tesla's energy strategy, but the company faced ongoing production challenges, including the need to scale manufacturing and manage costs effectively. The strategic importance of Solar Roof was underscored by its inclusion in Tesla's broader energy product offerings, though it continued to face hurdles in achieving profitability and production efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57214,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14527,
        "completion_tokens": 204,
        "total_tokens": 14732
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in \"Net pending transactions and other investments\" increased from $14 million as of December 31, 2022, to $54 million as of December 31, 2023. This increase suggests a strategic shift or expansion in Duke Energy's approach to managing its retirement trust investments, potentially indicating a greater focus on short-term or transitional investment opportunities within its broader asset allocation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 226,
          "pages": [
            224,
            225,
            226,
            227,
            228
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61552,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15623,
        "completion_tokens": 108,
        "total_tokens": 15732
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's defined contribution plan expenses increased from $109 million in 2023 to $112 million in 2024. Regarding the liability-driven investment framework, the pension plan asset composition shifted slightly from 18% equity securities in 2023 to 21% in 2024, while corporate bonds increased from 57% to 63%. The postretirement plan asset composition remained relatively stable, with equity securities at 57% in both years, though corporate bonds decreased slightly from 31% to 30%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51201,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13038,
        "completion_tokens": 127,
        "total_tokens": 13166
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and 2024, Qualcomm's strategic focus on On-Device AI evolved as the company emphasized the integration of high-performance, low-power computing and on-device artificial intelligence into its broader technology roadmap. In fiscal 2024, Qualcomm highlighted its continued investment in foundational technologies, including on-device AI, to extend its reach into industries and applications beyond mobile handsets, such as automotive and IoT. The company also underscored the importance of 5G combined with on-device AI in driving innovation across these sectors. Specific investments included research and development efforts to advance AI capabilities and the pursuit of strategic transactions to support its growth and diversification strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 191,
        "total_tokens": 14377
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, as both years reference the same agreement (Exhibit 9.1) titled \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004.\" This consistency indicates a stable governance structure, with no material changes to the agreement or its presentation in the filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            138,
            139,
            140,
            141,
            142
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51297,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13076,
        "completion_tokens": 125,
        "total_tokens": 13201
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, reflecting a modest decline. This slight reduction, despite ongoing exploration and development activities in the Middle East, indicates that the region's strategic importance to COP's global reserves portfolio has remained relatively stable but not significantly expanded in recent years. The region continues to play a role in COP's reserves, particularly through equity affiliates, but the growth in other regions, such as the Lower 48 and Canada, has outpaced developments in Asia Pacific/Middle East.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17633,
        "completion_tokens": 166,
        "total_tokens": 17799
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes, particularly with the deconsolidation of Corebridge in June 2024. In 2023, Corebridge's debt, which was guaranteed by AIG under specific collateral agreements, totaled $9,368 million. By 2024, following the deconsolidation, AIG no longer guaranteed Corebridge's debt, and its retained interest in Corebridge was classified as an equity method investment. In the period from June 10, 2024, to December 31, 2024, AIG recognized $601 million in equity method income from Corebridge, primarily driven by changes in Corebridge's stock price and dividends received. Additionally, AIG sold a significant portion of its Corebridge shares, including a 21.6% stake to Nippon Life for $3.8 billion, resulting in a $282 million gain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23064,
        "completion_tokens": 205,
        "total_tokens": 23269
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's investment strategy in Special Use Funds has shown a shift in allocation between fixed income and equity securities. In 2022, the total fair value of Special Use Funds for NEE was $2,505 million in fixed income securities and $5,511 million in equity securities. By 2024, this increased to $1,342 million in fixed income and $9,799 million in equity securities. This suggests a significant increase in equity exposure relative to fixed income, indicating a higher risk appetite and potentially a longer-term investment horizon. The shift may also reflect a strategic decision to capitalize on equity market opportunities while maintaining a portion of fixed income for liquidity and stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61085,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15517,
        "completion_tokens": 182,
        "total_tokens": 15700
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The adoption of 5G technology has increased the risk associated with site infrastructure sharing, as carriers utilize shared equipment and radio access network (RAN) sharing, reducing the need to lease new sites or maintain equipment on existing sites. Between 2022 and 2024, this trend has intensified, with 5G deployment leading to network redundancy and slower new lease activity. As a result, American Tower faces heightened risks of reduced leasing demand and potential decommissioning of existing equipment, which could negatively impact its growth and revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56112,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14264,
        "completion_tokens": 141,
        "total_tokens": 14405
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's investment in Angola LNG Limited, which holds a 36.4% interest in the company, decreased from $1,963 million to $1,762 million. Additionally, Chevron's equity in earnings from Angola LNG Limited dropped significantly from $1,857 million in 2022 to $513 million in 2023, indicating a substantial decline in the financial performance of this joint venture during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14336,
        "completion_tokens": 101,
        "total_tokens": 14438
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft's role in Gulfstream's product lineup remained prominent as a high-performance, large-cabin business jet. By the end of 2023, cumulative deliveries of the G600 had increased to over 250 from 150 in 2021, reflecting strong market acceptance. Performance-wise, the G600 continued to hold over 90 city-pair speed records, showcasing its speed and efficiency. The aircraft's production status remained stable, with no indication of changes to its ongoing production or its position within Gulfstream's lineup during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30751,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7909,
        "completion_tokens": 140,
        "total_tokens": 8049
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize greater strategic collaboration and financial co-investment. The company has increasingly partnered with franchisees to fund restaurant improvements and modernization initiatives, aiming to enhance performance and brand value. Additionally, the business model continues to prioritize franchising, with over 95% of restaurants being franchised in 2024, reflecting a strong and structured partnership that supports consistency, innovation, and profitability across the system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64031,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16226,
        "completion_tokens": 141,
        "total_tokens": 16368
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased from $22,476 million to $21,756 million. However, operating income remained relatively stable, decreasing only slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58355,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14807,
        "completion_tokens": 75,
        "total_tokens": 14882
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's product development and commercialization strategy has evolved through expanded therapeutic approvals and continued emphasis on collaboration. In 2024, Opdivo received multiple approvals, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) across several indications, approval for unresectable urothelial carcinoma in Japan, and EC approval for combination therapy in colorectal cancer. These approvals reflect BMY's strategy to strengthen Opdivo's position in oncology. Collaboratively, Opdivo remains central to joint efforts with Ono in Asia and partnerships like the Nektar collaboration for combination therapies, highlighting BMY's focus on leveraging alliances to drive innovation and expand Opdivo's therapeutic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 44405,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11336,
        "completion_tokens": 199,
        "total_tokens": 11536
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024 by transitioning from referencing LIBOR and EURIBOR to referencing SOFR. In 2022, debt instruments primarily referenced LIBOR or EURIBOR with applicable margins, as seen in the 2021 Credit Facility and related term loans. By 2024, the Nigeria Letters of Credit explicitly referenced SOFR as the benchmark rate for interest calculations. Additionally, covenants remained focused on maintaining debt service coverage ratios (DSCR) and compliance with financial reporting requirements, but the shift to SOFR reflects a broader industry move away from LIBOR-based instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50320,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12810,
        "completion_tokens": 168,
        "total_tokens": 12978
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize co-investment in real estate and modernization initiatives to enhance restaurant performance and brand value. The Company continues to generally own or secure long-term leases on restaurant land and buildings under conventional franchise agreements, while franchisees invest in equipment, signage, and décor. Additionally, McDonald's collaborates with franchisees through co-investment opportunities to fund restaurant improvements and operating system upgrades, aiming to meet consumer preferences and drive higher revenue. This strategy reflects a continued focus on leveraging franchisee partnerships to maintain high operational standards and modernize the McDonald's restaurant experience globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53410,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13570,
        "completion_tokens": 197,
        "total_tokens": 13767
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2023 filing. This update likely reflects adjustments to align director compensation with evolving governance standards or regulatory requirements. The evolution of the plan indicates Altria's ongoing commitment to structured, shareholder-approved governance practices, ensuring transparency and alignment with corporate objectives in compensating its board.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54631,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13900,
        "completion_tokens": 121,
        "total_tokens": 14022
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on American Tower's (AMT) leasing activity has intensified from 2022 to 2024, as these arrangements increasingly allow carriers to share infrastructure rather than lease new sites. In 2022, the filing noted that such arrangements could slow new lease activity or lead to decommissioning of existing equipment. By 2024, the impact was more pronounced, with the mention of RAN sharing, roaming, and resale arrangements linked to 5G technology explicitly reducing the need for new tower-based infrastructure. This evolution indicates growing competitive pressures, as carriers prioritize cost efficiency and network optimization over expanding their leased infrastructure footprint, thereby constraining AMT's new lease growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56112,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14268,
        "completion_tokens": 200,
        "total_tokens": 14469
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment to drive growth and modernization. The Company has increasingly collaborated with franchisees on capital-intensive initiatives, including co-investing in restaurant improvements to meet consumer preferences and enhance brand value. Operational expectations have also shifted to prioritize technology integration, digital engagement, and adherence to McDonald's Global Brand Standards, ensuring consistency and quality across all locations. This approach reflects a stronger partnership model, where franchisees are expected to actively participate in innovation and reinvestment efforts to support long-term profitability and brand strength.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55188,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14019,
        "completion_tokens": 195,
        "total_tokens": 14214
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by increasing the fair value of equity securities held. In 2022, the fair value of equity securities in the Special Use Funds was $2,349 million for NEE and $863 million for FPL. By 2024, this amount had grown to $2,614 million for NEE and $1,028 million for FPL. Additionally, the unrealized gains on equity securities improved significantly, shifting from a loss of $1,028 million in 2022 to a gain of $917 million in 2024, indicating a more favorable market performance and a strategic shift toward higher-value equity investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19157,
        "completion_tokens": 161,
        "total_tokens": 19318
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in net revenues, which decreased from $22,476 million in 2022 to $21,756 million in 2023. Operating income remained relatively stable, with a slight decrease from $10,688 million in 2022 to $10,670 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58133,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14752,
        "completion_tokens": 74,
        "total_tokens": 14826
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, Accenture plc increased its share repurchase activity, with the 2023 authorization for open-market share purchases rising to $6,129,296 from $3,129,296 in 2022. In 2022, the company repurchased 12,180,917 Class A ordinary shares for $4,111,266, while in 2023, the additional $3,000,000 in repurchase authority suggests a strategic focus on returning value to shareholders. These repurchased shares are held as treasury shares and may be used for employee benefits, such as equity awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8482,
        "completion_tokens": 127,
        "total_tokens": 8610
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants remained largely consistent in structure, focusing on financial metrics like debt service coverage ratios (DSCR) and restrictions on additional debt, asset sales, and liens. In 2022, the covenants primarily applied to USD and EUR denominated debt instruments under term loans and credit facilities, with interest rates benchmarked to LIBOR or EURIBOR plus a fixed margin of 1.125%. By 2024, the covenants continued to apply to similar debt instruments, including securitizations and subsidiary debt, with interest rates still tied to LIBOR or EURIBOR, though specific rates and spreads were not detailed for newer instruments. The core covenant framework remained focused on maintaining sufficient liquidity and financial stability to service debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48350,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12323,
        "completion_tokens": 202,
        "total_tokens": 12525
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar's subscriber base remained relatively stable, with approximately 36 million paid subscribers as of September 28, 2024, compared to the prior year. The consolidation of Star+ into Disney+ in Latin America during June 2024 streamlined Disney's international streaming strategy by simplifying its product offerings and enhancing content integration, allowing for a more cohesive and competitive presence in the region. This move reflects Disney's broader strategy to unify its streaming services and optimize user experience across markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46614,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11890,
        "completion_tokens": 148,
        "total_tokens": 12038
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 to around 2,100 in 2023. This reduction suggests that the company may be either renegotiating agreements with fewer employees or adjusting its workforce structure, while still maintaining a strategic focus on managing labor agreements with minimal disruption to operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38688,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9899,
        "completion_tokens": 95,
        "total_tokens": 9994
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value was $137 million, in 2023 it rose to $722 million, and by 2024, it reached $1,383 million (sum of $663 million for NEE and $522 million for FPL). This represents a significant increase of $1,246 million over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60827,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15431,
        "completion_tokens": 87,
        "total_tokens": 15518
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's portfolio has expanded significantly in terms of therapeutic approvals and manufacturing strategy. In 2022, Opdivo benefited from FDA's expedited review processes, such as the Assessment Aid pilot program, which accelerated its approval for non-small cell lung cancer (NSCLC). By 2024, Opdivo received multiple new approvals, including for urothelial carcinoma in Japan and the U.S., unresectable urothelial carcinoma in Japan, and new indications in colorectal cancer through the EC. Additionally, Opdivo Qvantig, a subcutaneous formulation, was approved in late 2024, enhancing delivery options. Manufacturing-wise, BMS maintained internal production capabilities while also utilizing third-party manufacturers to meet growing demand, reflecting a strategic shift toward flexible and scalable supply chain solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57654,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14642,
        "completion_tokens": 220,
        "total_tokens": 14862
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine remained under the Entertainment segment, where it is reported with Content Sales/Licensing. There is no indication of a structural change in its ownership or reporting within Disney’s portfolio during this period. However, its strategic positioning appears to have been reinforced through continued integration with Disney’s broader content and streaming platforms, such as Disney+, where National Geographic is a top-level tile. This suggests a focus on leveraging National Geographic's brand and content to enhance Disney’s direct-to-consumer offerings and global content library.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10864,
        "completion_tokens": 158,
        "total_tokens": 11023
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's description of its transaction management databases' capabilities in 2024 shows an expanded emphasis on supporting global payment processing in different currencies compared to 2023. In 2023, the document noted that PayPal's platform enabled transactions in approximately 150 currencies and allowed customers to hold balances in 24 currencies. By 2024, the description highlights that PayPal's platform supports sending payments in approximately 140 currencies, withdrawing funds to bank accounts in 57 currencies, and holding balances in 24 currencies, indicating a slight reduction in the number of supported payment currencies but an increase in withdrawal currency options. This evolution reflects PayPal's ongoing efforts to enhance its global payment infrastructure and adapt to regulatory and market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53642,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13641,
        "completion_tokens": 206,
        "total_tokens": 13847
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate terms associated with the Series K Debentures increased from an initial issuance in February 2020 to a reset rate of 6.051% per year in March 2023. This indicates that NEE's financing strategy involves leveraging remarketing opportunities to secure more favorable interest rates, reflecting a proactive approach to managing debt costs in a changing interest rate environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 101280,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25546,
        "completion_tokens": 98,
        "total_tokens": 25645
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method between 2022 and 2023 remained consistent in its core approach, with adjustments primarily driven by changes in proved reserves and commodity prices. In 2022, higher realized oil prices ($87.25 per barrel) compared to 2021 ($61.89) likely influenced reserve estimates and, consequently, depreciation rates. In 2023, despite a slight decline in oil prices to $69.85 per barrel, the method continued to rely on proved reserves as the basis for depreciation, with revisions reflecting updated reserve estimates and production data. Notably, the Corporation maintained its disciplined process for reserve estimation and asset depreciation, ensuring equitable cost allocation over the economic life of upstream assets, even as it adapted to evolving market conditions and regulatory environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12332,
        "completion_tokens": 215,
        "total_tokens": 12548
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly scaled its internal studio operations to produce original programming, as highlighted by its acquisitions such as Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and enhance control over content creation. The company is focusing on expanding its in-house capabilities in creative, marketing, and production disciplines to support its growing original content portfolio, which includes TV series, films, games, and live programming.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54993,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13979,
        "completion_tokens": 137,
        "total_tokens": 14116
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved to become a more integral part of its value-added services, emphasizing security and trust in digital transactions. The strategic positioning highlighted the importance of these solutions in preventing, detecting, and responding to fraud, ensuring secure transactions, and leveraging data analytics for insights. This evolution reflects Mastercard's broader focus on enhancing the safety and efficiency of the global payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45403,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11562,
        "completion_tokens": 128,
        "total_tokens": 11690
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved by emphasizing modular design and software optimization to enhance scalability and performance. In 2023, the company highlighted the integration of vehicle technologies into energy storage systems and the development of remote control and dispatch software. By 2024, Tesla expanded on these efforts, focusing on improving manufacturing efficiency and leveraging its expertise in power electronics to optimize grid interconnectivity. However, production challenges such as supply chain constraints and the need for localized procurement at new manufacturing facilities remain significant hurdles. Additionally, Tesla continues to rely on strategic supplier partnerships for key components, exposing it to risks related to component availability and cost volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45884,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11692,
        "completion_tokens": 209,
        "total_tokens": 11902
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "NextEra Energy Capital Holdings (NEECH) significantly expanded its issuance of floating rate debentures from 2023 to 2024. In 2023, NEECH issued $600 million of floating rate debentures due in 2026. By January 31, 2024, this strategy evolved with the issuance of an additional $600 million of floating rate debentures due in 2026, maintaining the same maturity structure but increasing the principal amount by $600 million compared to 2023. This reflects a more aggressive approach to leveraging floating rate instruments in early 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 120731,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 30415,
        "completion_tokens": 134,
        "total_tokens": 30549
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel expanded its collaboration focus and supplier engagement scope in supply chain responsibility initiatives. In 2023, the company emphasized verifying compliance and building supplier capacity to address risks like forced labor and human rights issues, primarily through audits and capability-building programs for critical direct suppliers. By 2024, Intel significantly broadened its engagement to include more suppliers and introduced new initiatives, such as expanding the number of suppliers covered by its programs and increasing efforts to reduce greenhouse gas emissions across the supply chain. Additionally, Intel set new sustainability targets, including linking executive and employee bonuses to water conservation and emissions reduction goals, and furthering collaboration on responsible minerals sourcing and industry-wide standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50032,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12740,
        "completion_tokens": 217,
        "total_tokens": 12957
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's framing of the standardized measure of discounted future cash flows continued to emphasize its limitations, particularly due to the use of first-day-of-the-month average prices. In both years, the company reiterated that this pricing methodology creates significant year-to-year variability and does not reliably reflect expected future cash flows or the value of its reserves. However, in 2023, the discussion became more concise, with no new qualitative changes in the characterization of the assumptions, while maintaining the critique of the standardized measure's reliability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85432,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21611,
        "completion_tokens": 152,
        "total_tokens": 21764
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved significantly by enhancing integration with open banking capabilities and expanding their reach across financial institutions. In 2023, Mastercard launched a new Consumer Fraud Risk solution leveraging AI and real-time payment data to help banks prevent payment scams. Additionally, their open banking platform achieved connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, directly and through partners. These advancements strengthened secure digital transactions and improved customer experiences by enabling seamless data sharing and fraud prevention across a broader network of financial institutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 34516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8858,
        "completion_tokens": 180,
        "total_tokens": 9038
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize improved installation capabilities and collaboration with real estate developers and builders on new homes, as noted in the 2024 filing. In 2023, the product was described as being in the process of enhancing installation efficiency, while by 2024, the focus had shifted toward expanding integration into new residential construction. Strategic dependencies remain on supply chain management for components and collaboration with partners to scale production and installation, with production challenges potentially tied to supplier constraints and the need for localized procurement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45884,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11693,
        "completion_tokens": 168,
        "total_tokens": 11862
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. introduced a Pledge Agreement on September 1, 2022, involving Deutsche Bank Trust Company Americas as Collateral Agent, Custodial Agent, and Securities Intermediary, and The Bank of New York Mellon as Purchase Contract Agent. This was followed by another Pledge Agreement on June 1, 2024, with the same counterparties. These agreements indicate an expansion or continuation of NextEra's structured financial arrangements in 2024 compared to 2023, where no Pledge Agreements were explicitly mentioned.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 102513,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25852,
        "completion_tokens": 130,
        "total_tokens": 25982
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel strengthened its strategic positioning in Edge AI by enhancing its software platform offerings and expanding ecosystem partnerships. In 2023, Intel focused on launching AI-enabled hardware like the 4th Gen Intel Xeon processors and the OpenVINO toolkit version 2023.1, while continuing to collaborate with partners such as Ericsson, Nokia, and Microsoft to drive software-defined edge infrastructure. By 2024, Intel further advanced its edge AI capabilities by introducing the Intel Xeon 6 processors and Intel Gaudi 3 AI accelerators, emphasizing performance and efficiency for edge and cloud workloads. Intel also deepened its ecosystem engagement, working with over 500 network builders and expanding its software platform to support modular, edge-native solutions for diverse industries like healthcare, retail, and smart cities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44305,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11300,
        "completion_tokens": 214,
        "total_tokens": 11515
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting $1.25 billion in aggregate principal amount for these notes. This indicates that the 1.75% senior notes due August 2030 were neither issued, redeemed, nor materially modified during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32197,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8282,
        "completion_tokens": 90,
        "total_tokens": 8372
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan became a more integral part of its pricing strategy and membership growth objectives. In 2023, the plan was introduced as a lower-priced option to attract price-sensitive consumers and expand market reach. By 2024, the company emphasized this plan further as part of its broader strategy to offer a range of pricing options, aiming to meet diverse consumer needs while driving membership growth. The ad-supported tier was positioned to help Netflix retain and attract members, particularly in competitive markets and during periods of economic uncertainty, thereby supporting its global expansion and operating margin goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49573,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12617,
        "completion_tokens": 172,
        "total_tokens": 12789
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Tesla Semi evolved from early production and deliveries in 2023 to entering pilot production in 2024, as outlined in the respective 10-K filings. In 2023, the Semi was mentioned as part of Tesla's planned electric vehicles with early production underway. By 2024, the Semi was specifically listed under pilot production in the Nevada region, indicating progress in manufacturing readiness and strategic positioning to ramp production. This shift reflects Tesla's focus on expanding its commercial vehicle offerings and leveraging its manufacturing capabilities to scale production for broader market deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36489,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9338,
        "completion_tokens": 164,
        "total_tokens": 9502
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024, as evidenced by the addition of new agreements for executives like Nicole J. Daggs and Brian Bolster, suggests a deliberate effort to ensure leadership continuity and reinforce the company's commitment to retaining key executive talent. This strategic emphasis on retention likely reflects the company's recognition of the value of experienced leadership in navigating its long-term goals, including growth initiatives and operational stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 123,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 94375,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23836,
        "completion_tokens": 135,
        "total_tokens": 23971
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and ecosystem expansion. In 2024, the company emphasized the x86 ecosystem and announced the creation of an advisory group to enhance compatibility across platforms and simplify software development. Intel is also prioritizing the development of a broad xPU portfolio, including GPUs, IPUs, FPGAs, and accelerators, to meet diverse computing needs. Additionally, the company is leveraging third-party foundry manufacturing where advantageous, providing flexibility and enabling the delivery of high-performance products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52848,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13431,
        "completion_tokens": 160,
        "total_tokens": 13592
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix's approach to advertising technology has evolved with a focus on developing the necessary infrastructure and expanding its advertising sales organization. In 2023, the company highlighted the nascent stage of its advertising offering and the risks associated with it, such as the need to build technology and infrastructure to support advertising and the development of an advertising sales team. By 2024, Netflix emphasized its efforts to drive value to advertisers through improved technology and infrastructure, indicating progress in scaling its advertising capabilities and enhancing the tools to measure and demonstrate the effectiveness of ads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62686,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15896,
        "completion_tokens": 170,
        "total_tokens": 16067
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging programs remained structured as performance obligations under ASC 606, with revenue recognized over time based on the expected ownership life of the vehicle. In 2024, Tesla continued recognizing revenue for unlimited free Supercharging on a straight-line basis, while limited incentives were based on actual usage or expiration. Notably, Tesla expanded its paid Supercharging revenue, which increased as part of the broader \"Services and Other\" segment, reflecting a potential shift toward monetizing Supercharging for some customers while maintaining free access as a bundled feature for others.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50589,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12870,
        "completion_tokens": 161,
        "total_tokens": 13031
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, with the 2024 issuance featuring a fixed coupon rate of 4.85% and a maturity date of August 15, 2055, compared to the 2023 issuance with a floating rate structure. This shift toward fixed-rate, long-term debt suggests a strategy to lock in favorable interest rates amid potential market volatility and to stabilize long-term financing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 137673,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 34665,
        "completion_tokens": 112,
        "total_tokens": 34778
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's consideration of OPEC investment activities in its impairment assessment framework remained focused on their influence on long-term oil supply dynamics. In both years, the Corporation emphasized that OPEC's investment and production policies impact global oil supply, which, along with declining production from mature fields, is offset by new investments and technological advancements. In 2023, the Corporation explicitly included estimated costs related to its 2030 greenhouse gas emission-reduction goals in its cash flow assessments, reflecting a more detailed integration of regulatory and environmental factors into impairment evaluations. However, the core framework continued to rely on long-term supply-demand fundamentals and OPEC's role in shaping oil market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41352,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10569,
        "completion_tokens": 203,
        "total_tokens": 10772
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan shows a notable shift in strategic emphasis from 2023 to 2024. In the 2023 filing, the ad-supported plan is mentioned in the context of pricing strategies and potential consumer adoption challenges, but with limited detail on its role in the broader business strategy. By 2024, the plan is explicitly highlighted as part of Netflix's core strategy to \"offer a range of pricing plans, including our ad-supported subscription plan, to meet a variety of consumer needs,\" indicating a more deliberate and prominent integration into the company's growth and operational goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40209,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10277,
        "completion_tokens": 157,
        "total_tokens": 10434
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers evolved between 2022 and 2024 by maintaining a strategic focus on price competitiveness and fulfillment efficiency. In 2022, shipping costs were driven by increased investments in the fulfillment network, labor, and carrier rates, partially offset by inefficiencies from supply chain constraints. By 2024, Amazon achieved fulfillment network efficiencies, including lower transportation costs, which helped reduce the growth rate of shipping costs. The company continued to leverage fast shipping offers as a key driver of customer demand while emphasizing operational improvements to mitigate expenses and enhance scalability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48406,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12326,
        "completion_tokens": 166,
        "total_tokens": 12492
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. In terms of asset allocation, the target allocation for the RCBP assets remained at 35% liability hedging and 65% return-seeking assets, while the DELPP assets shifted to 80% liability hedging and 20% return-seeking assets in 2024. Additionally, the actual allocations for the RCBP and DELPP assets showed minor adjustments, with the RCBP assets slightly deviating from the target in global equity and real estate and cash categories. The fair value measurements for the Master Retirement Trust also indicated a decrease in total assets from $7,241 million in 2023 to $6,969 million in 2024, reflecting changes in the valuation of equity and debt securities. Disclosure practices remained consistent, with detailed breakdowns of asset allocations and fair value measurements provided for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 218,
          "pages": [
            216,
            217,
            218,
            219,
            220
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66419,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16835,
        "completion_tokens": 240,
        "total_tokens": 17075
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Based on the information provided, Google's financial relationship with Google Network Partners between 2022 and 2024 has shown an increase in revenues, with Google Network revenues rising from $23,090 million in 2022 to $31,701 million in 2023 and further to $31,701 million in 2024. The cost structure related to these partners, primarily through Traffic Acquisition Costs (TAC), has remained a significant portion of the cost of revenues for ads placed on Google Network properties, indicating that payment obligations to these partners have continued to be substantial relative to the revenues generated from these properties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44347,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11313,
        "completion_tokens": 157,
        "total_tokens": 11471
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of offsetting swap positions, particularly in terms of fair value changes and settlements, showed a significant shift. In 2022, the company reported a loss of $69 million related to foreign currency exchange contracts not designated as hedges, recognized in investment income and other. In contrast, 2023 saw a much smaller loss of $7 million in the same category. This indicates a substantial reduction in the negative impact of non-hedge derivative settlements and fair value changes in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 38518,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9865,
        "completion_tokens": 138,
        "total_tokens": 10004
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 indicates a shift in the company's director compensation strategy toward emphasizing deferred compensation mechanisms. This suggests a potential focus on aligning director incentives with long-term shareholder value and enhancing retention through deferral options tied to company stock performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 245,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 113278,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 28550,
        "completion_tokens": 101,
        "total_tokens": 28651
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by increasingly focusing on differentiation through premium services, digital innovation, and enhanced customer experiences to counter competitive pressures and shifting consumer behaviors. In 2022, the company emphasized adapting to post-pandemic spending patterns and addressing challenges from alternative payment methods, while in 2024, it highlighted strategic investments in digital capabilities, expanding its premium dining and travel offerings, and deepening partnerships to deliver personalized and compelling value to Card Members. These efforts reflect a shift toward leveraging data-driven insights and expanding its ecosystem to meet the evolving needs of both consumers and businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13164,
        "completion_tokens": 199,
        "total_tokens": 13363
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing composition remained relatively stable, with a focus on maintaining low-interest, long-dated notes. In both years, the Corporation listed similar long-term notes, including the 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, all traded on the New York Stock Exchange. However, in 2024, the 0.142% Notes due 2024 listed in 2022 were no longer included, suggesting their maturity or retirement. The overall approach reflects a strategy of managing long-term debt with low-yield, extended maturity instruments to support financial flexibility and reduce refinancing risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12386,
        "completion_tokens": 163,
        "total_tokens": 12550
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has increasingly emphasized differentiating its corporate card and accounts payable expense management solutions by evolving its value propositions and introducing innovative features such as financing and payment solutions tailored for business customers. The strategic focus has shifted toward strengthening its global, integrated network to expand merchant acceptance and enhance services for partners, while also leveraging data analytics and fraud prevention tools to provide unique value to merchants and business clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30535,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7857,
        "completion_tokens": 142,
        "total_tokens": 7999
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Between 2022 and 2024, Amazon's financial relationship with AWS Services has shown significant evolution, particularly in cash flow generation and strategic emphasis. AWS demonstrated strong growth, with net sales increasing from $90,757 million in 2023 to $107,556 million in 2024, representing a 19% year-over-year growth in 2024. This growth contributed to AWS becoming a more prominent segment, accounting for 17% of Amazon's consolidated net sales in 2024. Additionally, AWS played a central role in Amazon's capital expenditures, with a significant portion of the $77.7 billion in 2024 cash capital expenditures supporting AWS infrastructure, underscoring its strategic importance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56502,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14348,
        "completion_tokens": 171,
        "total_tokens": 14520
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used to evaluate the historical consistency of regulatory asset balances expanded to include a more detailed assessment of regulatory recoverability for specific costs, such as coal ash-related asset retirement obligations and estimated storm costs. In 2023, trend analyses were used to evaluate historical consistency, while in 2024, they were combined with comparisons to independently developed expectations and analyses of commission-approved amortization and regulatory orders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54717,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13901,
        "completion_tokens": 135,
        "total_tokens": 14037
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco's strategy regarding the penetration of private-label items evolved in response to cost and pricing pressures by increasing their use as part of broader merchandising and pricing adjustments. In 2022, Costco mentioned increasing the penetration of private-label items to adapt to competition and cost increases. By 2023, this strategy continued as part of efforts to maintain competitive pricing and manage gross margins, particularly in the face of inflation and supply chain challenges. The focus remained on leveraging private-label items to provide value to members while mitigating the impact of rising merchandise costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82947,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20957,
        "completion_tokens": 164,
        "total_tokens": 21121
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly declined between 2023 and 2024. In 2023, Paxlovid contributed $1,279 million in revenues, a sharp drop from $18,933 million in 2022. By 2024, Paxlovid revenues further declined to $5,716 million. Additionally, remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, down from $5.1 billion in 2023, reflecting reduced future commitments and a transition to commercial market sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 98647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 24877,
        "completion_tokens": 116,
        "total_tokens": 24993
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a consistent approach to estimating credit loss reserves by incorporating historical loss experience and current and future economic conditions over a Reasonable and Supportable (R&S) Period. However, the 2024 disclosures indicate a more nuanced and data-driven evolution in the company's assumptions, particularly in how it models the probability of default, exposure at default, and incorporates economic forecasts. The increased emphasis on qualitative reserves to address model limitations and external factors suggests a more cautious and comprehensive approach to financial risk management, reflecting a proactive stance in navigating economic uncertainties and ensuring robust credit loss provisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42068,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10763,
        "completion_tokens": 190,
        "total_tokens": 10954
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy in 2020, as indicated in the 2022 10-K under Exhibit 4.6. By 2024, Amazon had not issued any new notes with similar low coupon rates, as reflected in the 2024 10-K's exhibits. Instead, Amazon's debt offerings in 2024 featured higher coupon rates, such as the 4.600% Note due 2025 (Exhibit 4.8), suggesting a shift in financing strategy likely due to rising interest rates during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44928,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11448,
        "completion_tokens": 117,
        "total_tokens": 11566
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated May 15, 2020, is consistently referenced in both the 2022 and 2024 SEC filings, indicating its ongoing relevance as part of the company's series of indentures. The lack of any new or updated references to it in the 2024 filing suggests that it has not been amended or superseded and remains in effect as a material contractual obligation. This continuity highlights its continued importance in the company's debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 249,
          "pages": [
            247,
            248,
            249,
            250,
            251
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 252,
          "pages": [
            250,
            251,
            252,
            253,
            254
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 78228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19791,
        "completion_tokens": 117,
        "total_tokens": 19909
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the repurchase activity for Class C Capital Stock evolved as follows:\n\n- In 2022, 450 million shares of Class C stock were repurchased for a total value of $52,868 million.\n- In 2023, 306 million shares of Class C stock were repurchased for a total value of $50,192 million.\n- In 2024, 306 million shares of Class C stock were repurchased for a total value of $50,192 million.\n\nThe total value of shares repurchased in each year was $52,868 million in 2022, $50,192 million in 2023, and $50,192 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58465,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14838,
        "completion_tokens": 132,
        "total_tokens": 14970
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was amended in the 2024 SEC filing with the addition of a new exhibit, \"10.16,\" titled \"Amendments of (i) the American Express Salary/Bonus Deferral Plan and (ii) the American Express Key Executive Life Insurance Plan,\" incorporated by reference from the 1997 filing. This suggests that while the plan itself was originally documented in 1988, a significant amendment affecting both the Salary/Bonus Deferral Plan and the Key Executive Life Insurance Plan occurred in 1997, and this amendment was newly referenced in the 2024 filing, indicating updated disclosure or emphasis on these changes. No specific new amendments to the plan were listed in the 2024 filing beyond this reference.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 165,
          "pages": [
            163,
            164,
            165,
            166,
            167
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 171,
          "pages": [
            169,
            170,
            171,
            172,
            173
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42507,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10851,
        "completion_tokens": 185,
        "total_tokens": 11037
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps decreased significantly between 2022 and 2024. In 2022, the balance sheet liability for interest rate swaps was $34.0 million, classified under other long-term liabilities, while in 2024, this liability was reduced to $19.2 million, still under other long-term liabilities. Additionally, the magnitude of outstanding interest rate swaps dropped from $1,100 million in 2022 to $350 million in 2024, indicating a reduction in both the liability and the overall exposure to these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18732,
        "completion_tokens": 133,
        "total_tokens": 18865
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "The Directors' Savings Plan has remained a deferral mechanism for director compensation, allowing outside directors to defer all or a portion of their annual compensation, typically in the form of retainers. Between 2022 and 2024, there is no indication of significant structural changes to the plan, as it continued to function as an unfunded account where deferred amounts were adjusted based on phantom investment options, including the Duke Energy Common Stock Fund. This consistency suggests that Duke Energy maintains a stable and transparent governance approach, emphasizing flexibility and alignment with long-term shareholder interests through deferral and investment choices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 258,
          "pages": [
            256,
            257,
            258,
            259,
            260
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 72435,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18345,
        "completion_tokens": 171,
        "total_tokens": 18516
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has continued to evolve as a key differentiator in its product offerings, emphasizing high-quality private-label merchandise at competitive prices. The brand remains central to Costco's strategy to offer value to members while achieving higher profit margins. There is no explicit mention of a significant shift in the risk profile of Kirkland Signature during this period, but the brand's reliance on maintaining quality standards and member demand remains a critical factor. Risks associated with supply chain disruptions, quality control, and competition persist, as Costco continues to expand the sales penetration of Kirkland Signature products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44880,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11433,
        "completion_tokens": 176,
        "total_tokens": 11609
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 BCF at the end of 2022 to 296 BCF at the end of 2024. Key changes included upward revisions in 2024 due to technical improvements and development plans, partially offset by downward adjustments from lower prices and operating costs. Additionally, extensions and discoveries in equity affiliates, primarily in the Middle East, contributed to reserve additions during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 167,
          "pages": [
            165,
            166,
            167,
            168,
            169
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 79039,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19989,
        "completion_tokens": 115,
        "total_tokens": 20105
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has shifted toward modernization and fleet optimization. As of 2022, FedEx Express owned 114 Boeing 767F aircraft with no leased units. However, by 2024, FedEx had significantly reduced its commitment to the 767F, with only 14 units scheduled for delivery in 2025 and no deliveries planned beyond 2026. This reflects a strategic focus on newer, more fuel-efficient aircraft like the Boeing 777F, which aligns with FedEx's modernization efforts to enhance operational efficiency and reduce long-term costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10376,
        "completion_tokens": 145,
        "total_tokens": 10521
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' involvement with roasted coffee showed an increase in inventory value, with roasted coffee inventory valued at $310.3 million in 2022 and growing to $430.9 million in 2024. In terms of production infrastructure, Starbucks maintained and expanded its roasting facilities, including significant roasting, warehousing, and distribution centers in locations such as York, PA; Minden, NV; Kunshan, China; and Kent, WA, indicating continued investment in its production capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42567,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10859,
        "completion_tokens": 126,
        "total_tokens": 10986
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the notes were referenced as part of the broader list of authorized debt instruments, with no specific changes or new issuances noted for the 2.750% Senior Notes due 2025 in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16636,
        "completion_tokens": 83,
        "total_tokens": 16719
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2022 to 2024, with deliveries dropping from 8 aircraft planned through 2026 in 2022 to only 2 aircraft planned by 2026 in 2024. This reduction indicates a diminished strategic role for the B777F in FedEx's fleet modernization plans, with a shift toward other aircraft types like the B767F and regional freighters such as the Cessna SkyCourier 408 and ATR 72-600F for long-term efficiency and operational needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10081,
        "completion_tokens": 118,
        "total_tokens": 10199
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolved as follows: in 2022, the net gains included in AOCI were $55.3 million, expected to reclassify $32.5 million within 12 months; by 2024, the net gains included in AOCI were $11.5 million, with $9.5 million expected to reclassify within 12 months. This decline suggests reduced exposure to foreign currency fluctuations over the period, indicating either a decrease in hedged positions or more stable currency conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65781,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16689,
        "completion_tokens": 140,
        "total_tokens": 16829
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 is reflected in broader debt instrument disclosures that show increased activity between 2023 and 2024. In 2023, PepsiCo disclosed the 4.550% Senior Notes due 2026 and the 5.125% Senior Notes due 2026, both issued in February and November 2023, respectively. By 2024, the disclosures expanded to include additional senior notes due in 2026, such as the 4.500% Senior Notes due 2026 and the 2.850% Senior Notes due 2026, indicating a more diversified set of instruments and ongoing management of its debt portfolio for this maturity year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16636,
        "completion_tokens": 149,
        "total_tokens": 16785
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 has increased, particularly as the company has intensified strategic investments in key priority areas such as AI, cloud, cybersecurity, and observability. In 2022, the focus was on adapting to market transitions like network programmability and SDN, while by 2024, the emphasis had expanded to include the integration of acquired technologies (e.g., Splunk) and the development of more complex, software-driven solutions. This evolution reflects a growing reliance on timely product development and innovation to maintain competitiveness, with heightened risks from technical challenges and the need to align with rapidly changing customer needs and industry standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 55469,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14098,
        "completion_tokens": 188,
        "total_tokens": 14287
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided information, Google Ad Manager's role in driving Google Network revenues remained a key contributor between 2022 and 2023. In 2022, Google Network revenues increased due to strength in AdMob, Google Ad Manager, and AdSense. In 2023, while specific figures for Google Network are not provided, Google Ad Manager continued to be highlighted as a core advertising platform used by customers to purchase advertising inventory, indicating its sustained importance in the revenue-driving ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44851,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11444,
        "completion_tokens": 128,
        "total_tokens": 11573
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other decreased from $0.3 million as of October 2, 2022, to $4.7 million as of September 29, 2024. The magnitude of the change was an increase of $4.4 million over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74021,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18725,
        "completion_tokens": 62,
        "total_tokens": 18787
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "In 2023, PepsiCo's 4.600% Senior Notes due 2045 were authorized as part of broader debt offerings, as noted in resolutions referenced in the 2023 filing. By 2024, the 4.600% Senior Notes due 2045 were explicitly issued, as detailed in the 2024 filing. This evolution indicates PepsiCo's strategy to extend its debt maturity profile and access long-term capital at favorable rates, aligning with its objective of maintaining a balanced and flexible capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16637,
        "completion_tokens": 116,
        "total_tokens": 16753
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region has shown a decline in proved reserves, from 764 BCF at the end of 2021 to 296 BCF at the end of 2024, with significant downward revisions in 2023 due to infrastructure constraints, lower prices, and technical adjustments. This trend suggests a reduced strategic focus on natural gas development in the region, as COP has shifted capital and exploration efforts toward its core U.S. assets, particularly in the Permian Basin. The company's emphasis on unconventional plays in the Lower 48 and its acquisition of Marathon Oil further indicate a realignment of priorities away from the Asia Pacific/Middle East natural gas segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 173,
          "pages": [
            171,
            172,
            173,
            174,
            175
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74215,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18783,
        "completion_tokens": 173,
        "total_tokens": 18957
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy has remained consistent as a key contributor, generating revenue primarily from the sales of apps and in-app purchases. However, in 2023, it is explicitly categorized under \"platforms\" as part of Google Services' non-advertising revenue streams, alongside consumer subscriptions (e.g., YouTube Premium) and device sales. This reflects a broader emphasis on diversifying non-advertising revenue sources, with Google Play continuing to play a central role in monetizing digital content and app ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49057,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12487,
        "completion_tokens": 146,
        "total_tokens": 12634
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, the projected utilization of the Cessna SkyCourier 408 by FedEx shifted from planned deliveries in 2023 and 2024 to being fully scheduled for 2025 and beyond. In 2022, 11 deliveries were planned for 2023 and 12 for 2024, but by 2024, all 31 planned deliveries were deferred to 2025 and later. This delay indicates a reduced immediate strategic reliance on the Cessna SkyCourier 408, suggesting FedEx may have shifted focus to other aircraft or adjusted its fleet modernization priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10087,
        "completion_tokens": 126,
        "total_tokens": 10213
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods for U.S. Excess Casualty has evolved by refining segmentation and analyzing more specific casualty lines. In 2022, the analysis focused on standard claims segmented by attachment point bands and included separate evaluations for automobile-related claims (shorter tail) and non-automobile claims, with further segmentation for latent exposures like construction defects and mass torts. By 2023, AIG continued this approach but emphasized higher attachment points in accident years, reflecting strategic changes in layer participations. Additionally, the 2023 methodology incorporated adjustments for external factors like the impact of the underwriting cycle and judicial trends, while maintaining a focus on recent accident years where credibility of reported losses remains low.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 260295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 65300,
        "completion_tokens": 211,
        "total_tokens": 65511
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the company's ongoing strategic adjustments. In 2022, the \"Others\" category included products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand, as well as certain adjustments not allocated to consumer-designated products. By 2024, the \"Others\" category retained a similar definition but showed a 6% increase in revenue contribution compared to the prior year, indicating a shift in how unallocated products were recognized or categorized. Additionally, the continued rollout of Nike's new Enterprise Resource Planning Platform in 2024 signaled a transition away from non-GAAP metrics like wholesale equivalent revenues, suggesting a potential future shift in how such unallocated or internal sales are reported.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11045,
        "completion_tokens": 213,
        "total_tokens": 11258
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued a 5.250% Senior Note due 2025 in November 2023 and later, in 2024, authorized a 3.500% Senior Note due 2025 as part of broader debt offerings. This evolution indicates that PepsiCo is actively managing its debt portfolio by diversifying maturities and interest rates, likely to optimize borrowing costs and manage refinancing risks as the 2025 maturity approaches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16638,
        "completion_tokens": 100,
        "total_tokens": 16738
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, ConocoPhillips (COP) significantly increased capital expenditures in the Lower 48 region, rising from $3,129 million in 2022 to $29,952 million in 2024, driven by major investments in exploration and development. Additionally, future cash inflow revisions for the Lower 48 reflected higher estimated revenues in 2024 ($164,264 million) compared to 2022 ($195,605 million), though this was partially offset by increased production and development costs, indicating a shift in economic conditions and operational strategies over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60167,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15272,
        "completion_tokens": 140,
        "total_tokens": 15412
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group remained largely consistent, with no significant changes in capital obligations or control structures. Comcast maintained its role as the sole third-party investor in Atairos, with a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. The governance structure remained unchanged, with Atairos controlled by management companies led by Comcast's former CFO, who holds all voting rights. Comcast's economic interest continued to absorb approximately 99% of potential losses and entitled it to 86% of residual returns. No new amendments or material changes to the arrangement were disclosed in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14519,
        "completion_tokens": 181,
        "total_tokens": 14700
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased significantly between 2022 and 2023 filings. In 2022, FedEx had committed to purchasing 49 Cessna SkyCourier 408 aircraft across 2023 to 2026, but by 2023, this number was reduced to just 31 aircraft scheduled for delivery in 2025. This reduction indicates a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F, B767F, and B777F, which retained more consistent delivery commitments. The shift suggests that FedEx may be prioritizing larger, more fuel-efficient freight aircraft over smaller regional aircraft like the Cessna SkyCourier 408 for its long-term fleet strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10187,
        "completion_tokens": 178,
        "total_tokens": 10366
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike's approach to the Air Max product line from 2022 to 2024 shows increased emphasis on technological innovation, particularly in integrating new cushioning technologies and expanding product applications. While 2022 documents primarily focus on revenue transparency through detailed geographic and product line revenue breakdowns, the 2024 documents highlight a stronger focus on innovation, mentioning technologies like Air-Sole and the expansion of cushioning components across footwear categories. Additionally, Nike's 2024 disclosures reflect a broader strategic emphasis on leveraging technologies to enhance performance and consumer experiences, indicating a shift toward innovation-driven growth for the Air Max line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56457,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14337,
        "completion_tokens": 181,
        "total_tokens": 14519
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy for Epic Universe evolved from 2023 to 2024 by shifting focus from land acquisition to active construction. In 2023, capital expenditures for theme parks included the acquisition of land for potential expansion opportunities, while in 2024, spending on theme park attractions increased, specifically including costs associated with the construction of Epic Universe in Orlando. This indicates a progression from planning and site preparation in 2023 to active development and construction in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10591,
        "completion_tokens": 134,
        "total_tokens": 10725
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft evolved as reflected in their fleet projections. In 2022, FedEx had 6 ATR 72-600F aircraft in its fleet, and the company had committed to purchasing 24 ATR 72-600F aircraft by 2026. By 2023, FedEx had increased its commitment, with a total of 10 ATR 72-600F aircraft planned for purchase by 2026, indicating a strategic shift to incorporate more of these aircraft into its fleet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10177,
        "completion_tokens": 112,
        "total_tokens": 10289
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, as it continued to base estimates on historical rates, specific identification of outstanding returns, and expectations for future returns. However, the data shows a decline in the sales-related reserve balance from $1,077 million in 2021 to $1,015 million in 2022, and further to $965 million in 2024. This reduction suggests improved confidence in return predictability or a decrease in return rates, indicating a potential refinement in revenue recognition practices, such as more accurate forecasting or tighter control over return authorizations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13631,
        "completion_tokens": 170,
        "total_tokens": 13801
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "Between 2022 and 2023, the planned fleet composition of the Cessna SkyCourier 408 increased for the years 2025 and beyond. In 2022, FedEx planned to deliver 12 units in 2025, but by 2023, this number rose to 17 units for 2025. This increase indicates a growing strategic reliance on the Cessna SkyCourier 408 model to support FedEx's operations, likely for regional or cargo transport needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10072,
        "completion_tokens": 97,
        "total_tokens": 10170
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing operational scale, implementing real-time payments infrastructure in 13 markets as of December 31, 2023, and enhancing integrated security capabilities through multi-layered protections, including fraud scoring and tokenization services. The infrastructure supports instant payments with enhanced data and messaging capabilities, enabling secure, direct account-to-account transactions for consumers, businesses, and governments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13808,
        "completion_tokens": 133,
        "total_tokens": 13941
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options evolved in terms of both financial liabilities and hedging strategy. In 2022, the total notional amount of outstanding foreign currency derivatives designated as cash flow hedges was $18.5 billion, with $607 million of deferred net gains expected to be reclassified to net income within 12 months. By 2024, the notional amount of these hedges had decreased to $16.2 billion, and the deferred net gains expected to be reclassified were reduced to $231 million. Additionally, undesignated derivative instruments increased from $3 billion in 2022 to $4.4 billion in 2024, indicating a shift in strategy to more directly manage specific balance sheet exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65162,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16518,
        "completion_tokens": 183,
        "total_tokens": 16701
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, the product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent. In both years, Puffs was listed under the \"Family Care\" sub-category, which includes products like paper towels, tissues, and toilet paper. Specifically, in 2022, Puffs was mentioned alongside \"Paper Towels, Tissues, Toilet Paper,\" and in 2023, it was similarly grouped under \"Family Care (Paper Towels, Tissues, Toilet Paper).\" There was no reclassification or change in its placement within the segment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12926,
        "completion_tokens": 140,
        "total_tokens": 13066
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax's categorization within P&G's product portfolio remained consistent as part of the \"Feminine Care\" sub-category under the \"Baby, Feminine & Family Care\" segment. In both years, Tampax was grouped with other feminine care brands like Always and Always Discreet. However, in 2023, the document provided a more specific breakdown, noting that Tampax is part of the \"menstrual care\" sub-category, with the segment reporting over 25% global market share in this area. There was no indication of any repositioning or rebranding of Tampax during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12936,
        "completion_tokens": 145,
        "total_tokens": 13081
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's strategy for Oracle Engineered Systems, part of its hardware business, continued to emphasize cloud-based infrastructure technologies and strategic hardware offerings, while de-emphasizing nonstrategic hardware products. This shift is reflected in the decline in hardware revenues, which decreased by 5% in fiscal 2022 and remained at 6% of total revenues in fiscal 2023. Oracle expects to continue investing in research and development for its hardware business to improve existing products and develop new offerings, though the focus remains on cloud services. Research investment expectations for fiscal 2023 align with Oracle's broader strategy of expanding cloud capacity and geographic footprint, with ongoing investments in cloud operations and infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53432,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13592,
        "completion_tokens": 203,
        "total_tokens": 13795
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans saw a shift in their investment in private funds. In 2022, the fair value of private funds was $36 million, classified as $54 million in Level 2 and $36 million in Level 3 of the fair value hierarchy. By 2023, the total investment in private funds increased to $74 million, with $41 million in Level 2 and $74 million in Level 3. This indicates a reallocation and growth in private fund investments, primarily within Level 3, reflecting changes in valuation and investment strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57599,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14636,
        "completion_tokens": 135,
        "total_tokens": 14771
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which were $1 billion principal amount 3.375% Senior Notes due April 2024, matured in April 2024 and were fully paid off. This marked the resolution of this debt obligation, with no remaining balance outstanding as of December 31, 2024. No specific actions were taken in 2024 regarding refinancing or restructuring of this debt, as it was fully repaid upon maturity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50931,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12954,
        "completion_tokens": 96,
        "total_tokens": 13050
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "The treatment and documentation of Lowe's Officer Indemnification Agreements remained consistent between 2022 and 2024, as evidenced by the inclusion of the \"Form of Lowe's Companies, Inc. Officer Indemnification Agreement\" in both years’ filings (10.23 in 2022 and 10.23 in 2024). This continuity suggests that Lowe's has maintained a stable executive risk management framework, ensuring consistent legal protections for its officers. The unchanged documentation reflects governance continuity and a commitment to safeguarding executives against potential legal risks, reinforcing the company's structured approach to executive compensation and liability management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9377,
        "completion_tokens": 166,
        "total_tokens": 9544
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "In the 2022 filing, Always Discreet was noted to have over 10% market share in key markets within the adult incontinence category. By 2023, the market share of Always Discreet in the adult incontinence category increased to about 15% in the markets where Procter & Gamble competes. This indicates an improvement in market share and a stronger category positioning for Always Discreet between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12935,
        "completion_tokens": 101,
        "total_tokens": 13036
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023, Oracle's strategic positioning of Engineered Systems evolved to further integrate them into its cloud transformation narrative. Engineered Systems, such as Oracle Exadata, are increasingly offered as cloud services within OCI, either as public cloud offerings, through Oracle Cloud@Customer, or as Dedicated Region Cloud@Customer solutions. This shift emphasizes Oracle's hybrid and multi-cloud strategy, allowing customers to deploy these systems in on-premise or distributed environments while still leveraging cloud automation and management. This evolution supports Oracle's broader cloud transformation by enabling customers to migrate workloads to the Oracle Cloud seamlessly and by reinforcing Oracle's differentiated infrastructure capabilities in performance, security, and scalability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47427,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12095,
        "completion_tokens": 204,
        "total_tokens": 12300
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 10-K filing, the 2020 Stock Plan is described as the successor to the 2011 Stock Plan, with shares available under the 2011 Plan being rolled into the 2020 Plan. By the 2023 10-K filing, the 2011 Stock Plan is no longer explicitly mentioned, and the 2020 Stock Plan is presented as the active plan, with no reference to a successor relationship. This indicates a simplification in the disclosure, focusing solely on the 2020 Stock Plan as the current vehicle for equity awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11482,
        "completion_tokens": 122,
        "total_tokens": 11604
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Between 2022 and 2023, Honeywell's allocation strategy toward private funds within its U.S. pension plans shows a slight decrease in the value of direct private investments, from $1,284 million in 2022 to $1,293 million in 2023, while real estate properties increased slightly from $1,005 million to $977 million. For non-U.S. plans, private fund investments decreased significantly from $90 million in 2022 to $74 million in 2023. This suggests a more conservative capital deployment approach, potentially prioritizing liquidity and stability over high-risk, long-term private investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15793,
        "completion_tokens": 147,
        "total_tokens": 15941
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock transitioned from being non-outstanding to becoming a newly issued class. In 2023, no shares of Class B-2 Common Stock were outstanding, as indicated by the note that \"no shares of class B-2 common stock were outstanding prior to the class B-1 common stock exchange offer.\" However, in 2024, following the Class B-1 Common Stock Exchange Offer on May 6, 2024, Visa issued approximately 120 million shares of Class B-2 Common Stock in exchange for 241 million shares of Class B-1 Common Stock. This issuance marked the first time Class B-2 Common Stock was outstanding. The Class B-2 shares are subject to conversion rate adjustments that have double the impact compared to Class B-1 shares, and they retain transfer restrictions until the resolution of U.S. covered litigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65336,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16561,
        "completion_tokens": 205,
        "total_tokens": 16766
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, as deferred revenue related to the program dropped from $89 million in 2022 to $19 million in 2024. This decline suggests that the program's structure or customer participation evolved, potentially shifting from a model with higher deferred obligations to one where rewards or benefits are recognized more immediately, or that the program's scale or complexity was streamlined over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10666,
        "completion_tokens": 124,
        "total_tokens": 10790
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $1,111 million as of December 31, 2022, to $996 million as of December 31, 2023. This decline in fair value suggests that market conditions, such as rising interest rates or increased risk perception, may have led investors to demand higher returns for holding Netflix's debt, resulting in a lower valuation of the notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11261,
        "completion_tokens": 96,
        "total_tokens": 11357
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock evolved through a May 2024 exchange offer, where 241 million shares of Class B-1 common stock were tendered, resulting in the issuance of 48 million shares of Class C common stock. This exchange offer reflects a strategic shift in equity classification, converting a portion of Class B-1 shares into Class C shares. Additionally, as of September 30, 2024, 10 shares of Class C common stock were issued and outstanding, consistent with the prior year. The Class C shares continue to represent a distinct class with different voting and conversion rights compared to Class A and B shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58585,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14868,
        "completion_tokens": 165,
        "total_tokens": 15034
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing from 2022 to 2024 has remained consistent in terms of business classification, as it is categorized under the \"Building Products\" division, which includes product categories like Building Materials, Electrical, Lighting, Lumber, Millwork, and Rough Plumbing. In terms of service offerings, Rough Plumbing is included in Lowe's installed sales model, where installation services are provided through independent contractors, and it is also covered under Lowe's Protection Plans, which offer extended protection and repair services for products, including Rough Plumbing. There is no indication of significant changes in classification or service offerings during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45910,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11697,
        "completion_tokens": 178,
        "total_tokens": 11875
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "Between 2023 and 2024, the introduction and evolution of Class B-2 common stock reflect a structural shift in Visa's capital structure. In January 2024, Visa implemented an exchange offer that redenominated existing Class B common stock as Class B-1 and authorized new Class B-2 common stock, which would be issued in future exchange offers. By May 2024, Visa executed the first such exchange, issuing 120 million shares of Class B-2 common stock in exchange for 241 million shares of Class B-1 common stock. This indicates that Class B-2 stock is part of a tiered structure designed to manage transfer restrictions and conversion rates, particularly in relation to litigation settlements. Its creation and issuance suggest a strategic approach to gradually release restricted shares into the market while maintaining control over conversion dynamics and capital flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67872,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17196,
        "completion_tokens": 218,
        "total_tokens": 17415
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased significantly from $117 million in 2024 to $19 million in 2022. This reduction in deferred revenue suggests that Target has been effectively recognizing and fulfilling its obligations related to the program, potentially indicating growth and increased engagement with members, as well as efficient management of program-related commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34298,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8800,
        "completion_tokens": 104,
        "total_tokens": 8904
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits and their regulatory impact on operations and customer data center expansion evolved between 2023 and 2024, as outlined in the provided documents. In 2023, NVDA acknowledged that new or proposed regulations related to pollution limits could result in increased direct costs, such as changes to manufacturing processes, capital expenditures for facility improvements, and higher compliance and energy costs to reduce emissions. These regulations could also indirectly affect NVDA by increasing costs from suppliers or customers passing along compliance expenses. \n\nBy 2024, the concern had expanded to include the potential for stricter pollution limits to impact the availability of energy and water, which are critical for data center operations. Specifically, power or water shortages or regulatory constraints on their availability could impair customers' ability to expand their data center capacity and consume NVDA's products and services. This highlights a growing awareness of how pollution-related regulations and resource availability could directly affect both NVDA's operations and its customers' expansion plans in the data center market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16438,
        "completion_tokens": 301,
        "total_tokens": 16740
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, Costco's Guaranteed Senior Notes, issued by its Japanese subsidiary, evolved as follows: In November 2023, four Guaranteed Senior Notes totaling $500 were issued, with fixed interest rates ranging from 1.400% to 2.120% and maturities from 2033 to 2043. These notes were valued using Level 3 inputs. In July 2024, $77 of these Guaranteed Senior Notes were repaid, reducing the outstanding balance. No further issuance or repayment of these specific Guaranteed Senior Notes is noted for the remainder of the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31494,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8102,
        "completion_tokens": 134,
        "total_tokens": 8236
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as evidenced by higher personnel-related costs in technology and development, as well as cybersecurity measures. In 2022, the company noted a $384 million rise in technology and development expenses due to headcount growth to support streaming service improvements. By 2024, the cybersecurity risk exposure was managed through an enterprise-wide information security program, including dedicated leadership (e.g., the Vice President of Security and Privacy Engineering), regular risk assessments, and third-party security programs. These measures reflect a strategic evolution in both personnel investment and proactive cybersecurity risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58423,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14842,
        "completion_tokens": 184,
        "total_tokens": 15026
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its Restricted Stock Unit (RSU) agreements, as evidenced by the filing of the 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.29 in the 2024 filing). This suggests a continued evolution in the lifecycle management of these equity instruments, potentially reflecting adjustments to align with executive compensation strategy, regulatory requirements, or shareholder expectations. While specific terms of the 2024 RSU agreement are not detailed in the provided pages, the filing indicates a structured approach to managing equity compensation, reinforcing the company's focus on long-term incentives and executive retention.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44759,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11441,
        "completion_tokens": 175,
        "total_tokens": 11617
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes were issued in November 2023 with a maturity date of April 15, 2029. As of January 28, 2024, the carrying amount of these notes was $743 million. By February 2, 2025, the carrying amount had increased to $744 million, reflecting the amortization of the initial discount. The maturity timeline remains unchanged, with the notes maturing in fiscal 2029.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13275,
        "completion_tokens": 93,
        "total_tokens": 13369
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturity dates from 2033 to 2043. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes, indicating a partial repayment of the issued debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33259,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8530,
        "completion_tokens": 86,
        "total_tokens": 8616
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "From 2022 to 2023, the risk associated with competitors developing after-market parts for DHR's products remained a concern but was not explicitly highlighted as a material change in the 10-K filings. In both years, the risk was mentioned in the context of competitive pressures and potential impacts on sales, with no significant evolution in terms of its direct impact on DHR's business or financial statements. The 2023 filing did emphasize broader competitive challenges, including pricing pressures and the introduction of low-cost alternatives, but no specific escalation in after-market parts risk was noted.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45313,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 153,
        "total_tokens": 11718
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved by introducing a lower-priced ad-supported subscription plan and increasing enforcement of terms of use to limit multi-household usage and shared viewing outside of a household. These changes were intended to address business challenges such as retaining members, managing costs, and improving revenue per membership. Additionally, the company aimed to sustain growth by expanding its content offerings, including games and live programming, to provide added value and differentiate its service in a competitive market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14825,
        "completion_tokens": 143,
        "total_tokens": 14968
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased risk exposure and financial recognition due to the long-term performance obligations tied to satellite contracts. In 2023, the company explicitly highlighted that in-orbit incentive payments are recognized as revenue during the construction period based on the net present value of expected fees, but these payments remain at risk if satellites fail to meet performance criteria for up to 15 years post-acceptance. This reflects a more conservative financial recognition approach compared to 2022, where such specifics were not as clearly outlined, and emphasizes heightened exposure to potential refunds and charges if performance issues arise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 31868,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8188,
        "completion_tokens": 184,
        "total_tokens": 8373
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on BNY Mellon's website at the same URL, indicating no change in its availability. However, the 2024 filing explicitly states the company's intention to disclose any amendments or waivers to the Directors' Code of Conduct on its website, emphasizing a commitment to transparency and updated disclosure practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35180,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9003,
        "completion_tokens": 96,
        "total_tokens": 9100
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, the role and deployment strategy of Mobileye Drive™ evolved from being primarily a self-driving system for commercial and fleet use to a more scalable and production-focused solution. In 2022, Mobileye positioned Mobileye Drive™ as a core component for Robotaxi and cargo delivery services, with partnerships such as Udelv and Transdev. By 2023, Mobileye expanded its deployment strategy to include production design wins for consumer-level autonomous driving, such as with Polestar and FAW, and emphasized scaling Mobileye SuperVision to serve as a foundation for its Chauffeur consumer AV product. Additionally, Mobileye Drive™ was integrated with Moovit’s mobility platform to support MaaS (Mobility as a Service) networks, reflecting a broader push into both fleet and consumer autonomous markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8148,
        "completion_tokens": 206,
        "total_tokens": 8354
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "The structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024 as follows: In 2022, the Tower Preferred Interests included two series—Class A-1 with a 5.0% initial distribution rate and Class A-2 with a 4.75% initial distribution rate, both resetting every five years. In 2024, these were restructured into Fixed Rate Class A Limited Membership Interests (paying 5.90%) and Floating Rate Class A Limited Membership Interests (paying SOFR + 250 basis points). The Floating Rate Interests will gradually transition from the Fixed Rate over five years, with the first $525 potentially converting by 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12699,
        "completion_tokens": 158,
        "total_tokens": 12857
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The Balanced Index Fund, which comprises approximately 60% equities and 40% debt securities, is valued using a market approach based on quoted market prices (Level 1), and its unrealized gains or losses are not specifically detailed for Level 3 assets. From 2022 to 2023, the Level 3 assets related to the fund showed a decrease in total value from $268 to $226. In 2022, the unrealized losses were significant, with a total net loss of $90, while in 2023, there was a net unrealized gain of $14, indicating an improvement in the performance of Level 3 assets during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44176,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11264,
        "completion_tokens": 144,
        "total_tokens": 11408
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has become more explicit and integrated into its strategic priorities. In 2023, accounting developments were mentioned as one of several external factors that could impact the company's financial reporting and operations. By 2024, the mention of accounting developments is more prominent and explicitly linked to strategic areas such as capital planning, risk management, and financial performance expectations. This evolution suggests a growing recognition of the material influence of evolving accounting standards on BNY Mellon's strategic decision-making and financial reporting framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8930,
        "completion_tokens": 174,
        "total_tokens": 9105
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The evolution of risks related to store safety and cybersecurity in 2023, as outlined in the 10-K filing, had a notable impact on the associate experience compared to the engagement-focused initiatives of 2022. In 2022, the company emphasized engagement through communication, recognition programs, and initiatives to support associate well-being and inclusivity. However, in 2023, the focus shifted toward addressing operational risks, such as increased shrink due to organized retail crime and cybersecurity threats, which required associates to adapt to heightened safety protocols and operational changes. These risks introduced potential stressors for associates, such as increased vigilance against theft and the need to navigate evolving technology systems, which could detract from the positive engagement initiatives of the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13606,
        "completion_tokens": 211,
        "total_tokens": 13817
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "Between 2022 and 2023, the role of the 'learning curve' in influencing cost and production estimates became more critical due to ongoing production challenges and uncertainties in program profitability and risk management. In 2022, the learning curve was a factor in estimating production costs and gross margins, particularly for complex programs like the 777X and 787, where production delays and rework impacted profitability. By 2023, the learning curve's influence was heightened by increased supply chain constraints, regulatory requirements, and production quality issues, which added complexity to cost estimation and risk management. The evolving learning curve assumptions were essential in adjusting production rates and managing program risks, especially as Boeing faced continued challenges in achieving anticipated cost reductions and maintaining program profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38591,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9878,
        "completion_tokens": 220,
        "total_tokens": 10098
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment and disclosure of the Dividend Reinvestment Plan in the 2024 SEC filing remain consistent with the 2023 filing, both referencing officer and director participation in the plan as part of broader equity and benefit arrangements. In both years, the filings disclose that certain officers or directors have elected to participate in the Dividend Reinvestment Plan, along with other plans such as the employee stock purchase plan and 401(k) plan. Additionally, they may have shares withheld to cover withholding taxes or pay the exercise price of stock awards, which may be structured under Rule 10b5-1 or as non-Rule 10b5-1 trading arrangements. There is no indication of substantive changes in the nature of officer or director participation or the associated trading arrangements between the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9133,
        "completion_tokens": 206,
        "total_tokens": 9340
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience evolved significantly from fiscal 2021 to fiscal 2023. In fiscal 2021, the company invested $2.6 billion in capital expenditures to support this initiative, focusing on blending digital and physical shopping experiences to meet customer expectations shaped by the pandemic. By fiscal 2023, this investment had increased to $3.2 billion, with a continued emphasis on enhancing digital capabilities, store experiences, and supply chain efficiency. Specific changes in tailoring the experience included improved mobile app functionality for personalized shopping, expanded fulfillment options (e.g., BOPIS, BORIS), and investments in store technology such as electronic shelf labels and self-checkout systems, all aimed at creating a seamless, frictionless journey for customers across channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11308,
        "completion_tokens": 217,
        "total_tokens": 11526
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron primarily reflects the integration of Aldevron, which was acquired in August 2021 for $9.6 billion. In 2022, DHR continued to invest in capital expenditures related to Aldevron, with $87 million in purchases of property, plant, and equipment partially offset by government grants. By 2023, the focus shifted toward the acquisition of Abcam for $5.6 billion, which became the major capital investment, while Aldevron remained part of the Life Sciences segment contributing to expanded product offerings and sales opportunities. No further major acquisition-related expenditures for Aldevron were reported in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46949,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11964,
        "completion_tokens": 169,
        "total_tokens": 12133
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $2,000 (Telco Class A-1) to $7,250, following additional issuances of $5,250 in April 2023 (Telco Class A-2 and A-3). In 2024, Telco LLC also agreed to issue an additional $2,250 of preferred interests (Telco Class A-4) in Q1 2025. The distribution rates varied by class: Telco Class A-1 had a 4.25% rate with a seven-year reset, while Telco Class A-2 and A-3 had a higher 6.85% rate with a reset on November 1, 2027. The Telco Class A-4, set to be issued in 2025, carries a 5.94% distribution rate with a reset on November 1, 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12721,
        "completion_tokens": 154,
        "total_tokens": 12875
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2024 has evolved to be more refined and tailored to specific insurance lines. In 2022, the Expected Loss Ratio method was primarily applied to short-tail classes like U.S. Property, where it was used in combination with other methods such as frequency/severity and loss development. The rationale was to account for low-frequency, high-severity losses and to adjust for inflation, rate changes, and market conditions.\n\nBy 2024, AIG expanded the application of Expected Loss Ratio methods to newer accident years and more complex lines, such as U.S. Excess Casualty and U.S. Workers' Compensation. The rationale for this expansion included addressing inconsistent loss development patterns, incorporating updated rate changes and inflation trends, and responding to evolving underwriting strategies (e.g., higher attachment points in Excess Casualty). Additionally, the Expected Loss Ratio method was weighted more heavily for recent accident years, reflecting a focus on current market conditions and emerging claim trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 288962,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 72470,
        "completion_tokens": 270,
        "total_tokens": 72740
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's approach to its owned brands from 2023 to 2024 has shown a stronger strategic emphasis on expanding and strengthening its owned and exclusive brands portfolio as a key differentiator. In 2023, the focus was on leveraging owned brands to deliver value and style, while in 2024, the strategy has evolved to include a broader and more curated portfolio of owned and exclusive brands, such as Project 62™, Threshold™, and Hearth & Hand™ with Magnolia, alongside exclusive adult beverage brands like SunPop™ and Wine Cube™. This evolution reflects a more intentional effort to enhance product differentiation, guest experience, and brand loyalty through a diverse and high-quality product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 25246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6530,
        "completion_tokens": 175,
        "total_tokens": 6706
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggests that the company is employing a diversified long-term debt financing strategy. By issuing new higher-yield notes while retaining lower-yield existing debt, IBM may be taking advantage of favorable market conditions to refinance or supplement its capital structure at attractive rates. This approach could indicate confidence in stable borrowing costs and the ability to manage debt maturity profiles effectively, while also potentially locking in lower interest expenses over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13470,
        "completion_tokens": 147,
        "total_tokens": 13617
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, the composition of AT&T's long-term debt instruments remained largely consistent, with the 4.000% Global Notes due June 1, 2049 (T 49A) listed in both the 2022 and 2024 10-K filings. No new long-term notes were explicitly added during this period based on the provided pages; the list of debt instruments in 2024 includes the same 4.000% Global Notes due in 2049 and aligns closely with the 2022 list, with no indication of new issuances beyond the existing instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 123,
        "total_tokens": 10883
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing from $258 million in 2023 to $560 million in 2024, primarily due to the full year impact of the NI acquisition in 2024. Restructuring costs related to the Heritage AspenTech acquisition were $97 million in 2022, $258 million in 2023, and $560 million in 2024, reflecting ongoing integration and operational adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37271,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9544,
        "completion_tokens": 112,
        "total_tokens": 9657
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved to place greater emphasis on segmentation by business types and the impact of large deductible accounts. In 2022, the expected loss ratio methods were given significant weight in the most recent five accident years, with adjustments made for rate changes, loss trends, and market conditions. By 2024, the proportion of large deductible business had increased, slowing the reporting pattern of claims and influencing the use of expected loss ratio methods. Additionally, AIG further segmented guaranteed cost and excess of deductible business by state and industry subset, reflecting meaningful differences in development patterns. These changes highlight a more refined and nuanced approach to reserving, driven by the evolving mix of business and risk-sharing structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 259353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 65078,
        "completion_tokens": 218,
        "total_tokens": 65296
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target's Cyber Fusion Center operations have remained a central component of its cybersecurity threat investigation and response strategy. In both years, the company emphasizes using a combination of industry-leading tools and in-house technologies to detect and respond to threats. In 2024, there is a slight expansion in the description of the Cyber Fusion Center's role, highlighting its proactive threat intelligence program and its integration with broader enterprise risk management. Additionally, Target continues to collaborate with external organizations across different industries to share threat intelligence, best practices, and regulatory insights, reinforcing its commitment to enhancing cybersecurity capabilities through external partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43284,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11057,
        "completion_tokens": 194,
        "total_tokens": 11252
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024, particularly in terms of revenue recognition. In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million recognized in the U.S. and $31.9 million outside the U.S. This marked a notable increase from 2022, where Baqsimi generated only $139.3 million. By 2024, the revenue from Baqsimi was no longer reported as a standalone product, as the rights for Baqsimi were sold in 2023, resulting in a one-time gain included in collaboration and other revenue. This shift reflects a transition from ongoing product sales to a one-time contractual arrangement through the sale of rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 173,
        "total_tokens": 12386
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T's approach to managing its capital structure through preferred interests evolved as follows: In 2023, the company repurchased all remaining Mobility Preferred Interests, valued at $5,414, primarily funded by the issuance of Telco LLC preferred interests. In 2024, AT&T expanded its Tower Holdings preferred interests by restructuring and resetting the rates of the 2019 Tower preferred interests, introducing a mix of fixed and floating rate distributions. Additionally, AT&T issued new Telco LLC preferred interests, including an additional $2,250 of Telco Class A-4 interests in October 2024, to further diversify its capital structure and fund preferred equity redemptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56033,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14254,
        "completion_tokens": 175,
        "total_tokens": 14429
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2023 to 2024, as Emerson announced a proposal to acquire the remaining shares of AspenTech not already owned, which would make Emerson the full owner. In 2023, Emerson already owned 55% of AspenTech, and by 2024, this ownership had increased to approximately 57%. Financially, this transformation had mixed impacts: AspenTech's performance in 2024 showed a decline in earnings, with a loss of $73 million compared to a $107 million loss in 2023. Additionally, Emerson's gross margin for the overall company was negatively affected by acquisition-related inventory step-up amortization of $231 million in 2024, which reduced gross margin by approximately 1.3 percentage points.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46771,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11921,
        "completion_tokens": 185,
        "total_tokens": 12106
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed 50% (2022), 54% (2023), and 50% (2024) to the total projected benefit obligations for non-U.S. pension plans. The weighted average discount rate for these Japan plans increased from 1.48% in 2023 to 1.81% in 2024, reflecting an improvement in the economic environment and adjustments based on the Mercer Yield Curve for Japan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 183,
          "pages": [
            181,
            182,
            183,
            184,
            185
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70746,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17927,
        "completion_tokens": 96,
        "total_tokens": 18023
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's disclosure about the impact of competitive stores on its business became more explicit in framing external market conditions as a growing and intensifying challenge. In 2022, the company noted that competition would intensify as international e-commerce and retail services grew, with local companies having a competitive advantage due to their understanding of local customers and established brands. In 2023, the framing expanded to include the adoption of evolving business models as a contributing factor to increased competition, emphasizing the broader and more dynamic nature of the competitive landscape. This evolution reflects a heightened awareness of the complexity and speed of market changes globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12690,
        "completion_tokens": 186,
        "total_tokens": 12877
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Based on the information provided in the 2023 and 2024 10-K filings, Target's exposure to port security risks has remained a concern due to its reliance on global supply chains, particularly with a significant portion of merchandise sourced from outside the U.S., including China. In both years, the company highlighted that disruptions at ports—such as closures, labor disputes, and congestion—could increase costs and impact inventory availability. However, in 2024, there is a more explicit emphasis on the broader implications of geopolitical conflicts and the increasing volatility of global trade dynamics, suggesting a heightened awareness and potential expansion of geographic and operational risks. Target continues to make alternative arrangements to mitigate these disruptions, but the evolving nature of port security risks indicates a growing operational impact as global trade conditions become more unpredictable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13014,
        "completion_tokens": 232,
        "total_tokens": 13246
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved primarily through acquisition-related amortization and restructuring costs. In 2023, amortization of intangibles related to the Heritage AspenTech acquisition was $258 million, while restructuring costs were $72 million. By 2024, amortization increased to $560 million, largely driven by the NI acquisition, and restructuring costs rose significantly to $228 million, reflecting broader operational adjustments and integration efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9992,
        "completion_tokens": 130,
        "total_tokens": 10122
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio methods between 2022 and 2024 has evolved to place greater emphasis on recent accident years, particularly in lines of business with low frequency and high severity losses, such as U.S. Financial Lines (D&O, E&O, EPLI) and U.S. Excess Casualty. In 2022, Expected Loss Ratio methods were given significant weight for the most recent five accident years, especially for business written above a deductible. By 2024, this approach was reinforced, with Expected Loss Ratio methods being used more prominently for recent accident years and loss development methods for more mature years. The weight given to Expected Loss Ratio methods was also influenced by changing market conditions, rate changes, and loss trends, with adjustments made for emerging claim experience and inflation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 270,
          "pages": [
            268,
            269,
            270,
            271,
            272
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 273698,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 68658,
        "completion_tokens": 203,
        "total_tokens": 68861
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups showed a modest increase in capitalized video and music content costs, rising from $16.7 billion to $17.4 billion. This suggests a continued investment in content, particularly for Amazon Prime memberships, though the growth in capitalized costs was relatively flat compared to the prior year. Additionally, total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023, indicating higher spending on licensing and production of content. The strategy appears to focus on maintaining and expanding the value of film groups as a unit in major geographies, with a continued emphasis on monetizing content through Prime memberships and digital subscriptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48616,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12382,
        "completion_tokens": 189,
        "total_tokens": 12572
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's financial relationship with Rothmans, Benson & Hedges (RBH) evolved significantly, primarily due to litigation and a proposed settlement. As of 2024, the court-appointed mediator in the Canadian tobacco claims proceedings proposed a settlement requiring RBH to pay CAD 32.5 billion (approximately $22.3 billion), though the allocation among RBH and other parties remained unresolved. This led PMI to assess its investment in RBH for impairment, concluding that the investment's fair value was lower than its carrying value. As a result, PMI recorded a non-cash impairment charge of $2,316 million (or $1.49 per diluted share) in 2024. This marked a significant financial impact on PMI's stake in RBH, reflecting increased risk and uncertainty in the relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 29834,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7682,
        "completion_tokens": 204,
        "total_tokens": 7886
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Between 2023 and 2024, the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities remained relatively stable. As of December 31, 2023, a 5% change in these liabilities would have resulted in a $615 million change in revenue, while as of December 31, 2024, the impact slightly decreased to approximately $600 million for a similar percentage change. This suggests that the overall exposure of net product revenue to fluctuations in these liabilities did not significantly increase, despite higher rebate volumes driven by incretin products in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43689,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11156,
        "completion_tokens": 148,
        "total_tokens": 11304
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2022, Bulk shipments generated $6.656 billion in freight revenues, representing a 12% increase from 2020 and driven by volume growth, core pricing gains, and higher fuel surcharge revenue. By 2024, Bulk shipments accounted for 32% of the company's total freight revenues, which amounted to $22.8 billion, indicating a continued significant contribution to the company's revenue mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43180,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11008,
        "completion_tokens": 128,
        "total_tokens": 11137
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "Between 2023 and 2024, the interest rate for IBM's 0.300% Notes due 2028 remained unchanged at 0.300%. This consistency in the interest rate suggests that IBM maintained a stable and long-term debt strategy, likely leveraging low-interest-rate environments to issue or retain fixed-rate debt, which can help manage interest costs and provide financial predictability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52951,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13452,
        "completion_tokens": 91,
        "total_tokens": 13544
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by repurchasing all outstanding Mobility Preferred Interests in April 2023, which eliminated this instrument from its capital structure. In 2024, AT&T introduced new preferred instruments, including the Telco Class A-4 preferred interests in its Telco LLC, which were set to be issued in early 2025 with an initial distribution rate of 5.94% and reset provisions. Additionally, AT&T issued Mobility II Redeemable Noncontrolling Interests in June 2023, offering a 6.8% annual distribution. These actions reflect a shift from the Mobility Preferred Interests to a more diversified approach involving new preferred instruments with varying terms and reset mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61801,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15685,
        "completion_tokens": 188,
        "total_tokens": 15874
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites shifted from a general acknowledgment of intensifying competition to a more specific emphasis on evolving business models and the growing influence of local companies. In 2022, the language focused on the intensification of competition as international e-commerce and omnichannel retail grow, with local companies having a competitive advantage due to their understanding of local customers and established brand presence. In 2023, the language expanded to highlight the adoption of evolving business models by competitors and reiterated the challenge posed by local companies, particularly in terms of their focus on local customers and brand strength. This shift suggests a recognition of more dynamic and adaptive competition, especially from regionally dominant players.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49832,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12689,
        "completion_tokens": 215,
        "total_tokens": 12905
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from a strategic collaboration in 2020 to a more integrated partnership by 2024, with KT&G's heat-not-burn products playing a significant role in PMI's smoke-free portfolio. The 2020 agreement allowed PMI to exclusively commercialize KT&G's heat-not-burn products globally, and by 2024, these products, including licensed brands like Fiit and Miix, were included in PMI's heated tobacco units (HTUs) and contributed to HTU shipment volume growth of 11.6%. This reflects PMI's increasing strategic reliance on KT&G's innovations to expand its smoke-free offerings and strengthen its market position in the transition away from combustible products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43555,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11118,
        "completion_tokens": 172,
        "total_tokens": 11290
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in its administration and scope. The PWCC Plan continued to be administered by the Executive Compensation and Management Resources Committee of the Board of Directors and was solely used to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who became IBM employees due to the 2002 acquisition. The terms and conditions of the PWCC Plan remained substantively identical to those of the 2001 Plan, and it did not fund awards for senior executives. No significant changes in administration or scope were noted during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9222,
        "completion_tokens": 154,
        "total_tokens": 9376
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T repurchased all outstanding Mobility Preferred Interests, which were initially issued in 2018. These interests, which carried a 7% annual distribution rate, were fully redeemed by April 2023, removing them from AT&T’s capital structure. In 2024, AT&T shifted focus to managing other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which were restructured or reset to align with market conditions and long-term strategic goals. This evolution reflects AT&T’s broader strategy to optimize its capital structure by reducing high-cost obligations and reconfiguring preferred equity to enhance flexibility and financial stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13051,
        "completion_tokens": 172,
        "total_tokens": 13223
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained consistent in terms of being subject to governmental and stock exchange regulations, as outlined in the \"Risks Related to Ownership of IBM Securities\" section in both years. However, the 2024 filing added more detailed context about the company's cybersecurity governance and risk management framework, which indirectly influences regulatory compliance and investor confidence. No significant evolution in direct regulatory exposure for debt securities was noted, but enhanced cybersecurity measures and oversight could affect broader compliance with evolving financial regulations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 37836,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9679,
        "completion_tokens": 166,
        "total_tokens": 9845
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's equity income contribution from A&E declined significantly from fiscal 2023 to 2024, decreasing by $207 million, with equity income from A+E being a primary factor in this decline. In fiscal 2024, equity in the income of investees totaled $575 million compared to $782 million in the prior year, largely driven by lower income from A+E. This suggests a deterioration in A+E's financial performance during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 32611,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8368,
        "completion_tokens": 106,
        "total_tokens": 8474
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16.973 billion in 2022 to $18.043 billion in 2023, indicating a $1.07 billion growth. This increase suggests that the company is actively utilizing securitization as a long-term funding strategy to diversify its funding sources and manage liquidity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47990,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12224,
        "completion_tokens": 80,
        "total_tokens": 12304
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus toward DTC platforms, which has impacted its international general entertainment channels. The company has moved away from traditional linear channel monetization in favor of streaming services like Disney+ and Disney+ Hotstar, which now serve as primary distribution channels for scripted and general entertainment content. This strategic shift is evident in the consolidation of services, such as merging Star+ into Disney+ in Latin America by June 2024, and the expansion of Disney+’s Star-branded tile to include general entertainment programming internationally. As a result, international general entertainment channels under the Fox, National Geographic, and Star brands have seen a reduced emphasis compared to the DTC-driven content strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39233,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10041,
        "completion_tokens": 200,
        "total_tokens": 10242
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "Tesla faced financial and operational challenges related to energy storage products from 2022 to 2023, particularly in terms of accounts receivable and production scaling. In 2022, accounts receivable were impacted by fluctuations in customer payments, government rebate collection timelines, and sales of regulatory credits, which can take up to a year to collect. By 2023, these challenges persisted, with continued reliance on efficient supply chains and production scaling to meet growing demand. Additionally, production scaling for energy storage products remained dependent on supplier capabilities and internal manufacturing ramp-ups, which could lead to delays if not managed effectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 49269,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12550,
        "completion_tokens": 174,
        "total_tokens": 12724
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained central to its operations, particularly in relation to bottling partners and fountain retailers. Syrups, including fountain syrups, are produced by Coca-Cola and sold to bottling partners, who either use them to produce finished beverages or sell them directly to fountain retailers for on-the-spot consumption. In 2023, syrups continued to be a key component of concentrate operations, which accounted for 58% of total net operating revenues, reflecting their importance in generating revenue through sales to bottlers and fountain retailers. Additionally, fountain syrup sales were included in the North America operating segment, emphasizing their role in supporting immediate consumption channels. The business model emphasizes collaboration with bottling partners and fountain retailers to ensure widespread availability of Coca-Cola products across various consumption settings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12333,
        "completion_tokens": 241,
        "total_tokens": 12574
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from fiscal year 2022 to fiscal year 2024, with the fair value rising from $84 million in 2022 to $166 million in 2024. However, the proportion of these investments relative to the overall fair value hierarchy decreased, dropping from 1% in 2022 to 1% in 2024, indicating a relatively stable but smaller share within the broader investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54786,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13938,
        "completion_tokens": 109,
        "total_tokens": 14048
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs expanded their focus areas to include air dominance and hypersonics in addition to their existing emphasis on unmanned and manned aerial systems, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. This evolution reflects a strategic shift toward next-generation military aircraft capabilities aligned with emerging threats and mission requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48402,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 112,
        "total_tokens": 12434
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla's approach to the Powerwall product has evolved by emphasizing integration with residential solar energy products and enhancing cross-selling opportunities. In 2022, the focus was on increasing production to meet demand and addressing global component constraints. By 2023, Tesla highlighted improved availability of Powerwall and growing customer interest driven by grid stability concerns, alongside efforts to streamline the customer experience through localized procurement and simplified online ordering. This shift reflects a stronger emphasis on integration strategy and leveraging synergies within Tesla's broader energy ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42117,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10749,
        "completion_tokens": 166,
        "total_tokens": 10915
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead has maintained Biktarvy as a cornerstone of its HIV portfolio, emphasizing its role as a leading single-tablet regimen for the treatment of HIV-1 infection. Biktarvy's position has remained strong due to its efficacy, convenience, and favorable resistance profile. However, the company faces commercial risks, including market share pressures from competitive products and the potential for generic alternatives. Additionally, evolving treatment paradigms and regulatory developments, such as FDA's class labeling changes for CAR T-cell therapies, highlight the need for Gilead to continue innovating and adapting its HIV portfolio to maintain its competitive edge and sustain revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47754,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12168,
        "completion_tokens": 180,
        "total_tokens": 12349
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan saw changes in the U.S. litigation escrow account balance, with deposits increasing significantly. In 2022, the escrow account balance increased from $894 million to $1,449 million, with $850 million deposited and $295 million paid out. In 2023, the balance rose further to $3,089 million, with $1,500 million deposited and $685 million paid out. Additionally, the plan now includes makewhole agreements as a new mechanism, which were not explicitly referenced in the 2022 disclosures. These agreements reimburse Visa for future deposits into the escrow account that would have otherwise reduced the conversion rate of class B-1 common stock for participating stockholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52216,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 184,
        "total_tokens": 13472
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, the strategic importance of Biktarvy for Gilead has remained significant due to its strong patent protection, with compound patent expiration estimated for 2033 in both the U.S. and the European Union. This extended exclusivity supports its role as a key revenue driver in Gilead’s HIV portfolio. However, the company continues to highlight the risk of HIV product dependency, noting that a substantial portion of its revenue comes from HIV treatments, including Biktarvy. The risk of competition, including from generics, and the potential for changes in treatment paradigms remain ongoing concerns, underscoring the need for continued innovation and diversification in Gilead’s product pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41788,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10677,
        "completion_tokens": 179,
        "total_tokens": 10856
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there is no indication of modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023 in terms of guarantee structure or referenced documentation. The guarantees for Illinois Bell Telephone Company are listed under historical exhibits (Exhibit 4-c) and do not show any updates or changes in the 2022 or 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41040,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10498,
        "completion_tokens": 102,
        "total_tokens": 10601
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no significant dilution or adjustment to the voting power of Class A common stockholders during this period. Since Class C shares carry fewer voting rights compared to Class A shares, maintaining a stable conversion rate implies that the relative influence of Class A stockholders in significant corporate transactions has remained largely unchanged, assuming no material changes in the number of outstanding shares of each class.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44430,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11343,
        "completion_tokens": 136,
        "total_tokens": 11479
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof evolved in terms of production focus and strategic dependencies by shifting toward greater integration with its broader energy generation and storage initiatives. In 2022, the Solar Roof was highlighted as part of Tesla's energy product offerings, emphasizing customization and installation through direct and channel partner sales. By 2023, the Solar Roof was increasingly positioned as part of a holistic clean energy ecosystem, with a focus on leveraging Tesla's manufacturing capabilities and strategic partnerships to streamline production and deployment. Additionally, the Solar Roof's development and production remained tied to Gigafactory New York, reflecting a continued strategic dependency on localized manufacturing and government incentives to support its growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45587,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11613,
        "completion_tokens": 209,
        "total_tokens": 11822
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to both concentrate and finished beverage operations, with a continued emphasis on their use in fountain channels. Syrups are produced by combining concentrates with water and sweeteners and are sold to bottling partners or fountain retailers for on-site mixing. In 2023, concentrate operations accounted for 58% of total net operating revenues, with syrups playing a central role in this segment. The relationship between syrups and finished beverage production remained unchanged, as bottlers and fountain retailers continue to rely on syrups to produce finished beverages for retail and immediate consumption. Distribution channels also remained consistent, with bottling partners and authorized wholesalers handling syrup distribution to maintain alignment with Coca-Cola's global beverage supply chain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11376,
        "completion_tokens": 224,
        "total_tokens": 11600
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's Africa/Eurasia segment showed modest growth in financial contribution. In 2022, the segment reported net sales of $1,082 million and operating profit of $228 million, while in 2024, net sales increased to $1,095 million and operating profit rose to $253 million. The geographic reporting structure remained consistent, with Africa/Eurasia classified as one of the five reportable operating segments under the Oral, Personal and Home Care product segment. Notably, the 2024 results reflect a slight improvement in profitability despite relatively stable sales, indicating a focus on operational efficiency in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35961,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9220,
        "completion_tokens": 165,
        "total_tokens": 9385
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's strategic presentation of its Orthopaedics business within the MedTech segment has emphasized steady global sales performance and a focus on enabling technologies. In 2023, Orthopaedics reported worldwide sales of $8,942 million, reflecting a 4.1% increase compared to 2022, with growth in both U.S. and international markets. By 2024, the company continued to highlight the Orthopaedics portfolio's role in supporting hips, knees, trauma, spine, sports, and other areas, with an emphasis on enabling technologies to enhance patient outcomes. This strategic emphasis aligns with the broader MedTech segment's focus on innovation and advanced healthcare solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50365,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12824,
        "completion_tokens": 176,
        "total_tokens": 13000
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements has shown notable evolution, particularly in the scope of U.S. covered litigation and liability allocation. In 2022, the U.S. litigation escrow account balance increased from $894 million to $1,449 million, primarily due to deposits of $850 million. By 2023, the balance further increased to $3,089 million, with an additional $1,500 million in deposits. This reflects a broader allocation of funds to address potential liabilities from U.S. covered litigation, including cases brought by merchants that opted out of the MDL 1720 settlement class. Additionally, the amendments to the loss sharing agreement in 2015 expanded the scope to include such opt-out cases, ensuring a more comprehensive liability management framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13557,
        "completion_tokens": 208,
        "total_tokens": 13765
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's investment in Guaranteed Investment Contracts (GICs) decreased significantly. In 2022, GICs were valued at $51 million for international plans, and by 2024, this amount dropped to $30 million. This reduction suggests a strategic shift in the company's pension plan asset allocation, likely aiming to diversify investments or reallocate funds to other asset classes such as fixed income or equity funds, which saw increases in their allocations. This shift may indicate a move toward more liquid or market-sensitive investments to better manage risk and returns in the pension portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39495,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10101,
        "completion_tokens": 157,
        "total_tokens": 10259
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved to become a more integral enabler of integration for digital assets and new technologies. In 2022, the platform was described as simplifying access to and integration of Mastercard's digital assets, offering a single access point with tools and capabilities to find APIs across a broad range of services. By 2024, the platform had expanded its role to support blockchain-based business models, including programmable payments through the Mastercard Multi-Token Network™, and enabling consumers to buy and spend cryptocurrencies. Additionally, the platform supported innovation by providing access to new technologies and early-stage fintech players through Mastercard Foundry, further enhancing its functionality in integrating digital assets and emerging technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11697,
        "completion_tokens": 208,
        "total_tokens": 11906
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans remained minimal between 2022 and 2024, with only $1 million allocated in 2024 and none in 2023, 2022, or earlier. This indicates that the company's strategic asset allocation continues to prioritize fixed income securities and other investments over direct equity holdings in its U.S. pension plans, aligning with its target allocation of 26% in equities for U.S. plans in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33265,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8545,
        "completion_tokens": 112,
        "total_tokens": 8658
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with a renewed emphasis on capital investment and operational risk management. In 2023, the company announced plans for additional expansion of its cruise ship fleet, reflecting a commitment to growing its Disney Cruise Line segment. This aligns with broader investments in the Parks & Experiences segment, which includes cruise ships, resorts, and theme parks. Operationally, Disney acknowledged risks such as disruptions from uncontrollable events (e.g., natural disasters, global health concerns) and the need for robust insurance and contingency planning to mitigate potential impacts on cruise operations. Additionally, the company highlighted the importance of aligning its offerings with evolving consumer preferences and managing costs associated with new ship launches and ongoing fleet maintenance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 51248,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13037,
        "completion_tokens": 220,
        "total_tokens": 13257
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard's use of short duration foreign exchange derivative contracts has increased between 2022 and 2024, as evidenced by the rise in notional amounts from $2,741 million in 2024 compared to earlier periods. These contracts are primarily used to manage foreign exchange risk arising from daily settlement activities, where exposure is typically limited to a few days. The Company employs these derivatives to offset potential gains and losses from currency fluctuations between transaction dates and settlement, ensuring stability in its financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61367,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15582,
        "completion_tokens": 140,
        "total_tokens": 15722
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved with a stronger focus on ecosystem integration and expanding its solution ecosystem. In 2023, the company emphasized managing a portfolio of strategic investments in enterprise cloud companies and technology startups, aiming to digitally transform industries and support corporate initiatives such as AI. By 2024, Salesforce further deepened this focus by introducing Agentforce, an agentic layer of the Salesforce Platform for deploying autonomous AI agents across business functions, which enhances integration with third-party applications and data sources. Additionally, the company continued to invest in and expand its partner ecosystem, including independent software vendors and system integrators, to accelerate market reach and innovation. These efforts reflect a strategic shift toward not only investing in but also more tightly integrating with enterprise cloud companies to drive growth and customer value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59851,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15188,
        "completion_tokens": 254,
        "total_tokens": 15443
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for recognizing vendor funds but refined its accrual rates based on updated purchase volume projections and vendor agreement provisions. In fiscal 2024, the company continued to adjust accrual rates throughout the year by analyzing historical purchase trends and confirming actual amounts with select vendors. The sensitivity to projected purchase volumes remained significant, particularly for programs with graduated funding tiers tied to volume thresholds. Any deviations between actual and projected volumes could still impact the amounts accrued, though the company emphasized that adjustments historically had not been material.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41170,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10523,
        "completion_tokens": 179,
        "total_tokens": 10703
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between LLY and Boehringer Ingelheim (BI) has seen increased legal involvement and continued collaborative dependency, particularly concerning the Jardiance product. In 2022, BI initiated U.S. patent litigation against generic companies seeking to market generic versions of Jardiance, with LLY not being a party to this litigation. By 2024, the collaboration remained significant as Jardiance was selected by the U.S. Department of Health and Human Services under the Inflation Reduction Act for government-set pricing, effective in 2026, which will impose a 66% discount on its price. This highlights both the ongoing dependency on Jardiance as a key revenue driver and the shared exposure to regulatory and pricing pressures within the partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12253,
        "completion_tokens": 199,
        "total_tokens": 12452
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy for cruise ships remained a key component of its Parks & Experiences business, with a focus on long-term growth and expanding offerings. In 2022, the Company highlighted its 550-acre land development in Eleuthera, scheduled to open as a Disney Cruise Line destination in 2024, indicating ongoing investment in cruise-related infrastructure. By 2023, the strategy emphasized continued capital spending on cruise ships and related experiences, aligning with broader investments in theme parks, resorts, and guest offerings. This reflects Disney's commitment to enhancing its cruise segment as part of its diversified leisure and entertainment ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12196,
        "completion_tokens": 176,
        "total_tokens": 12373
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has expanded its role in fostering innovation by deepening its engagement with emerging technologies and fintech partnerships. In 2022, it focused on identifying and experimenting with future technologies and early-stage fintech players. By 2024, Mastercard Foundry had evolved to offer more advanced solutions, such as blockchain-based payment models, enhanced tokenization, and AI-driven fraud detection, while also integrating with third-party platforms and central banks to support cross-border remittances and disbursements. Additionally, it launched initiatives like the Alias-Based Remittances and Payouts platform, demonstrating a stronger commitment to leveraging innovation for scalable and secure payment solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11689,
        "completion_tokens": 192,
        "total_tokens": 11881
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration with Boehringer Ingelheim, particularly regarding the diabetes drug Jardiance, has seen significant regulatory and pricing developments between 2022 and 2024. In 2022, Jardiance was submitted for new indications such as heart failure with preserved ejection fraction and chronic kidney disease, with the former receiving FDA Breakthrough Therapy and Fast Track designations. By 2024, the Inflation Reduction Act (IRA) had introduced pricing pressures, with the U.S. Department of Health and Human Services selecting Jardiance as one of the first drugs subject to government-set prices under Medicare, effective in 2026. This selection implies a 66% discount from the 2023 list price, marking a strategic shift from regulatory milestones to navigating significant pricing pressures under new legislative frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13045,
        "completion_tokens": 208,
        "total_tokens": 13253
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment evolved from 2023 to 2024 by securing international contracts and advancing production. In 2023, the Israeli Ministry of Defense signed a Letter of Offer and Acceptance (LOA) for 12 CH-53K helicopters, with the remaining awards completed by 2023. By 2024, the program was highlighted as a major program under RMS, emphasizing its role in heavy lift capabilities for U.S. and foreign governments, indicating its growing strategic importance in the segment's portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48004,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12226,
        "completion_tokens": 152,
        "total_tokens": 12378
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward streamlining and focusing on key diabetes therapies with broader therapeutic applications. In 2022, the portfolio included products like Trajenta, Jardiance, Glyxambi, Synjardy, and Basaglar, emphasizing a range of treatment options for type 2 diabetes. By 2024, the list had been simplified to Jardiance, Glyxambi, Synjardy, and Trijardy XR, omitting Basaglar and Trajenta. This suggests a focus on products with demonstrated cardiovascular and renal benefits (e.g., Jardiance and Glyxambi) and combination therapies, aligning with market trends toward integrated care and value-based outcomes. The shift reflects a strategic realignment to prioritize products with stronger differentiation and broader clinical utility in a competitive diabetes landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50725,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12912,
        "completion_tokens": 226,
        "total_tokens": 13139
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "Between 2023 and 2024, the JASSM program experienced notable production ramp-ups, contributing to increased net sales in both years. In 2023, JASSM was part of the $145 million increase in tactical and strike missile program sales within the Missiles and Fire Control (MFC) segment. In 2024, production ramp-ups on JASSM, along with MLRS and LRASM, drove a $1.2 billion increase in net sales for tactical and strike missile programs. However, MFC's operating profit declined sharply in 2024 due to a $1.4 billion loss on a classified program, which overshadowed the positive impact of JASSM's production growth. The JASSM program also contributed to higher backlog in 2024, as orders for JASSM increased.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46128,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11762,
        "completion_tokens": 176,
        "total_tokens": 11938
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "Between 2023 and 2024, JPM's focus in evaluating credit risk for Business Banking Loans has shifted toward incorporating more granular geographic and borrower-specific data, particularly in assessing delinquency trends and early signs of borrower distress. In 2023, delinquency rates were the primary metric, with a focus on 30+ days past due as an early warning signal. By 2024, the evaluation expanded to include refreshed FICO scores and LTV ratios as secondary indicators, allowing for a more nuanced understanding of borrower risk profiles. This shift enhances the ability to identify early signs of distress by linking regional economic factors and borrower creditworthiness to delinquency trends, enabling more proactive risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47694,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12159,
        "completion_tokens": 186,
        "total_tokens": 12345
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no explicit detail on the specific terms of Target Corporation's SPP II plan in either the 2022 or 2023 filings. However, the filings indicate that the SPP II (2016 Plan Statement) was \"amended and restated effective April 3, 2016\" in both years, with no further amendments noted in the 2023 filing. This suggests that the terms of the SPP II plan remained unchanged between 2022 and 2023, reflecting a stable executive compensation framework during this period. The lack of updates implies a consistent approach to long-term incentive compensation for executives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 26733,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6909,
        "completion_tokens": 152,
        "total_tokens": 7062
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "From 2022 to 2024, the financial obligations related to Incyte under the Olumiant collaboration remained structured around tiered royalty payments on worldwide net sales, with rates up to 20%, and an additional low-teens royalty on net sales for the treatment of COVID-19 exceeding a specified threshold. As of December 31, 2022, Incyte was eligible to receive up to $100.0 million in regulatory milestones and $100.0 million in sales-based milestones. By 2024, no new material milestone payments to Incyte were recognized, and the terms of the agreement remained unchanged, with future payments contingent on regulatory and commercial success.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40011,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10229,
        "completion_tokens": 161,
        "total_tokens": 10390
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. Revenue for APJC rose from $8,027 million in fiscal 2022 to $8,208 million in fiscal 2023, as reported in the segment information. Additionally, goodwill attributed to the APJC segment increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, primarily due to acquisitions like Splunk, which contributed $2,702 million to the APJC goodwill in fiscal 2023. These figures indicate a notable expansion in both revenue and asset exposure in the APJC region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40805,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10424,
        "completion_tokens": 141,
        "total_tokens": 10566
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved notably in response to regulatory changes, particularly under the U.S. Inflation Reduction Act of 2022 (IRA). In 2022, Jardiance was selected by the U.S. Department of Health and Human Services (HHS) as one of the first ten medicines subject to government-set prices under the IRA, with the price-setting effective in 2026. By 2024, HHS announced a 66% discount for Jardiance compared to its 2023 U.S. list price for a 30-day supply. This regulatory development has prompted the companies to adjust their strategies, as the IRA's price-setting mechanism accelerates revenue erosion for Jardiance prior to the expiration of its exclusivity, influencing business planning and investment decisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41072,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10494,
        "completion_tokens": 197,
        "total_tokens": 10691
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly concerning global platforms like the Chevrolet Bolt EV, showed a heightened awareness of the broader implications for the company's positioning in EV/AV technologies. In 2022, the risks were primarily outlined in terms of potential costs, brand damage, and operational disruptions due to recalls. By 2023, the discussion expanded to include the impact of recalls on GM's leadership in emerging technologies like EVs and AVs, emphasizing the importance of maintaining consumer trust and confidence in these innovations. This evolution reflects GM's strategic focus on aligning product safety with its broader goals in the EV/AV space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56460,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14358,
        "completion_tokens": 187,
        "total_tokens": 14545
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these notes. This activity indicates that Costco is utilizing long-term financing through its Japanese subsidiary to manage debt maturity profiles and potentially secure favorable interest rates, reflecting a strategy to maintain financial flexibility and optimize capital structure over the long term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 29783,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7675,
        "completion_tokens": 141,
        "total_tokens": 7816
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,206 million in 2022 to $9,865 million in 2023, indicating a reduction of $5,727 million. This decline suggests that Cisco may have liquidated a portion of its investment portfolio, likely to fund strategic initiatives such as the acquisition of Splunk and to return cash to shareholders through dividends and stock repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49171,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12518,
        "completion_tokens": 100,
        "total_tokens": 12618
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved with increasing complexity and frequency in 2024 compared to 2023. The 2024 filing highlights a heightened risk due to the expanding interconnectivity with third-party systems, the growing sophistication of cyber threats, and the integration of new technologies like cloud computing and artificial intelligence. Additionally, the document emphasizes the challenges in detecting and mitigating vulnerabilities in third-party open-source software and the potential for disruptions to cascade across interconnected financial systems. Data recovery challenges are underscored by the increased risk of ransomware and malware attacks, which can lead to extended delays in restoring stolen, manipulated, or destroyed data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52108,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13253,
        "completion_tokens": 213,
        "total_tokens": 13466
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "By 2024, Costco had made operational investments in processing, packaging, and manufacturing facilities to support the production of private-label items, as mentioned in the 2022 filing and reflected in the 2024 report. These investments align with Costco's strategy to grow its private-label offerings, enhancing its product range and value proposition for members.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80369,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20308,
        "completion_tokens": 91,
        "total_tokens": 20400
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding became more cautious and risk-conscious. In 2022, the company highlighted that bids were based on assumptions regarding enrollment, utilization, and medical costs, and noted that incorrect assumptions could adversely affect results. By 2023, the company emphasized the risks of chronic failure to meet benchmarks, which could lead to termination of government contracts. Additionally, the 2023 filing underscored the increasing complexity and uncertainty in the bidding process due to evolving program requirements and competitive pressures, reflecting a more strategic and risk-mitigated approach to ensure bid accuracy and contract sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15070,
        "completion_tokens": 186,
        "total_tokens": 15256
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "Based on the information provided in the document pages, MET's investment in Municipals remained classified entirely within Level 2 of the fair value hierarchy for both 2022 and 2023. In 2022, the estimated fair value of Municipals was $14,212 million, and in 2023, it was $14,212 million as well, with no change in its classification. This indicates that the valuation methodology and inputs used for these investments did not shift between levels during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17882,
        "completion_tokens": 116,
        "total_tokens": 17999
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft enhanced the licensing flexibility and customer agreement models for Office 365 by introducing more streamlined and adaptable options. In 2022, Office 365 subscriptions were recognized as a single performance obligation due to the integration of desktop applications and cloud services, with revenue recognized ratably over the contract period. By 2024, Microsoft expanded its licensing models to include simplified digital agreements such as the Microsoft Customer Agreement, which is non-expiring and supports customers purchasing directly or through partners. Additionally, the Microsoft Products and Services Agreement allowed medium and large organizations to license cloud and on-premises software as needed, with optional Software Assurance for perpetual licenses, offering greater flexibility in how customers access and manage their subscriptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 33454,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8587,
        "completion_tokens": 224,
        "total_tokens": 8812
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS decreased from 58 million to 64 million, indicating a slight reduction in investments in assets with low price transparency, such as private equity and real estate funds. This suggests a potential shift toward more liquid or observable assets, aligning with a more conservative or risk-mitigated investment strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 307,
          "pages": [
            305,
            306,
            307,
            308,
            309
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16166,
        "completion_tokens": 100,
        "total_tokens": 16266
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has strategically evolved Office 365 to be more deeply integrated with AI-driven capabilities and positioned it as a central component of its broader cloud services portfolio. In 2022, Office 365 was primarily highlighted as a subscription-based cloud service, with revenue recognized ratably over the contract period due to its integration with desktop applications and cloud services. By 2024, Microsoft emphasized the infusion of generative AI into Office 365 to enhance productivity and user experience, reflecting a response to competitive pressures in the AI-driven market. This evolution underscores Office 365's role as a key differentiator in Microsoft's cloud offerings, aligning with the company's broader focus on AI and cloud infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45493,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11615,
        "completion_tokens": 196,
        "total_tokens": 11812
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's recognition and handling of credit-related impairments remained largely consistent in terms of methodology, as the Company continued to evaluate available-for-sale debt securities for credit-related impairments by assessing expected cash flows, issuer credit quality, and its intent to hold the securities. In both years, the Company noted that unrealized losses were primarily driven by interest rate changes rather than credit deterioration, and no significant credit-related impairments were recorded. However, in 2023, the allowance for credit losses on held-to-maturity securities was not material, similar to 2022, but the overall fair value of debt securities increased, reflecting a larger investment portfolio. The financial impact of impairments remained immaterial in both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54575,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13875,
        "completion_tokens": 209,
        "total_tokens": 14084
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "The allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans slightly decreased from 2022 to 2023. In 2022, the actual allocation for U.S. pension benefits was 83%, while in 2023, it was 82%. For U.S. other postretirement benefits, the allocation remained high, decreasing slightly from 96% in 2022 to 94% in 2023. The valuation of these securities, as reflected in the fair value hierarchy, also showed changes, with the total estimated fair value of fixed maturity securities AFS for U.S. pension benefits decreasing from $6,802 million in 2022 to $6,714 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 305,
          "pages": [
            303,
            304,
            305,
            306,
            307
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66048,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16736,
        "completion_tokens": 154,
        "total_tokens": 16890
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category remained a key part of its Total Home strategy, with continued emphasis on providing comprehensive solutions for customers. In 2023, the company expanded its product offerings, such as the return of Klein Tools, which enhanced its hardware and electrical product lines, indirectly supporting the Kitchens & Bath category by improving overall product breadth and customer satisfaction. The Kitchens & Bath category is included in the Home Décor segment, which consistently accounted for around 35% of total sales in recent years, highlighting its significant role in Lowe's product portfolio. This suggests that Kitchens & Bath remains an important contributor to Lowe's revenue and strategic focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43538,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11117,
        "completion_tokens": 197,
        "total_tokens": 11314
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International has shifted its strategic focus on Cheese & Grocery from a growth category in 2022 to a divested or reduced emphasis by 2024. In 2022, Cheese & Grocery was listed as one of the company’s adjacent, locally relevant categories, indicating it was part of its diversified portfolio. However, by 2024, Cheese & Grocery is no longer explicitly mentioned in the company’s strategic priorities or category focus, suggesting a reallocation of resources toward core snack categories like chocolate, biscuits, and baked snacks. This evolution reflects Mondelez’s prioritization of high-growth, globally scalable snack categories for long-term value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46718,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11913,
        "completion_tokens": 167,
        "total_tokens": 12081
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10-K filing, Jevity is listed as a primary enteral feeding product alongside Freego™ (Enteral Pump) and Freego™ sets, with no specific differentiation in positioning between the two. However, in the 2023 10-K filing, Freego™ is not explicitly mentioned in the Nutritional Products segment, while Jevity remains highlighted as a key product in enteral feeding. This suggests a shift in focus or repositioning, with Jevity being emphasized more prominently in 2023, potentially at the expense of the Freego™ product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11437,
        "completion_tokens": 132,
        "total_tokens": 11570
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals showed an increase in fair value, rising from $14,212 million in 2022 to $14,656 million in 2023. The classification remained as fixed maturity securities available-for-sale (AFS). The increase in fair value suggests that MET's credit risk management strategy is effective in maintaining a stable and low-risk portfolio, as municipals typically have lower credit risk compared to other sectors. This strategy helps in preserving capital and ensuring steady returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16955,
        "completion_tokens": 128,
        "total_tokens": 17084
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased in notional value, from approximately $2.9 billion in 2022 to $2.2 billion in 2023. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the maturity of related long-term debt. These contracts are used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations to variable rates. The decrease reflects adjustments in Abbott's fixed-rate debt management strategy as certain hedged debt instruments reached maturity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56275,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14296,
        "completion_tokens": 153,
        "total_tokens": 14449
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed rate registered notes showed a reduction in total long-term debt, from $17,347 million in 2022 to $13,044 million in 2024. During this period, 3M repaid $1.1 billion in medium-term notes in 2024, along with $500 million in fixed-rate registered notes and $650 million in fixed-rate medium-term notes in 2023. In terms of interest rate strategies, 3M utilized interest rate swaps to convert portions of fixed-rate debt into floating rate debt, particularly for notes due in 2049 and 2050, with the interest rates transitioning from a three-month LIBOR index to a SOFR index. This reflects a strategic shift towards managing interest rate risk amid evolving market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 57955,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14715,
        "completion_tokens": 183,
        "total_tokens": 14899
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, securities issuances played a diminished role in Schwab's capital structure, as the Company reduced reliance on external debt financing and focused on managing liquidity through internal capital generation and asset optimization. In 2023, Schwab issued multiple senior unsecured notes with higher interest rates to support balance sheet growth and meet liquidity coverage requirements, reflecting active capital market engagement. However, by 2024, Schwab executed a net reduction of $14.9 billion in bank supplemental funding and saw increased client sweep cash inflows, reducing the need for new debt issuances. This shift indicates a strategic pivot toward leveraging organic capital generation, asset maturities, and client behavior to meet liquidity needs, aligning with Schwab's capital management goal of returning excess capital to shareholders while maintaining regulatory compliance and financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52016,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13236,
        "completion_tokens": 235,
        "total_tokens": 13471
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, rising from $3,017 million in 2023 to $6,126 million in 2024. This increase indicates that fairlife's performance against its financial targets has not met expectations, as the contingent liability is based on fairlife achieving certain financial milestones through 2024. The growing liability suggests that the projected payments have increased due to revised assumptions or lower-than-expected performance, resulting in a higher estimated obligation for Coca-Cola.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53168,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13522,
        "completion_tokens": 143,
        "total_tokens": 13665
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved to position it as a core component of its enterprise IT solutions, with a focus on global scalability and integration. Oracle has reinforced OCI's role as a flexible and interoperable platform, supporting on-premise, cloud-based, and hybrid deployment models. This positioning enables customers to tailor their IT environments to specific business needs, enhancing Oracle's global market competitiveness. Additionally, Oracle has integrated OCI with its broader suite of cloud services, including Oracle Cloud Software-as-a-Service (SaaS), to offer comprehensive and integrated applications and infrastructure solutions. This integration reflects Oracle's commitment to providing end-to-end enterprise IT capabilities that support both cloud and on-premise environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52329,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13317,
        "completion_tokens": 217,
        "total_tokens": 13535
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the credit loss allowance for Pledged Asset Lines (PALs) decreased significantly, with the allowance for credit losses on total bank loans dropping from 0.09% in 2023 to 0.05% in 2024. This reduction reflects improved credit quality metrics and lower projected loss rates. Additionally, all PALs remained fully collateralized by securities with fair values exceeding borrowings in both 2023 and 2024, meaning no allowance for credit losses on PALs was required as of those dates. This indicates a lower credit risk profile for PALs in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 146,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59281,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15042,
        "completion_tokens": 145,
        "total_tokens": 15187
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed growth in both revenues and operational emphasis. Revenues for APLA increased from $6,431 million in fiscal 2023 to $6,729 million in fiscal 2024, reflecting a strategic focus on expanding market presence and direct-to-consumer sales in the region. Additionally, EBIT for APLA remained strong at $1,885 million in 2024, slightly below the $1,932 million in 2023, indicating continued profitability and operational stability. Nike's operational structure in APLA also emphasized direct-to-consumer channels, with significant investments in digital commerce and localized retail strategies to better serve regional consumers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54382,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13827,
        "completion_tokens": 184,
        "total_tokens": 14011
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized growth and expansion in its U.S. Pediatric Nutritional business, with Pedialyte playing a central role. In 2022, the U.S. Pediatric Nutritionals segment reported a 10.3% sales increase, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, Abbott continued to highlight Pedialyte as a key growth driver within its Nutritional Products segment, reflecting strategic investments in product innovation and marketing to strengthen its market position. This evolution underscores Abbott's focus on expanding its pediatric portfolio and reinforcing Pedialyte's role as a flagship brand in the U.S. market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47982,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12227,
        "completion_tokens": 162,
        "total_tokens": 12389
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's financial position regarding its 7.100% notes due 2027 remained relatively stable from 2022 to 2023, with the balance decreasing slightly from $135 million in 2022 to $135 million in 2023. This minimal change indicates that RTX did not prioritize repaying or restructuring this specific debt obligation during the period. The company's broader debt management strategy appears focused on longer-term refinancing and optimizing its capital structure, as evidenced by significant long-term debt issuances in 2023 to fund share repurchases and manage maturities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43007,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10975,
        "completion_tokens": 141,
        "total_tokens": 11116
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse experienced a decline in revenue performance, with total revenues dropping by 14% to $2,082 million from $2,427 million. This decline was driven by a 16% decrease in wholesale revenues and a 15% decrease in direct-to-consumer revenues, primarily due to reduced sales in North America and Western Europe. Strategically, Converse faced challenges with lower average selling prices and increased promotional activity, which impacted profitability, as evidenced by a 30% decrease in Earnings Before Interest and Taxes (EBIT) to $474 million from $676 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50088,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12740,
        "completion_tokens": 150,
        "total_tokens": 12891
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola's financial risk assessment regarding digital evolution has shifted from a focus on potential challenges in 2022 to a more confident outlook in 2024. In 2022, the company highlighted the risk that failure to address digital transformation could negatively impact sales growth and cost efficiency. By 2024, the emphasis had shifted to leveraging digitalization as a strategic enabler, with the company stating that digital initiatives are critical to increasing sales and improving margins. This indicates a transition from viewing digital evolution as a risk to recognizing it as a key driver of growth and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 58253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14790,
        "completion_tokens": 160,
        "total_tokens": 14950
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has intensified from fiscal year 2022 to 2024, with increased research and development investment and a stronger positioning of cloud offerings relative to on-premise solutions. In fiscal 2022, Oracle invested $7.2 billion in R&D, and by fiscal 2024, this investment continued to support innovation in cloud technologies, including Oracle Cloud Infrastructure (OCI) and SaaS offerings. Oracle has positioned its cloud services as a preferred, flexible, and cost-effective alternative to on-premise solutions, emphasizing rapid deployment, interoperability, and the ability to migrate existing on-premise workloads to the Oracle Cloud. The proportion of cloud services and license support revenues relative to other revenue streams has consistently increased, reaching 71% in fiscal 2022 and continuing to grow through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12425,
        "completion_tokens": 219,
        "total_tokens": 12644
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan is no longer active for future awards or deferrals as of both 2023 and 2024. In 2023, the plan had 509 shares issuable upon distribution of deferred compensation benefits, with no remaining shares available for future issuance. By 2024, the number of shares issuable under the plan had decreased to 391, and no future awards or deferrals were permitted, indicating that the plan had been fully wound down and was no longer operational.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15079,
        "completion_tokens": 123,
        "total_tokens": 15203
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure on food safety concerns, particularly emphasizing supply chain risks and cost volatility. In 2022, the company highlighted its commitment to food safety as a top priority, noting the potential impact of food-borne illnesses and the need for robust systems to ensure safe food products. By 2023, the disclosure became more detailed, explicitly linking food safety to supply chain vulnerabilities, such as contamination risks and the challenges of managing product safety across a complex global network. Additionally, in 2023, McDonald's acknowledged the compounding effects of commodity cost volatility on food safety initiatives, noting that rising costs for ingredients like beef, chicken, and pork could strain resources dedicated to maintaining safety standards. This evolution reflects a more nuanced recognition of how supply chain and cost pressures intersect with food safety management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65952,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16711,
        "completion_tokens": 238,
        "total_tokens": 16949
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes decreased slightly from $700 million as of December 31, 2023, to $621 million as of December 31, 2024. The effective interest rate for these notes also decreased from 1.97% in 2023 to 1.96% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56491,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14334,
        "completion_tokens": 63,
        "total_tokens": 14397
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023. This suggests that RTX did not refinance or retire this specific long-term debt obligation during the period, indicating a strategy of maintaining existing long-term debt maturities rather than actively managing or reducing them in this instance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44758,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11415,
        "completion_tokens": 87,
        "total_tokens": 11502
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained largely consistent in terms of collecting rent and royalties, as these payments are based on a percentage of franchisees' sales. In 2022, the Company reported $8,381.1 million in rent and $4,645.1 million in royalties from franchised restaurants, while in 2023, these figures increased to $8,892.9 million in total revenues from franchised restaurants, though the exact breakdown of rent and royalties for 2023 is not provided in the given data. The continued reliance on sales-based payments reflects the ongoing impact of franchisees' operational performance on McDonald's income from these arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50338,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12806,
        "completion_tokens": 173,
        "total_tokens": 12980
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. decreased from 2022 to 2024, as evidenced by the reduction in the carrying value of the investment from $90 million in 2022 to $78 million in 2024, despite the fair value of Andina's shares increasing from $168 million to $90 million. This indicates a strategic decision by Coca-Cola to reduce its ownership in Andina, likely to optimize its portfolio and focus on other high-growth opportunities, as seen in the 2019 divestiture of a portion of its stake in Andina.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13637,
        "completion_tokens": 133,
        "total_tokens": 13771
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has emphasized internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle highlighted its expansion of the Oracle Cloud through increased data center capacity and new geographic locations to meet customer demand. By 2024, the company emphasized that Oracle Cloud Operations deliver Oracle Cloud Services via a secure, scalable, and enterprise-grade infrastructure, with automated tools enabling rapid delivery of the latest cloud capabilities on a quarterly cadence. Additionally, internal development efforts remained a priority, with significant resources dedicated to research and development to maintain and improve cloud offerings, reinforcing OCI's role as a key differentiator in Oracle's evolving product strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49164,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12529,
        "completion_tokens": 217,
        "total_tokens": 12747
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO acquired The Binding Site Group in January 2023 as part of its strategy to expand its Specialty Diagnostics segment, enhancing its portfolio with innovative diagnostic solutions for blood cancers and immune system disorders. By 2024, the company had successfully integrated The Binding Site Group, as evidenced by its focus on leveraging synergies and complementary capabilities across its segments. This progression indicates TMO's commitment to integrating acquired businesses to strengthen its market position and drive growth in high-potential areas like specialty diagnostics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13107,
        "completion_tokens": 146,
        "total_tokens": 13254
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure and accessibility of the Directors' Code of Conduct for BNY Mellon evolved in terms of website links and scope of application. In 2022, the Directors' Code of Conduct was posted at **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf** and explicitly stated that it applied to all directors of BNY Mellon. By 2024, the link was updated to **https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf**, and the scope remained consistent, continuing to apply to all directors of BNY. The updated link reflects a change in the website domain structure, but the scope of application and commitment to transparency remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35858,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9190,
        "completion_tokens": 191,
        "total_tokens": 9382
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis by increasing the number of franchised restaurants and reducing the number of company-operated locations. In 2023, franchised restaurants totaled 39,680 (up from 37,295 in 2021), while company-operated restaurants decreased to 2,142 (down from 2,736 in 2021). This shift reflects a continued strategic emphasis on franchise growth. Financially, the reporting of franchise-related revenues remained consistent, with royalties and rental income recognized based on a percentage of sales, while the Company maintained its focus on technology and brand licensing revenue streams. Additionally, the Company continued to account for franchisee-related transactions under existing accounting policies, with no material impact from recent accounting updates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67712,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17145,
        "completion_tokens": 219,
        "total_tokens": 17364
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023. This increase reflects changes in the fair value of the liability, which is measured using a Monte Carlo simulation model based on Level 3 inputs. The fair value adjustments are primarily driven by updated financial projections for net revenue, gross profit, and EBITDA, along with assumptions about discount and volatility rates. Additionally, the purchase price allocation for Clif Bar was adjusted in 2023, as noted in the 2024 10-K, which included purchase price allocation adjustments related to Ricolino and Clif Bar.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46856,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11959,
        "completion_tokens": 173,
        "total_tokens": 12133
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "Between 2022 and 2024, AMD's strategic emphasis on Vulkan API support has evolved to align with its broader focus on delivering high-performance, cross-platform graphics solutions. In 2022, AMD's discrete GPUs already supported modern APIs like DirectX 12 Ultimate and Vulkan, enabling developers to optimize performance and visual quality for gaming and compute workloads. By 2024, AMD continued to reinforce this support, particularly with its RDNA 3 architecture-based Radeon RX 7000 Series GPUs, which maintain compatibility with Vulkan and other APIs to ensure broad software ecosystem integration. This ongoing commitment to Vulkan reflects AMD's strategy to remain competitive in the discrete GPU market by providing robust, developer-friendly tools and ensuring cross-platform flexibility for gaming and professional applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47267,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12046,
        "completion_tokens": 209,
        "total_tokens": 12255
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges, particularly the Powder Metal Matter charge of $2.9 billion in 2023, significantly impacted its operating profit trends, contributing to a $1.9 billion decrease in operating profit compared to 2022. This charge, along with a decrease in the FAS/CAS operating adjustment, offset gains in operating profit from Collins and Raytheon, leading to a drop in the operating profit margin from 8.2% in 2022 to 5.2% in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54755,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13917,
        "completion_tokens": 112,
        "total_tokens": 14029
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar evolved from an acquisition in August 2022 to full integration into its operations by 2023. The acquisition of Clif Bar added $529 million in incremental net revenues through the one-year anniversary of the acquisition in 2023. By 2024, there were no further acquisition-related financial activities mentioned, indicating that Clif Bar had been fully integrated into MDLZ's operations, contributing to its ongoing revenue and operational performance without additional specific financial events tied to the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48226,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12275,
        "completion_tokens": 138,
        "total_tokens": 12414
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of the G700, which features all-new engines designed for superior high-speed performance and fuel efficiency. This shift is reflected in the G700's certification and entry into service in March 2024, as well as the continued development and delivery of the G500 and G600 aircraft, which replaced older models with improved fuel efficiency and reduced emissions. These developments underscore Gulfstream's commitment to sustainability and innovation in engine technology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31923,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8197,
        "completion_tokens": 143,
        "total_tokens": 8341
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have transitioned from being a niche revenue contributor to a more strategically emphasized segment, particularly in gaming and custom design solutions. In 2022, revenue from semi-custom SoCs was primarily tied to non-recurring engineering fees and sales to third parties, with revenue dependent on customer product success. By 2024, AMD positioned semi-custom SoCs as a key growth area, integrating them into broader product offerings and leveraging them for partnerships and custom design projects. This shift reflects AMD's strategic focus on diversifying revenue streams and capitalizing on opportunities in markets like gaming and embedded systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10945,
        "completion_tokens": 175,
        "total_tokens": 11120
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with no preferred shares issued or outstanding in either year. This indicates that the company has not utilized preferred shares as part of its capital strategy during this period, instead focusing on other forms of capital management, such as ordinary share repurchases and stock-based compensation programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46083,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11745,
        "completion_tokens": 104,
        "total_tokens": 11850
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has expanded to include broader concerns. In 2022, reputational risk was mentioned as a general risk factor, noting that adverse events, publicity, or government scrutiny could harm the business. By 2024, the language evolved to explicitly link reputational harm with sustainability concerns, including climate change and diversity, indicating a heightened awareness of how these factors could affect client activity levels and regulatory requirements. This shift reflects a more nuanced understanding of reputational risk as interconnected with broader societal and environmental issues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40815,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10432,
        "completion_tokens": 174,
        "total_tokens": 10606
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 by maintaining the investment as a convertible note classified as available-for-sale, reported at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss). In 2023, Amazon invested $1.25 billion in a convertible note from Anthropic, which was classified as a Level 3 asset. By 2024, the valuation of this investment remained subject to market price volatility and private company valuation complexities, with no significant changes in classification or impairment noted. The investment was primarily influenced by Anthropic's performance, market conditions, and the potential for conversion to equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9588,
        "completion_tokens": 186,
        "total_tokens": 9775
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The nature of the risks related to the protection of MDLZ's intellectual property, including know-how, between 2023 and 2024 remained largely consistent, with a notable emphasis in 2024 on the evolving challenges posed by developments in artificial intelligence technologies. Both years highlight the importance of trademarks, patents, copyrights, and trade secrets, as well as the use of legal protections and licensing agreements. However, in 2024, the risk discussion explicitly mentions the potential impact of AI advancements on the ability to protect intellectual property, indicating a heightened awareness of emerging technological threats to IP security.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55868,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14186,
        "completion_tokens": 165,
        "total_tokens": 14352
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024, as reflected in the referenced SEC filings. In the 2023 filing, the most recent referenced agreements were pre-2015 forms, such as the \"Form of Non-Employee Director RSU Award Agreement (pre-2015)\" and similar variations. By 2024, the filings included newer, unspecified forms such as \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled),\" indicating updated award structures. This suggests that Goldman Sachs revised its equity award agreements for non-employee directors in 2024, moving away from the pre-2015 templates to newer, likely more current agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10556,
        "completion_tokens": 185,
        "total_tokens": 10741
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities as the company continued to increase the proportion of transactions processed on a merchant basis. This shift allows BKNG to facilitate payments from travelers directly, enhancing its ability to offer flexible payment terms and improving its control over the transaction process. However, this also led to higher merchant-related expenses, including personnel, payment processing, and chargebacks, which negatively impacted operating margins. Additionally, BKNG's contractual responsibilities expanded as it assumed more obligations related to payment processing and fraud prevention, reflecting a more integrated role in the transaction lifecycle.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44080,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11242,
        "completion_tokens": 198,
        "total_tokens": 11441
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs revised the structure of its executive life insurance policy disclosures between the 2023 and 2024 10-K filings by removing specific policy details from the exhibits. In the 2023 filing, the life insurance policies for Participating Managing Directors (PMDs) with Metropolitan Life Insurance Company and Pacific Life & Annuity Company were explicitly listed as Exhibits 10.12 and 10.13, including policy specifications and restrictions. However, in the 2024 filing, these specific exhibits were omitted, and no direct references to the life insurance policies for PMDs appeared in the provided pages, indicating a shift toward less detailed public disclosure of these arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10544,
        "completion_tokens": 173,
        "total_tokens": 10718
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown due to their critical role in wireless communications, with Broadcom emphasizing their proprietary and innovative nature. In 2022, FBAR filters were highlighted as a key product leveraging internal fabrication to protect IP and accelerate time-to-market. By 2024, the company maintained this approach, continuing to manufacture FBAR filters internally using proprietary processes in the U.S. and Singapore, while outsourcing commodity processes. This strategy has strengthened Broadcom's competitive positioning by differentiating its offerings and supporting its leadership in high-performance semiconductor solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11667,
        "completion_tokens": 173,
        "total_tokens": 11840
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly. In 2023, Krazati was primarily focused on second-line (2L) colorectal cancer and advanced non-small cell lung cancer (NSCLC) with KRAS mutations. By 2024, following the acquisition of Mirati in January 2024, Krazati's development expanded to include first-line (1L) NSCLC in combination with a PD-1 inhibitor, as well as continued exploration in 2L colorectal cancer. Financially, the acquisition of Mirati, which included Krazati, added $4.8 billion in total consideration, with $640 million allocated to the definite-lived acquired marketed product rights for Krazati. This acquisition reflects BMY's commitment to enhancing its oncology portfolio and expanding Krazati's therapeutic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91473,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23090,
        "completion_tokens": 196,
        "total_tokens": 23286
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG continued to strengthen its partnerships with travel service providers by offering them broader distribution channels, enhanced inventory utilization, and access to new markets through its trusted brands and technological capabilities. In terms of financial obligations and incentives, BKNG primarily compensates travel service providers through commissions or margins on transactions, with revenue recognized when travelers begin using the booked services. The company also expanded its payments solutions, which likely improved transaction efficiency and transparency for partners. Additionally, BKNG introduced and scaled new offerings, such as flights and in-destination activities, which created additional value for partners and diversified revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49978,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12729,
        "completion_tokens": 197,
        "total_tokens": 12926
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers remained consistent as part of their broader wireless connectivity solutions. In both years, Broadcom positioned custom touch controllers as integral components for mobile handsets and tablets, emphasizing their role in processing signals from touch screens. However, in 2024, Broadcom expanded its product context by integrating these touch controllers within a broader ecosystem of mobile device connectivity solutions, including RF semiconductors, Wi-Fi, Bluetooth, and GPS/GNSS technologies. This reflects a more strategic and integrated approach to the product lifecycle, aligning touch controllers with other key components in mobile device design and enhancing their role in delivering comprehensive connectivity and user experience solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10627,
        "completion_tokens": 209,
        "total_tokens": 10837
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "From 2023 to 2024, Union Pacific's approach to freight cars evolved by emphasizing modernization and strategic asset replacement. In 2024, the company continued to invest in acquiring freight cars to support both replacement needs and growth opportunities, aligning with its broader capital plan to enhance operational efficiency and network capacity. Additionally, the company allocated resources to modernize its locomotive fleet and invest in infrastructure projects, such as siding extensions and terminal improvements, to accommodate growing intermodal and freight demands. This reflects a shift toward not only maintaining existing assets but also proactively upgrading and expanding capacity to support long-term growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45343,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11551,
        "completion_tokens": 181,
        "total_tokens": 11733
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain businesses to third-party distributors, had mixed financial and operational impacts. Revenues for APLA increased from $5,955 million in FY2022 to $6,729 million in FY2024, indicating growth despite the transition. However, EBIT for APLA remained relatively stable, rising slightly from $1,896 million in FY2022 to $1,885 million in FY2024, suggesting that the structural changes did not significantly impact profitability. Operationally, the transition likely reduced Nike's direct operational footprint in APLA, shifting some responsibilities to third-party distributors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51647,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13145,
        "completion_tokens": 168,
        "total_tokens": 13313
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement with InP lasers has remained a strategic focus within their internal fabrication strategy. In both years, Broadcom highlighted the use of InP lasers for fiber optic communications as part of their proprietary processes, which are manufactured internally to protect IP and accelerate time-to-market. In 2022, InP lasers were mentioned alongside GaAs-based lasers for fiber optic applications, while in 2024, the description remained consistent, emphasizing continued reliance on internal fabrication for these advanced laser technologies. This consistency suggests a stable internal strategy, with Broadcom maintaining a competitive edge in high-speed optical communications through its proprietary III-V semiconductor fabrication capabilities in the U.S. and Singapore.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 45750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11662,
        "completion_tokens": 202,
        "total_tokens": 11865
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership stake in NIKE, holding approximately 77% of Class A Common Stock as of June 30, 2022, and continuing to hold the same percentage as of June 28, 2024. This ownership structure grants Swoosh, LLC substantial influence over NIKE's governance, as holders of Class A Common Stock elect three-quarters of the Board of Directors. The stability in ownership implies continued concentrated control by the Knight family, specifically Travis Knight, who plays a key role in managing Swoosh, LLC's holdings. This concentration of voting power could limit shareholder influence and potentially deter hostile takeovers or external strategic shifts without Swoosh, LLC's approval.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50939,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12967,
        "completion_tokens": 184,
        "total_tokens": 13152
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved through portfolio integration and expanded market availability. In 2022, PMI acquired Swedish Match, a leader in oral nicotine delivery, enhancing its RRP portfolio with complementary products like ZYN nicotine pouches. By 2023, PMI integrated Swedish Match's operations into its regional structure and updated its segment reporting to include these results. Additionally, smoke-free products were available in 84 markets by December 31, 2023, reflecting expanded global availability and a stronger focus on transitioning adult smokers to better alternatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42440,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10833,
        "completion_tokens": 161,
        "total_tokens": 10994
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business from 2022 to 2024 has shifted toward emphasizing high-margin applications such as data center power generation and gas compression, which contributed to favorable price realization and a 3% increase in Energy & Transportation sales. This strategic focus, particularly in large reciprocating engines and turbine-related services, enhanced the segment's gross margin potential, as evidenced by a rise in profit as a percentage of sales from 17.6% in 2023 to 19.9% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43971,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11222,
        "completion_tokens": 134,
        "total_tokens": 11356
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct by posting updates on its website. In both years, the company stated its intention to disclose amendments or waivers of the Directors' Code of Conduct on its website. However, in 2023, there was a slight enhancement in transparency, as the specific website link for the Directors' Code of Conduct was updated to a new URL, indicating a more current or reorganized online disclosure structure. No additional mechanisms beyond website disclosure were explicitly outlined in either year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36359,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9331,
        "completion_tokens": 150,
        "total_tokens": 9482
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a shift in operational structure, particularly with the planned transition of its businesses in certain APLA countries to third-party distributors. In FY22, Nike announced agreements to sell its legal entities in Argentina, Uruguay, and Chile, which were classified as held-for-sale. This transition from a direct-to-consumer and wholesale model to a distributor model aimed to reduce selling and administrative expenses and mitigate foreign exchange risks. By FY23, this strategic realignment was reflected in the operational structure, with the APLA segment continuing to focus on optimizing its market participation through a more streamlined and cost-effective approach, aligning with Nike's broader Consumer Direct Acceleration strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44508,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11350,
        "completion_tokens": 206,
        "total_tokens": 11556
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability has shifted. In 2022, favorable price realization contributed to a 22% increase in sales and a 51% rise in operating profit, driven by higher demand and strategic pricing. By 2024, while sales decreased slightly by 3%, favorable price realization in Energy & Transportation partially offset lower sales volume and improved operating profit margin to 20.2% from 19.3% in 2023. Thus, favorable price realization remained a key profitability driver, though its impact on sales growth diminished as demand softened in some segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 73883,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18684,
        "completion_tokens": 157,
        "total_tokens": 18841
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity evolved by emphasizing strategic scaling and supply chain development. In 2023, GM focused on building EV manufacturing capabilities and reducing battery costs, while also addressing supply chain constraints and sourcing sufficient materials for battery production. By 2024, the company shifted to developing a more resilient, scalable, and sustainable North American-focused EV supply chain, including strategic investments in raw material suppliers and multi-year supply agreements. Additionally, GM refocused its autonomous vehicle strategy on personal vehicles, aiming to integrate ADAS technology into future EV models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62070,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15741,
        "completion_tokens": 175,
        "total_tokens": 15917
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations, decreased significantly from 2022 to 2024. In 2022, the remaining performance obligations for Paxlovid totaled approximately $18.9 billion, which dropped to $1.28 billion in 2023 and further to $1 billion by 2024. This decline is primarily due to the transition of Paxlovid from government contracts to commercial markets and the recognition of revenue as products were delivered.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 78984,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19967,
        "completion_tokens": 118,
        "total_tokens": 20086
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar has enhanced its approach to monitoring supplier financial viability by strengthening risk mitigation strategies and contractual agreements. The company continues to emphasize supplier financial viability as a key risk factor, but in 2023, there is a more explicit focus on leveraging global strategic sourcing models to build long-term supplier relationships and ensure timely delivery of materials. Additionally, Caterpillar employs a variety of agreements with suppliers to protect its intellectual property and processes, with increased attention to monitoring risks such as supplier financial stability, production flexibility, and business continuity. These contractual measures aim to mitigate potential business disruptions caused by supplier-related issues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 43552,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11116,
        "completion_tokens": 200,
        "total_tokens": 11316
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become more integrated within its value-added services, with a stronger strategic focus on leveraging AI and machine learning to enhance fraud prevention and authentication capabilities. In 2024, Visa introduced new products such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization, which are designed to reduce fraud across various payment types, including A2A and card-not-present transactions. These advancements reflect a more proactive and comprehensive approach to risk management, positioning Visa as a leader in secure digital payment solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35105,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9004,
        "completion_tokens": 176,
        "total_tokens": 9180
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "Between 2022 and 2023, Colgate-Palmolive's exposure to shelf space limitations as a risk factor remained significant but showed signs of mitigation through expansion into alternative retail channels. In 2022, the company highlighted risks from retail customer policies, including limitations on shelf space and inventory destocking, which could reduce sales or profitability. By 2023, while these risks persisted, the company emphasized its efforts to adapt to the evolving retail landscape by expanding into eCommerce and direct-to-consumer (DTC) channels, which helped offset some pressures from traditional retail constraints. This shift reflects a strategic response to both retail customer policies and changing consumer preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9148,
        "completion_tokens": 184,
        "total_tokens": 9332
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Between fiscal years 2023 and 2024, Oracle has increasingly emphasized hybrid deployments as part of its broader cloud strategy, particularly through offerings like Oracle Exadata Cloud@Customer and Dedicated Region solutions. In 2023, the company highlighted the flexibility of hybrid models to meet customer needs, while in 2024, it expanded on this by introducing programs to help customers migrate existing workloads to Oracle Cloud while retaining hybrid options. This reflects a strategic shift toward promoting Oracle Cloud Services while ensuring continued support for hybrid and on-premise environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46849,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11935,
        "completion_tokens": 153,
        "total_tokens": 12088
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid significantly decreased between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenues, whereas in 2023, this dropped to $1,279 million, and further declined to $5,716 million in 2024. Additionally, the remaining performance obligations for Paxlovid as of December 31, 2024, were approximately $1 billion, compared to much higher contracted revenue expectations in 2022. This reflects a substantial reduction in both immediate and future revenue commitments related to Paxlovid.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82039,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20735,
        "completion_tokens": 134,
        "total_tokens": 20869
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained structured under standard sales and service agreements, emphasizing the dealers' role in promoting and servicing Caterpillar products within defined geographic territories. There is no explicit mention of significant changes to contractual obligations during this period. However, the strategic emphasis appears to have shifted toward enhancing dealer performance and support, as reflected in the company's focus on dealer development, promotion of product sales, and maintaining a strong global dealer network to serve 191 countries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42997,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10973,
        "completion_tokens": 155,
        "total_tokens": 11128
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, Colgate-Palmolive's financial allocation and operational focus related to Africa/Eurasia showed modest changes in capital expenditures and restructuring charges. Capital expenditures for Africa/Eurasia increased from $13 million in 2022 to $33 million in 2023, indicating a higher investment in the region. Regarding restructuring charges, Africa/Eurasia accounted for 9% of the total charges in 2022 and 5% in 2023 under the 2022 Global Productivity Initiative, suggesting a reduced emphasis on restructuring in the region in 2023 compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 26416,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6831,
        "completion_tokens": 144,
        "total_tokens": 6976
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "Qualcomm's strategic focus on 5G technologies from 2022 to 2024 has evolved with increased investment in AI integration and expanding commercialization into new industries like automotive and IoT. In 2022, the emphasis was on developing foundational 5G technologies and enhancing product portfolios for mobile and emerging sectors. By 2024, Qualcomm had advanced its 5G commercialization through modem-to-antenna platforms, such as the Snapdragon 5G modem-RF products, and deepened its commitment to AI-driven performance improvements. Additionally, the company continued to invest in R&D and strategic acquisitions to support 5G adoption in automotive and IoT applications, reflecting a broader and more diversified approach to 5G innovation and market expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64268,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16290,
        "completion_tokens": 191,
        "total_tokens": 16481
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid's revenue contribution to Pfizer significantly declined, dropping from $18,933 million in 2022 to $5,716 million in 2024. This decline was driven by the transition from government contracts to commercial market sales, including a non-cash revenue reversal of $3.5 billion in 2023 related to returned EUA-labeled doses. Contractual commitments also evolved, with amended agreements allowing for flexibility in delivery schedules and future pandemic preparedness, such as the 2023 agreement with the U.S. government and the creation of a Strategic National Stockpile (SNS) for 1.0 million treatment courses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 90538,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22863,
        "completion_tokens": 159,
        "total_tokens": 23022
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023. In 2022, the risk was mentioned in the context of potential supplier challenges due to tighter credit or capital markets. By 2023, the risk was more explicitly highlighted, with specific reference to the impact of tighter credit or capital markets on suppliers and the broader list of disruptions, including geopolitical conflicts and climatic events. This evolution indicates a heightened vulnerability to external financial conditions, reflecting a more complex and volatile operating environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10807,
        "completion_tokens": 151,
        "total_tokens": 10958
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid significantly evolved from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenues, driven by government contracts for emergency use. By 2023, revenues dropped to $1,279 million due to a non-cash revenue reversal of $3.5 billion in Q4 2023, reflecting expected returns of EUA-labeled Paxlovid inventory by the U.S. government. In 2024, Paxlovid revenues rebounded to $5,716 million, supported by a $771 million favorable adjustment from returned inventory and a $442 million revenue recognition for supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) for pandemic preparedness. These figures reflect a transition from government contracts to commercial market sales and adjustments in contractual obligations under revised agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78028,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19731,
        "completion_tokens": 215,
        "total_tokens": 19946
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "The financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation decreased slightly from 2023 to 2024. As of December 31, 2023, the Company had an accrual of $62 million for Aearo-related liabilities, while by December 31, 2024, this amount had reduced to $51 million. This reduction suggests a potential decrease in estimated future claims or a shift in liability allocation among co-defendants. However, the Company continues to emphasize that the actual liability could be significantly higher due to uncertainties in projecting future claims and the complexity of allocating responsibility among multiple parties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61515,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15598,
        "completion_tokens": 165,
        "total_tokens": 15763
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. This decline contrasts with the shipment volume trend between 2020 and 2021, where Skoal's shipment volume decreased only slightly (from 208.5 million to 197.4 million), indicating a more stable retail share during that period compared to the sharper decline observed in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54151,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13761,
        "completion_tokens": 97,
        "total_tokens": 13858
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger focus on AI integration and expanding into new industries. In 2022, the company emphasized multimedia technologies such as camera, video, display, and computer vision as part of its broader R&D efforts. By 2024, Qualcomm had deepened its engineering focus in AI, including generative AI, with an emphasis on power efficiency and personalization across diverse applications. Additionally, multimedia technologies were increasingly integrated into product offerings beyond mobile handsets, such as automotive systems (connectivity, digital cockpit, ADAS/AD) and IoT, reflecting Qualcomm's strategy to diversify into new markets and leverage AI advancements to enhance performance and value for customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62321,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15807,
        "completion_tokens": 199,
        "total_tokens": 16006
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In 2023, 3M reconsolidated the Aearo Entities after the dismissal of their bankruptcy proceedings, which resulted in an immaterial income statement impact. At the end of 2022, 3M had a $0.7 billion equity investment in the Aearo Entities and a $0.6 billion net liability for intercompany balances. By the end of 2023, these balances were no longer reflected in the consolidated balance sheet due to reconsolidation. In 2024, 3M continued its financial commitment through the CAE Settlement, contributing a total of $6.0 billion between 2023 and 2029 to resolve litigation related to Combat Arms Earplugs, with payments made in cash rather than stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62474,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15843,
        "completion_tokens": 187,
        "total_tokens": 16030
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved significantly, enhancing their strategic positioning within the broader value-added services portfolio. In 2022, these solutions focused on leveraging data for fraud prevention and account authentication, offering tools like Visa Advanced Authorization, Visa Secure, and CardinalCommerce. By 2024, the suite expanded with the introduction of the Visa Protect suite, which includes AI-powered solutions such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization. These advancements reflect a stronger integration of artificial intelligence and machine learning, positioning Risk and Identity Solutions as a central pillar in Visa's efforts to secure both card-present and card-not-present transactions, as well as non-card flows like A2A payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42121,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 223,
        "total_tokens": 10983
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments' impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. These adjustments primarily consist of amortization of acquired intangible assets and property, plant, and equipment fair value adjustments, with minor variations across the segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56362,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14310,
        "completion_tokens": 94,
        "total_tokens": 14404
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud increased from $44.97 billion in 2022 to $54.88 billion in 2023, representing a significant growth of $9.91 billion or 22%. This growth trajectory indicates that Office 365 Commercial is becoming an increasingly dominant component of Microsoft's cloud ecosystem, reflecting strong adoption of its productivity and collaboration tools in commercial markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37729,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9672,
        "completion_tokens": 117,
        "total_tokens": 9789
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. Factors contributing to this growth include the expansion of Lynparza's use in various cancer treatments and the approval of new indications, such as its approval in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57526,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14598,
        "completion_tokens": 115,
        "total_tokens": 14713
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan is no longer active for future grants, as it is not listed among the plans allowing for future issuances in either the 2023 or 2024 filings. The 2019 Stock and Incentive Compensation Plan is the only active plan as of 2024, with 77 million shares available for future issuance. There is no indication of regulatory changes affecting the 2014 Plan's treatment between 2023 and 2024, and it remains included in equity compensation reporting as a historical plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70484,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17862,
        "completion_tokens": 131,
        "total_tokens": 17993
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan is no longer an active source of future equity compensation grants, as it is not listed as allowing for future issuances in the 2024 filing, unlike in the 2023 filing. The 2024 filing explicitly states that only the 2019 Stock and Incentive Compensation Plan permits future grants, indicating that the 1992 Plan has been superseded and no longer plays a role in the company's current equity compensation structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70898,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17952,
        "completion_tokens": 108,
        "total_tokens": 18061
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company has observed that clients have increasingly prioritized large-scale transformations, which convert to revenue over a longer period. This shift reflects a strategic emphasis on extended, complex projects rather than shorter-term engagements, as macroeconomic and geopolitical uncertainties have slowed spending on smaller, shorter-duration contracts and consulting services during fiscal 2024. The evolving focus underscores a trend toward more sustained client commitments and longer revenue conversion timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 42295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10801,
        "completion_tokens": 137,
        "total_tokens": 10938
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued $7,869,000 worth of Class A Ordinary Shares for employee share programs, compared to $8,883,000 in fiscal 2023, indicating a decrease in issuance. This issuance contributed to an increase in additional paid-in capital and impacted retained earnings, while also slightly increasing the total number of Class A Ordinary Shares outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35056,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8991,
        "completion_tokens": 92,
        "total_tokens": 9083
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased slightly between 2022 and 2023, with the notional amount of Canadian dollar notes dropping from $443 million in 2022 to $453 million in 2023. This minimal change contrasts with the broader trend of reducing exposure to other foreign currency-denominated debt, such as Swiss franc and euro notes, during the same period. Overall, the company appears to be managing its foreign currency risk by adjusting the composition of its net investment hedges, though Canadian dollar exposure remained relatively stable compared to other currencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52433,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13350,
        "completion_tokens": 151,
        "total_tokens": 13501
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 by enhancing strategic involvement and expanding investment activity through its innovation ecosystem. In 2023, the focus was on leveraging emerging technologies and incubating innovations via Accenture Ventures and Labs. By 2024, the company formalized its commitment to innovation by receiving SBTi approval for net-zero targets and increasing R&D spending to $1.2 billion, while also deepening partnerships with growth-stage companies through targeted investments and co-creation of scalable solutions. This reflects a more integrated and forward-looking strategy to drive long-term value and sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 23086,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5997,
        "completion_tokens": 174,
        "total_tokens": 6171
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca has shown growth in alliance revenue, with a 9% increase in 2024 compared to 2023 and a 7% increase in 2023 compared to 2022. Alliance revenue for Lynparza was $1,311 million in 2024, $1,199 million in 2023, and $1,116 million in 2022. In terms of asset amortization, the intangible asset balance related to Lynparza, which includes capitalized sales-based and regulatory milestone payments, was $1.1 billion at December 31, 2021, and is being amortized over its estimated useful life through 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53415,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13588,
        "completion_tokens": 152,
        "total_tokens": 13740
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has shifted from being one of three equal domains in the Distributed Software portfolio in 2023 to being highlighted as a central component in 2024. In 2023, ValueOps was listed alongside DevOps and AIOps as a domain, while in 2024, it is positioned as a key solution under the Distributed Software portfolio with a specific focus on value stream management and aligning business and development teams. This shift indicates that ValueOps is playing a more prominent role in AVGO's strategy to optimize the planning, development, and delivery of business-critical services, emphasizing its importance in driving business outcomes and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59885,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15196,
        "completion_tokens": 173,
        "total_tokens": 15369
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved to focus on improving the efficiency of package pickup, transportation, and delivery in the U.S. and Canada. In 2023, Network 2.0 was introduced as part of the DRIVE transformation to enhance long-term profitability. By 2024, the company had announced Tricolor, a redesign of the Federal Express international air network as part of the DRIVE program, aiming to improve efficiency and asset utilization. However, the implementation of Network 2.0 and related initiatives faced risks, including potential higher-than-expected costs, less-than-expected savings, and operational disruptions. The DRIVE transformation also introduced challenges such as labor-related issues, integration complexities, and the need to manage unforeseen expenses or delays.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63615,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16133,
        "completion_tokens": 213,
        "total_tokens": 16347
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "Between 2022 and 2023, the financial impact from equity method investment contracts shifted from a liability of $3 million in 2022 to a gain of $7 million in 2023. This indicates that MDLZ's engagement with these investments transitioned from a neutral or slightly negative impact to a modestly positive one, likely reflecting improved performance or favorable valuation changes in the underlying equity method investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51270,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13047,
        "completion_tokens": 105,
        "total_tokens": 13152
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from fiscal year 2023 to fiscal year 2024, dropping from $38 million to $38 million (no change in the estimated cost to complete). However, the percentage of completion increased from 67% to 100%, as the project was released during fiscal year 2024. This indicates that the development progress for this release was completed on schedule, aligning with the expected release date and demonstrating that the project met its development milestones as planned.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9379,
        "completion_tokens": 137,
        "total_tokens": 9516
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved by emphasizing seamless integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile or QR code and drop off packages in secure bins, streamlining the shipping process. Additionally, FedEx Office facilitates returns through FedEx Returns Technology, enabling in-store printing of return labels and offering consolidated returns with no box or label required. This evolution reflects FedEx's broader commitment to enhancing customer convenience and supporting the growing e-commerce market by providing efficient, technology-enabled logistics and returns solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13152,
        "completion_tokens": 182,
        "total_tokens": 13334
      }
    }
  ]
}